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2 Abstract 
 
The formation of a vascular network requires the connection and formation of a lumen 
between individual endothelial sprouts, a process called vessel fusion or anastomosis. In the 
vertebrate trunk of the zebrafish (Danio rerio), the intersegmental vessels (ISVs) develop by 
angiogenesis, i.e. the formation of new vessels by pre-existing vessels, in a conserved 
metameric manner, which allows the analysis of morphogenetic mechanisms of blood vessel 
development. From the dorsal aorta (DA) individual endothelial sprouts, led by tip cells and 
trailing stalk cells, grow between the somite boundaries dorsally towards the roof of the 
neural tube where they extend anterior and posterior. Neighboring extensions of sprouts fuse 
to each other and eventually form a continuous lumen, which results in the formation of a 
new vessel, the dorsal longitudinal anastomotic vessel (DLAV). In the past, many molecular 
key players of blood vessel formation have been identified and a number of studies 
described endothelial lumen formation in vivo. However, how individual cellular behaviors 
contribute to the process of vessel fusion have not yet been described. Thus, I engineered a 
transgenic zebrafish reporter system labeling endothelial cell-cell junctions by an EGFP-
hZO1 (human Zonula Occludens-1 protein fused to enhanced green fluorescent protein) 
fusion protein. This reporter system allowed analysis of the dynamics of endothelial tight 
junctions during intersegmental vessel fusion in vivo and thus, the relative behavior of 
individual endothelial cells (ECs). We previously proposed that neighboring ISVs make 
contact to each other by filopodial extensions. This behavior is reflected by the de novo 
formation of point-like junctional complexes (i.e. Vascular endothelial cadherin (VE-cadherin) 
and ZO1) which elaborate into ring-like structures as the contacting sprout extensions 
enlarge their mutual surface, suggesting the formation of new apical membrane 
compartments. Following individual cell-cell junctions in the fusing ISVs and analyzing a 
novel apical marker, podocalyxin2 (Pdxl2), we confirmed the formation of apical membrane 
compartments during the initial phase of vessel fusion and deciphered two distinct cellular 
mechanisms of blood vessel fusion, a cord hollowing and membrane invagination 
mechanism, that result in the formation of different types of biological tubes. In cord 
hollowing, cell rearrangements of ECs in fusing neighboring sprouts result in the formation of 
a multicellular tube. Here, a tip cell forms two apical membrane compartments, one with a 
stalk cell and another one with a neighboring tip cell. These are then brought together by cell 
rearrangements and coalesce into one larger membrane compartment that eventually 
integrates into a continuous lumen within the ISV/DLAV. During membrane invagination, the 
membrane of a tip cell, adjacent to a preexisting lumen, undergoes apicobasal polarization 
and invaginates through its own cell body and coalesces with one of the previously formed 
apical membrane compartments at the sites of contact between neighboring tip cells, which 
results in the formation of a seamless tube. 
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3 Introduction 
 
The development of multicellular organisms reaching a critical size, requires a system for the 
efficient transportation of liquids, gases, hormones, nutrients and immunogenic compounds 
(Chung et al., 2011). In vertebrates, this task is performed by the vascular system, a 
hierarchically branched tubular network of blood- and lymphatic vessels, which are formed by 
endothelial cells (ECs) that are organized into an epithelial structure, the endothelium. 
Aberrant regulation of its embryonic development results in malformations or even lethality of 
the growing embryo. Furthermore, it has essential roles during homeostasis in the adult 
organism, during wound healing and when miss-regulated, it contributes to many 
pathological processes, for instance during tumorigenesis. Thus, the vascular system is 
indispensable for proper development of a vertebrate embryo and not surprisingly, it is the 
first organ to be built and expands its capacity significantly during embryonic and postnatal 
growth (Chung et al., 2011; Alitalo et al., 2005).  
3.1 Biological tubes and their formation 
Polarized epithelia separate distinct body parts from each other and can form a huge variety 
of structures including biological tubes, which can be organized into hierarchically ramified 
tubular networks such as the lung, respiratory system of insects, the transport system of 
plants or the vascular system. Such tubular organs are often shaped and formed by 
branching morphogenesis which involves the remodeling of polarized epithelia into tubes 
(tubulogenesis) and their reiterative branching (Affolter et al., 2009, 2003; Datta et al., 2011). 
3.1.1 Epithelial and endothelial organization 
In epithelia, the plasma membrane of cells is polarized into specific domains which are 
differentially organized regarding their lipid and protein composition and exert distinct 
functions. The apical domain faces the lumen, whereas the basolateral surface contacts 
neighboring cells and the extracellular matrix (ECM). Further, cell-cell junctions connect 
individual cells to each other, form a barrier and maintain polarization by preventing diffusion 
between apical and basolateral proteins and lipids (Martin-Belmonte et al., 2008). In 
mammalian epithelia, for instance tubes, tight junctions (TJs) are located at the apical site 
whereas adherens junctions (AJs) are found basal to the TJs. (Figure 1) (Andrew et al., 
2010). 
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Figure 1 The organization of epithelial and endothelial cells. (A) Epithelial cells forming a tube:  Cells have a 
cuboidal shape, a basal membrane, a lateral membrane and an apical domain facing the luminal space. Tight 
junctions are sub-apical whereas adherens junctions seal individual cells together at the lateral side. (B) 
Endothelial cells forming a tube. Cells have a flat and more elongated shape. The apical domain faces the lumen 
whereas the basal membrane connects to the extracellular matrix. The lateral membrane is extremely small since 
endothelial cells are extremely thin, thus tight and adherens junctions are thought to be intermingled. Figure 
adapted from Xu and Ondine Cleaver, 2011. 
However, in the endothelium the TJs are intermingled with AJs all along the contact area of 
two cells since ECs display a very thin and elongated shape with the lateral side reduced to a 
minimum, which is in contrast to other epithelial cells that have a more cuboidal shape with 
larger lateral sides (Figure 1). In the endothelium (Figure 2), TJs are circumferential rings 
containing Claudins, Occludins, members of Junctional Adhesion Molecules (JAMs) and 
members of Endothelial Cell Selective Adhesion Molecules (ESAMs), at the apex of epithelial 
cells that seal adjacent cells to one another. In addition, there are many intracellular TJ 
proteins such as Zonula Occludens-1 and 2 proteins, which belong to the membrane-
associated guanylate kinases (MAGUK) family. ZO1 acts as a scaffold protein, providing an 
interface for many protein interactions through its distinct domains, for instance its three PDZ 
domains. AJs are cell-cell adhesion complexes, containing Cadherins, for instance Vascular 
Endothelial Cadherin (see below) and Catenins, attached to cytoplasmic actin filaments 
(Dejana, 2004). Vascular endothelial cadherin (VE-cadherin) is a type-II endothelial-restricted 
classical cadherin localized to the adherens junction complex. VE-cadherin has essential 
roles regarding endothelial integrity and barrier function by regulating the permeability of 
blood vessel walls for molecules. Further, VE-cadherin plays a key role during blood vessel 
formation. Mice, deficient for VE-cadherin, are lethal as a result of defects during remodeling 
processes of the endothelium (Vestweber, 2008; Harris et al., 2010). In the zebrafish, 
knockdown of VE-cadherin causes strong defects during the fusion of vessels; vessels do 
not form connections or a lumen and eventually collapse (Montero-Balaguer et al., 2009). 
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The basic structure of VE-cadherin consist of 5 extracellular domains (EC1-EC5, with Ca2+ 
binding sites between the repeats), which mediate homophilic Ca2+-dependent interactions, a 
transmembrane domain and a cytoplasmic domain specified into the “juxtamembrane 
domain”, binding to p120-catenin and the “catenin-binding domain” which binds β-catenin 
and plakoglobin. It is thought that the catenins couple VE-cadherin to the actin cytoskeleton. 
However, p120-catenin as well as β-catenin can translocate to the nucleus where they 
regulate the expression of genes (Harris et al., 2010). 
 
Figure 2 The organization of endothelial cell-cell junctions. Many different transmembrane adhesion proteins 
and intracellular binding proteins are found at endothelial cell-cell junctions. At tight junctions, adhesion is 
mediated by members of the claudin family, occluding, junctional adhesion molecules (JAMs) and the endothelial 
cell selective adhesion molecule (ESAM). At the TJs, many intracellular proteins, including zonula occuldens-1 
and 2 protein (ZO1, ZO2), contain PDZ domains, which interact with other proteins. ZO1 can interact with the 
claudins, occluding or JAMs and indirectly with the cytoskeleton by binding α-catenin via one of its PDZ domains 
and directly by an F-actin binding domain. PECAM (platelet endothelial cell adhesion molecule) contributes to 
adhesion between ECs. However, at the adherens junctions, the main adhesion molecule is Vascular Endothelial 
Cadherin (VE-cadherin). Vascular Endothelial Protein Tyrosine phosphatase (VE-PTP), which can modulate 
cadherin and catenin phosphorylation and vascular permeability, associates with VE-cadherin via its extracellular 
domain. The intracellular domain of VE-cadherin is thought to interact with p120-catenin, α,β-catenin and 
plakoglobin. These intracellular proteins interact direct or indirectly with the actin cytoskeleton of the cells. In 
addition, N-cadherin is expressed in ECs and promotes the binding to supporting cells such as pericytes which 
are essential for blood vessel maturation, whereas Nectin contributes to both, the AJs and TJs. Figure adapted 
from Dejana, 2004. 
3.1.2 Different types of biological tubes 
In every biological tube the apical side faces the luminal space whereas the basal side faces 
the outside of the tube. Based on their cellular architecture biological tubes can be divided 
into three different types of tubes which vary in their size and shape (Figure 3). In 
multicellular tubes many polarized cells contribute to tube formation and accordingly, in cross 
sections, more than one cell is found to constitute the tube circumference. Here, a mesh-like 
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distribution of junctions constitutes the connections between individual cells making the tube. 
In unicellular tubes the luminal surface is lined out by a single cell that closes the tube by 
auto-cellular junctions along its own axis. It is also possible that a lumen passes through a 
single cell. This type of tube is called a seamless tube since it does not display junctions 
along its tubular axis (Baer et al., 2009; Lubarsky and Krasnow, 2003). 
 
Figure 3 Different biological tubes: (A) Multicellular tube consisting of many epithelial or endothelial cells. Cells 
are connected to each other by cell-junctions. (B) Unicellular tube with auto-cellular junctions along the cell axis 
sealing the tube. (C) Unicellular, seamless tube where the lumen passes through the cell. Ring-like junctions are 
found at the end of each cell connecting it to the next unicellular, seamless cell. (black lines indicate cell(-cell) 
junctions). Figure adapted from Lubarsky and Krasnow, 2003. 
3.1.3 Different morphogenetic mechanisms of tube formation 
During tubulogenesis, cells of an epithelium/endothelium follow three common principles. 
First, cells need to know about their position and orientation compared to other cells in the 
environment. Thus, cells need to communicate with neighboring cells and the ECM to gain 
positional information. Second, when orientation has been specified, cells need to establish 
polarization. This means they will define apical, lateral and basal identity with the apical side 
at the future luminal site, whereas the basolateral site contacts the ECM and neighboring 
cells. Third, cells need to form (local) lumens at the apical side. Their expansion or 
coalescence eventually results in the formation of a tube (Datta et al., 2011). Despite these 
general principles, different morphogenetic mechanisms have been described of how a 
biological tube can be formed. Depending on the state of tissue polarity at the beginning of 
tubulogenesis, there are mechanisms where a pre-polarized epithelial structure is remodeled 
into a tube – wrapping and budding - or where polarization is generated simultaneously with 
and part of the tube formation process – cavitation, cord hollowing and cell hollowing (Figure 
4) (Baer et al., 2009; Andrew and Ewald, 2010; Lubarsky and Krasnow, 2003). 
3.1.3.1 Tubulogenesis by pre-polarized tissues 
The invagination and “rolling up” of selected cells from an epithelial sheet until the edges of 
the invaginating cell area connect to each other and thereby close the forming tube, is called 
wrapping (Baer et al., 2009; Lubarsky and Krasnow, 2003) (Figure 4). For example in the 
chicken embryo, the invagination of the neural plate into a neural groove, which is then 
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closed at the edges, results in the formation of the neural tube, a hollow nerve cord 
containing the rudiments of the adult nervous system (Colas and Schoenwolf, 2001). The 
shrinking of one side of a cell, is thought to cause the bending or invagination of an epithelial 
sheet (Rhumbler, 1902). Indeed, apical constriction has been shown to be an essential 
driving force during gastrulation and tubulogenesis, (reviewed in Sawyer et al., 2010) and is 
thought to be primarily driven by the contraction of an actomyosin network (Martin et al., 
2009; Hildebrand, 2005; Karfunkel, 1972).  
 
Figure 4 Different morphogenetic mechanisms of tubulogenesis: (A) Wrapping: A polarized sheet of 
connected cells undergoes coordinated bending along an axis until the edges of the bending region meet and 
seal, forming a tube running in parallel to the original sheet. (B) Budding: a budlike structure grows out from a 
tube (or a sheet) and extends as a direct extension of the original tube. (C) Cavitation: cell in the center of a solid 
multicellular cord are eliminated to convert it into a tube. (D) Cord hollowing: in a cylindrical multicellular cord a 
lumen is generated de novo between neighboring cells. (E) Cell hollowing: A single cell gets hollowed out and a 
lumen gets formed along the length of the cell. Figure adapted from Lubarsky and Krasnow, 2003. 
 
In budding, selected cells grow out from a pre-existing polarized tissue, and extend into the 
surrounding tissue to form a branch which is then transformed into a tube. Here, the new 
tube is thought to be a direct extension of the original tube (Baer et al., 2009; Lubarsky and 
Krasnow, 2003) (Figure 4). Budding events have been described in several organisms and 
tissues such as the kidney (Costantini and Shakya, 2006), the lung (Metzger et al., 2008), 
mammary gland (Cowin and Wysolmerski, 2010) and during tracheal development of 
Drosophila melanogaster (Samakovlis et al., 1996).  
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3.1.3.2 Tubulogenesis from non-polarized tissues 
In cavitation, inner cells of a cord, the cells that do not contact the ECM but only neighboring 
cells, are removed and thereby hollow out the original cord (Baer et al., 2009; Lubarsky 
Krasnow, 2003) (Figure 4). This mechanism has been shown to take place for instance 
during mammary gland (Cowin and Wysolmerski, 2010; Mailleux et al., 2007) and 
mammalian salivary gland (Tucker, 2007) formation. Apoptosis, the caspase-dependent 
programmed death of cells, (Guimarães and Linden, 2004; Elmore, 2007) is a critical process 
during cavitation since mice, deficient for a pro-apoptotic factor of the BCL2 family (Huang 
and Strasser, 2000), show a delay in lumen formation of the developing mammary gland. 
However, since cells of the mammary gland undergo a caspase-independent cell death in 
this mutant, other mechanisms than apoptosis that lead to the removal of cells might be at 
work. For example Autophagy (Greek for auto:self-phagy:eating), which is an alternative 
death style that has been described in 1963 for the first time at the CIBA Foundation 
Symposium on Lysosomes  in London by Christian de Duve (Mailleux et al., 2007; Klionsky, 
2007), in which the cytoplasmic components are degraded in membrane vesicles after their 
fusion with lysosomal compartments (Kundu and Thompson, 2008).  
During cord hollowing, a solid cord is hollowed out by the generation of extracellular spaces 
between the apical membranes of neighboring cells that face the future luminal side (Baer et 
al., 2009; Lubarsky and Krasnow, 2003) (Figure 4). In the intestine of the developing 
zebrafish embryo, multiple small local lumens at different positions extend and coalesce and 
thereby form a continuous lumen (Bagnat et al., 2007) whereas in the dorsal aorta of the 
embryonic mouse, a central lumen is formed between contacting ECs (Strilic et al., 2009 and 
see also 5.1.2, p.53 and 6.1.3, p.80).  
Cell hollowing generates a seamless tube, which is different from the two other mechanisms 
described above, during which multicellular tubes are generated. Here, a lumen forms within 
a single cell, resulting in unicellular tube (Figure 4) (Baer et al., 2009; Lubarsky and Krasnow, 
2003). This mechanism has been described in the excretory cell of C. elegans (Buechner, 
2002) and special tracheal fusion cells in Drosophila melanogaster (Lee and Kolodziej, 2002; 
Kakihara et al., 2007) and the intersegmental vessels (ISVs) of the zebrafish (Kamei et al., 
2006). In the endothelium vacuolar or vesicular intracellular fusion events have been 
described in vitro as well as in vivo and were suggested to be involved into this process 
(Iruela-Arispe and Davis, 2009; Lubarsky and Krasnow, 2003).  
Two rather new mechanisms of how a biological tube can be formed have been observed in 
heart tube development of Drosophila melanogaster and the digestive tract of C. elegans. 
The connecting part between the pharynx and the intestine in C. elegans is formed by single 
cells that wrap around the future luminal side and then undergo a self-fusion mechanism 
resulting in seamless cells arranged in a rod like fashion (Rasmussen 2008).  
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In the fly heart, cardioblast cells have evolved a mechanism, which is based on the 
establishment of specialized adhesion sites and active repulsion of the future apical 
membranes between contacting cells. In this scenario, dorsal and ventral specific “foci” 
establish contact to neighboring cells, whereas the region between these contact sites 
undergo an active repulsion mechanism to generate a lumen (Santiago-Martínez et al., 
2008). 
3.1.4 Molecular regulation of lumen formation 
3.1.4.1 Finding cell orientation and position 
As mentioned earlier, cells need to communicate with their environment during tubulogenesis 
(i.e. other cells and the ECM). Knowing their orientation and position then allows proper 
orientation of polarity, with apical at the future luminal site (Datta et al., 2011). Cells interact 
with neighboring cells via different adhesion receptors that include cadherins and nectins 
(Harris and Tepass, 2010). Such interactions give cells instructive cues where to start the 
polarization (see also 6.1.1, p.77). However, in a tissue, cells are also surrounded by the 
ECM, which provides them with further positional/instructive information.  Integrin-ECM 
interactions are thought to have crucial roles during blood vessel morphogenesis including 
the control of lumen formation (Rupp and Little, 2001; Avraamides et al., 2008) and β1-
integrin containing complexes have been shown to be essential key players in sensing the 
ECM (Datta et al., 2011). Furthermore, integrin signaling activates Rho GTPases, which 
controls the endothelial cytoskeleton and tube “morphogenetic responses” (Iruela-Arispe and 
Davis, 2009). For instance, the Rho GTPase Cdc42 (cell division control protein 42 
homologue) and Rac1 have recently been shown to be involved in EC lumen formation 
(Bayless and Davis, 2002) and are thought to be activated by integrin signaling (Davis and 
Bayless, 2003). Here, Cdc42 and Rac1 are essential for the process of intracellular vacuole 
formation and coalescence, which is thought to regulate endothelial lumen formation in three-
dimensional extracellular matrices (see also 3.2.4.2.7, p.25). In Madin-Darby Canine Kidney 
(MDCK) cells (cells that do form cyst when cultured in three-dimensional collagen gels), 
orientation of apical-basal polarity is regulated by a β1-integrin dependent pathway that 
requires Rac1, a Rho GTPase. Blocking this pathway with an antibody against β1-integrin 
results in the inversion of polarity, which can be rescued by activated Rac1 expression (Yu et 
al., 2005). Further, blocking β1-integrin in the chicken results in the total absence of lumens 
in the aorta (Drake et al., 1992) which demonstrates the importance of cell-(integrin)-ECM 
communication regarding endothelial polarization and lumen formation. 
After cells have determined the directionality of lumenogenesis, they need to generate an 
apical side at the future luminal site, thus they need to polarize. 
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3.1.4.2 Polarization of cells 
Endothelial cell polarization is essential for the process of lumen formation, but how EC 
polarization contributes to lumen formation is only at the beginning to be well understood. It 
is also thought that polarization of epithelial cells is different in several aspects than 
polarization of the endothelium (Iruela-Arispe and Davis, 2009). In general, polarization of 
epithelial cells is controlled and maintained by three conserved “core protein complexes”, the 
PAR (CDC42-PAR3-PAR6-aPKC), Crumbs (Crb-PALS-PATI) and Scribble (Scrib-Dlg-Lgl) 
complexes. In epithelial cells, the PAR and Crumbs complexes regulate formation of the 
apical side whereas the Scribble complex promotes basolateral identity. At least one of the 
three polarity complexes, the PAR complex, is involved in endothelial cell polarization and 
lumen formation (see below). However, at this moment, there is little information whether or 
how the Crumbs and Scribble complexes are involved in EC polarization and lumen 
formation (Iruela-Arispe and Davis, 2009). In general, during PAR complex activation, which 
is essential regarding apical polarization, PAR3 gets recruited to sites of contact between 
neighboring cells. A pre-formed PAR6-aPKC unit is then bound by active Cdc42 which 
results in the activation of the PAR3-PAR6-aPKC complex at the future apical surface and 
marks the separation between the basolateral and apical domains and site of TJ formation 
(Willenborg and Prekeris, 2011). CDC42 has been shown to interact with the PAR complex 
by directly binding to PAR6 (Garrard et al., 2003). In C. elegans, the deletion of a specific 
GAP controlling CDC42, results in polarity defects as well as ectopic localization of polarity 
complexes (Anderson et al., 2008). In endothelial cells, it was shown that a PAR complex 
lacking aPKC, localizes and interacts with VE-cadherin at the adherens junctions, which is 
different to vertebrate epithelial cells, where the PAR complex is thought to be localized at 
the tight junctions (Iden et al., 2006). However, a more recent study showed that lumen 
formation of ECs in three-dimensional collagen matrices is controlled by a Cdc42-Par3-Par6-
PKCζ complex (PKCζ = isoform of aPKC). Disruption of any member within this complex lead 
to impaired lumen formation, which demonstrates the importance of apical polarization 
regarding lumenogenesis (Koh et al., 2008). Further, in the aorta of the mouse, β1-integrin 
acts upstream of Par3, as part of a signaling cascade, during EC polarization and lumen 
formation (Zovein et al., 2010). 
The differential distribution of phosphatidylinositol-phosphates (PIPs) to distinct membrane 
domains is important regarding polarization since PIPs function as “apical and basolateral 
determinants”, recruiting proteins important for epithelial morphogenesis (Willenborg and 
Prekeris, 2011). However, there is less evidence for apical and basolateral protein sorting in 
ECs (Iruela-Arispe and Davis, 2009). PAR3 is thought to localize lipid phosphatase PTEN 
(phosphatase and tensin homologue deleted on chromosome 10) to tight junctions where it 
converts PIP3 into PIP2 (von Stein et al., 2005; Feng et al., 2008). In mammalian epithelial 
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cells, PIP2 is found at the apical surface, whereas PIP3 is localized at the basolateral site. 
Further, PIP2 is thought to recruit Cdc42 to the apical surface and PTEN depletion in MDCK 
cells results in reduced PIP2 levels and the generation of an apical lumen is inhibited. The 
action of PTEN at the tight junctions probably prevents PIP3 from entering apical areas by its 
phosphatase activity (Gassama-Diagne et al., 2006; Martin-Belmonte et al., 2007; Martin-
Belmonte and Mostov, 2007). In the endothelium, chemical inhibition of PTEN results in 
reduced formation of the dorsal aorta in the mouse whereas genetic disruption of PTEN 
results in rather normal formation of the dorsal aortae (Suzuki et al., 2007; Strilic et al., 
2009).  
Rab11, a small monomeric GTPase, is thought to be a key regulator of the polarized 
endocytotic transportation and sorting in epithelial cells (Prekeris, 2003). For instance, the 
AREs (apical recycling endosomes, distinct apical domain-specific organelles from the AEE = 
apical early endosomes (Willenborg and Prekeris, 2011)) transport cargo to the apical 
domain and are marked by the monomeric GTPase Rab11a/b (Brown et al., 2000). In 
addition to the specificity that is given by the Rab proteins, the so-called exocyst complex 
(Wu et al., 2008), plays a crucial role in the tethering and fusion of vesicles with the PM and 
thus, is essential for epithelial cell polarization. Localization and function of this complex are 
regulated by different binding proteins including members from the Rab family (Willenborg 
and Prekeris, 2011). Another set of proteins, which is essential for the fusion of vesicles with 
their target membrane, are the SNARE proteins (soluble N-ethylmaleimide-sensitive fusion 
protein-attachment protein receptors (Jahn and Scheller, 2006)). They are thought to act 
specifically at apical and basolateral sites. For instance, the snare protein syntaxin 3 is found 
at apical sites whereas syntaxin 4 is found at basolateral sites (Low et al., 1996). How a 
polarization complex is linked to the membrane traffic machinery has recently been reported 
by Bryant and colleagues who describe a Rab11 regulated molecular mechanism for the de 
novo formation of an apical surface and a lumen in mammalian MDCK cells. In this 
mechanism, Rab11 recruits Par3 and activated CDC42 to the apical membrane, which 
demonstrates the link between members of polarization complexes and the trafficking 
machinery during polarization and lumen formation (Bryant et al., 2010). 
3.1.4.3 Lumen expansion 
Expansion of small lumens is thought to happen to a certain extend by hydrostatic pressure, 
which is regulated by the activation of pumps and ionic channels (Datta et al., 2011). It has 
been shown that smaller lumens may expand and coalesce to form a single continuous 
lumen. Proteins of the Claudin family and the Na-K-ATPase play key roles during the 
expansion and coalescence of smaller lumens; for instance, multiple lumens are formed in 
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zebrafish gut lumenogenesis when Claudin 15 and Na-K-ATPase are down-regulated by the 
loss of the transcription factor Tcf2 (Bagnat et al., 2007; Gutzman and Sive, 2010). 
3.2 The vascular system and its formation 
The vertebrate vasculature is formed by two fundamental distinct processes - vasculogenesis 
and angiogenesis (Figure 5): The first extra- and intra-embryonic blood vessels are formed 
by vasculogenesis, the de novo formation of blood vessels. This is the differentiation of 
angioblasts, endothelial precursor cells (EPCs) derived from the mesoderm, their migration 
and subsequent aggregation into vessels (Risau and Flamme, 1995). These vessels will later 
undergo strong remodeling and eventually new vessels will be formed by these pre-existing 
vessels, a process called angiogenesis. Angiogenesis can occur in distinct ways: (i) non-
sprouting angiogenesis or intussusception and (ii) sprouting angiogenesis (Risau, 1997). 
During sprouting angiogenesis, individual sprouts or vessels need to connect to each other, a 
process called vessel fusion or anastomosis (Herbert and Stainier, 2011; Blum et al., 2008; 
Hogan and Kolodziej, 2002).  
 
Figure 5 Overview of vascular development. Vasculogenesis (formation of blood vessels de novo): 
Mesodermal derived angioblast migrate to distinct sites within the embryo, acquire arterial or venous fates and 
coalesce to form the first blood vessels, the dorsal aorta and the cardinal vein. In the zebrafish, the sorting of 
arterial and venous angioblasts and ventral venous angioblast sprouting, results in the formation of the distinct 
dorsal aorta and cardinal vein. Angioblasts also form so called blood islands, which will fuse and form capillary 
plexi. Angiogenesis (formation of blood vessels from pre-existing vessels): Angiogenic remodeling creates a 
highly branched vascular network of arteries, arterioles, capillary beds, venules and veins. During vessel 
maturation mural cells support and stabilize the nascent vessels. Additionally, sprouting of lymphatic cells from 
venous vessels generates the lymphatic system. Further, hematopoietic stem cells originating from arterial 
hemogenic endothelium give rise to myeloid and lymphoid blood cell lineages. Figure adapted from Herbert and 
Stainier, 2011. 
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3.2.1 Vascular anatomy of vertebrates 
In vertebrates, the early embryonic vasculature in the trunk is conserved regarding its body 
plan, which is later further branched and remodeled according species-specific 
developmental programs. However, at the early stage, vertebrates possess two axial main 
vessels, the dorsal aorta (DA) and posterior cardinal vein (PCV), which run along the 
anterior-posterior body axis. From these main vessels, smaller intersegmental vessels (ISVs) 
run dorso-ventrally between the somites, notochord and neural tube whereas the so called 
parachordal chain runs longitudinal on each side of the notochord and contributes to the 
lymphatic system (Figure 6) (Isogai et al., 2001; Isogai et al., 2003; Yaniv et al., 2006; Lim et 
al., 2011). 
 
Figure 6 A conserved vascular body plan in the early developing vertebrate embryo. (A) Vascular system in 
the zebrafish embryo at 6 dpf. (B) Vascular system in a mouse embryo at 9.5 dpc. In both organisms, the 
intersegmental vessels (ISVs), dorsal aorta (DA) and posterior cardinal vein (PCV) are conserved and established 
early in development. (A) adapted from Isogai et al., 2001 and (B) courtesy of V. Bautch, UNC (University of North 
Carolina). 
Later, in the adult, blood proceeds from the heart through tubes or vessels of different size, 
shape and characteristics (Figure 5). First, blood is pumped into arteries, later into arterioles 
and then into the peripheral parts of the body, which are nerved by very small vessels called 
capillaries, providing the connection of the circulatory loop between arteries and veins. From 
the capillaries, the blood is transported back to the heart via venules and veins. Intercellular 
protein-rich fluid, excreted from the blood vessels, is collected by “blind-ended”, 
unidirectional vessels of the lymphatic system draining it back through collecting vessels, 
lymph nodes, lymphatic trunks and ducts to the venous circulation (Alitalo et al., 2005; 
Adams and Alitalo, 2007).  
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3.2.2 Vascular development 
3.2.2.1 Vascular endothelial growth factors and its receptors 
Discovered in 1983, vascular permeability factor (VPA), later called vascular endothelial 
growth factor A (VEGF-A), was shown to be a strong angiogenic mitogen (Leung et al., 1989; 
Henzel and Press, 1989; Senger et al., 1983) and is key player during vascular development 
and growth (Chung, 2011; Ferrara, 2009). VEGF has mitogenic activities, it triggers vascular 
outgrowth and branching, it is involved in chemotaxis of monocytes, it regulates vascular 
permeability and it has been shown to act as a survival factor for ECs. VEGF is also involved 
in pathological angiogenesis (Ferrara et al., 2003), for instance during tumorigenesis where 
VEGF mRNA is shown to be up-regulated in human tumor cells (Factor et al., 1995). Mice 
deficient for only one single VEGF-A allele are embryonic lethal and show strong vascular 
abnormalities. These mutant mice display a delay in EC differentiation, have disorganized 
vessels, impaired blood-island formation and show a disturbed formation of hematopoietic 
cells (Carmeliet et al., 1996; Ferrara et al., 1996). VEGF is thought to be expressed under 
hypoxic conditions and recent findings suggest a VEGF-inducible role for sonic hedgehog 
(Shh) (Fraisl et al., 2009; Pola et al., 2001; Lawson et al., 2002). 
VEGF-A is a homodimeric glycoprotein and belongs to a bigger family of receptor-binding 
growth factors displaying a cysteine-knot like structure. This family, beside VEGF-A, includes 
VEGF-B, VEGF-C, VEGF-D as well as placental growth factor (PlGF) (Holmes and Zachary, 
2005; Neufeld et al., 1999; Lohela et al., 2009). In addition to these VEGFs, viral VEGF 
homologs (collectively called VEGF-E) and snake VEGFs (called VEGF-F) have been 
identified (Yla-Herttuala et al., 2007). VEGFs signal through different endothelial tyrosine 
kinase receptors (RTKs), the so called vascular endothelial growth receptors (VEGFRs) of 
which VEGFR-1/Flt1, VEGFR2/Flk1 and VEGFR3/Flt4 have attracted much attention in the 
last years (Figure 7).  
Among all the different VEGF forms, VEGF-A and its binding partners VEGFR1 and 
VEGFR2 are the best described signaling pathways during vascular development. Vegfr2 
null mice die during embryonic development displaying severe defects regarding 
hematopoietic and endothelial cells (Shalaby et al., 1995) similar to what has been described 
in vegf-/- mice (Carmeliet et al., 1996; Ferrara et al., 1996). VEGFR-2 signaling induces 
angiogenesis by triggering proliferation, sprouting and migration as well as the survival of 
ECs (Lohela et al., 2009; Masabumi and Claesson-Welsh, 2006). VEGFR3, as mentioned 
above, is thought to regulate blood vessel development, vein specification, as well as 
lymphangiogenic processes (Koch et al., 2011). During development VEGFR3 is expressed 
in the endothelium and later, in the adult stage, its expression gets restricted to the lymphatic 
system. In the postnatal mouse retina, it is predominately expressed at the front of growing 
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endothelial sprouts and its blocking results in impaired angiogenic sprouting and formation of 
a vascular network (Tammela et al., 2008) (Figure 7). 
 
Figure 7 Overview of different VEGFs and VEGFRs. Vascular endothelial growth factors (VEGFs) bind different 
homodimers and heterodimers of VEGF receptors (VEGFRs). Their signaling via VEGFR2, VEGFR3 or 
VEGFR2– VEGFR3 heterodimers is pro-angiogenic. PlGF (not shown in this figure) Maglione, D., Guerriero, V., 
Viglietto, G., Delli-Bovi, P. and Persico, M. G. (1991) and VEGF-B can signal through VEGFR-1, whereas VEGF-
B was shown to be regulating lipid metabolism in the heart (Olofsson et al., 1998; Tarallo et al., 2011; Lohela et 
al., 2009)(Olofsson et al. 1998, Park et al. 1994) and is commonly seen as an angiogenic modifier. VEGF-C and 
VEGF-D bind to VEGFR-3 and are important first of all during the formation of the lymphatic system (Achen et al., 
1998; Joukov et al., 1996; Lohela et al., 2009). VEGFR-2 signaling induces angiogenesis by triggering 
proliferation, sprouting and migration as well as the survival of ECs (Lohela et al., 2009; Masabumi Shibuya and 
Claesson-Welsh, 2006).The binding of VEGFA to VEGFR1 and its secreted version sVEGFR1, the extracellular 
domain of VEGFR1 are thought to function as a sink for VEGFA thereby decreasing VEGFR2 activity. The 
interaction of TIE2 receptor interaction with the matrix-bound form of angiopoietin 1 (ANG1) induces EC cell-
migration. In contrast ANG1 localized in the membrane of ECs binding to TIE2 at cell-cell junctions by trans-
complex formation with TIE2 on adjacent cells, promotes angiogenic quiescence. Such complexes involve 
vascular endothelial protein Tyr phosphatase (VE-PTP). ANG2 antagonizing the activity of ANG1 on TIE2 leads to 
vessels destabilization and supports angiogenic remodeling. Homophilic VE-cadherin interactions maintain the 
adherens junctional complex and are important for endothelial integrity and barrier function by the regulation of 
blood vessel permeability (3.1.1, p.4). DLL4-mediated Notch signaling upon the proteolytic release of the 
intracellular domain of Notch (NICD) represses angiogenic cell behavior. Jagged 1 interaction with Notch receptor 
can antagonize Notch signaling. Figure adapted from Herbert and Stainier, 2011. 
 
VEGF-A exists as different isoforms that have distinct binding affinities on heparin and 
heparan sulphates (HS), linear polysaccharides present on the surface of a cell or in the 
extracellular matrix (ECM), that can bind a large variety of proteins including growth factors 
to regulate biological processes (Herbert and Stainier, 2011). HS is found on syndecans and 
glypicans, two families of proteoglycans that are membrane-bound. The binding of a 
secreted molecule to heparin or HSPGs, glycoproteins that are bound to heparan sulphates 
(Bernfield et al., 1999), amplifies the capacity to be deposited in the ECM (Esko and Lindahl, 
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2001). VEGF isoforms that lack the presence of domains responsible for heparin or HSPG 
binding are thought to distribute differentially in the environment of cells secreting VEGFs 
(Houck et al., 1992). For instance the matrix binding isoform VEGF165 directs formation of 
filopodia, branching of vessels as well as the migratory behavior of ECs. Conversely, 
VEGF120, a freely diffusible isoform unable to bind heparan sulphate, results in impaired 
extension of filopodia at the tips of growing vessels, decreased branch points in capillary 
networks but a larger diameter of vessels. VEGF188, a solely binding isoform of heparin 
sulfate, displays the opposite phenotype, ectopic filopodial extensions, an excess of 
branching and thin vessels (Ruhrberg et al., 2002). Taken together, the different VEGF 
isoforms localized in the ECM provide spatially restricted information for the various EC 
behaviors that are required to establish vascular branching patterns (Ruhrberg et al., 2002; 
Stalmans et al., 2002; Carmeliet and Tessier-Lavigne, 2005). In addition, heparin-binding 
isoforms of VEGF-A also bind neuropilins (NP1/2), co-receptors which potentiate signaling 
via VEGFR2 or can signal independently of VEGFR2. It was found that VEGF165 stimulated 
migration of ECs in the presence of NP1 is enhanced in cells expressing a recombinant form 
of VEGFR2 (Prahst et al., 2008; Soker et al., 1998).   
3.2.3 Vasculogenesis 
3.2.3.1 ECs differentiation and formation of the first vessels 
As mentioned above, mesodermal cells differentiate into endothelial cells that later surface 
the inner wall of the vessels. During early somatogenesis, cells from the lateral plate 
mesoderm are specified by the expression of conserved families of transcription factors, 
such as members of the ETS or GATA family, into hematopoietic cells and endothelial 
precursor cells, so called angioblasts, which migrate to distinct places within the embryo 
where they will coalesce and form the first blood vessels (Simon, 1995; Risau and Flamme, 
1995; Weiss and Orkin, 1995; Brown et al., 2000). Fli1 (friend leukemia integration 1), an 
ETS family member, is thought to act at the top of the transcriptional network which regulates 
blood cell and endothelial cell development and a constitutively active form of this 
transcription factor is able to induce expression of key genes, that drive the differentiation of 
the hematopoietic and endothelial cell lineage. These genes include scl/tal1, lmo2, gata2, 
etsrp, and flk-1, the receptor for VEGF-A (Liu et al., 2008). However, the expression of Fli1 
becomes continuously restricted to the endothelium in the trunk as shown during zebrafish 
and Xenopus development (Meyer et al., 1995; Brown et al., 2000). In the yolk sac, but also 
the embryo itself, migrating angioblasts coalesce and contribute to the so called blood 
islands which will fuse and thereby form honey-comb like capillary plexi. Later theses 
capillary plexi are remodeled into a network of hierarchically organized arterioles, arteries, 
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capillaries, venules and veins by the process of angiogenesis (Figure 5) (Risau and Flamme, 
1995; Adams and Alitalo, 2007). The dorsal aorta and cardinal vein are thought to be formed 
directly by the aggregation of angioblasts at the midline of the embryo (Coultas et al., 2005; 
Coffin and Poole, 1988) and it has been shown that the notochord is an essential structure 
during DA formation and patterning (Fouquet et al., 1997; Sumoy et al., 1997; Cleaver and 
Krieg, 1998). VEGF is thought to be expressed at the midline (Cleaver and Krieg, 1998) as 
well as in the underlying notochord (Coultas et al., 2005) which attracts migrating angioblasts 
expressing VEGFR-2. Recently, chemokine signaling has been identified to be an essential 
pathway in patterning the first embryonic artery in the zebrafish (Siekmann et al., 2009). 
Here, missing Cxcl12b (chemokine C-X-C motif ligand 12b), a Cxcr4a ligand, in the 
underlying notochord phenocopies the deficiency effects of Cxcr4a which is an incomplete 
formation of the lateral dorsal aortae. In the zebrafish, live observations using endothelial 
specific transgenic reporter lines, particularly a fluorescence marker under the control of the 
ETS transcription factor fli1a (see above), have shown that angioblasts first appear at 12 hpf 
in the lateral plate mesoderm (LPM). Guided by stimuli from the endoderm they then migrate 
as individual cells in two waves to the midline of the embryo where they coalesce (Figure 8) 
(Lawson, 2002; Roman and Weinstein, 2000; Jin et al., 2005). Cells of the first wave at 
around 14 hpf are thought to form the dorsal aorta (DA), whereas cells of the second wave at 
around 16 hpf will generate the posterior cardinal vein (PCV). Initially, these cells form a 
structure called vascular cord, a simple cluster of angioblasts, which then at 17 hpf start to 
establish cell-cell junctions as shown with immunostainings using an antibody against the 
tight junctional protein Zonula Occludens-1 (ZO1) (Jin et al., 2005, see also Eriksson and 
Löfberg, 2000; Fouquet et al., 1997). At 17 hpf, angioblasts start to differentiate into arterial 
and venous ECs (Jin et al., 2005). EphrinB2, a member of the Eph ligand family, is 
detectable in future arterial cells (Zhong et al., 2001; Lawson et al., 2001) whereas Flt4 
becomes visible in venous cells (Thompson et al., 2008). At around 18 hpf the vascular cord 
is lumenized by cord hollowing to form the DA as suggested by live imaging and the analysis 
of polarity- and junctional proteins (Jin et al., 2005; Herbert et al., 2009). Alternatively, as 
shown by high-resolution live imaging of the embryonic zebrafish trunk, the PCV is formed by 
a ventral sprouting mechanism from a common precursor vessel with a mixed population of 
arterial and venous ECs (Figure 5 and Figure 8). Here, selected ECs sprout ventrally and 
separate from that common precursor vessel resulting in the formation of the DA and PCV. 
This observation is further supported by the fact that this ventral sprouting mechanism is 
disrupted when arterio-venous differentiation is blocked (Herbert et al., 2009). 
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Figure 8 Vasculogenesis in the zebrafish embryo. (A-D) Schematic cross-sections of the trunk region during 
different stages of development. (A) At around 14 hpf, angioblasts, originating from the lateral plate mesoderm 
migrate over the endoderm towards the midline where thy form a vascular cord below the hypochord. At around 
17 hpf, angioblasts start expressing markers of arterio-venous differentiation, such ephrin-B2a in more dorsally 
located arterial cells (marked in red). (B) These ephrin-B2a positive cells will give rise to the DA, whereas ephb4a 
positive cells are located more ventrally and will contribute to the PCV most-likely by a ventral directed sprouting 
process from the DA at around 21 hpf. (C) Cord hollowing lumenizes the DA which happens in the absence of 
blood cells and prior to the lumenization of the PCV and. Venous angioblasts aggregate and coalesce around the 
blood cells to ultimately form a tube.(D) At 30 hpf, both vessels are fully formed and carry blood flow. Endothelial 
cell junctions are indicated in green. Figure adapted from Ellertsdottir et al., 2009. 
3.2.3.2 Arterio-venous differentiation of endothelial cells 
For a long time it was believed that arterial venous differentiation is primarily driven by 
hemodynamic forces as recently shown for extraembryonic vessels in the chick embryo yolk 
sac (le Noble et al., 2004). However, differential expression of the arterial marker ephrin-B2 
and its receptor EphB4 which is expressed in veins in developing vessels already before the 
onset of circulation, changed this common idea of predominant extrinsic factors that regulate 
the differentiation process and intrinsic, i.e. genetic factors became more and more 
prominent (Wang et al., 1998; Rocha and Adams, 2009). Ephs are RTKs that bind to their 
ligands ephrins and are involved in embryonic development where they regulate patterning, 
neuronal targeting, vascular development and neovascularization (Cheng et al., 2002). After 
angioblasts have aggregated, they will undergo further differentiation to form either arterial or 
venous endothelium. Arterial differentiation has been shown to be driven by Notch 
dependent signaling. The expression of a non DNA-binding form of “Suppressor of hairless”, 
which acts as an inhibitor of Notch signaling, results in reduced ephrin-B2 expression but 
enhanced EphB4 expression in the zebrafish aorta, causing reduced size of the latter 
(Lawson et al., 2001). In addition the basic helix-loop-helix transcription factor genes Hey1 
and Hey2 (hairy- and enhancer of split-related with YRPW motif) are direct Notch target 
genes and mice deficient for Notch1 or Hey1/Hey2 fail to express the arterial specific marker 
ephrin-B2 and the paired dorsal aortae are strongly reduced or even missing (Fischer et al., 
2004). In addition, the gene Gridlock, a HEY family member, was shown to influence vessel 
specific cell fate decision since Gridlock mutants display disturbed formation of the aorta 
(Zhong, 2000). Furthermore, gradual reduction of the gene by morpholino knockdown leads 
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to a decrease in artery development but an expansion of the vein accompanied by increased 
expression of EphB4 and ephrinB2 reduction, respectively (Zhong et al., 2001). In contrast 
the orphan nuclear receptor COUP-TFII (chicken ovalbumin upstream promoter transcription 
factor 2), specifically expressed in venous ECs, was shown to repress Notch signaling 
thereby promoting vein identity (You et al., 2005). Altogether, Notch signaling seems to 
suppress venous differentiation during normal vascular development whereas COUP-TFII 
counteracts the Notch pathway to allow venous identity (Coultas et al., 2005).  
3.2.4 Angiogenesis 
Angiogenesis, the formation of new vessels from pre-existing vessels (Risau, 1991), occurs 
in different ways: (i) through non-sprouting angiogenesis which includes intussusception and 
(ii) through sprouting-angiogenesis (Risau, 1997). 
3.2.4.1 Non-sprouting angiogenesis 
During non-sprouting angiogenesis or intussusceptive angiogenesis (IA), first described by 
Caduff and colleagues in 1986, existing vessels are split by the local insertion of tissue pillars 
from surrounding tissues, i.e. transluminal tissue pillar formation. Such tissue pillars 
subsequently expand and fuse to each other resulting in new vessels or vessel branching 
(Makanya et al., 2009; Adams and Alitalo, 2007). Blood flow has been shown to directly 
influence IA whereas the molecular control remains still poorly described. There are three 
phases of IA which have been described: intussusceptive growth (IMG), intussusceptive 
arborization (IAR) and intussusceptive branching remodeling (IBR). IMG will increase the 
inner surface of vessels by expansion of tissue pillars. IAR demarcates future vessels by the 
insertion of vertical serial tissue pillars giving the vasculature a tree-like shape and IBR 
optimizes the geometry of vessel branching by intussusception pillars at bifurcations (points 
where a vessel splits into two) of vessels that will fuse with the connective tissue at the 
bifurcation site (Makanya et al., 2009; Djonov et al., 2002)  
3.2.4.2 Sprouting Angiogenesis 
3.2.4.2.1 Principles of sprouting angiogenesis 
In order to produce an angiogenic sprout that will become a stable vessel integrated into a 
vascular network, ECs exert a number of distinct cellular behaviors. VEGF-A acts upstream 
of a so called “angiogenic cascade”, a sequential series of events forming new blood 
vessels, which includes proteolysis of the ECM, migration, proliferation and finally the fusion 
of sprouts to form a (capillary) network (Augustin et al., 2009). 
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In fact, resting ECs have to overcome quiescence, they will have to loosen their cell-cell 
contacts, and form a bipolar sprout with a front and a connecting part linking the sprout to the 
parental vessel. The extracellular basement membrane needs to be degraded to allow 
migration of ECs towards angiogenic stimuli. Along their way, angiogenic sprouts need to 
elongate which is mainly achieved by cell proliferation and cell shape changes. The newly 
developed vessels will be stabilized by supporting cells and eventually fusion of individual 
sprouts occurs to allow blood circulation (Figure 5) (Herbert and Stainier, 2011; Ausprunk 
and Folkman, 1977; Carmeliet and Jain, 2011). 
3.2.4.2.2 Breaking angiogenic quiescence  
The vascular specific tyrosine kinase receptors, including Tyr kinase with Ig and EGF 
homology domains receptor 1 and 2 (Tie1/2) and their ligands angiopoietin1 and 2 (ANG1/2) 
have been shown to be essential during vessel assembly and maturation in the embryonic 
tissue. Further, this signaling system seems to be crucial during adult vascular homeostasis. 
The quiescent phenotype of ECs in parental vessels, maintained by ANG1/Tie2 signaling, 
can be antagonized by ANG2, leading to vessel destabilization and is thought to support the 
angiogenic remodeling (Augustin et al., 2009; Herbert and Stainier, 2011). Interestingly, the 
interaction of TIE2 receptor with ANG1 bound in the ECM induces migration of ECs 
(Saharinen et al., 2008). However, VEGF is the key pro-angiogenic stimuli and induces 
single ECs from a larger vessel to become more angiogenic than their neighboring cells. 
These cells will modify their cell-cell junctions, become more motile and start to express and 
secret proteases that will degrade the basement membrane (Adams and Alitalo, 2007). 
In order to effectively invade avascular territories to form vascular patterns according to local 
demands, ECs of angiogenic sprouts need to form a “bi-polar” sprout. This means ECs have 
to adopt “functional specialization” that allows navigation and elongation of the growing 
sprout towards angiogenic stimuli (Gerhardt 2005).  
3.2.4.2.3 Tip cell selection 
As mentioned above, upon VEGF-A signaling, some ECs will become more angiogenic than 
others and will leave the vessel wall first and thus, will be at the front of growing sprouts. 
Such leading cells called “tip cells” (TCs) (Gerhardt et al., 2003) scan the environment by 
filopodial extensions for attractive and repulsive signals. These extensions are induced by 
VEGF-A/VEGFR2 signaling too. Gerhardt and colleagues showed that perturbation of the 
normal VEGF-A gradient inhibits filopodial extension and the peripheral outgrowth of ECs in 
the mouse retina, suggesting that directed tip cell migration depends on the ability of the tip 
cell to distinguish signaling information at the tips of filopodia from other information provided 
at the cell body. Thus, the tip cells respond to VEGF-A by guided migration, whereas 
Introduction 
22 
 
neighboring less angiogenic ECs, so-called stalk cells (SCs), trail the leading tip cells 
(Gerhardt et al., 2003). Shown in vitro as well as in vivo, specific Notch receptors and delta-
like ligands are expressed in the endothelium (Phng and Gerhardt, 2009; Gridley, 2010). It 
turned out that hypoxia or VEGF-A can induce Dll4 expression and that haploinsufficient 
mice for dll4 are embryonic lethal due to severe arterial defects (Williams et al., 2006; 
Nicholas et al., 2004; Liu et al., 2003; Mailhos et al., 2001). Furthermore, VEGF induces 
dynamic expression of dll4 in the mouse retina, predominantly in the leading cells of growing 
vessels (Lobov et al., 2007). Recent studies have shown that VEGF-A mediated Notch 
signaling is a key signaling pathway to select tip cells in angiogenic sprouts (Figure 9) 
(Lawson et al., 2002).  
 
Figure 9 Selection of the tip cell. The tip cell behavior is induced by VEGF signaling, whereas the Dll4-mediated 
Notch signaling represses VEGF receptor signaling in adjacent cells and thus represses their angiogenic 
behavior. The tip cell is high in VEGFR signaling but low in Notch signaling. It forms multiple filopodial extensions, 
is highly motile and leads and guides a sprout through the avascular territory towards pro-angiogenic stimuli. The 
stalks cells in contrast are low in VEGFR signaling but high in Notch signaling. They maintain their junctions and 
connect to the parent vessel. Further they are trailing the tip cells and less motile and lumen morphogenesis 
starts in the region of the stalk. Figure adapted from Herbert and Stainier 2011. 
In the mouse retina, treatment with γ-secretase inhibitors block Notch cleavage and signaling 
or genetic disruption of the pathway leads to an increase in tip cell number (Hellström et al., 
2007). Local VEGF-A sources induce the expression of Dll4 in endothelial cells. Dll4 binds to 
Notch1 in adjacent ECs leading to the activation of specific target genes. In cells with high 
Notch signaling, VEGFR3 is down-regulated restricting angiogenic cell behavior to the tip cell 
(Siekmann and Lawson, 2007). Second, Notch signaling in the SCs leads to an up-regulated 
expression of the soluble- and membrane bound form of vascular endothelial growth factor 
receptor 1 ((s)flt1/(s)VEGFR1), and the soluble form is thought to function as a VEGF-A sink. 
This in counteracts pro-angiogenic VEGFR2/3 signaling in cells with high Notch signaling 
(Funahashi et al., 2010). Third, the Notch intracellular domain (NICD) activates dll4 itself 
leading to further pro-angiogenic suppression in neighboring stalk cells (i.e. lateral inhibition). 
A Notch Regulated Ankyrin Repeat-containing Protein (NRARP) up-regulates Wnt signaling, 
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which is important for cell proliferation and maintaining of cell-cell junctions. It also 
antagonizes NICD directly and thus has negative feedback control functions on Notch 
signaling (Phng et al., 2009).  
Taken together, VEGF-A induced Dll4-mediated Notch signaling is negatively controlling tip 
cell behavior in stalk cells. The tip cell, high in Dll4 expression, inhibits tip cell specific 
behavior in following, neighboring stalk cells via Notch signaling. However, this expression 
pattern is dynamic and can change during sprouting angiogenesis causing shuffling between 
tip and stalk cell fate and position (Jakobsson et al., 2010). 
3.2.4.2.4 Hypoxia and VEGF regulate the outgrowth of sprouts 
ECs are equipped with mechanisms sensing oxygen, as demonstrated by the constriction of 
the ductus arteriosus upon breathing after birth (Fraisl et al., 2009; Weir et al., 2002, 2005). 
Hypoxia, the lack of oxygen, can up-regulate VEGF expression (Forsythe et al., 1996), and 
mice deficient for the Hif-1α subunit (hypoxia-inducible-factor 1α, a molecular interface that 
allows the expression of many target genes including genes regulating angiogenesis 
(Semenza, 2003)) display a complete loss of the cephalic vasculature. The activity of HIF-1α 
is regulated by oxygen sensing enzymes including PHDs (prolyl hydroxylase domain 
proteins) and FIHs (factor inhibiting HIFs) (Kaelin and Ratcliffe, 2008). Under normal 
conditions, when enough oxygen is available, HIF-1α is degraded, whereas under hypoxic 
conditions, PHDs/FIHs become inactive and HIF-1α is stabilized and can activate target 
genes which will lead to the expression of pro-angiogenic genes such as VEGF-A (Fraisl et 
al., 2009; Forsythe et al., 1996) and the outgrowth of angiogenic sprouts into hypoxic 
regions. 
3.2.4.2.5 Guidance of angiogenic sprouts 
In a vertebrate organism nerves and blood vessels are often found alongside each other and 
share many similarities regarding morphology and behavior. For instance, the filopodia rich, 
invasive and very motile tip cells of vascular sprouts are similar to the growth cones of axons, 
a highly specialized structure at the tip of an axon, which guides it towards a target according 
to positive or repulsive stimuli (Eichmann et al., 2005; Carmeliet and Tessier-Lavigne, 2005; 
Gerhardt et al., 2003). Beside their similarity in structure and behavior, it is now clear that 
growing axons and growing vascular sprouts share many common molecules guiding them 
to their target tissues.  
One of these common molecules is Netrin which, for example, has either attractive or 
repulsive functions during axon guidance depending on which receptor it binds to in the 
axon. The family members of the Uncoordinated 5 Receptors (UNC5) have been shown to 
promote axon repulsion, whereas receptors of the Deleted on Colorectal Cancer (DCC) 
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family reveal attractive guidance on axons (Dickson and Keleman, Carmeliet et al., 2005, 
2002, Adams and Eichmann 2010). UNC5B was found to be expressed specifically in arterial 
sprouting capillaries and tip cells (Lu et al., 2004; Suchting et al., 2007). Mice deficient for 
Unc5b or zebrafish morphants lacking both UNC5B and Netrin1a show an excessive 
branched vasculature, as well as uncontrolled filopodial extensions in tip cells (Lu et al., 
2004). Supporting evidence comes from the chick model where Netrin-1 repels UNC5B 
expressing blood vessels (Bouvrée et al., 2008). This suggests that UNC5B is an 
evolutionary conserved repulsive receptor that is also used during blood vessel 
morphogenesis. However, it might be that Netrin has also pro-angiogenic effects, since 
UNC5B provokes apoptosis in the absence of its ligand Netrin (Castets et al., 2009).  
Other common signaling molecules are found within the semaphoring/plexin ligand-receptor 
family. Semaphorins are either membrane bound and bind directly to plexin receptors 
thereby influencing cell motility, whereas the secreted semaphorin class III members need 
neuropilins as co-receptors for plexin signaling. In the vasculature, secreted Sema3e signals 
independently of a neuropilin co-receptor directly to PlexinD1 receptor, which is expressed in 
ECs (van der Zwaag et al., 2002; Gu et al., 2005). In mice, interruption of the PlexinD1 
pathway leads to patterning defects, increased endothelial sprouting and neolethality (Gitler 
et al., 2004). In zebrafish a mutant form of the receptor PlexinD1 (obd: out of bounds) (Childs 
et al., 2002; Torres-Vázquez et al., 2004) causes enhanced ISV sprouting and abnormal ISV 
patterning in the trunk of the embryo. Normally ISVs grow between intersomitic boundaries in 
the trunk, in obd mutants the ISVs do not grow between somites but rather form 
interconnecting patterns and sprout ectopically along the trunk. Here, a possible binding 
partner might be Sema3a since knockdown experiments reveal similar phenotypes to those 
found in the obd-mutant background (Torres-Vázquez et al., 2004). These studies show that 
Semaphorin/Plexin signaling plays an important role in vascular path finding.  
3.2.4.2.6 Vessel maturation 
Developing vessels need to undergo maturation which is essential for their survival and 
proper perfusion of the surrounding tissues. During vessel maturation, vessels are stabilized 
by the attraction of mesenchymal derived mural cells and the generation of ECM. The 
supporting mural cells, pericytes and vascular smooth muscle cells (vSMC), are embedded 
within the basement membrane at the outer surface of the vessel walls protecting developing 
vessels from disturbing signals (Jain, 2003). It has been shown that TGFβ signaling is 
involved in the differentiation of mesenchymal cells into mural cells as well as ECM 
deposition (Pepper, 1997; Chambers et al., 2003). The expression of platelet derived growth 
factor B (PDGF-B) by ECs attracts mural cells, which express the PDGFR-β receptor on their 
surface, and stimulates their proliferation and migration (Hellström et al., 2001). Mural cells 
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themselves express Angiopoietin 1 (Ang1) thereby activating Tie2 receptor in endothelial 
cells (Suri et al., 1996), which promotes vessels stabilization by the facilitation of interactions 
between ECs and mural cells as well as the ECM and ECs. Furthermore, Tie2 activation is 
thought to suppress apoptosis of ECs (Jain, 2003).  
3.2.4.2.7 Formation of the intersegmental vessels and their fusion 
To form a fully functional network of vessels that allows blood circulation, growing angiogenic 
sprouts have to fuse to each other, i.e. establish a stable contact and subsequently form a 
continuous lumen, which interconnects the former individual sprouts. In the zebrafish 
embryonic trunk vasculature, the formation of the intersegmental vessels (ISVs) serves as an 
in vivo model to study angiogenesis. In general, during ISV development, endothelial sprouts 
leave the epithelium of the dorsal aorta (DA), grow dorsally towards the roof of the neural 
tube, where they make contact with neighboring intersomitic sprouts, and subsequently 
establish a lumenized tube, the dorsal longitudinal anastomotic vessel (DLAV) (Isogai et al., 
2003). In more detail, in a “primary sprouting” process, beginning at about 20 hpf, endothelial 
tip cells grow out from the DA adjacent to intersomitic boundaries in a stereotyped manner, 
whereas following ECs, the stalk cells, trail these leading cells. Such bi-polar sprouts then 
grow towards the dorsal side between the somite boundaries and the notochord until they 
have passed the horizontal myoseptum. From here, they leave the somitic boundaries and 
growth dorsally between the neural tube and the somites. When reaching the dorsolateral 
roof of the neural tube, the tip cells extend anterior and posterior into two branches that will 
fuse with the branches of neighboring sprouts to form the dorsal longitudinal anastomotic 
vessel(s) (DLAV(s)) on either side of the neural tube (Figure 10).  
 
Figure 10 Model of the morphogenetic events that lead to the formation of ISV and DLAV. At 22 hpf ECs of 
the DA form sprouts (A) that grow along the somite boundaries up to the dorsal roof of the neural tube (B). Here, 
at the dorsal side of the embryo, anterior and posterior filopodial extensions between the tip cells establish 
contacts. During this phase, the ECs establish a scaffold consisting of a vascular cord that is not yet lumenized 
(B, C). A continuous apical surface is built which results in the formation of a lumen (yellow) (D). At around 32 hpf, 
a secondary wave of angiogenic sprouts emerges from the PCV. These sprouts either generate a group of 
lymphatic cells, called parachordal lymphangioblasts (chain) (not shown), or connect with the adjacent primary 
vessel (D, on the right), which will become a segmental vein. Blood flow in ISVs commences after SA, SV and 
DLAV have been established (E). Figure adapted from Ellertsdottir et al., 2009. 
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At about 1.5 dpf, secondary sprouts arise from the PCV. These new sprouts grow bilaterally 
in every myotomal segment, like primary sprouts do, but less synchronously. About half of 
these sprouts eventually connect to adjacent primary ISVs and link the PCV to the primary 
network. The other half will build up so called lymphatic parachordal chain (Lim et al., 2011), 
lying horizontally along the myoseptas, and a few sprouts simply disappear. By this 
“secondary sprouting” process, the DA and PCV are connected to each other and blood flow 
through the ISVs and DLAVs can occur (Figure 10). At 3 days of development, the zebrafish 
embryo has a closed circulation of a complex blood system in the head and all organs, such 
as gut, liver, kidney and pancreas and in the trunk region and strong closed blood flow can 
be observed within DA, ISVs and DLAVs (Isogai et al., 2003; Torres-Vázquez et al., 2004; 
Childs et al., 2002; Roman and Weinstein, 2000). During such vessel fusion, a lumen has to 
be built between anastomosing sprouts. In three-dimensional extracellular matrices the 
GTPases Cdc42 and Rac1 target vesicles to vacuolar membranes and are required during 
lumen formation in ECs since the expression of dominant-negative forms impairs the 
formation of vacuoles and a proper lumen (Bayless and Davis, 2002). Live imaging using a 
fli:EGFP-cdc42 transgenic zebrafish reporter line labelling vacuolar membranes in vivo 
suggested that vacuolar fusion events to hollow out single cells in the intersegmental vessels 
(Kamei et al., 2006). In this scenario, three ECs are arranged in a rod-like fashion, as 
described by (Childs et al., 2002). These live observations suggested that vacuoles fused to 
large intracellular compartments in SAs, which then later fused with neighbouring intracellular 
vacuoles to generate an intercellular continuous lumen. This behaviour of ECs during ISV 
tubulogenesis results in the generation of a seamless, unicellular SA.  
A recent study from our lab analyzing ISV/SA architecture during their development and the 
initial steps of fusion, i.e. contact formation (see below), in greater detail found SAs to be of 
multicellular architecture, where ECs overlap to a large extend all along their stalks. This 
finding suggests an alternative mechanism of lumen formation where the lumen is formed by 
a cord hollowing mechanism after neighboring SAs have established contact by filopodial 
extensions (Blum et al., 2008). Recently, Essner and colleagues defined such a novel cord 
hollowing mechanism during the initial phases of ISV tubulogenesis where integration of 
intracellular vacuolar structures into the luminal membrane is driving the expansion of a 
primary lumen (Wang et al., 2010). In polarized endothelial cells, both Actin and Myosin are 
localized apically and at the adherens junctions (Bretscher et al., 2002; Strilic et al., 2009). 
Using a Moesin1-EGFP endothelial specific transgenic zebrafish reporter line, they found 
intracellular vacuoles fusing with the apical, luminal membrane (as defined by adherens 
junctions) between at least two ECs. These fusion events lead to an expansion of the 
primary lumen between endothelial cells in ISVs all along their cell-cell junctions (Wang et 
al., 2010). Both studies mentioned (i.e. (Kamei et al., 2006; Wang et al., 2010)), provide 
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insight into endothelial tubulogenesis, suggesting stepwise luminal expansion by the 
involvement of intracellular vacuolar structures that either undergo intracellular and later 
intercellular fusion events (Kamei et al., 2006) or fuse with the luminal membrane between 
ECs (Wang et al., 2010). Both studies suggest de novo formation of luminal spaces that are 
reached and integrated by an expanding lumen. However, both studies lack detailed cellular 
resolution and are limited in temporal description. First of all, both a proper junctional marker 
as well as an apical marker labeling the (future) luminal side, for in vivo analysis are missing. 
Furthermore, none of the studies addressed the question of vessel fusion – how the lumen is 
formed and connected between neighboring endothelial tip cells which is part of the process 
of anastomosis or vessel fusion. Recently, we and others (Armer et al., 2009) have shown 
that during vessel fusion, endothelial tip cells of individual growing sprouts make contact to 
neighboring tip cells via filopodial extensions. We found that those tip cells subsequently 
increase their mutual surface. This behavior is reflected by a dynamic deployment of 
junctional components (i.e. ZO1 and VE-cadherin) at the sites of cell contacts at the onset of 
the fusion process. Based on immunostainings using antibodies against ZO1 and VE-
cadherin at different time points, we proposed a model (Figure 11) where after filopodial 
contact formation dot-like junctional structures appear, and that these, as the fusion process 
proceeds, subsequently enlarge into ring-like structures suggesting the formation of new 
apical membrane compartments within the junctional rings between these cells. However, 
how individual cell behaviors contribute to the fusion process of neighboring SAs/ISVs 
remained somewhat unclear and is the main focus of this thesis. 
 
Figure 11 (A–C) Schematic representation of immunostaining based junctional protein (ZO-1) patterns during 
contact formation between fusing vessels. Junctional proteins accumulate at the contact site of two tip cells, which 
then increase their mutual surface which leads to the formation of a junctional ring suggesting the formation of a 
new apical membrane compartment between the cell extensions within this ring. Figure adapted from Blum et al., 
2008. 
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3.3 Goal of thesis 
The goal of this thesis was to resolve morphogenetic mechanisms of intersegmental blood 
vessel fusion at the single cell level in an in vivo system, the zebrafish embryo. 
Blood vessel fusion or anastomosis, which is the inter-connection of dead-ended vascular 
sprouts, creates a network of vessels where blood flow is allowed away from and towards the 
heart.  The temporal and spatial coordination of cellular events, such as cell migration, cell 
rearrangements, cell division or cell shape changes during the fusion of individual vessels 
had been ill described. In the zebrafish, the metameric arrangement and relative anatomical 
simplicity of the intersegmental vessels (ISVs) makes them an ideal paradigm to study 
morphogenetic cellular mechanisms during their fusion. Cell-cell junctions are located 
between individual cells, demarcating the outline of a cell. Thus, tracking the dynamics of 
individual cell-cell junctions allows analysis of single cell behaviors such as relative cell 
movements and cell shape changes during morphogenetic processes. Therefore, tagging 
endothelial cell-cell junctions with a fluorescent marker provides the necessary information to 
investigate cellular behaviours during blood vessel fusion. The UAS/Gal4 system offers an 
excellent opportunity to label and investigate junctional proteins during morphogenetic 
processes such as the formation of tracheal branches (Ribeiro et al., 2004; Brand and 
Perrimon, 1993). Thus, the goal of this thesis was, to label endothelial cell-cell junctions and 
analyze and better understand the cellular behaviors during intersegmental vessel fusion in 
vivo using the Gal4/UAS system. 
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4 Materials and Methods 
 
4.1 Materials 
4.1.1 Materials used for molecular cloning 
For all (biochemical) reactions ddH20 provided from the local kitchen was used. 
4.1.1.1 Pipettes and tips 
• Gilson PIPETMAN 1000 µl 
• Gilson PIPETMAN 200 µl 
• Gilson PIPETMAN 20 µl 
• Gilson PIPETMAN 2 µl 
• 1000 µl blue tips (Treff Lab) 
• 200 µl yellow tips (Greiner bio-one) 
• 20 µl white tips (Treff Lab) 
4.1.1.2 Tubes 
• Eppendorf tubes 1.5 ml (eppendorf) 
• Eppendorf tubes 2.0 ml (eppendorf) 
• Falcon tubes 50 ml (BD) 
4.1.1.3 Machines 
• BioPhotometer (eppendorf) 
• NanoDrop (Thermo Fischer Scientific) 
• ULTROSPEC II (Ukb Biochrom) 
• Centrifuge 5415 D 
• HiCen 21 C (Herolab) 
• Megafuge 1.0 R (Hereaus) 
• T3 Thermocycler (PCR machine) (Biometra) 
• Thermocycler (eppendorf) 
4.1.1.4 Reagents for DNA restriction digestion (enzymes/buffers) 
• NEB or Roche restriction enzymes and their corresponding buffers from NEB or 
Roche were used.  
4.1.1.5 Reagents for PCR 
• DNA Pfu Polymerase (Promega) 
• Pfu 10x buffer (Promega) 
• Taq Polymerase (Promega) 
• ThermoPol buffer 10x (Promega)  
• Phusion® Enzyme (Finnzymes) 
• Phusion® Enzyme buffer 5x (Finnzymes) 
• Individual Primers: Corresponding PCR primers (Sigma-Aldrich),                      
100µM 1st,tock5 µM 2nd stock 
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4.1.1.6 Reagents for DNA ligation 
• T4 DNA ligase (NEB) 
• Ligase 10x buffer (NEB) 
4.1.1.7 Reagents for DNA blunting 
• T4 DNA Polymerase (NEB)  removal of 3’ overhangs 
• 10x restriction digestion buffer 2 (NEB)  
• Klenow enzyme (Roche)  refilling of 5’ overhangs 
• Klenow buffer 10x (Roche) 
• 1mM dNTPs for blunting with T4 DNA Polymerase 
• 10mM dNTPs for blunting with Klenow enzyme 
4.1.1.8 Reagents for DNA dephosphorylation 
• Shrimp Alkaline Phosphatase (Roche)  
• 10x SAP buffer (Roche) 
4.1.1.9 Reagents for agarose gels 
• Ethidiumbromide 
• Agarose (Eurogentec) 
• 50x TAE-buffer (242 g Trizma, 57.1 ml Aceticacid, 100ml 0.5 M EDTA, fill up 
with ddH20 to 1000ml; 1x TAE: 20 ml 50x TAE in 980ml ddH20) 
• running chambers (Amersham Bioscience ®) 
• 10x orange standard loading buffer 
• 1kb plus ladder (Promega) 
4.1.1.10 Reagents for blue-white selection 
• X-Gal (100mg dissolved in 2ml N,N’-dimethylformamide, wrapped in aluminium 
folia) 
• 1.5ml aliquoted IPTG (stock: 1.2 g in 50 ml ddH20) 
Individual primers (rev/fwd) ordered from Sigma Aldrich  
• Individual DNA templates 
4.1.1.11 Cells and plates 
• Top10 cells (electrocompetent) 
• Plates Amp (10 µg/µl) and Kan (50 µg/µl) 
4.1.1.12 Kits 
• QIAGEN Gel extraction Kit (QIAGEN) 
• QIAGEN Plasmid Midi Kit (QIAGEN) 
• QIAGEN PCR purification Kit (QIAGEN) 
• SIGMA GenEluteTM Plasmid Miniprep Kit 
• pENTR™⁄D-TOPO® Cloning Kit (Invitrogen) 
4.1.1.13 Filters 
• 0.025 µm membrane filter paper (Millipore®) 
• Folted filters (Schleicher and Schuell) 
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4.1.1.14 Cloning software 
• Ape v2.0.37 (A plasmid-editor, open source) 
4.1.1.15 Solutions to transform electrocompetent cells 
SOC medium (filter-sterilized, protocol from Promega!) 
• 2.0g Bacto®-tryptone 
• 0.5g Bacto®-yeast extract 
• 1ml 1M NaCl 
• 0.25ml 1M KCl 
• 1ml Mg2+ stock 
• (1M MgCl2 . 6H2O, 
• 1M MgSO4 . 7H2O), 
• filter-sterilized 
• 1ml 2M glucose, 
• Bring to 100ml with distilled water. Add Bacto®-tryptone, Bacto®-yeast extract, 
NaCl and KCl to 97ml distilled water. Stir to dissolve. Autoclave and cool to room 
temperature. Add 2M Mg2+ stock and 2M glucose stock, each to a final 
concentration 20mM. Filter the complete medium through a 0.2µm filter unit. 
Adjust the pH to 7.0. 
• LB medium (standard protocol from local kitchen!) 
• LB medium with ampicilin (10 µg/µl) or Kanamycin (50 µg/µl) 
4.1.1.16 Sequencing 
All DNA samples have been sequenced by Microsynth (Economy Bar Service), 
Switzerland 
4.1.2 Materials used for Fish protocols  
4.1.2.1 Materials used for injections 
• eppendorf FemtoJet ® or free hand modules (tritech research) 
• eppendorf Microloader tips  
• Glass needles: GB100F-10 (with and without filament)  Science Products  
• 1.5% agarose filled petri dishes (microinjection chambers) 
4.1.2.2 Materials for Immunostainings 
primary antibodies: 
• mouse anti human ZO1, 1:200 (Zymed) 
• rabbit anti-zf-CDH5  1:1000  
secondary antibodies: 
• Alexa-568 goat anti-rabbit IgG, 1:1000 
• Alexa-568 goat anti-mouse IgG, 1:1000  
• Alexa-633 goat anti-mouse IgG, 1:1000  
• (All secondary antibodies were purchased from Invitrogen) 
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4.1.2.3 Solutions / mounting media 
• Egg water: 0.3 g sea salt in 1 l of ddH2O with 1ml methylen-blue 
• 50x PTU (10mM) stock: Sigma P7629, dissolved in water  
• PBST: 1 x PBS with 0.1 % Tween-20 (Fluka) 
• PBSTX: 1 x PBS with 0.1% Tween-20 (Fluka) and 0.1% TritonX-100 (Fluka) 
• PFA: 4% Paraformaldehyde (Polyscience) in PBS 
• 10% BSA (Bovine Albumin Serum, Sigma Aldrich) 
• 1% NGS (Normal Goat Serum, Sigma Aldrich) 
• Methylcellulose 2% in egg water 
• Pronase 10mg/ml in Danieau’s 
• Vectashield ® (Vector Laboratories, Inc. Burlingame) 
4.1.2.4 Materials used for genomic DNA extraction  
• 99.9 % ethanol 
• 70 % ethanol 
• 99.9% Isopropanol 
• Na-Acetat (3 M, pH 4.6) 
• DNA extraction buffer (filter-sterilized) 
• 10mM Tris-HCl (pH 8.2) 
• 10mM EDTA 
• 200mM NaCk 
• 0.5% SDS 
• + 200ng/µl Proteinase K 
4.1.3 Material used for live Imaging 
4.1.3.1 Microscopes and imaging software 
• Leica SP5 MP confocal microscope  
• Leica SP5-II-Matrix 
• Leica confocal microscope DME-7 
• Leica confocal software (LCS) 
• Leica MZFLIII binocular  
• Leica M205 FA stereo binocular 
• Leica DM6000B laser cutting microscope 
• Zeiss Stani SV 11 binocular (Zeiss) 
4.1.3.2 Imaging software 
• ImageJ 1.44p (open source: Rasband, W.S., ImageJ, U. S. National Institutes of 
Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/, 1997-2011. and (M. 
D. Abràmoff et al.)) 
•  (Imaris 4.15) 
• Adobe Illustrater CS5 and Adobe Photshop, Microsoft Powerpoint 
 
4.1.3.3 Mounting materials 
• MatTek Glass bottom culture dishes P35G-1.5-10-C 
• 0.7% low-melting agarose (Sigma Aldrich) 
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4.1.4 Fish strains  
4.1.4.1 Fish strains 
wild type strains: 
 
• AB/EK and EK/TL (W. Driever, Freiburg) 
 
transgenic zebrafish lines: 
 
• Tg(fli1:EGFP)y1(N. Lawson, 2002) 
• Tg(UAS:RFP) (Asakawa et al., 2008) 
• Tg(UAS:KAEDE)rk8 (Hatta et al., 2006) 
• Tg(kdrl:EGFP)S843 (S.-W. Jin et al., 2005) 
• Tg(fli1ep:GAL4FF)Ubs2,Ubs3,Ubs4 (this thesis) 
• Tg(UAS:EGFP-ZO1-cmlc2:EGFP)Ubs5, Ubs6,Ubs7 (this thesis) 
4.2 Methods 
4.2.1 Standard cloning protocol 
4.2.1.1 Polymerase Chain Reaction (PCR) 
For all PCRs done in this work the following mix was set up: 
Template DNA    100-200 ng 
Primers (5µM)    1 µl each 
DNA polymerase buffer 10x/5x5 or   10 µl 
DNA polymerase (Tag, Phusion or Pfu)  1 µl 
dNTPs (2 mM each dNTP)    5 µl  
ddH2O up to     50 µl  
4.2.1.2 DNA restriction digestion 
Commercial restriction enzymes and 10x buffers (NEB, Roche) were used for double and 
single digestions.  
DNA       0.5-2 µg  
10x buffer      2µl  
enzyme(s)      1µl  
ddH2O up to      20µl 
 
Depending on enzymes, the reaction mixture was put at 30°C, 37°C or 50°C for 1-2h or o/n 
in a heating block. 
4.2.1.3 Pouring of standard 1% agarose gels 
Digested backbones, inserts and PCR fragments were separated via a 1% agarose 
(Eurogentec) gels.  
1xTAE buffer      50 ml  
Agarose      0.5 g  
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were heated up in an Erlenmeyer flask in the microwave until boiling was observed and the 
whole agarose was melted and solved in the 1x TAE-buffer. 5 µl of Ethidiumbromide were 
added and the solution was filled into a gel chamber with a desired comb (depending on the 
type of gel: 8 lanes to extract DNA, 12-16 lanes for analytical gels (minipreps!)). After 
polymerization occurred, the comb was removed and the gel chamber was placed in a 
running chamber (Amersham Bioscience ®), filled with 1x TAE buffer. DNA, mixed with 
orange loading buffer (1x) was loaded and the gel was run at 100 V for 30min-1h. As a 
reference a single lane with 1kb plus ladder (marker) was run in parallel. 
4.2.1.4 DNA isolation   
In order to isolate PCR products, linearized plasmids, or inserts, DNA was run on standard 
agarose gel (1-2 %) and extracted. 
4.2.1.5 DNA gel extraction 
To cut out specific DNA bands, gels were placed on an UV-table at 75% for as short as 
possible to prevent mutations in the DNA. At 75% UV power, the desired DNA bands were 
cut out with a razor blade and put into a 1.5 ml eppendorf tube. For safety reasons (to 
prevent nasty mutations and burnings by the UV light) a helmet consisting of plexiglas and 
gloves were used. For analytical gels, pictures were taken at 100% UV light. 
The extraction was made following the QIAGEN Gel Extraction protocol. DNA was eluted in 
30 µl ddH2O. 
4.2.1.6 DNA ligation 
For efficient ligation, 1 µl of the digested DNA fragments were measured with a NanoDrop 
(Thermo Fischer Scientific) 
Using http://www.insilico.uni-duesseldorf.de/Lig_Input.html or the following calculation, 
optimal ligation concentration was calculated:  
 
In almost all cases, a molecular vector insert ratio of 1:3 was used. 
 
vector        x µl  
insert        y µl 
10x ligase buffer       1 µl 
T4 DNA Ligase     1 µl 
ddH2O up to 10µlreaction volume     z µl 
 
Ligation reaction was mixed and put on 18°C o/n or at 4°C for 2 days. 
kb size of vector 
x molar ratio of insert/vector = ng of insert 
ng of vector x kb size of insert 
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4.2.1.7 Transformation of electrocompetent cells 
Electrocompetent E. coli bacteria TOP-10 were used for transformation. Upon 
electroporation, ligation-mixture was dialysed against ddH2O on a 0.025 µm membrane filter 
paper (Millipore ®) o/n to lower the salt concentration and thus, increase transformation 
efficacy. The whole transformation procedure was performed on ice. Frozen E. coli (50 µl in 
eppendorf tubes) from the -80°C freezer were thawed on ice. 1-3 µl of the DNA ligation was 
added and mixed by pippeting gently up and down. Then the bacteria were transferred to a 1 
mm electroporation cuvette (Bio Rad). The bacteria were electroporated (Bio Rad 1.8 mV, 
200 ohm, 25 µF) and then transferred with 0.5 ml preheated (37°C) LB or SOC medium 
!without! antibiotica to a 1.5 ml eppendorf tube. Bacteria were grown at 37°C on a shaker or 
rotator for 1 hour and then centrifuged down at 1500 rpm, resuspended in 200 µl and plated 
on an agar plate with the appropriate antibiotic by the use of glass beads. Colonies were 
grown over night, upside-down in the 37°C breeding incubator. 
4.2.1.8 Minipreps 
Clones were picked from agar plates and grown in 3 ml LB medium, in test-tubes with the 
appropriate antibiotic on a shaker at 37°C o/n. Then minipreps were performed following the 
SIGMA GenEluteTM Plasmid Miniprep Kit. DNA was eluted in 90 µl ddH2O. 
4.2.1.9 Midipreps 
50 ml LB medium with appropriate antibiotics were inoculated by positive clones. Culture was 
grown over night and then centrifuged for 15 min in a Heraeus centrifuge at 4°C. Then the 
QIAGEN Plasmid Midi Kit was followed. DNA was eluted in 90µl ddH2O. Purity and amount 
were measured with NanoDrop (Thermo Fischer Scientific). 
4.2.2 Fish protocols 
4.2.2.1 Fish maintenance and stocks, breeding and collection of eggs 
Zebrafish were maintained at standard conditions (Westerfield, 2000). Embryos were staged 
by hours post-fertilization (hpf) at 28.5 °C (C. B. Kimmel et al., 1995).  
4.2.2.2 Dechorionation of eggs 
Dechorionation was done by hand with watch maker forceps (Dumont #5F).  
4.2.2.3 Inhibition of pigmentation 
When working with fixed embryos older than 36 hpf, pigmentation of embryos was inhibited, 
since at around 28 hpf, pigmentation of embryos starts. To inhibit pigmentation PTU 
(propylthiouracil) was used. Egg water of 24 hpf old embryos was exchanged with PTU egg 
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water. PTU egg water was produced by adding 10 ml of a 50x PTU stock solution to 490 ml 
of egg water. As usual methylen blue was included in the egg water.  
4.2.2.4 Fixing of embryos 
Dechorionated embryos in a 2 ml eppendorf tube were anesthetized on ice for 5 min. Then 
egg water was exchanged by 1 ml pre-chilled 4% PFA. After 5 min PFA was replaced by 
fresh pre-chilled 4% PFA. The eppendorf tube was wrapped in aluminium folia to prevent 
bleaching of the fluorescent proteins and put on the shaker in the 4°C room o/n. 
4.2.2.5 Microinjections 
Capillaries were pulled to produce very thin glass needles. Microinjection chamber plates 
were made by pouring 1% agarose (solved in egg water) into a petridish and putting a mold 
(template) on the agarose. The mold was removed after polymerization of the agarose. The 
plate were stored at 4°C and covered with egg water. Freshly laid eggs (one cell stage) were 
oriented so that they had the cells looking up and then gently pressed into the rills of the 
injection plate. Needles were filled with the DNA solution using Eppendorf Microloader. 
Needles were mounted on the eppendorf FemtoJet injector ® or the or free hand modules 
(tritech research) and broken by forceps, plunged into the eggwater and tested for outflow. 
Needle was filled with DNA solution and pressure was adjusted (ca. 300 kPa). For best 
results whenever possible the cell and not the yolk was injected. Drop sizes were as small as 
possible (~4nl / embryo). For all injections Tol2 transgeneis RNA was used. 
4.2.2.6 Immunofluorescence 
4.2.2.6.1 Immunostaining protocol 
Embryos from 22–48 hpf were fixed in 4% paraformaldehyde for 2 h at room temperature. 
Embryos were then washed 4×5 min in PBST (PBS+0.1% Tween20) and once in PBSTX 
(PBS+0.1% Tween20+0.1% Triton ×100). Embryos were then blocked in PBSTX+10% 
BSA+1% NGS for 2 h. Embryos were incubated with primary antibodies (in PBSTX+1% 
BSA+0.1% NGS) overnight at 4 °C. Embryos were then washed 6×1 h in PBSTX+1% BSA+ 
0.1% NGS and then incubated with the secondary antibody (in PBSTX+1% BSA+0.1% NGS) 
overnight at 4 °C. Embryos were finally washed several times in PBST. All steps were 
performed at RT except for antibody incubations. The following antibodies were used: mouse 
anti human ZO1, 1:200 (Zymed); rabbit anti-zf-CDH5 (Blum et al., 2008), 1:1000; Alexa-568 
goat anti-rabbit IgG, 1:1000; Alexa- 568 goat anti-mouse IgG, 1:1000; Alexa-633 goat anti-
mouse IgG, 1:1000 (All secondary antibodies were purchased from Invitrogen.). 
After fixation, PFA was replaced by PBST and embryos were incubated for at least 30 min at 
RT on a shaker in the dark. As the trunk vasculature was the object of interest, the embryos 
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were transferred into a Petri dish containing PBST and the head and yolk were cut off at the 
yolk / yolk extension boundary. This made the specimen way thinner and scanning with the  
objectives more agreeable. The tails were mounted in 0.7% low-melting agarose placed in 
Matek 0.17 mm bottom petri dishes.  
4.2.3 Imaging  
All confocal pictures within this thesis (collaborations excluded) have been taken using either 
a Leica SP5 or SP1 confocal microscope. 
4.2.3.1 Principles of confocal microscopy 
The optical system of a confocal microscope focuses a spot of light onto a single point at a 
specific depth within a sample, whereas widefield epi-fluorescence microscopes focus a wide 
cone of illumination onto a large volume of a sample. This whole region is then uniformly and 
simultaneously illuminated (Figure 12).  
 
Figure 12 Widefield illumination versus confocal illumination 
In confocal microscopes, strong laser light from a pinpoint illumination passes through a 
pinhole onto a single point in the sample. The emitted light from this point is collected by a 
detector. Here, a pinhole aperture is placed in front of the detector which is at a position that 
is confocal with the illuminated point in the sample. Confocal means, it is positioned precisely 
where the rays, which are emitted from the illuminated point in the sample, come to a focus 
(confocal point). Thus, the significant amount of fluorescence emission occurring at points 
above and below the objective focal points are not confocal with the pinhole and excluded 
(Figure 13). This is different in a normal fluorescent microscope setup, where the pinhole 
aperture in front of the detector is missing and thus, also “out-of-focus-rays” are allowed to 
pass. Since by this method only single points of a plane of interest are illuminated, such a 
plane needs to be illuminated sequentially point by point to generate an image. This 
reiterative illumination of other points of the same and other planes (scanning) allows 3D 
reconstruction of the original sample by computer software. 
(http://micro.magnet.fsu.edu/primer/index.html and Alberts et al., 2008) 
Materials and Methods 
38 
 
 
Figure 13 Overview of confocal microscopy 
4.2.3.2 Live imaging and embryonic manipulations  
4.2.3.2.1 Selection of Tg(fli1ep:Gal4FFubs3;UAS:RFP;UAS:EGFP-ZO1ubs5) 
embryos 
Triple transgenic embryos Tg(fli1ep:Gal4FFubs3;UAS:RFP;UAS:EGFP-ZO1ubs5) were selected 
using a Leica MZ FLIII fluorescent stereomicroscope. Embryos were selected for RFP 
ensuring the presence of the fli1ep:Gal4FF and UAS:RFP transgene and for the presence of 
the heart marker cmlc2:EGFP. Selected embryos were anaesthetized using tricaine and 
mounted in a 35 mm glass bottom petri dish (0.17 mm, MatTek), using 0.7% low melting 
agarose (Sigma) containing 0.01% tricaine and 0,003% PTU. All movies have an initial frame 
size of 512x512 pixels. Routinely, z-stack consisted of 50-80 slices with a step size of 0.8-1.0 
μm. Stacks were taken every 5 minutes, unless noted differently.  
4.2.4 Photoconversion 
To label individual ECs, KAEDE photoconversion was done on a Leica SP5 fluorescence 
microscope by 20-second exposures using a solid-state laser (405nm). At 2 dpf, when nuclei 
of individual ECs are easily discernible in ISVs having an inflated lumen, 
fli1ep:GAL4FF;UAS:KAEDE transgenic embryos were anaesthetized with tricaine, mounted 
in 0.7% low melting agarose and a defined region of interest (ROI) within individual nuclei 
was exposed to the violet light. Subsequently high resolution x,y,z stacks were acquired with 
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a 63x glycerol immersion objective using the suggested slice thickness by the confocal 
software. Slice numbers ranged from 80 to 200 slices per stack. 
4.2.5 Quantum Dot-injection 
705 nm Quantum Dot (Invitrogen) were injected into the sinus venosus of mounted embryos 
at a concentration of 1:2. Special manufactured glass needles (Biomedical Instruments, 
Jena, Germany) with tip opening of 10 µm and beveled tip were utilized to reduce damage to 
the embryo.  
4.2.6 In vivo time-lapse analysis 
Embryos were imaged overnight on a Leica SP5 confocal microscope using a 63x glycerol 
immersion objective with a numerical aperture of 1.2 with additional zoom of 1-1.3x. In some 
cases resonance scanning with an optical zoom of 1.7 was used. All movies have an initial 
frame size of 512x512 pixels. Routinely, z-stack consisted of 50-80 slices with a step size of 
0.8-1.0 µm. Stacks were taken every 5 minutes, unless noted differently.   
4.2.7 Image processing 
All stacks were processed with ImageJ (or occasionally Imaris). All images were further 
processed with a standard deviation and an edge preserving filter to sharpen the image and 
get rid of background. All images have the anterior to the left and dorsal to the top.  
4.3 Gal4/UAS System 
In 1993 A. Brand and N. Perrimon designed an indirect gene expression system, the 
Gal4/UAS system, which allows in vivo expression of a gene of interest in a spatiotemporal 
way (Brand and Perrimon, 1993). Under the control of the regulatory sequence of a given 
gene H, which provides temporal and spatial specificity, the yeast transcriptional factor Gal4 
binds to 5 repeated Upstream Activation Sites (UAS elements from yeast) located upstream 
of a minimal promoter from heat shock gene hsp70.  These two regulatory units precede the 
open reading frame (ORF) of a gene of interest, which will be expressed upon Gal4 binding 
(Figure 14).  
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Figure 14 General genetic setup of the inducible Gal4/UAS system. The UAS/Gal4 system is an in vivo 
system consisting of two transgenic organisms (black boxes in figure) allowing the expression of a given gene of 
interest in a spatial and temporal restricted manner: a driver line expressing the yeast transcriptional activator 
(Gal4) under the control of a specific regulatory sequence of a gene H, is crossed to an effector line encoding 
upstream activating sites as well as a minimal promoter element, here hsp70. After crossing, Gal4 binds as a 
dimer to these UAS elements (here 5 elements) and induces the expression of a given gene of interest encoded 
downstream of the UAS sites. Upstream activating sequences (UAS) are 18 bp long sequences with two 
palindromic triplets at the 5 and 3 prime ends spaced by 11 nucleotides that are recognized by the zinkcluster 
elements of DNA binding domain of Gal4 homodimers i.e. CGG and CCG (Ptashne and Gann, 2002). 
 
This system has been adapted recently to the zebrafish where several modifications (for 
example: number of UAS sites, enhanced Gal4 versions) have been introduced to increase 
its efficiency in this vertebrate model organism (Asakawa et al., 2008; Köster and Fraser, 
2001; Distel et al., 2009; Akitake et al., 2011; Scheer and Campos-Ortega, 1999). The 
Gal4/UAS system has several advantages. First, the concept of indirect expression allows 
separation of an UAS-driven gene of interest from the transcriptional activator Gal4 in two 
distinct transgenic lines, a driver and effector/responder line, which, for instance, allows the 
expression and analysis of otherwise toxic genes or lethal mutations until the developing 
organism eventually dies. Second, ectopic target gene expression can be directed to 
different tissues since driver and effector lines can be crossed in any given combination. 
Third, expression of the gene of interest is enhanced; therefore, fluorescent signals are 
amplified and easier to detect. 
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4.4 Cloning of vectors and generation of transgenic zebrafish lines 
General note: 
All the different constructs I generated have been sequenced by Microsynth©, Switzerland. 
Sequences are found on the DVD in the appendix of this thesis. All transgenic lines have 
been generated by Tol2 transgenesis technique (Kawakami et al., 2000), thus all vectors are 
flanked by Tol2 transposable elements. 
4.4.1 Cloning of constructs 
4.4.1.1 Cloning of pT2fli1ep:Gal4FF 
pT2fli1ep:Gal4FF was generated by Gateway cloning technology using a newly generated 
pENTER:Gal4FF entry clone and a pTolfli1epDest destination clone (Villefranc et al., 2007). 
To generate the pENTER:GFF entry clone, a PCR amplified Gal4FF fragment from 
pT2KhspGal4FF vector (Kawakami lab) was directional TOPO cloned into pENTR™/D-
TOPO® (Invitrogene) using following primers (fwd pr. 5’-caccatgaagctactgtcttc-3’ / rev pr. 5’-
ttagttacccgggagcatatc-3’). Using Gateway technology the Gal4FF insert was cloned into 
pTolfli1epDest vector (Lawson lab). 
4.4.1.2 Cloning of pT214xUAS:EGFP-hZO1-cmlc2:EGFP 
A XhoI/AgeI 14xUASE1b fragment was PCR amplified using the following primers (fwd. pr. 
5’-gtgacCTCGAGaagcttaggcctccaagg-3’ rev.pr. 5’- gtatcACCGGTtcgagggaattcgtgtgg -3’), cut 
and cloned via triple ligation together with an EGFP-humanZO1 fragment isolated from 
pG1UAS: EGFPhZO1 (prior cloned in the Affolter lab)* with AgeI/Asp718 into SalI/Asp718 
cut vector pDestTol2CG2 (Chien lab).  
Note: it is possible that due to recombination events in some of the recovered plasmids the 
two transgenes UAS:EGFPhZO1 and cmlc2:EGFP share now a single SV40 site which is 
readable in both orientations (for more information see sequence found on DVD in the 
appendix). 
* A XhoI/AgeI-cut 14xUASE1b fragment, generated by PCR using the following primers, fwd. 
pr. 5’-gtgacCTCGAGaagcttaggcctccaagg-3’ and  rev. pr. 5’- 
gtatcACCGGTtcgagggaattcgtgtgg-3’ and pBUASE1b vector (gift from Reinhard W. Köster) 
as a template, was cloned into the XhoI and AgeI digested pG1 flk-1:EGFP-ZO1 (cloned by 
HG. Belting, Affolter lab) vector. 
4.4.1.3 Cloning of pT2fli1ep:Gal4FF-cmlc2:EGFP 
A BglII cut and blunted cmlc2:EGFP insert from pDestTol2CG2 (Chien lab) was ligated into 
ApaI cut and blunted pT2fli1ep:Gal4FF vector (see above). cmlc2:EGFP inserted 
downstream of the  Gal4FF transgene in reverted orientation.  
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4.4.1.4 Cloning of pT25xUAS:VEcad∆CD-EGFP 
Generation of the VEcad∆CD-EGFP deletion: a pENTER:VEcadEGFP entry clone was 
generated and cloned into pTolfli1epDest vector using Gateway technology© (Lawson lab). 
To generate pENTER: VEcadEGFP entry clone, a PCR amplified VEcadEGFP fragment 
from pBS-VEcadEGFP vector (Essner lab) was directional TOPO cloned into pENTR™/D-
TOPO® (Invitrogene) using following primers (fwd pr. 5’- caccatgatgaaacagtgtgccagg-3’ / rev 
pr. 5’-ttacttgtacagctcg-3’). In this new construct, pT2fli1ep:VEcadEGFP, the cytoplasmic 
domain (CD=aa615–aa719, cytoplasmic domain determined after 
http://www.uniprot.org/uniprot/Q68SP4  Q68SP4; cdh5, Danior rerio full-length VE-cadherin 
676 aa) was deleted (∆),using single primer mutation technique (single primer: 
gtgttgagacggcgctatcaaactagtgtgagcaagggcgag) (Makarova et al., 2000) resulting in 
pT2fli1ep:VEcad∆CDEGFP vector. To generate the pT25xUAS:VEcad∆CD-EGFP construct, 
a fwd. BglII-primer (gccgtgAGATCTatgatgaaacagtgtgcc) and rev. EcoRV-primer 
(gccgtgGATATCttacttgtacagctcgtc) PCR amplified VEcad∆CDeGFP fragment was cloned 
into BglII/EcoRV cut pT2UAS:MCS vector (gift from K. Kawakami). 
4.4.1.5 Cloning of pT24XnrUAS:EGFP-hZO1 
A AgeI/SpeI cut EGFP-hZO1 insert (including polyA and Tol2 arm downstream of hZO1) 
from pT2cmlc2:EGFP-5xUAS:EGFP-hZO1 vector (previously cloned by L. Herwig, Affolter 
lab*) was ligated into AgeI/SpeI cut pT24XnrUAS:FR-mKate vector (cloned previously by L. 
Sauteur, Affolter lab)**. *An ApaI cut cmlc2:EGFP insert was ligated into pT25xUAS:MCS 
(kind gift from K. Kawakami) in reverse orientation upstream of the 5xUAS cassette, resulting 
in vector pT2cmlc2:EGFP-5xUAS:MCS. From pEGFP-C1-hZO1 vector (vector obtained from 
H-G. Belting, Affolter lab) an Eco47III/SmaI EGFP-hZO1 insert was ligated into EcoRV cut 
pT2cmlc2:EGFP-5xUAS:MCS vector resulting in pT2cmlc2:EGFP-5xUAS:EGFP-hZO1. **A 
SphI/BglII insert from pUC57_4Xnr (synthetic plasmid with 4XnrUAS (according Akitake et 
al., 2011) and MCS from ATG:biosynthetics company) was ligated into SphI/BglII cut 
pT2UASMCS_FRmKate2 (cloned by Y. Blum, Affolter lab)*** resulting in pT24XnrUAS:FR-
mKate vector. *** An EcoRI/XhoI PCR amplified FR-mKate insert was ligated into 
pT25xUAS:MCS resulting in pT2UASMCS_FRmKate2. 
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4.4.2 Vector maps of cloned constructs 
4.4.2.1 pT2fli1ep:Gal4FF 
 
 
4.4.2.2 pT214xUAS:EGFP-hZO1-cmlc2:EGFP 
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4.4.2.3 pT2fli1ep:Gal4FF-cmlc2:EGFP 
 
 
4.4.2.4 pT25xUAS:VEcad∆CD-EGFP 
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4.4.2.5 pT24XnrUAS:EGFP-hZO1 
 
4.4.3 Transgenic zebrafish lines 
4.4.3.1 Generation of Tg(UAS:EGFP-hZO1-cmlc2:EGFP)ubs5-6 
Line description: 
The Tg(UAS:EGFP-hZO1-cmlc2:EGFP)ubs5-6 zebrafish lines encode the ORF of the human 
Zona Occludens  gene 1 (ZO1), fused N-terminal to the enhanced version of GFP 
(Enhanced-GFP = EGFP) downstream of 14xUAS sites. Downstream of the human ZO1 
reading frame, a cmlc2:EGFP cassette is encoded in reversed orientation. 
Generation of line: 
Approximately 150 embryos (EK/TL strain) were injected at the one cell stage with 
pT214xUAS:EGFP-hZO1-cmlc2:EGFP generated construct (see above) and Tol2 
transgenesis RNA (concentrations: DNA and RNA both 25ng/µl, 2-4nl/egg). Between 24 hpf 
and 48 hpf, embryos were screened for transient EGFP expression in the heart. Embryos 
showing strong transient expression were selected and raised separately. This G0 
generation was crossed and screened for germ line transmission. 8 (A-H) transgenic carriers 
were recovered which displayed EGFP in the heart. Line A, C and F showed mosaic Gal4FF 
dependent EGFP-hZO1 expression in the vasculature and were used to generate stable F1 
generations with the allelic designation ubs5, ubs6 and ubs. Line ubs was not used for this 
study  
Note: In all three alleles, the expression of EGFP-hZO1 was found to be extremely mosaic. 
This means, even though that the transgene was present (indicated by the cmlc2:EGFP 
cassette) the expression level or fluorescent strength in the ECs ranged from no signal at all 
to very strong expressing  in ECs throughout the endothelium. In ECs with a very high signal, 
EGFP-hZO1 was often found to be miss-localized and distributed over the whole cell 
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(background!) which made it difficult to follow the junctional complexes. However, in many 
cases we detected cells with a strong expression level but low background and thus 
junctions could be followed more easily. 
4.4.3.2 Generation of Tg(fli1ep:Gal4FF;UAS:KAEDErk8)ubs3-4 
Line description: 
The Tg(fli1ep:Gal4FF;UAS:KAEDErk8)ubs3-4 zebrafish line encodes Gal4FF, a Gal4 derivative, 
downstream of the short endothelial specific fli1 enhancer-promoter fragment and the 
14xUAS-driven KAEDE transgene. Gal4FF drives KAEDE expression in the vasculature or 
any other UAS-driven transgene of interest. Both transgenes are separable, i.e. are not on 
the same chromosome. 
Generation of line: 
Approximately 150 embryos (UAS:KAEDErk8 line (obtained from ZIRC, originally generated 
by (Hatta et al., 2006)) were injected at the one cell stage with pT2fli1ep:Gal4FF generated 
construct (see above) and Tol2 transgenesis RNA (concentrations: DNA and RNA both 
25ng/µl, 2-4nl/egg). Embryos were screened for Gal4FF dependent transient KAEDE 
expression between 24 hpf and 48 hpf. Embryos showing strong transient expression in the 
developing vasculature were selected and raised separately. These G0 selected fish, were 
crossed at the adult stage and screened for germ line transmission. 3 transgenic carriers (G0 
founders) were recovered which displayed Gal4FF dependent KAEDE expression in the 
vasculature. These 3 carriers were crossed to UAS:KAEDE fish to generate stable F1 
generations with the allelic designation ubs3, ubs4 and ubs2, respectively, which was not 
further propagated due to a low fecundity of the F1 generation. 
Note: The Tg(fli1ep:Gal4FF;UAS:KAEDErk8)ubs3-4 zebrafish were crossed to UAS:RFP 
positive fish (kind gift from K. Kawakami) (Asakawa et al., 2008) to generate 
Tg(fli1ep:Gal4FF;UAS:RFP)ubs3-4 zebrafish lines. 
4.4.3.3 Tg(fli1ep:Gal4FF-cmlc2:EGFP;UAS:VEcad∆CD-EGFP)ubs12 
Line description:  
The Tg(fli1ep:Gal4FF-cmlc2:EGFP;UAS:VEcad∆CD-EGFP)ubs12 line encodes a version of 
VEcadEGFP deficient for the cytoplasmic domain of VEcad downstream of 5xUAS sites. It 
further encodes a fli1ep:Gal4FF transgene including the cmlc2:EGFP transgenesis cassette 
(Kwan et al., 2007) downstream of Gal4FF.  
Generation of line: 
Approximately 150 embryos were injected at the one cell stage with generated constructs 
pT2fli1ep:Gal4FF-cmlc2:EGFP and pT25xUAS:VEcad∆CD-EGFP (see above) as well as 
Tol2 transgenesis RNA (concentrations: DNA and RNA both 25ng/µl, 2-4nl/egg). Embryos 
displaying transient expression in the heart due to the cmlc2:EGFP cassette were selected 
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and raised to the adult stage. Here, the cmlc2:EGFP cassette served as an indirect marker 
for the UAS transgene integration. From previous experiments we knew that co-injected 
transgenes often are expressed in the same cells (pers. communication E. Ellertsdottir, 
Affolter lab and observations L. Herwig). The transgenesis cassette thus served as a positive 
control for the efficiency of the injections and integration of the pT25xUAS:VEcad∆CD-EGFP 
construct. From a mass cross of these G0 fish, I isolated 8 fish showing VEcadΔCD-EGFP 
expression in the vasculature and EGFP expression in the heart. Some ectopic expression 
was observed in neurons in the region of the neuronal tube. Unfortunately I was not able to 
identify the founder fish, thus, there might be multiple insertions at different loci. Only 7 fish 
survived until adult stage and when crossed to fli1ep:Gal4FF;UAS:RFP positive fish, only 
one of them showed still strong and uniform expression of the UAS-driven transgene in the 
vasculature. This F1 founder fish was used to generate a stable line Tg(fli1ep:Gal4FF-
cmlc2:EGFP;UAS:VEcad∆CD-EGFP)ubs12 by crossing it either to wild type fish or 
fli1ep:Gal4FF;UAS:RFP positive fish.  
Notes: It should be mentioned that the two transgenes I injected are two individual 
transgenes, they are not coupled on the same plasmid. The two transgenes might be located 
on different chromosomes (UAS:reporter can be lost if only selected for the heart marker 
cassette!). Therefore, the UAS: VEcad∆CD-EGFP transgene needs to be screened visually 
in every generation. The expression pattern of VEcad∆CD-EGFP is found almost uniformly 
throughout the whole vasculature. In some cases I observed, a weak expression signal or a 
total absence of it. The expression in the head vasculature is strong (pers. communication A. 
Lenard, Affolter lab) and is slightly weaker in the trunk vasculature but again increases in the 
caudal vein (plexus). However it is not clear whether this is a result of the UAS-transgene 
itself or the driver Gal4FF which might differentially expressed in this regions. 
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5 Results 
 
5.1 Distinct Cellular Mechanisms of Blood Vessel Fusion in the 
Zebrafish Embryo 
5.1.1 Analysis of vessel fusion using an endothelial specific transgenic 
reporter system  
In order to drive Gal4 dependent transgenes in the vasculature of the zebrafish and to label 
single endothelial cells at the (sub)-cellular level, which allows the analysis of relative 
behaviors of cells during morphogenetic events such as vessel fusion, I have engineered 
endothelial-specific transgenic reporter systems in the zebrafish, Danio rerio.  I have 
generated a DNA construct encoding a Gal4 derivative (Gal4FF) (Asakawa et al., 2008) 
under the control of the endothelial specific enhancer-promoter element fli1ep (Villefranc et 
al., 2007). Injections of this construct together with Tol2 transgenesis RNA (Kawakami et al., 
2004) into fertilized Tg(UAS:KAEDE)rk8 zebrafish eggs (Hatta et al., 2006), resulted in 
transient, mosaic expression of the UAS-driven green to red photoconvertible fluorescent 
protein KAEDE in endothelial cells (ECs). From these transiently expressing embryos, I 
successfully isolated three allelic locations of Gal4FF, designated as ubs2-4, from three 
individual founder fish resulting in the stable Tg(fli1ep:Gal4FFubs2-4;UAS:KAEDErk8) zebrafish 
lines. Allele ubs3 and ubs4 were raised as stable stocks, whereas ubs2 was not further 
propagated due to a low fertility of the F1 generation (pers. communication with J. Torres-
Vazquez, Skirball Institute of Biomolecular Medicine, NYC). Although this zebrafish line is 
endothelial specific, some mosaic, ectopic and weak expression of Gal4-dependent KAEDE 
can be observed in the notochord and somites as well as cells in the eye region of the ubs3 
allele. The ubs4 allele displays weak ectopic expression in the notochord and stronger 
ectopic expression in neuronal cells in the region of the neural tube (data not shown, pers. 
observation L. Herwig). 
In order to visualize the endothelium in red, I crossed the generated Tg(fli1ep:Gal4FFubs2-
4;UAS:KAEDErk8) with an Tg(UAS: RFP) zebrafish line (Asakawa et al., 2008) and specifically 
selected RFP positive fish larvae (Figure 15). 
 
 
The full publications from collaborations can be found in the appendix section 9.2.2, p.107. In 5.5, p.68, each publication is 
mentioned as an individual chapter, including title, authors, journal information and date of publication. A short explanation of 
what I have contributed in these papers is found within these chapters too. Each paper, including the full supplementary data, is 
stored on a DVD in the appendix section. 
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Figure 15 Expression of Gal4FF in different UAS backgrounds. Tg(fli1ep:Gal4FF;14xUAS:KAEDE) 
zebrafish line crossed with a 5xUAS:RFP transgenic zebrafish line. All different possible genotypes from this 
cross are listed. Green fish in figure: (Tg(fli1ep:Gal4FF;UAS:KAEDE), this transgenic line allows to convert 
single cells by UV conversion of the KAEDE protein and trace single endothelial cell behavior during 
morphogenetic processes by confocal live imaging. Red fish in figure:   (Tg(fli1ep:Gal4FF;UAS:RFP), this line 
can be crossed to any UAS transgenic line available and of interest that does encode a green fluorescent 
reporter protein. In addition all Gal4FF positive genotypes may be crossed with any non-fluorescent UAS-
driven transgene of interest. 
 
These transgenic lines allowed us to undertake two approaches: First, the photoconversion 
of specific regions of interest (ROIs), for example single ECs, from green to red in 
Tg(fli1ep:Gal4FF;UAS:KAEDErk8)  embryos (Figure 16). Second, the visualization of any 
UAS-driven green fluorescent reporter construct, including constructs labeling finer sub-
cellular structures of endothelial cells, such as components of the junctional complexes, 
within the red labeled endothelium of Tg(fli1ep:Gal4FF;UAS:RFP) embryos. 
Thus, since we wanted to investigate the cellular behaviors during vessel fusion by the 
analysis of the dynamics of endothelial cell-cell junctions, I further engineered a 14xUAS-
effector line (Köster and Fraser, 2001) expressing an EGFP tagged version of the human 
tight junctional protein Zonula Occludens-1 (hZO1), albeit in a highly mosaic fashion, when 
crossed to Tg(fli1ep:Gal4FFubs3-4) driver fish (Figure 17). Downstream of the UAS:EGFP-
hZO1 transgene, a 900bp enhancer–promoter from the cardiac myosin light chain gene 
(cmlc2) fused to EGFP (cmlc2:EGFP) is encoded in reversed orientation. This cassette 
serves as a transgenesis marker (Kwan et al., 2007) and labels specifically the developing 
heart (Huang et al., 2003; Auman et al., 2007) and facilitated generation and identification of 
two UAS:EGFP-hZO1 alleles, ubs5 and ubs6, respectively.  
Taken together, these two reporter setups, i.e. Tg(Gal4FFubs3-4;UAS:EGFP-hZO1ubs5-
6;UAS:RFP) and Tg(fli1ep:Gal4FFubs3-4;UAS:KAEDErk8) (Figure 16 and Figure 17) allowed the 
identification and in vivo tracking of junctional complexes and individual endothelial cells 
during the fusion process of ISVs in the zebrafish trunk.  
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Figure 16 Overview of the UAS:KAEDE reporter system. (i) Crossing between Tg(fli1ep:Gal4FFubs3;UAS:KAEDErk8) 
driver-effector line and Tg(UAS:KAEDE)rk8 effector line results in double positive transgenic embryos, where (ii) 
Gal4FF drives endothelial specific expression of the photoconvertible 14xUAS driven KAEDE protein. (E1b, minimal 
promoter element; Tol2, left and right transposable tol2-arms for transgenesis; pA, polyadenylation signal (iii) embryos 
were raised until 2 dpf and a single endothelial cell within the stalk of an ISV was photoconverted by a short UV 
impulse (ca. 1min) targeting 4 small regions of interest (white points in B, F and J). (C, G) and (K) represent a 2x 
magnification of the squares in (B, F) and (J) and the laser path of the UV impulse is visible in blue. Different channels 
for non-converted KAEDE (green: E-H) and converted KAEDE (red: A-D) as well as the merged channel (merge: I-L) 
are shown. All channels are represented before (left column), during (two middle columns) and after the UV impulse 
(right column). Green KAEDE fluorescence is strongly reduced and converted into red KAEDE (compare E and H, 
asterisks) whereas in (L) the boarders of the converted cell are visible (see white arrows). 
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Figure 17 Overview of the UAS:EGFP-hZO1 reporter system. (i) Crossing between 
Tg(fli1ep:Gal4FFubs3;UAS:RFP) driver-effector line and Tg(UAS:EGFP-hZO1ubs5) effector fish results in triple 
positive transgenic embryos, where (ii) Gal4FF drives endothelial specific expression of the 5xUAS-driven RFP 
and 14xUAS-driven EGFP-hZO1 protein. The heart marker cassette (cmlc2:EGFP) drives EGFP expression in 
the heart which facilitates selection of EFGP-hZO1 positive fish. (E1b, minimal promoter element; Tol2, left and 
right transposable tol2-arms for transgenesis; pA, polyadenylation signal) (iii) Single combined confocal pictures 
(40x, 1.7x zoom) from a triple positive zebrafish trunk that expresses EGFP-hZO1 in a highly mosaic fashion. 
Magnification of a single picture of the region indicated.  
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In the following chapter I will summarize the highlights of the publication : 
 
 
Distinct Cellular Mechanisms of Blood Vessel Fusion in the Zebrafish Embryo 
 
 
Lukas Herwig*, Yannick Blum*, Alice Krudewig, Elin Ellertsdóttir, Anna Lenard, Heinz-Georg 
Belting and Markus Affolter *these authors contributed equally to this work 
 
 
Current Biology 21 (2011) 1942–1948 
Published online November 22, 2011 
 
 
This publication was mentioned as an editor’s choice article in Science 9 December 2011, 
Network development, Beverly A. Purnell (see 9.3, p.107) 
 
Contribution: 
I generated the transgenic zebrafish reporter assay we used in this study to analyze the 
basic morphogenetic aspects of vessel fusion (see above). I performed the live imaging 
experiments (using wild type, transgenic and morphant fish embryos) together with Y. Blum. 
Together we did the data/imaging analysis and discussed and proposed the resulting 
models. I critically read the manuscript (written by M. Affolter and HG. Belting) during the 
writing and reviewing process, discussed it and proposed improvements to it. Together with 
Y. Blum I made, edited or contributed to all the figures.  
 
The full publication and supplementary information can be found in the appendix section of this thesis on page 9.2.1, p. 103; 
supplementary information (movies and figures) and the full publication are also stored on a DVD enclosed in the appendix 
section. 
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5.1.2 Summary of the publication: “Distinct Cellular Mechanisms of 
Blood Vessel Fusion in the Zebrafish Embryo” 
During ISV vessel fusion, neighboring sprouts of ISVs establish contact and subsequently 
form a lumen between each other. This process of vessel fusion or anastomosis, results in 
the formation of a new vessel, the dorsal longitudinal anastomotic vessel (DLAV) (Figure 18 
and Movie 1 on DVD in appendix), which is found along the anterior-posterior axis, on either 
side of the neural tube.  
 
Figure 18 Overview on the process of vessel fusion. (A-D) Different steps during dorsal longitudinal 
anastomotic vessel (DLAV) formation. Tip cells reach the dorsal side of the embryo and send filopodia in anterior 
and posterior directions (arrow in 00:18 [hr:min]). The adjacent tip cells contact each other, fuse and form the 
future DLAV (arrow in 00:48). Later the lumen opens from the stalk and proceeds into the DLAV (arrows in 4:12 
and 7:08). Scale bar = 20µm. Figure adapted from Herwig et al., 2011. 
As a first step, we compared the expression pattern of our reporter EGFP-hZO1 with the 
endogenous wild type protein using a VE-cadherin antibody which co-localizes with ZO1 
(Blum et al., 2008). We found that EGFP-hZO1 recombinant protein co-localized with 
endogenous VE-cadherin and thus endogenous ZO1 and is expressed throughout vascular 
development (Figure 33, p.105). Further, we observed a dynamic behavior of EGFP-hZO1 
during the fusion process revealing for the first time, in vivo, the dynamics of junctional 
complexes during blood vessel development.  
We next characterized the cellular architecture of the DLVA at 48 hpf, when it is fully 
lumenized, by the photoconversion of single cells in this vessel in Tg(fli1ep:Gal4FFubs3-
4;UAS:KAEDErk8) embryos. Followed by immunostainings, using a VE-cadherin antibody, we 
detected different cellular architectures in the DLAV: multicellular tubes as well as seamless 
tubes (Figure 19). In accordance with these results, live observations at 2 dpf using 
transgenic fli1ep:Gal4FFubs3;UAS:EGFP-hZO1ubs5 embryos revealed the same results (Figure 
20).  
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Figure 19 Different vessel architectures in the intersegmental vessel (ISV)/DLAV I. Single, photo-converted 
cells (red) show a unicellular (A) or a multicellular arrangement (B). Inserts (i–iii) in (A) and (B) show a surface 
calculation (i), a sagittal section (ii) and a cross-section (iii) at the sites indicated by crosshairs (n = nucleus). (C–
D) Single photo-converted cells (red) and corresponding VE-cadherin (VE-cadherin) immunostainings. 
Arrowheads indicate regions of unicellular (C and C’) and multicellular (D and D’) tubes. All pictures 48hpf, 63x 
and 4x zoom, scale bar = 20µm. Figure adapted from Herwig et al., 2011. 
 
We have previously suggested a model for vessel anastomosis (Blum et al., 2008), where at 
the beginning of each fusion event filopodial extensions of neighboring tip cells contact each 
other and increase their mutual surface, which is demarcated by a “dot-to-ring-like” transition 
of junctional proteins (VE-cadherin; ZO1) (see Figure 11, p.27). Following the in vivo 
dynamics of the EGFP-hZO1 protein, localized at these sites of contact, we were able to 
confirm our previously proposed model. Endothelial cells contact each other and form a dot 
like spot of junctional protein that, within about 40 min, extends into a ring as the contacting 
extensions increase their mutual surface (Figure 21 and Movie2). This surface within the 
elaborating ring-like structure can be classified as an apical membrane compartments as 
indicated by immunostainings using an antibody against the apical protein Podocalyxin2 
(Pdxl2) (Figure 24 and Figure 33, p.105).  
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Figure 20 Different vessel architectures in the intersegmental vessel (ISV)/DLAV II. A unicellular tube 
outlined by EGFP-hZO1 fusion protein is shown in (A), and multicellular/unicellular arrangements represented by 
EGFP-hZO1 protein are shown in (B). (A) Individual cells (n=nucleus) are separated by each other by junctional 
rings, no junctions are found along the tubular axis. The yellow arrow in (A), points at delocalized EGFP-hZO1 
protein in the cell membrane, most likely due to elevated levels of protein. (B) Multiple junctions run along the axis 
of the ISV, representing multicellular tubes. These are connected to rings in the DLAV, where again seamless 
tubes can be found. (A’ and B’) show different views/angles from (A) and (B). All pictures 48hpf, 63x and 4x zoom, 
scale bar = 20µm. Figure adapted from Herwig et al., 2011. 
 
 
Figure 21 Contact formation during vessel fusion. (A–C) VE-cadherin immunostainings of 30hpf old 
Tg(fli:EGFP)y1 embryos. Dot-like structures, small and larger rings are shown (see white arrows). (D–F) Still 
pictures of Movie 2 found on DVD in appendix) showing a time-lapse of a 
Tg(fli1ep:GalFFubs3;UAS:RFP;UAS:EGFP-ZO1ubs5) embryo. An initial contact spot of EGFP-ZO1 (arrow in D) is 
elaborated into a small (arrow in E) and subsequently into a larger ring (arrow in F). The yellow arrow in (F) points 
to delocalized EGFP-ZO1 in the cell membrane. 32hpf, 63x, scale bar = 20µm, [hr:min]. Figure adapted from 
Herwig et al., 2011. 
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Our in vivo analysis of Tg(fli1ep:Gal4FFubs3;UAS:RFP;UAS:EGFP-hZO1ubs5) embryos 
revealed two distinct cellular morphogenetic mechanisms of how individual neighboring ISVs 
fuse to each other, which ultimately results in the formation of tubes of different cellular 
architecture. In a first mechanism, we found neighboring ISVs to fuse by a cord hollowing 
mechanism (see also 3.1.3.2, p.9), that depends on cell rearrangements and results in the 
formation of a multicellular tube (Figure 22 and Movie3).  
 
Figure 22 Anastomosis by cord hollowing. Still pictures from Movie 3 on DVD in the appendix, showing a time-
lapse figure series of a Tg(fli1ep:GalFFubs3;UAS:RFP;UAS:EGFP-ZO1ubs5) embryo during vessel fusion (total 
length: 9:20 [hr:min]). (A–C) A tip cell has established contact with an adjacent tip cell (right arrow) and has 
contact with a stalk cell (left arrow), which results in two rings of EGFP-ZO1 (A). These loops extend and 
eventually meet (B and C). (A’–D’) shows the junctional outline of participating cells (yellow: ‘‘central’’ cell, green: 
stalk cell, red: DLAV cell moving in from posterior). The two initial cell contacts are shown in yellow/green and 
yellow/red, respectively. When the stalk cell and the adjacent DLAV cell meet, they establish a new contact with 
‘‘green and red’’ junctions (arrow in D, green and red line in D’). (all pictures, 63x, scale bar = 20µm). (E) 
Schematic overview of pictures (A-D):  (i) several cells (pink, blue and yellow) enlarge their contact surfaces. (ii) 
Further cell rearrangements generate a novel contact between the pink and yellow cell and lead to a local 
detachment of the blue cell at the novel contact site (ii-iii). As a result, two local compartments (blue/pink and 
blue/yellow) merge into a single multicellular lumen. Longitudinal sections along the black line (see (i)) are shown 
below each step (i-iii). Figure adapted from Herwig et al., 2011. 
 
Here, cell rearrangements of at least three cells increase and bring together two apical 
membrane compartments, demarcated by junctional rings of EGFP-hZO1 that will coalesce 
and form a continuous luminal space. In this scenario, a tip cell is connected to a stalk cell 
and a neighboring tip cell. The two latter ones will rearrange over the central tip cell thereby 
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bringing together two apical membrane compartments, the one formed between the two tip 
cells and the one formed between the central tip and stalk cell. This behavior results in the 
formation of a new junction at the site of contact between the individual membrane 
compartments. We suggest that dislocation of the tip cell at the site of the newly established 
contact results in the coalescence of the former individual compartments to one continuous 
membrane compartment (Figure 22).  
 
Figure 23 Anastomosis by membrane invagination. Still pictures from Movie 4 on DVD in the appendix, 
showing a time-lapse of a Tg(fli1ep:GalFFubs3;UAS:RFP;UAS:EGFP-ZO1ubs5) embryo (total length: 10:25 
[hr:min]). (A and B) A tip cell has formed initial contacts and subsequently forms loops of EGFP-ZO1 with its 
adjacent partner (white arrows). The stalk shows a multicellular organization (two lines of EGFP-ZO1, arrowhead 
in B) and an opening lumen (yellow arrow in B). (C) The lumen projects into the fusion cell (follow arrow from C to 
E) and finally reaches the left ring of EGFPZO1, which is subsequently inflated (arrow in F). The lumen then 
continues to extend into the unlabeled fusion cell on the left (arrow in G). A blood cell then passes through the 
newly formed lumen (follow arrowhead from G–J). Insets show the blood cell passing behind the junction (G) and 
in front of the junction (H). (all pictures, 63x, scale bar = 20µm). (J) Schematic overview of pictures (A-I):  A lumen 
extends from the dorsal aorta into the stalk and pushes into the “fusion/tip” cell (blue) (i) (The lumen is visualized 
in a lighter shade of the color of the surrounding cell). As the lumen reaches the distal end of the fusion cell (ii), it 
merges with a local luminal compartment at the contact and begins to push into the neighboring EC (iii). Figure 
adapted from Herwig et al., 2011. 
 
Results 
58 
 
In a second fusion scenario, we observed a membrane invagination mechanism depending 
on strong cell shape changes in the tip cell, which will generate a seamless or “transcellular” 
tube. Here, apical membrane invaginates (Figure 24 and Movie 4) and extends through a tip 
cell until this membrane reaches and coalesces with one of the previously formed apical 
membrane compartments (at the sites of contact between neighboring ISVs), thereby 
generating a continuous lumen (Figure 23). A lack of blood pressure does not affect cell 
rearrangements during ISV fusion, since the observed dynamics of EGFP-ZO1 in zebrafish 
embryos treated with an ATG-morpholino against tnnt2a gene (silent heart) (Sehnert et al., 
2002), which blocks the contraction of the heart, are comparable to the wild type condition 
(Movie 5). However, the apical marker Pdxl2 in this morphant background was only found 
between junctional complexes, labeled by VE-cadherin antibodies, and a complete absence 
of the apical protein in seamless regions (regions where no junctions were detected) was 
observed (Figure 24). This indicates that blood pressure is a driving force for membrane 
invagination, and thus, is essential for the membrane invagination mechanism; in contrast 
cell rearrangements during the cord hollowing mechanism seems to be unaffected.  
 
Figure 24 Apical membrane during ISV vessel fusion. Pdxl2 is localized within a junctional ring (arrow) at the 
contact site of two tip cells at the onset of anastomosis (36 hpf). (B–B’’) Apical membrane invagination of a tip cell 
at 36 hpf is shown by Pdxl2 immunostaining. (C–C’) In silent heart morphants at the same stage, the Pdxl2 
staining is only seen within the junctional rings, indicating that apical membrane invagination does not take place 
in the absence of blood flow. ZO1 antibody is shown in white, Pdxl2 antibody in green, and kdrl:EGFP in red. 
Scale bar = 20µm, kdrl = VEGFR2. Figure adapted from Herwig et al., 2011. 
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Figure 25 A model of cellular mechanisms during anastomosis. (A and A’) Contact formation during vessel 
fusion is shown in (A) and corresponding sagittal sections in (A’). At the contact site of two neighboring tip cells 
(green and purple), junctional proteins are deposited (yellow spot in i). As the cells increase their mutual surface, 
this spot transforms into a ring (ii and iii), and the enclosed membrane compartment becomes apically polarized 
(dark green and dark purple areas). Subsequently, two different cellular mechanisms are used to complete the 
fusion process (see B and C). (B) A cord hollowing mechanism results in a multicellular tube. Cell rearrangements 
bring together two junctional rings, i.e., two apical membrane compartments that then merge into one membrane 
compartment. This is achieved by the formation of a new junction (orange) between the green and blue cell, 
which leads to the detachment of the middle cell (purple) at the site of the new contact. (C) Cell membrane 
invagination leads to the formation of a unicellular, seamless tube. Here, apical membrane of the green cell 
invaginates into the green cell. It then fuses with its own apical membrane at the previously formed contact side 
between the green and purple cells (see A). From here the lumen, i.e., the apical membrane of the neighboring 
cell (dark purple), begins to invaginate. Endothelial cells are shown in green, purple, and blue; apical membranes 
are shown in dark green, dark purple and dark blue; endothelial cell junctions are shown in yellow; and new 
endothelial cell junctions are shown in orange. Figure from Herwig et al., 2011. 
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Taking together, using transgenic zebrafish reporter assays (see also 5.1.1, p48), which 
allow the labeling of single ECs and endothelial cell-cell junctions in a mosaic fashion, and 
generation and analysis of a novel apical marker (Pdxl2), we deciphered a membrane 
invagination and cord hollowing mechanism during intersegmental vessel fusion in the 
zebrafish embryo. These two mechanisms lead to the formation of tubes of different cellular 
architecture, i.e. seamless tubes and multicellular tubes, respectively.  
5.2 A VE-cadherin EGFP fusion reporter line 
While ZO1 is a general epithelial tight junctional protein, VE-cadherin is an endothelial 
transmembrane specific adherens protein localized at the adherens junction complex 
between cells in the endothelium. It is this transmembrane component of the adherens 
junction complex, that plays a key role in barrier function, angiogenesis and intracellular 
signaling, which controls cell dynamics and cell cycle progression (reviewed in Harris and 
Nelson, 2010; Vestweber, 2008, see also 3.1.1, p.4). Therefore, I further engineered a 
transgenic zebrafish UAS-reporter line carrying an EGFP tagged version of VE-cadherin 
(Figure 26 and Figure 27). Since a full-length fusion construct was shown to be toxic 
(personal communication H-G. Belting (Affolter lab) and J. Essner, Iowa State University), my 
goal was to generate a biological inert (non-dominant negative) VE-cadherin recombinant 
reporter protein, which does not signal and interact with the cytoskeleton of ECs but still 
exerts its adhesive functions. It is well known that the cytoplasmic domain of cadherins can 
be bound directly by β-catenin and plakoglobin, which in addition can be both bound by α-
catenin (Aberle et al., 1994; Jou et al., 1995; Nieset et al., 1997; Obama and Ozawa, 1997). 
α-catenin, in turn, binds directly to actin (Rimm et al., 1995). Thus, VE-cadherin is thought to 
be coupled to the actin cytoskeleton by such cytoplasmic interactions, i.e. by β-catenin, 
plakoglobin and α-catenin (Harris and Nelson, 2010; Lampugnani and Dejana, 1997). 
Furthermore, VE-cadherin, in confluent cells, can bind via β-catenin to VEGFR2 and thereby 
reduces its signaling (Lampugnani et al., 2003; Lampugnani et al., 2006; Rahimi and 
Kazlauskas, 1999). In addition, a specific conserved amino acid motif (YDEEGGGE) is 
critical for p120-catenin binding to E-cadherin and VE-cadherin (Thoreson et al., 2000; 
Ferber et al., 2002). Interestingly, p120-catenin has been suggested to be involved in cell 
proliferation since cell proliferation is reduced in the presence of a mutant form of VE-
cadherin lacking this conserved amino acid motif (Ferber et al., 2002). Furthermore, as 
mentioned earlier, β-catenin and α-catenin are thought to shuttle from their VE-cadherin 
binding sites to the nucleus where they can regulate gene expression. Taken together, the 
cytoplasmic domain of VE-cadherin is likely involved in signaling and actin cytoskeleton 
interactions. 
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To this end, I used a full-length VE-cadherin EGFP fusion construct (a kind gift from J. 
Essner) and deleted the intracellular domain of VE-cadherin by “single-primer mutation 
technique” (Makarova et al., 2000), which resulted in VEcad∆CD-EGFP. In transient 
expression experiments I found that this EGFP-tagged deletion construct is expressed in 
ECs and appeared as dots and lines of stronger signal. This behavior was quiet similar to 
what I had seen previously in transient expression experiments using a pG1UAS:EGFP-
hZO1 construct (Figure 34, p.106) and see also Master Thesis of L. Herwig, 2007, p.63, 
Figure 28). 
 
Figure 26 A non-dominant negative VE-cadherin deletion construct. The cytoplasmic domain of VE-cadherin 
in a full-length EGFP fusion construct was deleted using single-primer technique and cloned downstream of a 
5xUAS cassette. Primer sites (3’-header and 5’-tailer = black broken arrow), specific domains (colored triangles) 
of VE-cadherin, EGFP (green arrow) and sequence after the deletion are given: red, signaling sequence; blue, 
extracellular domains; pink, ionic region; purple, transmembrane domain; orange, cytoplasmic domain. As visible, 
the full cytoplasmic domain has been deleted except for the 5 first amino acids of the cytoplasmic domain. 
Therefore, in order to generate a stable transgenic zebrafish reporter line, I co-injected the 
described deletion construct together with a fli1ep:Gal4FF-cmlc2:EGFP construct and Tol2 
transgenesis RNA into wild type embryos. From transiently expressing embryos I was able to 
select a positive founder fish that gave rise to a Tg(fli1ep:Gal4FF-
cmlc2:EGFP;UAS:VEcad∆CD-EGFP) line with the allelic designation ubs12 Figure 27 (for 
more information see also 4.4.3.3, p.46). In this line, VEcad∆CD-EGFP recombinant protein 
co-localizes with endogenous ZO1 and is almost uniformly expressed in the whole 
vasculature (Figure 27 and Figure 35, p.106). Further, I observed a similar dynamic behavior 
of this protein during the fusion process as seen in the transgenic UAS:EGFP-ZO1 reporter 
fish and, thus, was able to confirm some of our findings regarding the processes of 
intersegmental vessel fusion (see below and previous chapter 5.1.2, p.53).  
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Figure 27 Overview of the VEcad∆CD-EGFP reporter system. (i) Crossing between Tg(fli1ep:Gal4FF-
cmlc22:EGFP;UAS:VEcad∆CD-EGFP)ubs12 driver-effector line and Tg(UAS:RFP) effector fish results in triple 
positive transgenic embryos, where (ii) Gal4FF drives endothelial specific expression of the 5xUAS-driven RFP 
and 5xUAS-driven VEcad∆CD-EGFP protein. The heart marker cassette on the fli1ep:Gal4FF allele drives EGFP 
expression in the heart, and facilitated the generation of the VEcad∆CD-EGFP allele (for more information see 
4.4.3.3, p.46). (E1b, minimal promoter element; Tol2, left and right transposable tol2-arms for transgenesis; pA, 
polyadenylation signal; TATA, TATA-box). (iii) Single combined confocal pictures (40x, 1.7x zoom) from a triple 
positive zebrafish trunk that expresses VEcad∆CD-EGFP uniformly in the whole vasculature. Magnification of a 
single picture of the region indicated.  
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During the fusion process, immediately after filopodial extensions made contact to each 
other, VEcad∆CD-EGFP became apparent as dot-like structures which elaborated into rings 
(Figure 28, p.63 and Movie6) as we had seen and described using the UAS:EGFP-hZO1 
reporter line  (see Figure 21, p.55 and Movie 2). I further was able to observe the membrane 
invagination mechanisms described above when following VEcad∆CD-EGFP after adjacent 
tip cells had established their contact (Figure 29 and Movie7, see also Figure 23, p.57 and 
Movie 4 and Figure 23).  
 
Figure 28 Contact formation visualized by VEcad∆CD-EGFP.  (A-H) Still pictures from a time lapse (Movie6 on 
DVD) of a Tg(fli1ep:Gal4FF;VEcad∆CD-EGFP;UAS:RFP) embryo during intersegmental contact formation. (i) 
Filopodial extensions of neighboring tip cells contact each other. In (A and B), extensions have not yet established 
contact. VEcad∆CD-EGFP appears as a small puncta or dots in (C) and then subsequently elaborates into a ring 
(follow white arrows and insets (C-H)). Picture series from confocal time lapse movie, 32 hpf, with 40x, 1.7x zoom. 
 
Figure 29 Membrane invagination visualized by VEcad∆CD-EGFP. (A-H) Still pictures from a time lapse 
(Movie 7 on DVD) of a Tg(fli1ep:Gal4FF;VEcad∆CD-EGFP;UAS:RFP) embryo during intersegmental vessel 
fusion. (ii) Membrane invagination during ISV vessel fusion is indirectly visualized by VEcad∆CD-EGFP.  The tip 
cell makes contact to one of its neighboring tip cells (yellow arrow in A-H)) while it remains connected to the stalk 
of the ISV (yellow arrow head in A-H). As visible (follow white arrows in A-H) the membrane  invaginates and 
extends into the fusion cell and eventually reaches and coalesces (H) with the previously formed apical 
membrane compartment between the neighboring fusion cells resulting in a transcellular lumen (see also Figure 
23, p.57). Picture series from confocal time lapse movie, 32 hpf, with 63x, 1.7x zoom. 
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5.3 Further observations regarding vessel fusion 
Using the UAS:EGFP-hZO1 line, that labels the tight junctions of endothelial cells, I was able 
to observe further fusion events between other endothelial sprouts/vessels than the 
neighboring ISVs.  
During ISV fusion a new vessel, the DLAV, is generated on each side of the neural tube 
(Isogai et al., 2001 and this thesis). At around 48hpf endothelial cells in each of the bilaterally 
aligned DLAVs form lumenized sprouts that migrate over the neural tube and eventually fuse 
with the DLAV on the other side of the tube. These connecting sprouts between the lateral 
DLAVs seem to be luminized already upon fusion (Figure 36, p.107 and Movie 8). Still, these 
vessels depict the same mechanism, of dot-to-ring-like junctional elaboration (Figure 30 and 
Movie 9 and Movie 10).  
 
Figure 30 Contact formation between the neighboring DLAVs which run in parallel on each side of the 
neural tube. (A-H) A sprout from the DLAV located on the other side of the neural tube fuses with the neighboring 
DLAV. (A) Extensions of a sprout become apparent and (B) make contact to the junction(s) of the neighboring 
DLAV, as visualized by the dot like deposition of EGFP-hZO1 protein. This dot elaborates into a ring as seen in 
Figure 21. Small insets represent top view of the site undergoing vessel fusion. (I) The white insets represent a 
rendering of the site indicated, (green; junctions only, green/red; junctions and cytoplasmic RFP). It is visible, that 
a unicellular tube is connected to the DLAV by the newly generated ring. Picture series from confocal time lapse 
movie (see Movie 9 and Movie 10) of a Tg(fli1ep:Gal4FFubs3;UAS:EGFP-hZO1ubs5) embryo, 48hpf, 63x, 2x zoom, 
scale bar = 20µm. 
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Further, during secondary sprouting (see also 3.2.4.2.7, p.25), when endothelial sprouts from 
the posterior cardinal vein connect to the previously formed ISVs, I again observed this 
behavior. Here, a lumenized sprout contacts the previously formed ISV by filopodial 
extensions. As soon as a contact is established a junctional ring is formed at the site of 
contact and finally the two vessels fuse displaying a continuous lumen that allows blood cell 
circulation, as shown by a number of blood cells passing serendipitously through the newly 
formed ring and vessel connection (Figure 31 and Movie 11). 
 
Figure 31 Contact formation between a secondary intersomitic sprout and a primary ISV. (A-H) A 
secondary sprout fuses with a primary ISV. (A) A filopodial extension is growing towards an ISV (white arrow 
head) and makes contact to its junctions, as represented by a small dot/circle (white arrow in B). This ring is 
subsequently transformed into a bigger ring (follow white arrows from (C-G)) and eventually blood cells can pass 
the two connected vessels (asterisk in H). (H) The white insets represent a rendering of the site indicated. As 
visible the blood cells pass through the newly generated ring, demonstrating a patent luminal space and a new 
connection between the former individual vessels. Picture series from confocal time lapse movie (see Movie 11) 
of a Tg(fli1ep:Gal4FFubs3;UAS:EGFP-hZO1ubs5) embryo, 48hpf, 63x, 2x zoom, scale bar = 20µm. 
Interestingly, in both fusion events the filopodial structures connect at sites of endothelial 
cell-cell contacts since the elaborating rings are formed and integrated at previously 
established junctional complexes of the target vessels (Figure 30 and Figure 31). 
5.4 Transient expression of a non-repetitive UAS-driven EGFP-
hZO1 reporter construct 
The adaption of the Gal4/UAS system to the zebrafish (Scheer and Campos-Ortega, 1999; 
Köster and Fraser, 2001) has opened up new possibilities regarding gene expression 
analysis and the generation and use of novel fluorescent reporter lines. However, we and 
other laboratories have encountered difficulties maintaining a uniformly expressing UAS 
reporter line when using the 14xUAS cassette (see also 6.2.2, p.86). Recently, a 4x non-
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repetitive UAS-driven GFP reporter construct (4Xnr:GFP) had been shown to be strongly 
expressed and less silenced than a 14xUAS reporter line over several generations (Akitake 
et al., 2011). Therefore, I cloned a 4Xnr:EGFP-hZO1 reporter construct and injected it into 
fertilized Tg(fli1ep:Gal4FF;UAS:RFP) zebrafish eggs at the one cell stage (Figure 32).  
 
Figure 32 Transient expression of a 4x non-repetitive UAS:EGFP-hZO1 reporter construct. ((A-H) and (A’-
H’), green channel only)) 4XnrUAS-driven EGFP-hZO1 localizes to the tight junctional complex in ECs when 
activated by endothelial specific Gal4FF driver fish. Junction between the tip cell and a stalk cell are visible (white 
arrow in (A and B) and small inset in (B). This junction subsequently enlarges into a ring between the cells (F). In 
(F) asterisks and small inset indicate sites of contact formation between the tip cells. (H) A junctional ring 
connecting two cells is well visible (small inset). Picture series from confocal time lapse movie, 32hpf-38hpf, 40x, 
1.7x zoom, scale bar = 20µm, n = nucleus. 
These embryos showed strong and transient expression of EGFP-hZO1 in single endothelial 
cells. The dynamics of EGFP-hZO1 protein in such a cell, followed over time (ca. 32 hpf – 38 
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hpf), is comparable to behaviors as we have them observed in the stable Tg(UAS:EGFP-
hZO1) line I generated (see Figure 17, p.51), which demonstrates the functionality of the 
construct and makes it a possible candidate for a less mosaic and silenced junctional 
reporter line. I have injected this construct into fli1ep:Gal4FF positive fish and I am currently 
screening for putative G0 founder fish. 
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During embryonic development, the vertebrate vasculature is undergoing vast growth and remodeling.
Blood vessels can be formed by a wide spectrum of different morphogenetic mechanisms, such as budding,
cord hollowing, cell hollowing, cell wrapping and intussusception. Here, we describe the vascular
morphogenesis that occurs in the early zebrafish embryo. We discuss the diversity of morphogenetic
mechanisms that contribute to vessel assembly, angiogenic sprouting and tube formation in different blood
vessels and how some of these complex cell behaviors are regulated by molecular pathways.
© 2009 Elsevier Inc. All rights reserved.
Introduction
Branched tubular organs, such as the insect tracheal system or the
vertebrate cardiovascular system, kidney or lung, are found throughout
the animal kingdom. Formation of such tubular networks from
precursor cells or tissues involves a variety ofmorphogenetic processes,
such as tube formation, elongation, branching and fusion. These
processes are brought about by complex cellular behaviors, which
include cell polarization, cell migration, cell rearrangements, cell shape
changes and cell division. Although tubular organs are extremely
diverse in anatomy and function, the cellular activities that govern tube
formation and branching morphogenesis appear to be quite similar
(Baer et al., 2009; Andrew and Ewald, 2010). In this review,we describe
the current understanding of blood vessel formation in the early
zebrafish embryo. We are placing special emphasis on the morphoge-
netic processes that contribute to vascular development and discuss
the regulatory components that accompany these events.
In vertebrates, the cardiovascular system constitutes a highly
ramified network of tubes that transports gas, nutrients, hormones
and metabolites throughout the body. It also has important roles in
the regulation of homeostasis and wound healing and is involved in
the pathology of numerous diseases including cancer and inflamma-
tion (Carmeliet, 2003). The cardiovascular system emerges as one of
the first organs during embryonic development and retains morpho-
genetic plasticity in adult life. Blood vessels are an integral component
of all organs and are vital not only for their function but also for their
formation during embryonic development (Nikolova and Lammert,
2003; Red-Horse et al., 2007; Sakaguchi et al., 2008). Blood vessels are
highly diverse: they differ in size and are specialized depending on
their function and the tissue or organ they are embedded in (Aird,
2007; Rocha and Adams, 2009). In general, they consist of an inner
epithelium (endothelium) lining the lumen; depending on the type of
vessel, this endothelium is surrounded by a basal lamina and bymural
cells, such as pericytes and smooth muscle cells, which both support
and regulate the function of the endothelium (Armulik et al., 2005).
Over the last decade, the molecular pathways controlling vascular
development have attracted much attention, and a large number of
key molecules has been identified that regulate different aspects of
blood vessel morphogenesis. The basic frameworks of the vascular
anatomy are conserved among vertebrates, whichmakes it possible to
assign homologies between distinct blood vessels and to directly
compare the formation of these vessels in different vertebrate species
(Isogai et al., 2001; see Fig. 1). The zebrafish embryo has proven to be
a useful model to study vascular morphogenesis in vivo. The vascu-
lature can be easily visualized using a variety of labeling techniques,
such as endothelial specific expression of fluorescent protein or by
microangiography (Fig. 1). Its small size, experimental accessibility,
optical clarity and rapid development allow to observe cellular
activities, such as cell migration, cellular rearrangements and cell
divisions, as they occur during blood vessel formation in the embryo.
It is also possible to follow cardiovascular mutant phenotypes for
several days because oxygenation of the early zebrafish embryo does
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SUMMARY
Sprouting angiogenesis expands the embryonic
vasculature enabling survival and homeostasis. Yet
how the angiogenic capacity to form sprouts is
allocated among endothelial cells (ECs) to guarantee
the reproducible anatomy of stereotypical vascular
beds remains unclear. Here we show that Sema-
PlxnD1 signaling, previously implicated in sprout
guidance, represses angiogenic potential to ensure
the proper abundance and stereotypical distribution
of the trunk’s segmental arteries (SeAs). We find
that Sema-PlxnD1 signaling exerts this effect by
antagonizing the proangiogenic activity of vascular
endothelial growth factor (VEGF). Specifically,
Sema-PlxnD1 signaling ensures the proper endothe-
lial abundance of soluble flt1 (sflt1), an alternatively
spliced form of the VEGF receptor Flt1 encoding
a potent secreted decoy. Hence, Sema-PlxnD1
signaling regulates distinct but related aspects of
angiogenesis: the spatial allocation of angiogenic
capacitywithin aprimaryvessel andsproutguidance.
INTRODUCTION
Blood vessels form a pervasive tubular network that distributes
oxygen, nutrients, hormones, and immunity factors. The first
blood vessels assemble de novo via EC coalescence or vasculo-
genesis. Later, they expand via angiogenesis, the growth of new
blood vessels from preexisting ones. In some locales, this
process is stereotypic and vascular sprouts form with evolution-
arily conserved and organ-specific distribution, abundance and
shapes (Carmeliet, 2005; Isogai et al., 2001; Isogai et al., 2003).
For example, zebrafish SeAs sprout bilaterally from the trunk’s
aorta just anterior to each somite boundary (SB) (Figure 1A).
SeA sprouts contain migratory, proliferative and filopodia-rich
arterial angiogenic ECs molecularly distinct from the sedentary
‘‘phalanx’’ ECs remaining in the aorta (De Bock et al., 2009; Siek-
mann and Lawson, 2007; Torres-Va´zquez et al., 2004). Normally,
only aortic ECs near SBs acquire angiogenic capacity (Ahn et al.,
2000; Childs et al., 2002). It is thought that nonendothelial para-
crine VEGF signals promote angiogenic capacity, while Notch-
mediated lateral inhibition between ECs antagonizes it (Phng
and Gerhardt, 2009; Siekmann et al., 2008). However, the
mRNA expression of vegf-a and Notch pathway genes is incon-
sistent with the distribution of SeA sprouts. vegf-a is not tran-
scribed along SBs, but rather expressed dorsal to the aorta at
both the flanking somites’ centers and the hypochord, a midline
endodermal cell row. Notch pathway genes are expressed con-
tinuously along the aorta or broadly through the body (Hogan
et al., 2009b; Lawson et al., 2002; Leslie et al., 2007; Phng
et al., 2009; Siekmann and Lawson, 2007) (C.M.G., J.B., and
J.T.-V., unpublished data). Hence, other cascades likely modu-
late VEGF and/or Notch signaling at presprouting stages to
enable the stereotypical allocation of angiogenic capacity within
the aorta. Perturbing these unidentified cascades might change
the SeA sprouts’ reproducible number or distribution, the ratio of
aortic ECs that acquire angiogenic capacity, and/or the respon-
siveness of these cells to angiogenic cues.
Besides VEGF and Notch activity, proper SeA development
requires paracrine Sema-Plxn signaling. Type 3 semas (sema3s)
are repulsive guidance cues secreted by somites. Sema3s direct
SeA sprout pathfinding by modulating cytoskeletal dynamics via
the endothelial Sema3-receptor PlxnD1. Hence, sema3 or
plxnD1 inactivation yields similar SeA sprout pathfinding defects
in zebrafish and mice (Gay et al., 2011). Two observations made
in zebrafishmake Sema-PlxnD1 signaling a candidatemodulator
of angiogenic capacity. First, sema3 and plxnD1 expression
begins hours before SeAs sprout from the aorta at 21 hr post-
fertilization (hpf). Second, loss of Sema-PlxnD1 signaling
induces ectopic SeA sprout launching (Childs et al., 2002;
Torres-Va´zquez et al., 2004).
In wild-type (WT) animals SeA sprouts grow dorsally with
a chevron-like shape, bifurcate anteroposteriorly at the neural
tube’s roof level and interconnect with their ipsilateral neighbors
at 32 hpf forming the paired Dorsal Longitudinal Anastomotic
Vessels (DLAVs) (Isogai et al., 2003). In contrast, in plxnD1 (out
of bounds - obd) mutants and plxnD1 morphants, SeA sprouts
are misshaped and interconnect ectopically with their ipsilateral
Developmental Cell 21, 301–314, August 16, 2011 ª2011 Elsevier Inc. 301
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5.5.3 The novel transmembrane protein Tmem2 is essential for 
coordination of myocardial and endocardial morphogenesis 
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INTRODUCTION
The embryonic heart tube is initially a two-layered structure: the
outer layer of muscular myocardium contracts to propel circulation
and the inner layer of endothelial endocardium provides continuity
with the rest of the vasculature. Myocardial and endocardial cells
originate in neighboring regions of the lateral mesoderm
(Schoenebeck et al., 2007). During the process of cardiac fusion,
both cell types migrate medially in a synchronized fashion and
merge at the midline to assemble the heart tube (Bussmann et al.,
2007; Holtzman et al., 2007; Moreno-Rodriguez et al., 2006). At
later stages, cardiac maturation involves remodeling of both
juxtaposed layers during valve formation and trabeculation
(Armstrong and Bischoff, 2004; Hinton and Yutzey, 2010; Sedmera
et al., 2000). Despite the continual proximity of the myocardium
and endocardium, little is known about the mechanisms that
coordinate their development.
The coordination of myocardial and endocardial development
has been particularly well established in the context of
atrioventricular canal (AVC) formation. Both the myocardium and
endocardium undergo specialized differentiation in order to create
the characteristic morphology of the AVC and to establish the
endocardial cushions that will remodel into the atrioventricular
valve (Armstrong and Bischoff, 2004; Beis et al., 2005; Chi et al.,
2008; Hinton and Yutzey, 2010). Several studies indicate that
myocardium-endocardium communication regulates these spatially
coincident events (Armstrong and Bischoff, 2004; Hinton and
Yutzey, 2010). For example, chick explant experiments suggest that
signal transduction between atrioventricular myocardium and
atrioventricular endocardium induces endocardial cushion
formation (Mjaatvedt et al., 1987). Although several signaling
pathways have been implicated in promoting endocardial cushion
development (Armstrong and Bischoff, 2004; Beis et al., 2005;
Hinton and Yutzey, 2010), it is less clear which genes are
responsible for attenuating these signals so as to spatially restrict
atrioventricular differentiation.
Myocardium-endocardium coordination is also crucial during
cardiac fusion. The synchronization of myocardial and endocardial
migration suggests that both tissues respond to the same cues in the
extracellular environment. Some cues may emanate from the
endoderm: both myocardial and endocardial fusion are inhibited
when endodermal specification or morphogenesis is disrupted (e.g.
Holtzman et al., 2007; Kikuchi et al., 2001; Kupperman et al.,
2000). Additionally, either diminished or excessive deposition of
extracellular matrix (ECM) can hinder myocardial and endocardial
movement (e.g. Arrington and Yost, 2009; Garavito-Aguilar et al.,
2010; Trinh and Stainier, 2004). Furthermore, the myocardium and
endocardium may impact the behavior of one another.
Cardiomyocytes display aberrant migration patterns in the absence
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SUMMARY
Coordination between adjacent tissues plays a crucial role during the morphogenesis of developing organs. In the embryonic
heart, two tissues – the myocardium and the endocardium – are closely juxtaposed throughout their development. Myocardial
and endocardial cells originate in neighboring regions of the lateral mesoderm, migrate medially in a synchronized fashion,
collaborate to create concentric layers of the heart tube, and communicate during formation of the atrioventricular canal. Here,
we identify a novel transmembrane protein, Tmem2, that has important functions during both myocardial and endocardial
morphogenesis. We find that the zebrafish mutation frozen ventricle (frv) causes ectopic atrioventricular canal characteristics in
the ventricular myocardium and endocardium, indicating a role of frv in the regional restriction of atrioventricular canal
differentiation. Furthermore, in maternal-zygotic frv mutants, both myocardial and endocardial cells fail to move to the midline
normally, indicating that frv facilitates cardiac fusion. Positional cloning reveals that the frv locus encodes Tmem2, a predicted
type II single-pass transmembrane protein. Homologs of Tmem2 are present in all examined vertebrate genomes, but nothing is
known about its molecular or cellular function in any context. By employing transgenes to drive tissue-specific expression of
tmem2, we find that Tmem2 can function in the endocardium to repress atrioventricular differentiation within the ventricle.
Additionally, Tmem2 can function in the myocardium to promote the medial movement of both myocardial and endocardial cells.
Together, our data reveal that Tmem2 is an essential mediator of myocardium-endocardium coordination during cardiac
morphogenesis.
KEY WORDS: Zebrafish, Heart development, Atrioventricular canal, Cardiac fusion
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The hypothalamic neuropeptide oxytocin is required for formation of the 
neurovascular interface of the pituitary. 
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SUMMARY
The hypothalamo-neurohypophyseal system (HNS)
is the neurovascular structure through which the
hypothalamic neuropeptides oxytocin and arginine-
vasopressin exit the brain into the bloodstream,
where they go on to affect peripheral physiology.
Here, we investigate the molecular cues that regulate
the neurovascular contact between hypothalamic
axons and neurohypophyseal capillaries of the ze-
brafish. We developed a transgenic system in which
both hypothalamic axons and neurohypophyseal
vasculature can be analyzed in vivo. We identified
the cellular organization of the zebrafish HNS as
well as the dynamic processes that contribute to
formation of the HNS neurovascular interface. We
show that formation of this interface is regulated
during development by local release of oxytocin,
which affects endothelial morphogenesis. This cell
communication process is essential for the estab-
lishment of a tight axovasal interface between the
neurons and blood vessels of the HNS. We present
a unique example of axons affecting endothelial
morphogenesis through secretion of a neuropeptide.
INTRODUCTION
The neuroendocrine system is composed of neurosecretory
brain cells that transfer hormones into the bloodstream to influ-
ence the function of target cells throughout the body. The hypo-
thalamo-neurohypophyseal system (HNS) is a major neuroendo-
crine conduit through which the brain controls peripheral
physiology (Burbach et al., 2001). The anatomy and activities
of the HNS are conserved in all vertebrates. Ramon Cajal
was the first to provide a description of the nerve fibers that
connect the hypothalamus with the posterior pituitary (Cajal,
1911). It has since been established that these hypothalamic
neurons themselves secrete neurohormones directly into the
blood circulation, a finding that arose from experiments in both
fish and mammalian models (Bargmann, 1949; Harris, 1948b;
Scharrer, 1928). The hypothalamic neuropeptides arginine-
vasopressin (AVP) and oxytocin (OXT) are synthesized in mas-
sive magnocellular neurons in the hypothalamus, transported
along axons all the way down to the neurohypophysis, where
they are secreted (Brownstein et al., 1980). Within the neurohy-
pophysis, AVP and OXT are released from axons of the supraop-
ticohypophyseal tract into fenestrated capillaries, thus leaving
the brain and entering the general circulation without disrupting
the blood-brain barrier (Burbach et al., 2001).
In the general circulation, secreted AVP regulates water
homeostasis by increasing water permeability of the collecting
duct of the kidney, and oxytocin regulates labor and milk let
down by causing the respective contraction of the smooth
muscle of the uterus and of the myoepithelial cells of breast
ducts (for review, see Burbach et al., 2001; Gimpl and Fahren-
holz, 2001; Verbalis, 2007). These physiological activities are
conserved: in teleost fish, the AVP-like neuropeptide (Avpl)
(a.k.a. arginine-vasotocin) regulates water balance by affecting
filtration in the kidney (Amer and Brown, 1995; Macfarlane and
Maetz, 1974; Peter and Fryer, 1983) and oxytocin-like neuropep-
tide (Oxtl) (a.k.a. isotocin) regulates contraction of smooth
muscles in the ovary and oviduct during parturition or oviposition
of live bearing and egg laying fish (La Pointe, 1977; Peter and
Fryer, 1983). Avpl and Oxtl also regulate blood pressure in the
ventral aorta (Chan, 1977; Kulczykowska, 1998; Le Mevel
et al., 1993; Peter and Fryer, 1983). TheHNS is therefore a central
point of interface between the hormonal, neuronal, and vascular
systems common to all vertebrate species.
The neurohypophysis is an elaborate three-dimensional struc-
ture, which substantially complicates the interpretation of
cellular interactions and dynamics based solely on tissue
sections. Although the anatomical structures of the neurohypo-
physeal axons and blood vessels have been the focus of intense
study for over a century (Bargmann, 1949; Fink and Smith, 1971;
Harris, 1948a; Scharrer, 1928), little progress has been made in
uncovering the molecular and cellular processes that underlie
formation of the interface between hypothalamic axons and
642 Developmental Cell 21, 642–654, October 18, 2011 ª2011 Elsevier Inc.
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6 Discussion 
 
6.1 Blood vessel fusion 
In this thesis, I have used the zebrafish intersegmental vessels (ISVs) as an in vivo model to 
study single cell morphogenetic mechanisms that underlie the process of blood vessel 
fusion. During vessel fusion, endothelial cells (EC) face different tasks: ECs need to find their 
appropriate partners within the tissue, they need to establish a stable contact and finally, they 
need to form a lumen de novo, which will interconnect the two former individual sprouts, 
resulting in the formation of a new vessel. Using confocal live imaging technique, novel 
transgenic zebrafish lines (fli1ep:Gal4FFubs3 and UAS:EGFP-hZO1ubs4) and immunostainings, 
including an apical marker (zf-podocalyxin2), we found a specific behavior during contact 
formation between neighboring extensions of fusing ISVs. Further, we observed two distinct 
cellular mechanisms - a membrane invagination and a cord hollowing mechanism - that both 
can contribute to vessel fusion between the zebrafish ISVs. These two mechanisms are 
intrinsically connected to lumen formation but use two distinct cellular behaviors, i.e. 
membrane invagination and cell rearrangements, and lead to the formation of tubes of 
different cellular architecture - seamless tubes and multicellular tubes, respectively (Figure 
25, p.59). The process of vessel fusion, has (up to the publication found in this thesis, Herwig 
et al. 2011) not been analyzed in vivo. However, already more than 20 years ago Kubota and 
colleagues designed an “endothelial cell tube formation assay” that allows the formation of 
capillary-like structures by human umbilical vein endothelial cells (HUVECs) when cultured 
on a basement membrane protein matrix (Kubota et al., 1988). Further, Nakatsu and 
colleagues have developed an optimized  three-dimensional in vitro assay using HUVECs, 
that entails the major steps of angiogenesis, including the sprouting, migration, alignment, 
proliferation, tube formation, branching, and anastomosis of endothelial sprouts (Nakatsu et 
al., 2003; Nakatsu and Hughes, 2008). Such in vitro assays, including the many steps of 
angiogenesis, have thus been used for many applications, for instance, the screening for 
angiogenic or anti-angiogenic factors (Arnaoutova et al., 2009). A major contribution, 
however, is their use in getting a better molecular understanding of endothelial tube 
formation during angiogenic sprouting (reviewed in Davis et al., 2011). Although the same 
genes and morphologic behaviors are required during in vitro and in vivo tubulogenesis, in 
vitro systems can not model or mimic all the complex interactions that are taking place during 
angiogenesis in vivo. The lack of blood flow or the native environment of blood vessels, for 
instance, cannot be integrated, or only to a limited extend, when using in vitro systems 
(Nakatsu and Hughes, 2008). Thus, the work using in vivo systems of different vertebrate 
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organisms such as the mouse, zebrafish or chick embryo, has led to important advances in 
the understanding of angiogenic processes. 
6.1.1 Contact formation during blood vessel fusion 
As early as neighboring filopodial extensions contact each other during contact formation of 
fusing ISVs, we observed dot-like cell-cell junctions that are transformed into junctional rings 
within less than 40 minutes, as the mutual surface of the extensions enlarges (Figure 21, 
p.55). Using an antibody against zebrafish podocalyxin2 (podocalyxin is a known apical 
marker in epithelial cells (Meder et al., 2005) belonging to the family of CD34 sialomucins), 
we observed polarization of the contact area within the elaborated rings (Figure 24, p.58), 
specifying them as apical membrane compartments. Podocalyxin and CD34 have been 
recently shown to localize apically during lumen formation of the mouse dorsal aorta (Strilic 
et al., 2009). In this system, podocalyxin and CD34 are recruited to cell-cell contacts 
between ECs that initially form a cord-like structure, in which neighboring cells are connected 
to each other and express junctional molecules (VE-cadherin) all along their entire cell–cell 
contacts. After the relocalization of junctions between the neighboring ECs (VE-cadherin 
becomes localized to the cell borders), an apical, future luminal domain is specified by 
podocalyxin and CDC34 and is outlined by VE-cadherin positive junctions; later, a lumen is 
formed at this site. This establishment of an apical domain, where a future lumen is going to 
be formed, is similar to what we have seen at the site of contact formation of anastomosing 
ISVs. However, we were not able to resolve a luminal space between the two apical 
membranes at the site of contact. Polarization of these membrane compartments, prior to the 
morphogenetic movements, that lead to lumen coalescence (see below and Figure 25, p.59), 
as well as their immediate inflation (see Movie 3 and Movie 4) after coalescence with an 
extending lumen, however, suggest early formation of an extracellular space between the 
neighboring membranes in such compartments at the site of contact. The generation of such 
an extracellular space might be partially explained by electrostatic cell-surface repulsion, 
generated by sialic acids found on the extracellular domain of podocalyxin. Such electrostatic 
forces have been shown to be essential for lumen formation in developing blood vessels 
since removal of the negative charge of sialic acids reduces vascular lumen formation in the 
DA (Strilic et al., 2010). Further, mice deficient for podocalyxin fail to form a lumenized DA 
(Strilic et al., 2009). It will be interesting to see whether Pdxl2 has similar functions in the 
zebrafish during vessel fusion or even at earlier stages when the DA is formed.  
The establishment of the observed apical compartments requires the de novo formation of 
apical membrane. It has recently been suggested by Bryant and colleagues that MDCK cells 
use so called apical membrane initiation sites (AMIS) during the polarization/lumen formation 
process to specify the site of apical polarization (AMIS: specific sites between contacting 
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MDCK cells formed at a stage where tight junction markers and podocalyxin cannot be 
resolved by confocal microscopy). In knockdown experiments Rab11a positive vesicles were 
found to recruit podocalyxin, initially localized at the periphery of the cells, to AMIS at the 
future apical/luminal site between neighboring cells. Such AMIS are then transformed into 
pre-apical patches (PAPs), the sites where the future luminal space will be formed (Bryant et 
al., 2010) (PAPs: early apical structures where tight junctions are localized differentially from 
podocalyxin that generates a separation of two opposing plasma membranes, which, 
however, is not yet resolvable optically (Ferrari et al., 2008)). It was also shown that VE-
cadherin knockout mice fail to proper localize podocalyxin and CD34 to the future luminal 
side (Strilic et al., 2009) and murine endothelial cells, genetically ablated for VE-cadherin, 
display ectopic podocalyxin at their basal side in 2D culture (Lampugnani et al., 2010). 
Further, it is suggested that epithelial cell-cell interactions provide important cues regarding 
the initiation of the polarization of an epithelium. Cell-cell interactions cause the calcium-
dependent trafficking of E-cadherin to the sites where cells contact each other. These first 
contacts appear as E-cadherin positive “spot-like” or “puncta-like” structures  in filopodia or 
lamelipodia (Yonemura et al., 1995; Adams et al., 1996). Such “primordial cell-cell contacts” 
might serve the cell as positional cues that instruct the cells where to localize and activate 
the polarization machinery (Ebnet et al., 2004). It is then thought that subsequent 
accumulation of adhesion molecules at these sites recruits the polarity complexes that will 
initiate formation of adherens junctions (AJs) and tight junctions (TJs) and mediate the 
polarization process (Willenborg and Prekeris, 2011).We detected VE-cadherin localization 
as soon as the tip cells make contact to each other (Figure 21, p.55 and Figure 28, p.63), 
which raises the question, whether these molecules serve the tip cell as a landmark for 
polarization as the AMIS do in MDCK cells. HG. Belting (Affolter lab) is currently 
characterizing the role of VE-cadherin during ISV/DLAV formation, analyzing a VE-cadherin 
null mutant, which displays defects in vessel growth and fusion (pers. communication with H. 
Belting). The analysis of this mutant alone and in the EGFP-hZO1 background in 
combination with the Pdxl2 antibody will help to answer the question of whether VE-cadherin 
is required for proper polarization. Further, following EGFP-hZO1 in VE-cadherin morphant 
zebrafish embryos, using a splice morpholino (E2I2) against zf-VEcad (Nicoli et al., 2007), 
revealed that tip cells still contact each other but localization of EGFP-hZO1 is less specific 
and the ring-like structures we observed during contact formation in wild type embryos, are 
more “diffuse” (data not shown, and see above) indicating that polarization does not occur 
properly. However, these preliminary results need to be further quantified, as mentioned, by 
using the Pdxl2 antibody in the VE-cadherin null and EGFP-hZO1 background or by the 
generation of transgenic fish lines expressing apical fluorescent markers. 
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6.1.2 Fusion by membrane invagination mechanism 
“Seamless endothelial” cells, as described in this thesis (Figure 19, p.54 and Figure 20, p.55) 
have initially been observed in the diaphragm of the rat by electron microscopy in 1964 by 
Wolff and colleagues and were reported to be exclusively found in capillaries (Wolff, 1964; 
Bär et al., 1984). The formation of such seamless tubes in vivo has only been elucidated 
recently by Kamei and colleagues based on a previously suggested model, where ISVs are 
composed of three ECs arranged in a rod-like fashion, i.e. an inverted T-shaped cell linking 
to the dorsal aorta, a connecting cell and a T-shaped tip cell, which connects to neighboring 
ISVs (Childs et al., 2002). Using a cdc42-EGFP live marker, labeling vesicular structures in 
ECs (Bayless and Davis, 2002) as well as red quantum dot, labeling the forming lumen, it 
was suggested that in the ISVs these single cells are hollowed out by the stepwise 
intracellular fusion of vacuoles and vesicles formed de novo at distinct sites within the ECs. 
Here, the intra- and intercellular fusion of these vesicles is thought to extend a growing 
lumen in a stepwise manner, resulting in seamless vessels (Kamei et al., 2006). However, 
using our reporter system (Figure 17, p.51), we observed strong morphogenetic movements, 
i.e. cell shape changes represented by the continuous invagination of membrane into and 
finally through contacting tip cells of ISVs (Figure 23, p.57 and Movie 4). Specified as an 
apical membrane, as shown with the Pdxl2 antibody (Figure 24, p.58), this membrane is 
continuously invaginating through a single, seamless tip cell, with no junctions detected 
along its whole axis (Figure 24, p.58 and Figure 25, p.59) until the luminal invaginationit 
reaches and coalesces with the apical compartments at the site of contact. This behavior of 
membrane invagination generates an extracellular space, the lumen, which continuously 
extends and passes through the tip cell, and thus can be termed a “transcellular” lumen 
(Figure 24, p.58 and Figure 25, p.59). This finding is different to the previously proposed 
model of a stepwise cell hollowing or extension of a lumen through vacuolar fusion events. 
Furthermore, we did not see any intracellular vesicular/vacuolar fusion events, when doing 
live imaging experiments using an endothelial specific moesin-EGFP zebrafish reporter line 
(data not shown and personal communication with Elin Ellertsdottir, Affolter lab). 
The membrane invagination mechanism we describe is quite similar to a fusion mechanism 
in the tracheal system of Drosophila melanogaster, where two single tracheal cells of the 
dorsal trunk, called fusion cells, connect two individual branches to each other (Samakovlis 
et al., 1996; Tanaka-Matakatsu et al., 1996). During this fusion event, these special fusion 
cells establish a new contact, demarcated by DE-cadherin which is essential for contact 
formation (Uemura et al., 1996), and then, systematically, invaginate their membranes 
towards the common contact site. This results in two seamless “doughnut shaped” cells that 
interconnect the two former individual sprouts by a continuous lumen. In our model of 
membrane invagination, we suggest that the growing and invaginating apical membrane in 
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the tip cell of anastomosing ISVs fuses with the apical membrane which was formed de novo 
at the site of contact between the neighboring tip cells (Figure 25, p.59). Unfortunately, we 
have not been able to directly follow this membrane fusion event in vivo. However, in the 
tracheal system of Drosophila melanogaster, Samakovlis and colleagues proposed that 
during the fusion mechanism of the tracheal fusion cells, small vesicles assemble in a linear 
fashion throughout the fusion cells, fuse to each other and finally facilitate the connection 
with the apical membrane facing the neighboring fusion cell. Thereby, a continuous lumen 
between the fusion cells is generated (Samakovlis et al., 1996). Two recent studies have 
resolved these events in more detail. Inside the fusion cells, microtubular tracks, associated 
with F-actin, are thought to span through the fusion cell along the future luminal axis. These 
tracks are then used to connect the two apical membranes, the one facing the contact side 
and the one of the luminal tip invaginating into the fusion cell. Here, guided apical membrane 
invagination occurs since small membranous vesicles are thought to be transported and 
localized by these tracks to the growing invaginating membrane and thus, drive its 
invagination and growth. Finally the two apical membranes become juxtaposed and localized 
membrane fusion, probably facilitated by vesicle-to-vesicle and vesicle-to-plasma membrane 
fusion, occurs in this narrow space and causes the opening of the tube (Lee and Kolodziej, 
2002; Kakihara et al., 2007). Moreover, it was shown that a mutant of Arf-like 3, a small 
GTPase that localizes the exocyst complex to the fusing membranes, fails to undergo the 
intracellular fusion event. Proper localization of the exocyst might thus be a key step in 
intracellular membrane fusion (Kakihara et al., 2007). Whether these mechanisms are also at 
work during ISV fusion will be interesting to see. Thus, taken together, our proposed model 
of membrane invagination into and through the tip cell to at least one of the contact sites 
resembles the mechanisms that have been described in the tracheal system and thus does 
not exclude the existence of, probably, very small apical vesicular structures. But it is more 
likely that such vesicles are transported towards the invaginating membrane where they are 
integrated by membrane fusion and drive its growth and invagination. Whether this 
membrane growth is guided in a similar way by microtubular tracks and why the membrane 
is only growing towards one of the contact sites will be interesting to see. New zebrafish lines 
such as an UAS:Gtuba2 line (Asakawa and Kawakami, 2010), encoding a GFP tagged 
version of one of the subunits of the tubulin heterodimer might help to solve these questions. 
6.1.3 Fusion by cord hollowing mechanism 
In the cord hollowing mechanism, at least three cells migrate, rearrange and thereby bring 
together two apical membrane compartments at a new contact site, which results in their 
coalescence and thus the formation of a continuous luminal space. Cord hollowing 
mechanisms have been described in several systems, for instance, during formation of the 
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mouse dorsal aorta, the zebrafish intestine and the neural tube (Strilic et al., 2009; Bagnat et 
al., 2007; Munson et al., 2008). However, in the cord hollowing mechanism in the fusing ISVs 
that leads to the formation of a multicellular tube, lumen formation is based on cell 
rearrangements rather than the expansion of small lumens. A very similar mechanism to our 
proposed model of cord hollowing has been described in the larval stage of the ascidian 
Ciona intestinalis (Dong et al., 2009). Here, a multicellular rod-like cord consisting of about 
40 notochordal cells is hollowed out by subsequent cell rearrangements resulting in a 
multicellular tube. In our model, we suggest that during the cord hollowing mechanism, two 
individual apical membrane compartments are brought together by cell rearrangements of 
two outer cells over a central tip cell and that dislocation of the latter results in lumen 
coalescence (Figure 25, p.59 and Movie 3). Since ECs are extremely thin and elongated in 
the ISVs, we were not able to resolve this dislocation properly. This dislocation, however, is 
well seen in the notochordal system of Ciona intestinalis, where in the rod-like cord, two cells 
that initially are not in contact with each other, rearrange over a common neighboring central 
cell until they contact each other and form a new contact site as indicated by an E-cadherin 
reporter. As the two outer cells contact each other, the central cell in-between retracts or 
dislocates, loses its radial symmetry and becomes endothelial-like and part of a multicellular 
tube. This dislocation results in the coalescence of two neighboring luminal spaces that have 
been built between the central cell and its two outer neighboring, rearranging cells, prior to 
their described morphogenetic movements (Dong et al., 2009). Thus, formation of a new 
junction at the site of contact between the individual compartments and the fast inflating 
lumen within this region (see Movie 3 and Figure 22, p.56) demonstrate that the two 
individual membrane compartments must have coalesced, which per se is a clear sign of the 
dislocation of the central cell.  
6.1.4 Blood pressure driving apical polarization and membrane 
invagination 
In most cases, epithelial cells have one basolateral and one apical side facing the lumen 
(Andrew and Ewald, 2010). The tip cell in the ISV is somewhat special since it has to 
establish an apical surface at three distinct locations that somehow will be transformed into 
one continuous apical membrane during the vessel fusion process (see also 6.1.5, p.82). 
These sites are found at the connection to a stalk cell as well as at the newly forming contact 
sites anterior and posterior to the tip cell (Figure 21, p.55 and Figure 24, p.58). We found 
blood pressure to be essential to drive apical membrane invagination since in embryos that 
lack blood pressure (Figure 24, p.58), Pdxl2 is only found between junctions in multicellular 
regions and is totally absent in unicellular regions. This suggests that pressure drives apical 
polarization and membrane invagination. Thus, most likely, the tip cell uses first the contact 
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sites as a landmark or instructive cue regarding polarization (see also 6.1.1, p.77) and then, 
later, blood pressure as an instructive signal to drive invagination of the membrane. 
Interestingly, the fusion cells in the dorsal branches of the tracheal system face a similar 
issue since these cells are connected to a stalk cell, a terminal cell and undergo a fusion 
event with a neighboring fusion cell. This means, they also have to establish three apical 
sites at distinct locations that have to be transformed into one continuous apical membrane, 
which outlines or faces the lumen. However, here, other driving forces than pressure might 
be responsible for membrane invagination (Gervais et al., 2011 and personal communication 
A. Ochoa-Espinosa, Affolter lab). 
6.1.5 Further considerations and fusion events  
To generate a fully lumenized tube, the tip cell will have to bring together its three individual 
apical membranes by either one of the mechanisms described in this thesis. However, in the 
movies we analyzed we found that only one of the apical compartments at the contact sites 
initially coalesced with either an invaginating membrane or with the apical membrane 
compartment between the tip cell and the stalk by cord hollowing mechanism. How is then 
the other contact site integrated later into the fusion process? We have not yet fully 
elucidated how this happens. However, we have seen that at 48hpf fully lumenized 
unicellular cells exist (Figure 20, p.55), suggesting that a membrane invagination 
mechanism, as we have described, most likely must have hollowed out the whole cell. It is 
likely, that this happens in a second membrane invagination process from the side of the 
DLAV. We have also seen that membrane invagination can follow the cord hollowing 
mechanism to complete the fusion process (see Movie3, time point 03:45 – 04:55). Most 
likely, the cells can use these two mechanisms as modules and integrate them into the fusion 
process where and when they are needed. However, it will be interesting to identify the cues 
- when and why the two mechanisms are chosen - and molecular key players that trigger and 
regulate these two mechanisms. Blood pressure seems to be the main driving force for 
membrane invagination (Figure 24, p.58 and see above). Furthermore, it takes more cells to 
undergo fusion by cord hollowing. Therefore, does cell number play a role? Does a 
multicellular environment favor a fusion event by cord hollowing? As seen in the fusion 
events between the two neighboring DLAVs, these short already lumenized sprouts, budding 
from a single cell (Figure 36, p.107 and Movie 9), fuse very likely by a membrane 
invagination mechanism. It will be interesting to see and compare fusion events at distinct 
anatomical sites and stage of development when different levels of blood pressure and 
number of ECs are available and to see what other mechanisms cells can use to efficiently 
generate capillary networks. 
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As we have shown, contact formation between filopodial extensions of fusing endothelial 
intersegmental sprouts is demarcated by a dot-to-ring like behavior of junctional complexes 
(Figure 21, p.55). I have further shown that also secondary sprouts and sprouts from the two 
neighboring DLAVs behave according to this model (Figure 30, p.64 and Figure 31, p.65). 
These two latter types of sprouts grow out and make contact to other vessels as lumenized 
sprouts, which is in contrast to the ISVs which are not lumenized. The ISVs at sites of vessel 
fusion first make contact and then subsequently form a lumen de novo. I further observed 
that the filopodial extensions in both situations connected to junctional complexes localized 
between the ECs of the previously formed target vessels. Thus, the new junction was 
integrated into an established network of junctions. It will be interesting to see whether such 
later sprouts can only connect to established junctions and whether an increased cell 
number, i.e. increased number of junctions, would facilitate fusion events. However, fusing 
endothelial sprouts may also connect and form a ring at the cytoplasm of patent vessels. 
Interestingly, such an observed junctional connection immediately got integrated into the 
junctional network by cell rearrangements of the fusing vessels (pers. communication with A. 
Lenard, Affolter lab). Such efficient integration might be partially explained by the tendency of 
cells to maximize their interadhesive-bonding energy (see below). 
Fusion events in the endothelium are not only restricted to small diameter vessels or 
capillaries as we have described in our study (Herwig et al., 2011). Larger diameter blood 
vessels might be formed by fusion events between neighboring smaller blood vessels, as it 
has been observed in the formation of the descending dorsal aorta (Drake and Fleming, 
2000) which is formed by the fusion of smaller bilateral aligned multicellular vessels, the 
dorsal aortae. Further, at early stages during endocardium formation, multiple endothelial 
tubes at the midline of the heart are observed which are later transformed into a single blood 
vessel, the endocardium (Drake et al., 2006). Uniluminal vascular spheroids (multicellular 
spheres derived from VEGF stimulated embryonic mouse allantois tissue, cultured in 
hanging drops (Gentile et al., 2008)) have recently been shown to serve as a model for blood 
vessel assembly, since individual uniluminal vascular spheroids may fuse to each other 
(Fleming et al., 2011). During these spheroidal fusion events, the cells behave according 
principles that underlie the differential adhesion hypothesis (DAH). This hypothesis suggests 
that cells of a mobile, cohesive cell population rearrange in such a way that their inter-
adhesive bonding energy is maximized whereas the free energy of the system is minimized 
(Steinberg, 2007). The morphological behavior of these spheroids during fusion is very 
similar to the events that have been described during the fusion of the dorsal aortae which 
suggests that in vivo anastomosis of blood vessels may involve a mechanism similar to DAH 
(Fleming et al., 2011). Furthermore, a novel in vitro approach allows the guided formation of 
perfusable blood vessels and vascular fusion in a microfluidic device consisting of two main 
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channels and ladder-like microstructures (Yeon et al., 2011). Further, after transplantations, it 
is critical that the engrafted tissue gets perfused fast and efficiently. A recent study 
demonstrates that transplanted engineered blood vessels anastomose with the host 
vasculature in a so called “wrapping and tapping” mechanism. Here, the implanted ECs first 
wrap around the host vessels at the host-implant interface and cause the reorganization of 
pericytes and eventually the replacement of the underlying host endothelium and thereby 
anastomose with the host vessels (Cheng et al., 2011). 
6.1.6 Concluding remarks 
For the first time, we have described in vivo at the single cell level the morphogenetic events 
that underlie vascular network formation, i.e. vessel fusion or anastomosis, which is essential 
for normal development and growth of a vertebrate embryo. In general, such single cell 
resolution analysis as well as the identification of key players will allow a more detailed 
understanding of the biological processes underlying angiogenesis and probably can be 
compared to other tubular systems such as the kidney or lung. Detailed morphogenetic and 
molecular understanding will provide new target sites to design novel drugs interfering with 
tumor angiogenesis and other vascular processes. Considering this, the combined expertise 
from (novel) in vitro systems (see above) and in vivo models, plus the use of novel 
techniques will not only lead to rapid advances in our understanding of vascular development 
but will also be of major advantage regarding the design of novel therapeutic treatments. 
 
6.2 The UAS/Gal4 system 
The Gal4/UAS system allows indirect expression of any gene of interest in a spatiotemporal 
manner. Furthermore, transgenes are expressed at high levels when using this system (see 
also 4.3, p.39). This provides an excellent condition for the expression of an EGFP-hZO1 
Gal4-dependent transgene in the endothelium. The expression of an EGFP-hZO1 transgene 
under the direct control of an endothelial promoter element (flk1) (Jin et al., 2005) was 
unsuccessful due to several problems, such as toxicity and weak expression levels (personal 
communication with M. Affolter and H-G. Belting, Affolter lab). Thus, to specifically label 
endothelial cell-cell junctions, I have adapted the Gal4/UAS system to the vasculature in the 
zebrafish and generated several transgenic zebrafish lines, including an UAS:EGFP-hZO1 
reporter line. 
6.2.1 Considerations regarding different Gal4 variants 
Initially the Gal4/UAS system was designed for the use in Drosophila melanogaster (Brand 
and Perrimon, 1993; Fischer et al., 1988) but had been soon after adapted to the zebrafish 
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(Scheer and Campos-Ortega, 1999). The expression of full-length Gal4 and 5 identical 
copies of UAS sites in the embryo, however, resulted in weak expression of UAS-driven 
transgenes. Most likely, these weak expression levels resulted from concatemerized 
transgene integration, which made those transgenes a target for gene silencing (Goll et al., 
2009; Akitake et al., 2011) and see below). Thus, to compensate for the weak expression 
levels Köster and Fraser introduced Gal4-VP16, a more potent Gal4 variant, as well as a 
14xUAS multicopy site (Köster and Fraser, 2001; Rorth, 1996; Scheer and Campos-Ortega, 
1999 and see below). Later, Tol2 transgenesis technique was introduced, which is thought to 
allow the integration of transgenes as single copies, preventing the silencing problems 
caused by concatemerization (Kawakami et al., 2004; Kawakami et al., 2000). Gal4-VP16 is 
a recombinant protein which encodes the 147 amino acid DNA binding domain of full-length 
Gal4 and the 58 carboxy-terminal amino acids of the transcriptional activation domain from 
herpes simplex virus gene vp16 (Sadowski, 1988). Its modification lead to increased 
expression levels of transgenes but a high degree of toxicity, i.e. lethal developmental 
defects were observed and no stable transgenic lines were generated. ‘‘Squelching,’’ the 
overexpression of a strong transcription activator, for instance Gal4VP16, can cause the 
inhibition of gene expression by the titration of other transcription factors of the transcription 
machinery that interact with the activation domain of the overexpressed transcriptional 
activator (Sadowski, 1988; Gill and Ptashne, 1988). However, a more recent study found 
only episomal genes to be “squelched”, whereas genes integrated into the chromatin were 
immune (Rivera et al., 1997), suggesting a reconsideration for the described squelching 
effect.  Whatever the explanation for the observed toxicity, less toxic versions of Gal4-VP16, 
i.e. Gal4FF and KalTA4 (Distel et al., 2009; Asakawa et al., 2008) have been recently 
generated. Gal4FF encodes the DNA binding domain of Gal4 plus two 13 amino acid long 
modificated transcriptional activation domains of VP16 that contain a critical phenylalanine 
(FF= 2xPADALDDFDLDML), whereas KalTA4 encodes a 5’-Kozak sequence 
(GCCGCCACC) followed by the DNA binding domain and three minimal transactivation 
domains TA4 (TA4=PADALDDFDLDML-PADALDDGDLDML-PADALDDYDLDML) (Baron et 
al., 1997). KalTA4 is codon optimized for the use in zebrafish and a luciferase assay using 
5xUAS sites showed 1.5 fold stronger activation than Gal4TA (no Kozak sequence), which 
itself reaches 74% of the activation level of Gal4VP16 (Distel et al., 2009). Since Gal4VP16 
had been shown to be toxic in the zebrafish, I specifically used Gal4FF to generate the 
endothelial specific Gal4 line (Tg(fli1ep:Gal4FF)ubs2-4). In our hands, over several 
generations, no detectable reduction in the expression level or a toxicity (i.e. embryonic 
developmental defects or lethality) was observed. Although KalTA4 is codon optimized for 
the use in zebrafish, both versions are strong activtors and either version, i.e. Gal4FF or 
KalTA4, is suitable to efficiently drive Gal4-dependent transgenes (pers. communication with 
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M. Distel, Köster lab). It should be mentioned that all these different versions of the original 
full-length Gal4 are lacking the transcriptional activation domain ARII of Gal4, which is the 
essential Gal80 binding site, preventing the transcriptional machinery to be recruited when 
bound by Gal80 (Ptashne and Gann, 2002). Thus, to generate conditional expression 
systems using KalTA4 or Gal4FF, other techniques than the use of Gal80 will be needed 
(see also 6.2.4, p.90). However, despite the availability of the more potent Gal4 derivatives 
described above, the Chien lab showed that native Gal4 mediated expression but not 
Gal4VP16 mediated expression of a UAS:GFP-reporter line was inhibited by Gal80. In 
addition, a temperature sensitive Gal80 was shown to permit or restrict Gal4-mediated 
expression at high or lower temperatures, respectively (Fujimoto et al., 2011).  
6.2.2 Considerations regarding different UAS variants 
I was able to generate a Gal4 dependent 14xUAS responder line which visualizes cell-cell 
junctions by the localization of EGFP-hZO1 at tight junctions. However, the expression 
pattern of the transgene in this line is extremely mosaic and the expression level of EGFP-
hZO1 was further reduced over generations (G0 – F4, personal observation/communication 
between L. Herwig and Y. Blum and A. Lenard, Affolter Lab). This behaviour is most likely 
due to epigenetic silencing effects, for instance DNA methylation. In vertebrates DNA (de-
)methylation, the covalent addition or removal of a methyl group to a cytosine nucleotide, 
occurs only at a cytosine followed by a guanine residue, a CpG dinucleotide, and is regulated 
by DNA methyltransferases (DNMTs). The reversible adding of such methyl groups changes 
the normal biophysical characteristics of the DNA and is thought to have two major effects, 
which are inhibition and facilitation of protein binding (Hamilton, 2011; Gibney and Nolan, 
2010). DNA methylation is thought to repress genes and has been shown to silence genes in 
plants, vertebrates and fungi, but is, however, absent in many invertebrate organisms 
(Miranda and Jones, 2007; Goll and Bestor, 2005). In vertebrates, tandem repeats are 
thought to be frequently methylated and thus silenced (Garrick, 1998; Miranda and P. A. 
Jones, 2007). In mice, the homozygous loss of the DNA methyltransferase gene results in 
strong developmental defects and lethality (Li et al., 1992), which demonstrates that 
methylation is an essential process during development. The 14x(CGG-N11-CCG)-UAS 
cassette1 (Rorth, 1996) I used to generate the EGFP-hZO1 responder line is a tandem 
repeat and is rich in CpG dinucleotides and thus, very likely, represents a target of 
methylation and silencing. In a recent study in 2009, Goll and colleagues, have shown that 
                                                          
1 14xUAS = 
CGGAGTACTGTCCTCCGGGCTGGCGGAGTACTGTCCTCCGGCAAGGTCGGAGTACTGTCCTCCGACACTAGAGGTCGGA
GTACTGTCCTCCGACGCAAGGCGGAGTACTGTCCTCCGGGCTGCGGAGTACTGTCCTCCGGCAAGGTCGGAGTACTGTC
CTCCGACACTAGAGGTCGGAGTACTGTCCTCCGACGCAAGGTCGGAGTACTGTCCTCCGACACTAGAGGTCGGAGTACT
GTCCTCCGACGCAAGGTCGGAGTACTGTCCTCCGACACTAGAGGTCGGAGTACTGTCCTCCGACGCAAGGCGGAGTACT
GTCCTCCGGGCTGGCGGAGTACTGTCCTCCGGCAAGGGTCGACTCTAGAGGGTATATAATGGATCCCATCGCGTCTCAGC
CTCACTTTGAGCTCCTCCACAC 
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this is indeed the case. In this study they used a fluorescent, self-reporting Gal4-VP16 
gene/enhancer trap vector and monitored the epigenetically controlled down-regulation (i.e. 
DNA methylation of the multicopy UAS) of this reporter construct. Initially, stable self-
reporting lines showed strong and robust fluorescence, which got mosaic and finally 
disappeared after several generations. This demonstrates that the silencing effect is 
heritable, however, it can be reactivated by the increase of Gal4-VP16 expression levels or in 
mutants lacking DNA methyltransferase-1 (dnmt1) (Goll et al., 2009). The mosaicism we 
experienced is to some extend advantageous regarding the description of single cellular 
behaviors during morphogenetic events such as the fusion of neighboring ISVs. If only very 
few cells express the construct in a visible manner (Figure 22, p.56 and Figure 23, p.57), the 
labeled junctions can be more easily assigned to individual single cells. A single cell 
expressing EGFP-hZO1 labels per se all its contacts to neighboring cells, and as soon as an 
unlabeled cell contacts a labeled cell, the new junction becomes visible. Thus, the relative 
behavior of single cells regarding neighboring cells can be analyzed using such a mosaic 
reporter line. This facilitated the deciphering and analysis of the two processes described in 
this thesis (Figure 25, p.59) but made it also extremely time consuming to collect a decent 
amount of data (time lapse movies) that could be analyzed and quantitated.  
In the publication Herwig et al., 2011 we have described the basic behaviors during vessel 
fusion at the cellular level but we have not yet deciphered the molecular key players 
controlling this process. The fast analysis of wild type fish, mutants, morphants or chemically 
treated embryos in a highly mosaic reporter line is tedious, since screening for EGFP-hZO1 
positive cells in a mosaic line is time consuming. A junctional reporter line labeling all the 
endothelial cells, thus, would greatly facilitate the identification of such molecular regulators 
and their function during the fusion process. Single insertions of a 4x non-repetitive  UAS 
GFP-reporter (4Xnr; four distinct UAS sites and a minimal promoter)2 have been shown to 
be less silenced over three generations in zebrafish larvae than insertions encoding 14 of the 
same UAS sites (Akitake et al., 2011). Further, to improve expression levels, Distel et al. 
introduced a GI domain (GI = rabbit β-globin intron) between the stop codon and polyA signal 
of UAS-driven transgenes which is supposed to increases gene expression as splicing 
targets the mRNA for nuclear export  (Distel et al., 2009; Adam et al., 1995; Perz-Edwards et 
al., 2001). This might be considered advantageous when working with large open reading 
frames such as the one of ZO1 which is about 5,3 kb in size. Thus, I cloned a 
4XnrUAS:EGFP-hZO1 construct and tested its functionality in transient expression 
experiments (Figure 32, p.66). It will be interesting and useful to see, whether we can raise a 
                                                          
2 4Xnr = 
CGGTGGCTTCTAATCCGTGAGTCCTAGCGGGTGACAGCCCTCCGTCTTCACAGGCGGAGGAGAGTCTTCCGTAGGGTTC
CTCGGAGTACTGTCCTCCGACGCGTGCAAGGGTCGACTCTAGAGGGTATATAATGGATCCCATCGCGTCTCAGCCTCACTT
TGAGCTCCTCCACACG 
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stable transgenic line expressing this construct. In addition L. Sauteur (Affolter lab) has used 
the same 4XnrUAS background and does see strong transient and rather uniform expression 
of different fluorescent reporters in the endothelium (personal communication L. Sauteur). 
Interestingly, the KAEDE-reporter line encodes the 14xUAS multicopy cassette and has been 
stable over several generations in our lab. In some of these fish, however, mosaic or weaker 
expression was detected and in other lines without the 14xUAS cassette a similar 
phenomenon was observed (pers. communication K. Hatta, Center for Developmental 
Biology, Riken, Japan). Taken together, depending on the type of experiment, it might be of 
advantage to generate either a transgenic line encoding 4XnrUAS sites, which should result 
in a more uniform expression pattern or 14xUAS sites of the same type, where mosaics are 
more likely to be expected. However, the site of transgene integration (positional effects), is 
probably still a main issue regarding the generation of good UAS reporter lines (see below). 
6.2.3 Technical observations and comments regarding the Gal4/UAS 
system 
The generation of transgenic lines is time consuming, first of all the screening for positive 
founder fish. Since UAS-driven transgenes in the absence of Gal4 are not visible, founder 
fish have to be analyzed in a Gal4 background or by PCR technique. In addition, more than 
one founder fish has to be identified since the genetic environment of site of transgene 
integration might influence the transgene expression in an enhancing or repressing way 
(positional effects), which makes it even more time consuming to find good effector lines. It 
might be possible, that an endogenous enhancer directly interacts with the minimal promoter 
of the UAS cassette and thus activates the UAS-transgene in a Gal4-independent manner 
((Davison et al., 2007) and pers. communication with K. Kawakami, Kawakami lab and M. 
Müller, Affolter lab)). I have used a cmlc2:EGFP transgenesis-cassette, labeling the heart in 
green (Huang et al., 2003; Kwan et al., 2007; Auman et al., 2007), which facilitated the 
screening process regarding UAS positive founder fish and later during the screening when 
doing experiments. This cassette is supposed to be silent in all other tissues except the 
developing heart. However, if the heart marker cassette is in very close relation to an UAS-
driven transgene, the cmlc2 control region might interact with the UAS sites in one or the 
other direction (pers. communication with M. Müller, Affolter lab). I have screened G0 and F1 
transgenic zebrafish that encode the heart marker cassette upstream of a 5xUAS:life-act-
MkOrange cassette in reverted orientation. In this situation, an up-regulation of the otherwise 
silenced heart marker cassette is likely expected, i.e. the UAS sites upon Gal4FF binding 
would also activate to some extend the heart marker cassette resulting in a cytoplasmic 
EGFP background in endothelial cells. Interestingly, in these fish, the heart marker most 
likely down-regulated the UAS-transgene since I neither observed an EGFP background or 
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UAS-driven life-act-MkOrange expression, when crossing F1 fish to the endothelial specific 
Gal4-driver line. The recovered positive founder and F1 fish exclusively expressed EGFP in 
the heart (data not shown). Interestingly, a 5xUAS-driven rabbit-gp135-RFP (gp135 = 
podocalyxin), again in the same background (line engineered by Y. Blum), efficiently 
expressed the transgene but unfortunately displayed a rather cytoplasmic expression pattern 
of the gp135-RFP and was mosaic to some extend and thus not further analyzed (data not 
shown). It is of course extremely difficult to explain what is responsible for these variations 
regarding the UAS transgene expression or repression we experienced when using this 
cmlc2:EGFP-5xUAS background. One explanation might be that in some cases the heart 
marker cassette simply silences the transgene. Another explanation might be the lack of a 
real minimal promoter downstream of the 5xUAS element, which in these fish precedes only 
a minimal TATA sequence. This should result in a weak or even total absence of 
transcription (pers. communication M. Müller, Affolter lab). However, the transgenic 
UAS:RFP and UAS:GFP fish, that  have been generated encode this minimal TATA element, 
and show robust and strong expression (Asakawa et al., 2008). The same is true for the 
Tg(UAS:VEcadΔCD-EGFP) line I generated. It displays strong and uniform expression of the 
transgene (Figure 27, p.62). It should be mentioned that this three lines mentioned do not 
encode the heat marker cassette. One might speculate that differences such as the length of 
DNA between the TATA box and the ATG of the gene of interest might influence transcription 
or ribosomal binding. If this spacing DNA is too short, transcription might be very inefficient 
and later also ribosomes fail to bind and thus no or very inefficient translation might occur or 
transcription itself does not take place at all (pers communication with M. Müller, Affolter lab). 
However, the VEcad-reporter line does not have a large spacer (4.4.2.4, p.44) and is fully 
functional regarding transcription and translation (Figure 27, p.62). For the future, I 
recommend to use an UAS background that encodes a real minimal promoter. The 14xUAS 
and 4xnr constructs do have such a minimal promoter (E1b) (see figures X and Y). It is a 
compact promoter of 49 bp and encodes a TATA box (5’-TATATAAT-3’) preceding an 
initiator element from the common carp (Carpio carpio) β-actin gene (5’-
CATCGCGTCTCAGC-3’) that controls the transcriptional initiation. The last residue 
corresponds to the +1 nucleotide of polII transcripts (Huang et al., 2006). Further, in the 
14xUAS:EGFP-hZO1 line the heart marker cassette is cloned downstream in reverted 
orientation of the UAS-driven EGFP-hZO1 and thus might not influence the UAS sites (Kwan 
et al., 2007). This should be considered for future constructs too if a transgenesis cassette is 
planned to be integrated. 
 
As discussed above, improving techniques can be extremely helpful for the generation of 
transgenic lines as described in this thesis, but at the same time cause new issues to think 
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about. Taken together, I suggest, to clone and engineer, UAS-driven constructs/lines in 
several versions (i.e. with and without a transgenesis cassette, different number of UAS 
sites) and to carefully analyze what the constructs look like regarding their sequence, locus 
and relative position between the different coding regions to minimize genetic interference 
and maximize the expression level of the transgenes.  
6.2.4 Outlook 
Different groups in the field are constantly improving various components of the Gal4/UAS 
system (Distel et al., 2009; Köster and Fraser, 2001; Goll et al., 2009; Asakawa et al., 2008). 
However, none of this group, to date, has established an efficient (fast and accurate, non-
leaky) system, that allows “experimentator controlled” conditional expression of a transgene 
regarding both, space and time, in the endothelium. Such a system, would allow specific 
overexpression of genes, such as dominant-negative receptors, during the vessel fusion 
process in vivo at the single cellular level. A recent study (Kennedy et al., 2010) has 
engineered a light inducible protein-protein interaction system using two proteins involved 
into the flowering process of Arabidopsis thaliana. Here, illumination by blue light causes 
dimerization of a basic-loop-helix protein CIB1 and cryptochrome 2 (CRY2), which is a blue 
light-absorbing photo-sensor that can bind the CIB1 protein when photo-excited (Liu et al., 
2008). The group adapted the system to Gal4, and blue light-dependent UAS-driven 
expression of a reporter was observed in cell culture and thus, might be suitable for the use 
in zebrafish. However, this system is possibly leaky or it does need a long illumination phase 
to induce interaction in a certain depth within the tissue of the zebrafish (pers. 
communication with O. Biehlmaier, Imaging Core Facility (IMCF), Biozentrum Basel). Further, 
only fluorescent reporters which are illuminated above 500nm can be followed using this 
system. Another possibility would be to use a photo-activatable CreERT2-system that has 
recently been designed and reported to be functional and reaching high spatiotemporal 
resolution. Here a photo-inducible ligand (caged 4-OH cyclofen) is un-caged and activates a 
CreERT2 fusion protein. In a Tg(Eef1α:loxP-GFP-loxP-dsRed2) zebrafish line single cells in 
the retina have been successfully reported to express dsRed upon two-photon illumination 
(Resolution et al., 2010). Combination with the Gal4 system (loxP-Gal4-loxP) or a direct 
Gal4ERT2 fusion protein expressed in the vasculature is thinkable. Further, such a system in 
combination with “cre-recombinase” and “flipase” based insertional mutagenesis as reported 
by different groups (Madison meeting 2010) might allow to turn mutated genes from ON-
OFF-ON or OFF-ON-OFF, respectively, in single cells. It will be useful to adapt/generate 
such a system described above in combination with Gal4 or alone to analyze at the single 
cellular level molecular/morphogenetic mechanisms or mutant cells during morphogenetic 
processes in the endothelium.  
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6.2.5 Concluding remarks 
New molecular technologies or their adaption to the fish field, are growing fast. Examples 
are: BAC-recombineering (www.ncifcrf.gov/research/brb/protocol.aspx), Tol2 transgenesis 
(Kawakami et al., 2000), Gal4/UAS system (Scheer and Campos-Ortega, 1999), Cre-Lox 
system (Langenau et al., 2005; Pan et al., 2005), zinc-finger mutagenesis technique (Meng 
et al., 2008) or the use of caged morpholinos to down regulate genes at a given time point 
(Shestopalov et al., 2007) or protein knockout mediated by anti-GFP nanobody (Caussinus 
et al., 2011). The innovation regarding the engineering and screening for new or improved 
technologies, and first of all, their combination, will allow to answer biological questions in a 
more detailed way.  
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9 Appendix 
 
9.1 Supplementary figures 
 
 
Figure 33 EGFP-ZO1 colocalizes with endogenous VE-cad. (Ai) shows a stalk cell and (Aii) shows a tip cell, 
where both proteins colocalize along cell junctions and presumptive autocellular contact points (white arrows). 
Since expression of EGFP-ZO1expression is mosaic, some VE-cad positive junctions are not labeled by EGFP-
ZO1 (green arrows). Delocalized ZO1-EGFP protein is found in the cell membrane (yellow arrow). Luminal 
localization of Pdxl2 in the zebrafish vasculature. (B) Optical sections through an ISV at 38hpf showing the 
distribution of apical and junctional staining in ECs. Sagittal (Bi-iii) and cross (Biv-vi) sections are indicated by 
crosshairs (i, iv). Pdxl2 is visible only in the luminal site i.e. the apical side (white arrow in ii) of the cells and not 
the basal side (yellow arrow in ii). (i-vi) ZO1 (white) and Pdxl2 (green) immunolocalization on Tg(kdrl:EGFP S843) 
(red) embryos. The scale bar in all panels represents 20 μm. Figure adapted from Herwig et al, 2011. 
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Figure 34 Transient expression of VEcad∆CD-EGFP in endothelial cells. (i) pT25xUAS:VEcad∆CD-EGFP 
was injected into fertilized eggs from Tg(fli1ep:Gal4FF) zebrafish. Embryos were raised until 32 hpf and checked 
for transient expression. (ii) Two individual ISVs with ECs expressing VEcad∆CD-EGFP. VEcad∆CD-EGFP 
localizes as dots and lines in between/in these cells. 
 
 
Figure 35 VEcad∆CD-EGFP co-localizes with endogenous ZO1. (A-D) shows upper part and parts of an ISV 
and the DLAV. Both proteins co-localize along cell junctions (for instance white arrow in (B)). Since expression of 
EGFP-ZO1expression is mosaic, some VE-cad positive junctions are not labeled by EGFP-ZO1 (green arrows). 
Delocalized ZO1-EGFP protein is found in the cell membrane (yellow arrow). Figure courtesy of A. Lenard, 
Affolter lab. 
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Figure 36 Formation of a sprout in the DLAV at 48 hpf. (A) A seamless EC cell bridging two ISV segments. 
The two junctional complexes connecting the cell at its anterior and posterior to the nucleus (n) are indicated by 
yellow arrows. White arrow shows future site of sprout formation. (B-H) The outgrowing lumenized sprout from the 
DLAV (follow white arrows). EGFP-hZO1 localizes to the tip of the sprout as visible in (C-H).(see Movie8 on DVD)  
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Summary
Although many of the cellular and molecular mechanisms of
angiogenesis have been intensely studied [1], little is known
about the processes that underlie vascular anastomosis. We
have generated transgenic fish lines expressing an EGFP-
tagged version of the junctional protein zona occludens 1
(ZO1) to visualize individual cell behaviors that occur during
vessel fusion and lumen formation in vivo. These life obser-
vations show that endothelial cells (ECs) use two distinct
morphogenetic mechanisms, cell membrane invagination
and cord hollowing to generate different types of vascular
tubes. During initial steps of anastomosis, cell junctions
that have formed at the initial site of cell contacts expand
into rings, generating a cellular interface of apicalmembrane
compartments, as defined by the localization of the apical
marker podocalyxin-2 (Pdxl2). During the cord hollowing
process, these apical membrane compartments are brought
together via cell rearrangements and extensive junctional
remodeling, resulting in lumen coalescence and formation
of a multicellular tube. Vessel fusion bymembrane invagina-
tion occurs adjacent to a preexisting lumen in a proximal
to distal direction and is blood-flow dependent. Here, the
invaginating inner cell membrane undergoes concomitant
apicobasal polarization and the vascular lumen is formed
by the extension of a transcellular lumen through the EC,
which forms a unicellular or seamless tube.
Results and Discussion
Generation and expansion of vascular beds by vascular
remodeling involves a variety of morphogenetic mechanisms
such as angiogenic sprout and lumen formation, as well as
blood vessel fusion (anastomosis) and vessel pruning. Anasto-
mosis is the essential process that converts dead-end sprouts
into a functional vascular network. Angiogenic sprouts are
guided by so-called tip cells, which are more motile and
send out more filopodia than the trailing stalk cells [2]. During
the first step of anastomosis, tip cells from neighboring
sprouts establish contact with each other [3, 4]. Subsequently,
endothelial cells (ECs) from neighboring sprouts form a contin-
uous endothelium and their lumens are connected. How these
events are achieved and coordinated at the cellular level is not
known.We have used the zebrafish dorsal longitudinal anasto-
motic vessels (DLAV) as a model to analyze the cellular mech-
anisms that underlie vascular anastomosis in vivo. To this end,2These authors contributed equally to this work
*Correspondence: heinz-georg.belting@unibas.ch (H.-G.B.), markus.
affolter@unibas.ch (M.A.)we generated transgenic reporter lines that label endothelial
cell junctions [Tg(fli1ep:GAL4FFubs2-4) and Tg(UAS:EGFP-
ZO1ubs5-6), see Figure S1 available online]. These lines allowed
us to follow individual cell junctions and, consequently, rela-
tive cell movements and cell shape changes, as they occur
during vascular remodeling.
The DLAV is formed in a seemingly stereotypic pattern by
the anastomosis of neighboring segmental arteries (SA) [5].
Tip cells of individual SAs that have reached the roof of the
neural tube extend processes laterally both in rostral and
caudal directions. Some of these filopodia emanating from
neighboring tip cells eventually contact each other, stabilize,
and integrate into the DLAV. During further development,
a lumen extends through the SA and the DLAV (see Figure 1A
and Figure S1A). We first examined the cellular architecture of
the DLAV to determine whether this vessel is made of unicel-
lular or multicellular tubes. By photoconversion of the fluoro-
phore KAEDE in Tg(fli1ep:GAL4FFubs3; UAS:KAEDErk8)
embryos, we labeled single cells within the DLAV and deter-
mined whether these spanned the circumference of the
DLAV either entirely or partially (Figures 1B and 1C). In 16 out
of 24 cases, we found cells enclosing the entire lumen repre-
senting a unicellular tube, whereas in 8 out of 24 cases, labeled
cells covered the vessel only partially, which is indicative for
multicellular tubes. To test whether the different cellular
arrangements correspond to the patterns of EC junctions, we
performed photoconversion experiments and subsequently
visualized adherens junctions by immunofluorescence using
an antibody against zebrafish-VE-cadherin (zf-VE-cad) [6].
Consistently, we found that unicellular regions did not contain
junctions (Figures 1D and 1D0), whereas photoconverted cells,
which are nested within a multicellular region, were demar-
cated by longitudinal lines of VE-cad (Figures 1E and 1E0).
To visualize endothelial cell contacts in vivo, we gener-
ated transgenic reporter lines Tg(UAS:EGFP-ZO1ubs5-6)
(Figure S1B). In double transgenic embryos (Tgfli1ep:
GAL4FFubs3; UAS:EGFP-ZO1ubs5), we compared the localiza-
tion of the EGFP-zona occludens 1 (ZO1) fusion protein with
the distribution of VE-cad and found that it specifically labels
cell junctions, albeit in a mosaic fashion (Figure S1C). Further-
more, we confirmed the heterogeneity in vascular architecture
described above by the junctional patterns observed in vivo in
these embryos.We found regions that had predominantly ring-
shaped cell contacts (Figure 1F) as well as regions that con-
tained more complex junctional patterns (Figure 1G). Thus,
DLAVs are heterogeneous in their architecture and can consist
of different types of tubes: unicellular tubes, multicellular
tubes, and tubes of mixed cellular arrangements.
To analyze the cellular dynamics of DLAV formation, we first
focused on the initial events of contact formation between
neighboring tip cells. From studies using immunofluorescent
detection of ZO-1, we previously proposed a model in which
interactions between tip cells lead to the generation of junc-
tional spots at the contact sites [6]. These spots elaborate
into rings as the cells increase their mutual surface area.
Analysis of VE-cad protein revealed identical patterns (Figures
1H–1J). Because this sequence of events was inferred from
observations in fixed tissues, we wanted to test this model in
Figure 1. Anastomosis and Heterogeneity of Endothelial Tubes
(A) Still pictures of a time-lapse movie (data not shown) showing steps during dorsal longitudinal anastomotic vessel (DLAV) formation. Tip cells reach the
dorsal side of the embryo and send filopodia in anterior and posterior directions (arrow in 00:18 [hr:min]). The tip cells contact each other and form the future
DLAV (arrow in 00:48). Later the lumen opens from the stalk and proceeds into the DLAV (arrows in 4:12 and 7:08).
(B–G) Different vessel architectures are found in the intersegmental vessel (ISV)/DLAV. Single, photoconverted cells (red) show a unicellular (B) or a multi-
cellular arrangement (C). Inserts (i–iii) in (B) and (C) show a surface calculation (i), a sagittal section (ii), and a cross-section (iii) at the sites indicated by cross-
hairs (n = nucleus).
(D–E0) Single photoconverted cells (red) and corresponding VE-cadherin (VE-cad) immunostainings. Arrowheads indicate regions of unicellular (D and D0)
andmulticellular (E and E0) tubes. A unicellular tube outlined by EGFP-zona occludens 1 (ZO1) fusion protein is shown in (F), andmulticellular/unicellular and
mixed arrangements represented by EGFP-ZO1 protein are shown in (G). The yellow arrow in (F) points at delocalized EGFP-ZO1 protein in the cell
membrane, most likely due to elevated levels of protein.
(H–J) VE-cad immunostainings of 30 hrs postfertilization (hpf) old fli:EGFP embryos. Spots and small and larger rings are shown in (H), (I), and (J), respec-
tively (see arrows).
(K–M) Still pictures of Movie S1 showing a time-lapse of a fli:GAL4FF; UAS:RFP; UAS:EGFP-ZO1 embryo. An initial contact spot of EGFP-ZO1 (arrow in K) is
elaborated into a small (arrow in L) and subsequently into a larger loop (arrow inM; Movie S1). The yellow arrow in (M) points to delocalized EGFP-ZO1 in the
cell membrane (compare F and Figure S1). Scale bar in all pictures represents 20 mm.
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1943an in vivo situation by performing confocal time-lapse anal-
yses on our EGFP-ZO1 reporter lines. In essence, the pattern
of EGFP-ZO1 was congruent with our previous observations,
thus confirming the above model (Figures 1K–1M; Movie S1).
Moreover, junctional remodeling is extremely dynamic—the
transformation from spots to rings occurs within less than
40 min.Whereas initiation of anastomosis appeared to be consis-
tently associated with formation of ring-shaped junctions,
the subsequent establishment of the DLAV showed consider-
ably greater complexity and variety—in respect to (1)
junctional remodeling, which corresponds to extensive cell
rearrangements, (2) the generation of a continuous endothe-
lium with apical-basal polarity, and (3) lumen formation. After
Figure 2. Anastomosis by Cord Hollowing
Still pictures from Movie S2 showing a time-lapse of a fli:GAL4FF; UAS:RFP; UAS:EGFP-ZO1 embryo (total length: 9:20).
(A–C) A tip cell has established contact with an adjacent tip cell (right arrow) and has contact with a stalk cell (left arrow), which results in two loops of EGFP-
ZO1 (A). These loops extend and eventually meet (B and C).
(A0–D0) shows the junctional outline of participating cells (yellow: ‘‘central’’ cell, green: stalk cell, red: DLAV cell moving in fromposterior [right]). The two initial
cell contacts are shown in yellow/green and yellow/red, respectively. When the stalk cell and the adjacent DLAV cell meet, they establish a new contact with
‘‘green and red’’ junctions (arrow in D, green and red line in D0). Scale bar in all pictures represents 20 mm.
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1944analysis of 15 time-lapse movies representing 19 fusion
events, we were able to discern two distinct behaviors with
regard to junctional remodeling, which show two alternative
cellular mechanisms that underlie DLAV formation (Figure 2;
Figure 3).
In many instances (7 out of 19 events), we observed amech-
anism that is primarily driven by cell rearrangements (Figure 2;
Movie S2). Here, cell contacts between at least three adjacent
cells generate two junctional rings, which converge toward
each other as the outer cells migrate over a central cell. This
convergence ultimately leads to novel contacts between the
outer cells, the establishment of a new junction, and the
detachment of the medial cell at this site of contact (summa-
rized in Figure S2). Thus, the outcome of this process is the
merging of local lumens, which are contained within thejunctional rings, to form a continuous luminal space. In prin-
ciple, this mechanism of luminal coalescence can act locally
or, if occurring iteratively, can be used to lumenize longer
stretches to generate a patent tube.
In the majority of time-lapse movies (12 out of 19 events), we
observed an alternate mechanism of vessel fusion that is
intrinsically connected to a different mechanism of lumen
formation. In these instances, junctional rings did not move
or extend toward each other, the cells exhibited much less
migratory behavior, and we did not find continuous adherens
junctions along the vascular axis (Figure 3; Movie S3). Instead,
the ECs maintained their junctions in a ring shape throughout
the process of lumenization. Imaging the dynamics of lumen
formation in vivo, either by intravascular quantum dot injection
or by lack of cytoplasmic RFP, revealed that the lumen
Figure 3. Anastomosis by Membrane Invagination
Still pictures from Movie S3 showing a time-lapse of a
Tg(fli:GAL4FFubs3; UAS:mRFP rk8; UAS:EGFP-ZO1ubs5)
embryo (total length: 10:25).
(A and B) A tip cell has formed initial contacts and subse-
quently forms loops of EGFP-ZO1 with its adjacent
partner (white arrows). The stalk shows a multicellular
organization (two lines of EGFP-ZO1, arrowhead in B)
and an opening lumen (yellow arrow in B).
(C) The lumen projects into the fusion cell (follow arrow
from C to E) and finally reaches the left ring of EGFP-
ZO1, which is subsequently inflated (arrow in F). The
lumen then continues to extend into the unlabeled fusion
cell on the left (arrow in G). A blood cell then passes
through the newly formed lumen (follow arrowhead
from G–J). Insets show the blood cell passing behind
the junction (G) and in front of the junction (H). More
examples of membrane invagination are shown in Movie
S4, Movie S6, and Figures S3B and S3C. Scale bar in all
pictures represents 20 mm.
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1945extended through a single cell between two separate sites of
contact (Figure S3B; Movie S3; Movie S4, summarized in Fig-
ure S2). This mechanism thus leads to a transformation of
the tip cell into a ‘‘fusion cell,’’ which forms a unicellular
tube. This was demonstrated by a blood cell serendipitously
passing through the two junctional rings of a hollowed-out
EC (insets in Figure 3 and Movie S3).
De novo formation of an epithelial lumen is initiated by the
apical-basal polarization of cell membranes [7]. Members ofthe CD35 family of sialomucins have been
shown to localize to the luminal (apical) mem-
brane compartments of ECs in the mammalian
vascular system [8]. To examine apical polari-
zation during DLAV formation, we generated
antibodies against zebrafish podocalyxin-2
(Pdxl2) and found that it specifically localized
to the luminal membranes throughout the
zebrafish vasculature (Figure 4A; Figure S1D;
data not shown). Importantly, we observed
Pdxl2 in membrane compartments within
junctional rings shortly after contact formation
(Figure 4B), indicating that the future luminal
membrane becomes apically polarized during
early steps of anastomosis prior to the
morphogenetic movements that lead to lumen
coalescence during cord hollowing. In agree-
ment with our live observation, we also found
Pdxl2 in junction-free segments of DLAVs and
intersegmental vessels (ISVs) (Figure S1D).
Examination of younger embryos (36 hrs post-
fertilization [hpf]) revealed patterns of Pdxl2
protein extending from a multicellular base of
SAs into the tip cell (Figure 4C). This contin-
uous Pdxl2 domain is consistent with an
expansion of the vascular lumen from a multi-
cellular into a unicellular surrounding and
indicates that the tip cell becomes polarized
as its cell membrane invaginates.
Because cell membrane invagination occurs
directionally and can form a patent lumen
within a few hours, we tested whether blood
flow is required for lumen formation during
anastomosis by the injection of antisensemorpholinos against cardiac troponin (silent heart, sih, tnnt2a)
[9] into Tg(fli:gal4FF;UAS:GFP-ZO1) embryos. We recorded
a total of six time-lapse movies and observed that the initial
steps of anastomosis, i.e., the formation and elaboration of
the initial junctional rings, were relatively normal and that cell
movements appeared unaffected (Figure S3A; Movie S5;
data not shown). However, the vascular lumen of sih mor-
phants does not inflate, and lumen formation proved difficult
to monitor in vivo. Therefore, we used the Pdxl2 antibodies
Figure 4. Visualization of Apical Membrane during Anastomosis
(A–A00) Pdxl2 antibodies label apical cell membranes in ISVs and DLAV at 48 hpf.
(B–B00) Pdxl2 is localized within a junctional ring (arrow) at the contact site of two tip cells at the onset of anastomosis (36 hpf).
(C–C00) Apical membrane invaginating into a tip cell at 36 hpf is shown by Pdxl2 immunostaining.
(D–D0) In sihmorphants at the same stage, the Pdxl2 staining is only seen within the junctional rings, indicating that apical membrane invagination does not
take place in the absence of blood flow.
Also compare Movie S3 and Figure S3A. a-ZO1 is shown in white, a-Pdxl2 in green, and kdrl:EGFP in red. Scale bar in all pictures represents 20 mm.
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phant embryos and found that Pdxl2 was largely restricted to
multicellular domains except for spurious signals in unicellular
regions (Figure 4D). During examination of 60 tip cells at 36 and
48 hpf, respectively, we did not find any occurrence of
membrane invagination (see Table S1). These findings indicate
that blood flow is dispensable for cell rearrangements during
DLAV formation and for EC polarization per se. It is, however,
required for membrane invagination, which leads to the forma-
tion of unicellular tubes, indicating that blood pressure may be
the driving force of this morphogenetic process.
Taken together, we have shown that vascular anastomosis
during DLAV formation can occur by very different morphoge-
netic mechanisms, either by a cord hollowing process
generating a multicellular tube or by cell membrane invagina-
tion resulting in a unicellular tube, as summarized in Figure 5.
In both cases, anastomosis is intrinsically connected with
de novo lumen formation at the site of vessel fusion, andthe future luminal membrane compartments show apical
polarization before the blood vessel becomes patent. At the
cellular level, these mechanisms are drastically different
because they are driven by cell rearrangements and cell shape
changes, respectively. Cord hollowingmechanisms have been
described in different vertebrate tissues including the mouse
dorsal aorta [8] and the zebrafish neural tube [10, 11] and intes-
tine [12]. However, the cord hollowingmechanismwe describe
appears unique, because it is driven by cell rearrangements
rather than lumen expansion. In contrast, a mechanism of
remarkable similarity has been described for hollowing the
notochord in the ascidian Ciona intestinalis [13]. In both
systems, the zebrafish DLAV and Ciona notochord, lumeniza-
tion commences with the de novo establishment of apical
domains between neighboring cells and is followed by
cell movements and cell shape changes, which result in the
fusion of luminal spaces and the formation of a continuous
endothelium.
Figure 5. A Model of Cellular Mechanisms during Anastomosis
(A and A0) Contact formation during vessel fusion is shown in (A) and corresponding sagittal sections in (A0). At the contact site of two neighboring tip cells
(green and purple), junctional proteins are deposited (yellow spot in i). As the cells increase their mutual surface, this spot transforms into a ring (ii and iii), and
the enclosed membrane compartment becomes apically polarized (dark green and dark purple areas). Subsequently, two different cellular mechanisms are
used to complete the fusion process (see B and C).
(B) A cord hollowing mechanism results in a multicellular tube. Cell rearrangements bring together two junctional rings, i.e., two apical membrane compart-
ments that thenmerge into onemembrane compartment. This is achieved by the formation of a new junction (orange) between the green and blue cell, which
leads to the detachment of the middle cell (purple) at the site of the new contact.
(C) Cell membrane invagination leads to the formation of a unicellular, seamless tube. Here, apical membrane of the green cell invaginates into the green cell.
It then fuses with its own apical membrane at the previously formed contact side between the green and purple cells (see A). From here the lumen, i.e., the
apical membrane of the neighboring cell (dark purple), begins to invaginate.
Endothelial cells are shown in green, purple, and blue; apical membranes are shown in dark green, dark purple, and dark blue; endothelial cell junctions are
shown in yellow; and new endothelial cell junctions are shown in orange.
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1947During the formation of unicellular tubes, the fusion cell
undergoes drastic cell shape changes, as the proximal apical
cell membrane compartment, which faces the preexistinglumen, invaginates into the cell along the future vascular
axis (Figure 5). It thereby generates an extracellular space,
which extends through the cell and can be classified as
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1948a ‘‘transcellular lumen.’’ According to our model, the invagi-
nating membrane fuses with the distal membrane compart-
ment to convert the fusion cell into a patent tube. Although
we are not able to directly visualize membrane fusion in vivo,
intracellular cell membrane fusion has been described during
the development of the tracheal system of Drosophila [14–
16]. The fusion cell of the DLAV may be considered analogous
to the so-called doughnut cell, which is important for tubular
fusion within the Drosophila tracheal system and eventually
forms a seamless tube. In the case of the tracheal doughnut,
it has been shown that this unicellular tube is generated by
cell shape changes, which eventually lead to an intracellular
membrane fusion [17]. The cell shape changes, which occur
during vascular fusion, are far more dramatic than those in
the tracheal system. We observed asymmetric cell shape
changes, because the tip cell became hollowed in a proximo-
distal direction. Furthermore, the direction of invagination was
independent of the anatomical orientation and occurred either
in a ventral to dorsal or dorsal to ventral direction (Figures S3B
and S3C; Movie S4; Movie S6). In all cases, the lumen was
formed in a continuous fashion, and we did not detect isolated
luminal spaces within the cell.
Here, we have studied the anastomosis of ISVs, which
results in the formation of a new vessel, the DLAV.We describe
two morphogenetic mechanisms that govern vascular tube
formation. These mechanisms, although used by the same
type of blood vessel, employ very different cellular activities,
cell rearrangements and cell invagination, respectively, to
form and connect novel lumens and therefore lead to vessels
of distinct cellular architectures. Both mechanisms are used
at a comparable rate of instances, suggesting a stochastic
selection of the process. Future experiments will explore the
parameters, such as blood pressure, vessel size, and cell
motility and number, which may influence the choice of mech-
anism, as well as the molecular mechanisms that underlie
blood vessel fusion.
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Figure S1. QD Labeling of the Lumen and Characterization of 
fli1ep:Gal4ffubs3;UAS:ZO1-EGFPubs5 Transgenic Lines, Related to Figure 1 
(A) Lumen formation can be visualized by quantum dot (QD) injection and indirectly by a 
lack of RFP fluorescence. Picture series from a movie (data not shown). (i) merged images, 
(ii) RFP, (iii) QD. QD injected into the sinus venosus spread in the circulation visualizing 
patent lumens.  Initially, QD are restricted to the dorsal aorta (DA) (time 00:00 in iii). Later 
the lumen is successively filled from the DA through the ISV and the DLAV (arrowheads in 
iii). The distribution of QD in the ISV correlates with a displacement of cytoplasm, which 
also correlates with a reduction of the cytoplasmic RFP signal (arrows in ii).  
(B) DNA Gal4ff-driver and UAS-responder constructs used to generate transgenic reporter 
lines: Tol2 transposon sequences are shown as grey boxes. (i) schematic of the 
pT2fli1ep:GAL4FF driver construct, (ii) schematic of pT2UAS:EGFP-hZO1-cmlc2:EGFP 
responder construct.  
(C) EGFP-ZO1 colocalizes with endogenous VE-cad. (i) shows a stalk cell and (ii) shows a 
tip cell, where both proteins colocalize along cell junctions and presumptive autocellular 
contact points (white arrows). Since expression of EGFP-ZO1expression is mosaic, some 
VE-cad positive junctions are not labeled by EGFP-ZO1 (green arrows). Delocalized ZO1-
EGFP protein is found in the cell membrane (yellow arrow).  
(D) Luminal localization of Pdxl2 in the zebrafish vasculature. Optical sections through an 
ISV at 38hpf showing the distribution of apical and junctional staining in ECs. Sagittal (i-iii) 
and cross (iv-vi) sections are indicated by crosshairs (i, iv). Pdxl2 is visible only in the 
luminal site i.e. the apical side (white arrow in ii) of the cells and not the basal side (yellow 
arrow in ii). In (vii-viii) the Pdxl2 apical membrane staining in the DLAV at 36 hpf present 
throughout the cell (left arrow) indicates transcellular lumen formed by a cell invagination 
process. The Podocalyxin2 apical membrane staining between the junctions (white arrow) 
indicates extracellular lumen formation by cell rearrangements. (i-viii) ZO1 (white) and 
Pdxl2 (green) immunolocalization on Tg(kdrl:EGFP S843) (red) embryos. The scale bar in all 
panels represents 20 µm. 
 
 
 
 
Figure S2. A Schematic Representation of the Sequence of Morphogenetic Events 
Observed in Movies S2 and S3, Related to Figures 2 and 3 
(I) Neighboring tip cells deposit junctional proteins (EGFP-ZO-1) at the sites of contact 
formation (B). These areas expand leading to a transformation of the initial junctional spots 
into rings. Individual tip cells are shown in green, blue and yellow, respectively). The ISV 
stalk can be either unicellular or multicellular. For simplicity, a single adjoining stalk cell is 
shown in pink. Junctions are shown in two colors corresponding to the cell on either site of 
the cell contact. From here, two different morphogenetic mechanisms lead to two different 
types of tubes i.e. unicellular/seamless tubes (II) or multicellular tubes (III).  
(II) A lumen extends from the dorsal aorta into the stalk and pushes into the “fusion/tip” cell 
(blue) (A) (The lumen is visualized in a lighter shade of the color of the surrounding cell). As 
the lumen reaches the distal end of the fusion cell (B), it merges with a local luminal 
compartment at the contact and begins to push into the neighboring EC (C).  
(III) Several cells (pink, blue and yellow) enlarge their contact surfaces (A). Further cell 
rearrangements generate a novel contact between the pink and yellow cell (B) and lead to a 
local detachment of the blue cell at the novel contact site (C). As a result, two local 
compartments (blue/pink and blue/yellow) merge into a single multicellular lumen. (A’) to 
(C’) show longitudinal sections along the black line shown in (A). The scale bar in all panels 
represents 20 µm. 
 
 
 
 
Figure S3. Lumen Invagination Visualized by QD Injection, Related to Figure 4 
(A) Cell rearrangements do not depend on blood circulation. Series of pictures from movie 
S3. Fusion spots are transformed into rings (arrow at 01:50) and cell rearrangements (arrows 
at 08:25 and 10:20) still occur in sih morphant embryos.  
(B) Microangiography in Tg(fli1ep:Gal4ffubs3; UAS:RFP; UAS:ZO1-EGFPubs5) embryos. 
Still pictures from movie S5. (i) show merge and (ii) show QD channel only.  The SA to the 
left undergoes membrane invagination, similar to the events shown in Fig. 4. By invagination 
the lumen reaches the proximal site of the dorsal fusion point (arrow and arrowhead at 3:50). 
Anastomosis is completed when the luminal space within the fusion point becomes filled by 
QD (arrow and arrowhead at 8:35). (C) Dorsal to ventral lumen invagination. Still pictures 
from movie S6. The lumen extends from the DLAV (arrowhead) into the ISV (follow arrow 
from 01:50-03:35). The absence of longitudinal junctions indicates a transcellular lumen 
formation. The scale bar in all panels represents 20 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S1. Transcellular Tip Cell Invagination Requires Blood Flow 
 
 Total # 
of tip 
cells 
# of tip cell 
invaginations 
Percentage of 
invaginated tip 
cells 
36 hpf 
uninj. 
62 13 20.97% 
36 hpf 
sih MO 
68 0 0.00% 
48 hpf 
uninj. 
19 5 26.32% 
48 hpf 
sih MO 
61 0 0% 
 
Pdxl2 staining, within a single tip cell. Invagination was inferred from a Pdxl2 domain that 
stretches continuously from an intercellular junction into the cell (as seen in Fig.4C). uninj. = 
uninjected embryos 
Experimental Procedures 
Generation of Transgenic Zebrafish Lines 
The plasmids used to generate transgenic fish were constructed using the Gateway® cloning 
system (Invitrogen) [1] and are schematically shown in figure S1. The Tg(fli1ep:GAL4FFubs2-
4)activator line has been previously published [2]. pT2UAS:EGFP-ZO1-cmlc:EGFP was 
generated by ligating a 14xUAS-E1b promoter [3] to a EGFP-hZO1 fragment [4] and cloned 
into pDestTol2CG2 [5]. Details are provided upon request. Plasmid DNA was coinjected 
with tol2-mRNA and injected embryos showing transient cardiac EGFP expression were 
selected and raised separately. Founder fish were screened for germ line transmission. Three 
carriers showed Gal4FF dependent EGFP-ZO1 expression in the vasculature, two of these, 
Tg(UAS:EGFP-ZO1, cmlc:EGFPUBS5-6), were used in this study. 
 
Anti-zf-podocalyxin Antibodies 
2 different peptides derived from zf-pdxl2 (XP_692207) were synthesized, coupled to 
keyhole limpet hemocyanine and used to raise polyclonal anti-sera in rabbits using standard 
immunization procedures (Peptide Specialty Laboratory, Heidelberg, Germany). Peptide 
sequences: zf-pdxl2-pep1 (aa470-485):  CHSRPSQTRSDYGKLF; zfpdxl2-pep2 (aa573-
588): (C)-KPGKDEEDNQEEDTHL. 
 
Immunofluorescence and Imaging 
Antibody staining was done as previously described with minor modifications [6]. The 
following antibodies were used: rabbit anti-zf-pdxl2 1:200 (this study), rabbit anti-zf-CDH5 
[6] 1:200; Alexa-568 goat anti-rabbit IgG, 1:1000; Alexa-568 goat anti-mouse IgG, 1:1000; 
Alexa-633 goat anti-mouse IgG, 1:1000 (All secondary antibodies were purchased from 
Invitrogen.). Images were taken with a Leica SP5 confocal microscope using a 63x glycerol 
immersion objective and analyzed using Imaris (Bitplane) and Image J software [7]. 
 
In Vivo Time-Lapse Analysis and Embryonic Manipulations 
Triple transgenic embryos were selected using a Leica MZ FLIII fluorescent 
stereomicroscope. Embryos were selected for mRFP ensuring the presence of the 
fli1ep:GAL4FF and UAS:mRFP transgene and for the presence of the heart marker 
cmlc2:EGFP. Selected embryos were anaesthetized using tricaine and mounted in a 35 mm 
glass bottom petri dish  (0.17 mm, MatTek), using 0.7% low melting agarose (Sigma) 
containing 0.01% tricaine and 0,003% PTU. All movies have an initial frame size of 512x512 
pixels. Routinely, z-stack consisted of 50-80 slices with a step size of 0.8-1.0 µm. Stacks 
were taken every 5 minutes, unless noted differently. To label individual ECs KAEDE 
photoconversion was done on fli1ep:GAL4FF;UAS:Kaede transgenic embryos using a Leica 
Sp5 confocal microscope by 20-second exposures using a solid-state laser (405nm). At 2 dpf, 
when nuclei of individual ECs are easily discernible, embryos were anaesthetized with 
tricaine, mounted in 0.7% low melting agarose and a defined region of interest (ROI) within 
individual nuclei was exposed to the violet light. 705 nm Quantum Dots (Invitrogen) were 
injected into the sinus venosus of mounted embryos at a dilution of 1:2 using glass needles 
(Biomedical Instruments, Jena, Germany) with tip opening of 10 µm and beveled tip.  
 
 
 
 
Fish Maintenance and Stocks 
Zebrafish were maintained at standard conditions [8]. Embryos were staged by hours post-
fertilization (hpf) at 28.5 °C (Kimmel et al., 1995). Embryos derived from wild-type fish 
(AB/EK and EK/TL), Tg(fli1ep:EGFP)y1 [9], Tg(kdrl:EGFP)S843 [10], Tg(UAS:Kaede)rk8 
[11], Tg(UAS:RFP) [12] and Tg(fli1ep:GAL4FF)UBS2-4 [2] and Tg(UAS:EGFP-ZO1-
cmlc:EGFP)UBS5-7 (this study) were used. 
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ZebrafishDuring embryonic development, the vertebrate vasculature is undergoing vast growth and remodeling.
Blood vessels can be formed by a wide spectrum of different morphogenetic mechanisms, such as budding,
cord hollowing, cell hollowing, cell wrapping and intussusception. Here, we describe the vascular
morphogenesis that occurs in the early zebrafish embryo. We discuss the diversity of morphogenetic
mechanisms that contribute to vessel assembly, angiogenic sprouting and tube formation in different blood
vessels and how some of these complex cell behaviors are regulated by molecular pathways.
© 2009 Elsevier Inc. All rights reserved.Introduction
Branched tubular organs, such as the insect tracheal system or the
vertebrate cardiovascular system, kidney or lung, are found throughout
the animal kingdom. Formation of such tubular networks from
precursor cells or tissues involves a variety ofmorphogenetic processes,
such as tube formation, elongation, branching and fusion. These
processes are brought about by complex cellular behaviors, which
include cell polarization, cell migration, cell rearrangements, cell shape
changes and cell division. Although tubular organs are extremely
diverse in anatomy and function, the cellular activities that govern tube
formation and branching morphogenesis appear to be quite similar
(Baer et al., 2009; Andrew and Ewald, 2010). In this review,we describe
the current understanding of blood vessel formation in the early
zebrafish embryo. We are placing special emphasis on the morphoge-
netic processes that contribute to vascular development and discuss
the regulatory components that accompany these events.
In vertebrates, the cardiovascular system constitutes a highly
ramified network of tubes that transports gas, nutrients, hormones
and metabolites throughout the body. It also has important roles in
the regulation of homeostasis and wound healing and is involved in
the pathology of numerous diseases including cancer and inflamma-
tion (Carmeliet, 2003). The cardiovascular system emerges as one of
the first organs during embryonic development and retains morpho-. Belting).
ll rights reserved.genetic plasticity in adult life. Blood vessels are an integral component
of all organs and are vital not only for their function but also for their
formation during embryonic development (Nikolova and Lammert,
2003; Red-Horse et al., 2007; Sakaguchi et al., 2008). Blood vessels are
highly diverse: they differ in size and are specialized depending on
their function and the tissue or organ they are embedded in (Aird,
2007; Rocha and Adams, 2009). In general, they consist of an inner
epithelium (endothelium) lining the lumen; depending on the type of
vessel, this endothelium is surrounded by a basal lamina and bymural
cells, such as pericytes and smooth muscle cells, which both support
and regulate the function of the endothelium (Armulik et al., 2005).
Over the last decade, the molecular pathways controlling vascular
development have attracted much attention, and a large number of
key molecules has been identified that regulate different aspects of
blood vessel morphogenesis. The basic frameworks of the vascular
anatomy are conserved among vertebrates, whichmakes it possible to
assign homologies between distinct blood vessels and to directly
compare the formation of these vessels in different vertebrate species
(Isogai et al., 2001; see Fig. 1). The zebrafish embryo has proven to be
a useful model to study vascular morphogenesis in vivo. The vascu-
lature can be easily visualized using a variety of labeling techniques,
such as endothelial specific expression of fluorescent protein or by
microangiography (Fig. 1). Its small size, experimental accessibility,
optical clarity and rapid development allow to observe cellular
activities, such as cell migration, cellular rearrangements and cell
divisions, as they occur during blood vessel formation in the embryo.
It is also possible to follow cardiovascular mutant phenotypes for
several days because oxygenation of the early zebrafish embryo does
Fig. 1. The vascular system in mouse and fish embryos. (A) Visualization of the vascular system by immunohistochemical localization of PECAM-1 in a day 10 mouse embryo (photo
courtesy of Ralf Adams, MPI, Münster, Germany). Owing to the opacity of the mouse embryo, only superficial blood vessels can be seen. BA: branchial arches (1st and 2nd); ISV:
intersegmental vessel; DLAV: dorsal longitudinal anastomotic vessel. (B–D) The vascular system in a 3-day-old zebrafish embryo visualized by reporter gene analysis (TG:flk1:EGFP
in green) and bymicroangiography using quantum dots (red in panels C and D). Some blood vessels are indicated according to Isogai et al. (2001). AA: aortic arches (1–6); CV: caudal
vein; CCV: common cardinal vein; DA: dorsal aorta; PCV: posterior cardinal vein; PHS: primary head sinus; SA: segmental artery; SV segmental vein. At these stages, anatomical
similarities between the two species are best observed in the branchial arches and in the ISV of the trunk. ISV and DLAV form quite similarly in both species (Isogai et al., 2003;Walls
et al., 2008).
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ward and reverse genetics have shown that the molecular compo-
nents that regulate vascular development are conserved between
mammals and fish (Beis and Stainier, 2006; Lawson and Weinstein,
2002b; Thisse, 2002). Thus, the zebrafish embryo presents a unique
system in which live imaging can be combinedwith functional studies
to gain a more complete insight into how the molecular and
morphogenetic mechanisms are integrated at the (sub)cellular level
to shape the vascular tree.
Vasculogenesis
The formation of vertebrate blood vessels is commonly subdivided
into two distinct morphogenetic processes, called vasculogenesis and
angiogenesis. Vasculogenesis is defined by in situ aggregation of
angioblasts into a blood vessel (Coffin and Poole, 1988; Poole and
Coffin, 1989; Risau, 1995; Risau et al., 1988), while further sprouting
of vessels from existing vessels occurs via a process called angiogen-
esis (Risau, 1995).
Origin and specification of endothelial cells
Angioblasts are precursors of endothelial cells not yet incorporated
into blood vessels. They originate from the ventrolateral mesoderm
(Kimmel et al., 1995; Stainier et al., 1995). Analyses of genes ex-
pressed in the hematopoietic and endothelial cell lineages have
revealed a remarkable conservation between vertebrate species. In
particular, transcription factors belonging to the ETS, GATA and LMO
families have been shown to control specification of these lineages in
mammals as well as fish (De Val et al., 2008; Detrich et al., 1995; Liu
and Patient, 2008; Thompson et al., 1998; Zon et al., 1991). At the
beginning of somitogenesis, transcription factors, such as scl/tal1 and
lmo2, which specify angioblasts and hematopoietic cells, are
expressed in two domains along the body axis, the anterior and the
posterior lateral mesoderm (Dooley et al., 2005; Liao et al., 1998;
Patterson et al., 2007). During somitogenesis these cell populationsacquire unique gene expression profiles. For example, flk1-positive/
scl-positive precursor cells differentiate into flk1-positive/scl-nega-
tive and flk1-negative/scl-positive cells, which will give rise to
endothelial and hematopoietic cells, respectively (Gering et al.,
1998). There seems to be no transcriptional factor regulating
exclusively the endothelial specification but a combination ofmultiple
factors with overlapping expression patterns (reviewed by De Val and
Black, 2009).
Formation of the dorsal aorta and the cardinal vein
The basic anatomy of the initial embryonic circulatory system is
quite similar among vertebrates. In addition, the first embryonic
vessels to appear, the dorsal aorta (DA) and the posterior cardinal vein
(PCV), are formed by a distinct morphogenetic mechanism called
vasculogenesis in all vertebrates (Isogai et al., 2001). In zebrafish,
angioblasts are specifiedwell before the first blood vessels are formed.
Expression of molecular markers such as fli1a shows that angioblasts
are located in two lateral stripes at 12–14 hpf. By 28–30 hpf, the DA
and the PVC can be discerned and are fully lumenized (Roman et al.,
2002). In vivo imaging, using a Tg(fli1a:EGFP) reporter fish line, has
shown that angioblasts migrate as individual cells towards the
embryonic midline where they coalesce (Lawson and Weinstein,
2002b). During recent years, a considerable amount of research has
focused on how this migration process is regulated, how these cells
form the axial vessels and how DA and PCV are specified. As indicated
in Fig. 2, the PCV forms subsequently to the DA (Eriksson and Löfberg,
2000; Herbert et al., 2009; Jin et al., 2005), and this relationship
appears to be conserved among vertebrates (Coffin and Poole, 1988;
Hirakow and Hiruma, 1981; Meier, 1980).
Formation of the DA in zebrafish has been studied by transmission
electronmicroscopy (TEM) (Eriksson and Löfberg, 2000; Meier, 1980)
and more recently by analysis of transgenic zebrafish embryos
(Herbert et al., 2009; Jin et al., 2005; Lawson and Weinstein,
2002b). During vasculogenesis, angioblasts are attracted towards
the midline by guidance cues thought to emanate from the endoderm
Fig. 2. Phases of vasculogenesis in the zebrafish embryo. Schematic cross sections of the trunk region at representative stages of development (according to Herbert et al., 2009 and
Jin et al., 2005). (A) Medial migration. From 14 hpf onward, angioblasts (purple) that originate in the lateral plate mesoderm migrate over the endoderm towards the midline just
below the hypochord, where they aggregate to form a vascular cord (B). (B) Arterio-venous segregation and ventral sprouting. At around 17 hpf, angioblasts start to express markers
of arterio-venous differentiation, such as ephrin-b2a in arterial cells (marked in red). These cells are located in the dorsal portion of the vascular rod and will give rise to the DA,
whereas ephb4a expressing cells are located more ventrally and will contribute to the PCV and CV. At 21 hpf, angioblasts located in the ventral part of the vascular cord start
migrating ventrally and accumulate below the forming DA (B, C). (C) Lumen formation. The DA forms and lumenizes prior to the PCV and CV in the absence of blood cells (brown) by
cord hollowing. Venous angioblasts aggregate and coalesce around the blood cells to ultimately form a tube. (D) Functional Vasculature. At 30 hpf, both vessels are fully formed and
carry blood flow. Endothelial cell junctions are indicated in green.
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embryonic midline, they form aggregates and tube formation
commences (Fig. 2B). TEM studies have shown that angioblasts
initially form “aggregates of tightly packed cells” between hypochord
and the underlying mesoderm (Eriksson and Löfberg, 2000). These
aggregates are discontinuous along the anterior–posterior axis and
the cells are spherical at the beginning of the process. At around the
17-somite stage (17.5 hpf), more flattened tube forming cells are
found posterior to the 7th–9th somite in the fish embryo. From
analysis of transgenic zebrafish, it has been suggested that endothelial
cells migrate in two waves to the midline and it has been suggested
that the first wave contributes to the DA while the cells of the second
wave will form the primary vein (Jin et al., 2005). Alternatively,
endothelial cells from both migratory waves may join in a single
medial cord and segregate independently from this structure. The
latter possibility has recently gained strong support from in vivo time-
lapse analyses, which showed that the precursor cells of the caudal
vein dissociate from the primordium of the DA by a process termed
ventral sprouting (Herbert et al., 2009). Ventral sprouting is initiated
around 20 h post-fertilization shortly before the emergence of dorsal
sprouts, which will give rise to segmental arteries (SA) (see below) at
a time when the DA is not yet lumenized. This finding together with
the observation that the expression of the arterial marker ephrinb2a
(efnb2a) is restricted to a subpopulation within the vascular cord
suggested that the primary arteries and veins are derived from a
common primordium that contains a mixed population of arterial as
well as venous angioblasts (Herbert et al., 2009; Jin et al., 2005).
Specification of arterial versus venous fates has been shown to
depend on the interaction of the VEGF and Notch signaling pathways
(reviewed by Lawson and Weinstein, 2002a; Siekmann et al., 2008).
Sonic hedgehog (SHH) signals from the notochord lead to an
activation of vegf-a expression in ventral somites (Lawson et al.,
2002). VEGF-A is sensed by the angioblasts via VEGF-receptor-2/
KDR/FLK1 (KDR-Like/KDRL in zebrafish), which leads to the activa-
tion of Notch signaling and the transcriptional activation of other
factors which results in arterial differentiation in a subset of
angioblasts (Cermenati et al., 2008; Lawson et al., 2003; Pendeville
et al., 2008; Zhong et al., 2001). In contrast to arterial development,
specification of venous fates is independent of VEGF-A signaling
(Covassin et al., 2006; Lawson et al., 2003). In agreement with these
concepts, modification of VEGF or Notch signaling levels influences
the segregation and ventral sprouting behavior. Angioblasts showed
excessive ventral migration, when VEGF-A and Notch signals were
blocked, whereas downregulation of FLT4 led to a reduction in ventral
sprouting (Herbert et al., 2009).
Arterial and venous specification of angioblasts is reflected by
particular gene expressions (Lawson and Weinstein, 2002a). Notably,two members of the Eph-ephrin subclass of the receptor tyrosine
kinase family are differentially expressed in arteries (EphrinB2/Efnb2)
and veins (EphB4) (Adams et al., 1999; Lawson et al., 2001). Genetic
analyses in mouse have demonstrated an important role for
bidirectional Ephb4-Efnb2 signaling for vascular morphogenesis
(reviewed by Adams and Alitalo, 2007). In mouse and fish, EPHB4-
Efnb2 signaling has been shown to be involved in sorting of neuronal
cells, which leads to their segregation into adjacent hindbrain
segments (Kemp et al., 2009; Mellitzer et al., 1999). To test whether
these factors also play a role in the segregation of arterial and venous
angioblasts in the primary vascular cord, Herbert and colleagues
(2009) modified EPHB4a and EfnB2a levels and interfered with
forward and reverse properties of EPHB4a-EfnB2a signaling. Either
overexpression or knockdown of EPHB4a/Efnb2a function caused
aberrant migration of transplanted angioblasts consistent with
defects in arterio-venous segregation. Taken together, these findings
show that repulsive EPH4a-EfnB2 signaling regulates arterio-venous
segregation, thereby controlling the directionality of angioblast
sprouting.
Anterior–posterior differences in artery formation
While the process of vasculogenesis has been best described in the
dorsal aorta of the trunk, there is increasing evidence of regional
differences in the way the primary vessels form and it has been
proposed that distinct cues guide endothelial cells in different
domains of the body (Coffin and Poole, 1991; Eriksson and Löfberg,
2000). In agreement with this view, several zebrafish mutants have
been isolated that exhibit vascular defects in particular regions of the
body (Jin et al., 2007).
Some experiments have shed light on the differences that regulate
the formation of the DA of the trunk and the paired lateral dorsal
aortae (LDA), which is located in anterior body regions. In an earlier
study, the role of the endoderm for formation of the DAwas examined
in casanova (sox32) mutants that lack endoderm (Jin et al., 2005). In
these embryos, medial migration of angioblasts was slowed but the
DA formed normally, suggesting that endoderm is dispensable for DA
formation. However, it has more recently been shown that the
endoderm plays an essential role for LDA formation in the anterior
region of the embryo (Siekmann et al., 2009). Strikingly, mutants for
the chemokine receptor cxcr4a, which is expressed in the LDA, lack
the LDA. CXCR4 is known to bind to CXCL12, which is specifically
expressed in the anterior endoderm underlying the developing LDA.
Furthermore, loss of CXCL12 function phenocopies the cxcr4a
deficiency. These findings illustrate the molecular diversity in
endothelial cells and the importance of local extrinsic cues for the
formation and patterning of the primary aorta.
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vessels
The morphogenesis of biological tubes has been a longstanding
interest in developmental biology and it has been shown that tubes
can form in very different ways (Baer et al., 2009; Lubarsky and
Krasnow, 2003). After angioblasts have aggregated into a cord-like
structure, they ultimately have to assemble a tube. This could in
principal occur by different morphogenetic processes, including (i)
cell hollowing, where cells form vacuoles that fuse between cells to
form a continuous intracellular lumen; (ii) wrapping, where cells
migrate in a polarized state and surround the future lumen; (iii) cord
hollowing, where cells within the cord attain apical–basal polarity and
the lumen is formed by membrane separation and fluid influx; or by
(iv) cavitation, where cells in the middle of the rod undergo apoptosis
leaving a luminal space behind (Hogan and Kolodziej, 2002; Kucera et
al., 2007; Lubarsky and Krasnow, 2003).
Tube formation of the DA has been studied at the cellular level by
transgenic and immunofluorescent analyses in zebrafish embryos (Jin
et al., 2005). Shortly after angioblasts have formed a cord, the DA
begins to lumenize (21 hpf; Figs. 2B, C). Analysis of proteins involved
in apical–basal polarization, such as fibronectin or β-catenin, has
shown that this process is preceded by endothelial polarization and
the formation of junctions between ECs, suggesting that a cord
hollowing process forms the lumen of the DA. At the 20-somite stage
(19 hpf), cell junctions, as visualized by ZO-1 and Claudin5, are
discernable between the cells forming the dorsal aorta (Jin et al.,
2005). The mechanisms of lumen formation in the zebrafish dorsal
aorta and caudal vein have recently been examined by in vivo time-
lapse analyses (Herbert et al., 2009). These studies confirmed a cord
hollowing mechanism in the DA, whereas the lumen of the CV is
formed by ventrally sprouting venous angioblasts that coalesce
around resident blood cells. This mode of lumen formation has not
been described before and it is likely to be different from cell
wrapping as described above because the sprouting angioblast do not
seem to migrate as an epithelial sheet of cells.
In a recent, comprehensive study, lumen formation of the paired
dorsal aortae has been examined in the mouse embryo (Strilić et al.,
2009). By anatomical and immunofluorescent analyses, Strilić and
colleagues show that the lumen of the dorsal aortae forms in discrete
steps similar to those observed in the zebrafish and, for the first time,
they were able to decipher themolecularmechanisms involved in this
process. Consistent with observations in zebrafish, the first steps of
lumen formation are initiated upon formation of intercellular
adherens junctions between angioblasts. Junctional remodeling then
leads to an apical interface between adjacent ECs, followed by an
accumulation of anti-adhesive CD34-sialomucins, such as CD34 and
Podocalyxin (PODXL). Proper localization of these proteins to the
apical surface depends on the presence of VE-cadherin. The
subsequent formation of the aortic lumen is driven by a VEGF-A-
dependent constriction of the apical surfaces as well as EC elongation
induced by the F-actin cytoskeleton. These cell shape changes
apparently rely on interactions between Moesin with CD34-sialomu-
cins, which lead to an apical localization of F-actin. This view is
supported by the analysis of Moesin and of Podxlmutants which both
exhibit reduced levels of apical F-actin and a delay in aortic lumen
formation. Furthermore, loss of Podxl leads to a reduction of Moesin at
the sites of endothelial contacts, suggesting that PODXL connects with
Moesin in order to recruit F-actin.
In summary, these studies indicate that the morphogenetic
mechanisms that drive lumen formation in the dorsal aorta/aortae
have been conserved between teleosts and mammals. In either case,
coalescence of ECs and subsequent apical–basal polarization of a
vascular cord appear to be the primary steps. The lumen is then
formed between apical surfaces of apposing ECs by a cord hollowing
process. Whether the molecular mechanisms that underlie lumenformation are conserved between fish and mouse remains to be
determined. Furthermore, it will be interesting to learn about the
morphogenetic processes that may be required to further inflate the
lumen.
Angiogenesis
While the primary axial vessels are formed by vasculogenesis,
elaboration of the vasculature, i.e. the formation of secondary blood
vessels, occurs via angiogenesis, a process by which new blood vessels
are generated from a pre-existing one. However, with respect to
morphogenetic cell behaviors, angiogenesis can occur in quite
different ways. Originally, it has been described as a sprouting
process, by which a new vessel is branching off a primary vessel
(reviewed by Patan, 2000). In addition to sprouting, a considerably
different mode of angiogenesis called intussusception has been
described in mammals (reviewed by Makanya et al., 2009). During
intussusceptive angiogenesis, a vessel splits along its longitudinal axis
into two new branches, thus effectively enlarging the vascular surface
area. This process plays an important role in vascular remodeling
during plexus formation. In zebrafish, angiogenesis by intussuscep-
tion has not yet been described and therefore we focus our discussion
on sprouting angiogenesis.
Sprouting angiogenesis
Sprouting angiogenesis was described as a general mechanism of
microvascular growth during the 1970s, and its relevance for tumor
growth and metastasis was soon recognized (Folkman, 1982). Early
on angiogenesis was studied in a variety of in vivo and tissue culture
systems such as the chorion allantoic membrane of the chick or the
corneal pocket (reviewed by Patan, 2000). As an outcome of these
studies, sprouting angiogenesis was described as a sequence of events
that include (i) migration of ECs toward the angiogenic stimulus, (ii)
alignment of ECs in a bipolar mode, (iii) lumen formation and cell
divisions distant to the tip of the sprout and (iv) connection of
individual sprouts to initiate circulation (Ausprunk and Folkman,
1977; Patan, 2000).
In recent years, much progress has been made in establishing
systems in which angiogenic processes can be followed in detail.
These include the retinal vasculature of the mouse, which develops
postnatally, and the zebrafish embryo, in which all aspects of
angiogenesis can be followed in vivo. Embryonic vasculogenesis and
angiogenesis in zebrafish occur in ways very similar to those in
mammals. In contrast to the latter, zebrafish embryos do not require
extra-embryonic vasculogenesis due to their extrauterine develop-
ment. This greatly facilitates the analysis of embryonic blood vessel
formation, as it is not influenced by prior extra-embryonic events.
Although all major blood vessels are easily accessible in the zebrafish
embryo, the intersegmental blood vessels (ISV) have been most
thoroughly studied because of their metameric organization and
relatively simple anatomy.
ISV formation in the zebrafish embryo
Formation of ISVs in the zebrafish embryos involves two waves of
angiogenic sprouting (Isogai et al., 2003). ECs of the primary wave
form the segmental arteries (SA). During the primary wave, ECs
sprout from the DA at ∼22 hpf. These sprouts grow dorsally and –
once they have reached the level of the dorsal neural tube – connect
with their neighbors from anterior and posterior segments to form the
future dorsal longitudinal anastomotic vessel (DLAV). The second
wave, which starts at 32 hpf, involves ECs from the PCV (Yaniv et al.,
2006). These sprouts will either connect to an existing SA, thereby
transforming it into a vein (SV), or, alternatively, they will grow up to
the level of the horizontal myoseptum and form a population of cells
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Isogai, 2003). The majority of these cells eventually migrates away
from the horizontal myoseptum and contributes to the lymphatic
vasculature (Hogan et al., 2009).
Formation of the SA has been described in detail by in vivo time-
lapse and immunofluorescent analyses (Blum et al., 2008; Childs et al.,
2002; Isogai et al., 2003; Lawson andWeinstein, 2002b). These studies
have led to several models of SA morphogenesis. While earlier studies
suggested that the SA ismade up by 3 cells that are arranged serially in
a head to tail fashion (Childs et al., 2002), mosaic analyses and the
analysis of endothelial cell junctions showed that SAs are composed of
4–6 cells that extensively overlap along the proximodistal axis of the
vessel (Blum et al., 2008). Taken together, these findings suggest a
model of SA formation, as shown in Fig. 3. Initially, one or two cells
migrate out of the epithelium of the DA forming the sprout (Fig. 3A).
During dorsal outgrowth, this sprout consists usually of 3–4 cells, one
tip cell and two or three stalk cells (Fig. 3B).When the tip cell hasmade
contacts with its anterior and posterior neighbors, the basic scaffold of
the SA is formed (Fig. 3C). Because of cell divisions that occur at
varying time points, the stalk can consist of a variable number of cells
generating a large degree of morphological heterogeneity, which is
illustrated by the variation of junctional patterns (Blum et al., 2008).
However, further cell divisions and cellular rearrangements during
vessel assembly lead to a paired configuration of cells along the
proximodistal extent of the SA, which then forms a lumen. In the
following section, we discuss some of the morphogenetic and mole-
cular mechanisms that govern the different aspects of SA formation.
Sincemuchprogress has also beenmade in other angiogenesismodels,
we will discuss them in comparison with SA formation.
Sprouting of SA and SV appears to be triggered by different signals.
For example, VEGF-A is critical for SA formation, while it appears
dispensable for SV formation, since SV sprout normally in embryos
that are mutant for phospholipase C-γ (plc-γ , which is a downstream
mediator of VEGF-A/VEGFR-2 signaling; Bahary et al., 2007; Habeck et
al., 2002; Lawson et al., 2003; Nasevicius et al., 2000; Covassin et al.,
2009; Covassin et al., 2006). Here, wewill focus on themorphogenesis
of the SA. The regulation of angiogenesis by VEGFs and their receptors
has been studied in many previous publications in great detail
(reviewed by Cébe-Suarez et al., 2006; Matsumoto and Mugishima,
2006; Olsson et al., 2006; Shibuya and Claesson-Welsh, 2006;
Yamazaki and Morita, 2006). While early studies focused on general
pro-angiogenic functions of VEGF signaling, more specific roles for
VEGF signaling in patterning of angiogenic sprouts have recently been
revealed (Covassin et al., 2006; Gerhardt et al., 2003; Ruhrberg et al.,
2002). Upon VEGF-A/VEGFR-2 signals, ECs initiate the angiogenicFig. 3. Amodel for the morphogenetic events that lead to the formation of ISV and DLAV in th
cells are indicated in green and purple, respectively. At 22 hpf ECs of the DA form sprouts (
During these stages, the sprout consists of 2 to 4 cells that are stabilized by interendothelial
toward their anterior and posterior neighbors to establish connections. During this phase, t
Further cell rearrangements and cell divisions lead to formation of a continuous apical surfa
wave of angiogenic sprouts emerges from the PCV. These sprouts either generate a group of
adjacent primary vessel (D, on the right), which will become a segmental vein. Blood flowprogram, which entails the loosening of junctional connections with
neighboring cells, migratory behavior towards the angiogenic
stimulus and cell division (reviewed by Lampugnani and Dejana,
2007). Cells within the nascent sprout respond in different ways to
the VEGF-A. Whereas cells located at the base (termed stalk cells)
show increased rates of proliferation, the leading cell (termed tip cell)
sends long and dynamic filopodia into the surrounding environment
to guide the growing sprout towards the stimulus (Gerhardt et al.,
2003). Endothelial tip and stalk cells do not only have different
functions and behaviors (discussed below), they also show differ-
ences in gene expression. For example, Platelet derived growth factor
B (Pdgfb) and Flt4 are expressed at higher levels in the tip cell than in
the stalk cell (Gerhardt et al., 2003; Siekmann and Lawson, 2007).
Patterning and angiogenic behavior of sprouts are regulated by the
cooperation of the Notch and VEGFR-2 signaling pathways (Hellström
et al., 2007; Siekmann et al., 2008; Siekmann and Lawson, 2007;
Suchting et al., 2007; reviewed by Phng and Gerhardt, 2009;
Siekmann et al., 2008). The tip cell, receiving the highest level of
VEGFR-2 signal, responds with an upregulation of the Notch ligand
Delta-like-4 (DLL4), which leads to increased intracellular Notch
signaling in the neighboring stalk cells (Hellström et al., 2007). In
zebrafish, loss of DLL4 function leads to prolonged angiogenic activity
in the ISVs, whereas over-activation of Notch signaling leads to a
quiescent phenotype (Leslie et al., 2007; Siekmann and Lawson,
2007). DLL4 also regulates angiogenesis by suppressing VEGF-C
dependent FLT4 (VEGFR-3) signaling in endothelial cells in mouse
and fish (Hogan et al., 2009; Tammela et al., 2008). In zebrafish, VEGF-
C/FLT4 signaling is required for venous and lymphatic development
(Covassin et al., 2006; Küchler et al., 2006). However, a “kinase-dead”
allele of FLT4 is able to rescue the hyperbranching phenotype caused
by the loss of DLL4 function (Hogan et al., 2009). Furthermore, in the
absence of DLL4, arterial cells becomemore sensitive to varying levels
of VEGF-C in the embryo (Hogan et al., 2009). These experiments
point out a mechanism for how different endothelial lineages can
respond specifically to sources of VEGF-C in the trunk. Venous and
lymphatic cells, which do not express dll4, are able to respond to
VEGF-C/FLT4, whereas in arterial cells this pathway is inhibited by
DLL4 (Hogan et al., 2009).
Although the molecular mechanisms that control angiogenic
behavior in the sprout may not be identical in fish and mouse, there
is a common theme in that differences in intracellular Notch signaling
confer different cell behaviors along the proximodistal axis of the
sprout. Tip cells (low Notch) extend numerous filopodia, are highly
migratory and thus display the strongest angiogenic behavior while
the proximal stalk cells (high Notch) appear less migratory. It hase Trunk. Two neighboring sprouts are depicted as representative examples. The leading
A) that grow along the somite boundaries up to the dorsal roof of the neural tube (B).
junctions (not indicated). At the dorsal side of the embryo, the tip cells send extensions
he ECs establish a scaffold consisting of a vascular cord that is not yet lumenized (B, C).
ce that may surround initial luminal spaces (yellow) (D). At around 32 hpf, a secondary
lymphatic cells, called parachordal lymphangioblasts (not shown), or connect with the
in ISVs commences after SA, SV and DLAV have been established (E).
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important to maintain sprout integrity and connection to the DA
(Siekmann et al., 2008).
While the general aspects of angiogenesis in the ISVs of the fish
and the postnatal vasculature of the mouse retina are very similar,
there appear to be differences in gene expression and pattern of cell
proliferation. While in the mouse retina cell proliferation is largely
restricted to the stalk (Gerhardt et al., 2003), in fish similar rates can
be observed in stalk and tip cells (Blum et al., 2008). Furthermore,
based on gene expression—intersegmental sprouts in the fish appear
not as polarized as those in the mouse retina. In contrast to the mouse
retina, the tip cell markers dll4 and flt4 are quite uniformly expressed
in tip and stalk cells of the sprouting SA (Hogan et al., 2009; Leslie etal., 2007; Siekmann and Lawson, 2007). Similar to zebrafish, ISV
sprouts in the mouse embryo show a relatively even distribution of
DLL4 protein (Tammela et al., 2008). These differences between
distinct types of blood vessels raise the possibility that, compared to
themouse retina, the state of the tip cell in ISV is less defined. It will be
interesting to see whether these differences are due to different
interpretations of VEGF/Notch signals or whether they are connected
to different morphogenetic processes occurring in the two systems
(see below).
How the angiogenic sprout lumenizes is still controversial.
Different morphogenetic behaviors and cellular configurations in
the sprout can have significant impact on how a vessel is formed. In
principle, there are at least 3 different morphogenetic processes of
tubulogenesis that may occur in an angiogenic sprout: budding, cord
hollowing or cell hollowing (see Fig. 4A).When a novel tube is formed
by budding, the ECs that follow the tip cells maintain their epithelial
character with a defined apical–basal polarity. During budding, the
luminal space of the sprout remains continuous with that of the
parent vessel, extending up to the tip cell. Tube branching by budding
has been described in many experimental systems including the
tracheal system in Drosophila and several branched organs in
mammals (Baer et al., 2009). Vessel branching by budding appears
to occur in larger caliber capillaries that are constantly perfused. In the
mouse retina, the lumen is located immediately adjacent to the tip cell
(see Fig. 4B). In addition, in vivo time-lapse recording of blood vessels
in the zebrafish brain appears consistent with such morphogenetic
mode of tubular branching (Huisken and Stainier, 2009).
Formation of ISV does not occur by budding since the initial
sprouts do not contain a lumen continuous with the DA (Fig. 4C).
Rather, the lumen becomes patent at the time when SA, DLAV and SV
have formed proper connections. After labeling circulating blood with
fluorescent tracer dyes, it was observed that (from the perspective of
the DA) the lumen opens up in a stepwise manner from proximal toFig. 4. Different morphogenetic mechanisms that underlie sprouting angiogenesis. (A)
Three examples for the cellular organization of an angiogenic sprout. Depending on
how the cells are arranged in the sprout, different types of vessels may form. Left:
Branching morphogenesis by budding. ECs remain epithelial, while the sprout grows
via cell division within the stalk. The lumen remains open and continuous at all times.
Middle: Formation of a multicellular tube by cord hollowing. This shows an example,
where cells grow in a paired configuration maintaining an apical surface in between.
The lumen remains open at the base but is closed in distal region. Close to the tip, cells
may be of a more mesenchymal character and undergo cell divisions. Cellular
rearrangements will then lead to a continuous apical surface and open up the luminal
space. Right: Formation of a unicellular tube with an intracellular lumen. At the tip of a
capillary, the lumen may also form within a string of cells. The cells hollow out by
vacuole formation followed by exocytosis. This mode of lumen formation will generate
a so-called intracellular lumen. (B) Lumen formation behind the leading tip cell in the
mouse retina. The lumen of the nascent sprout extends to the tip of the growing sprout.
This situation is in agreement with the configuration shown in panel A. Isolectin B4
labeling (green) of an endothelial tip cell projecting long filopodia. Nuclei, Dapi, blue
(B). Semithin (B′) and close up of ultrathin (B″) en face section of the sprouting front in
the retina illustrating continuous lumen formation (l) just behind the tip cell (t). The
endothelial tip cell in panel C is pseudocolored brown. Figure courtesy of Denise Stenzel
and Holger Gerhardt, London Research Institute—Cancer Research UK. © Gerhardt et al.,
2003. Originally published in J. Cell Biol. doi:10.1083/jcb.200302047. (C) Lumen
formation in the ISV and DLAV of a zebrafish embryo. During scaffold formation, neither
ISV nor DLAV are perfused, suggesting that the lumen is formed subsequently. Blood
flow is initiated after subsequent remodeling and establishment of the intersegmental
veins (compare to Fig. 3). Confocal still pictures from an in vivo time-lapse movie of a
transgenic zebrafish embryo (TG:fli1a:EGFPy1;gata1:DsRedsd2). ECs are labeled in green;
erythrocytes are labeled in red. (D) Alternate models of lumen formation in the
zebrafish ISV. Depending on the cellular arrangement of cells in an angiogenic sprout,
de novo lumen formation can occur in at least two different ways. If cells are arranged in
a serial fashion, the lumen may be generated by cell hollowing (left, see also A). In this
process, ECs pinocytose solutes from extracellular space and form vacuoles that
coalesce and fuse to give rise to an intracellular lumen. Eventually intracellular vacuoles
of neighboring cells will fuse by exocytosis and form a patent lumen (see Kamei et al.,
2006). Alternatively, if cells are arranged in a paired fashion, they may form a lumen by
cord hollowing (right, see also A). This process requires establishment of a continuous
apical surface that is bounded by at least two ECs. Vacuoles can then be exocytosed into
this intercellular space, which will eventually become the vascular lumen.
62 E. Ellertsdóttir et al. / Developmental Biology 341 (2010) 56–65distal (Kamei et al., 2006). Because vacuole formation and fusion has
long been considered an important component of lumen formation,
the stepwise expansion of luminal space was interpreted as a
succession of vacuolar fusion events that generate a unicellular tube
containing an intracellular lumen (Kamei et al., 2006; Fig. 4D).
Capillaries that contain intracellular lumens have indeed been
described (Bar et al., 1984) and have been called “seamless tubes”
because they are characterized by the absence of cell junctions along
the longitudinal axis of the vessel. More recently, analyses of cell
junctions within nascent sprouts and patent ISVs showed that the
cells in the stalk overlap extensively along the proximodistal axis and
that ISVs are multicellular tubes containing an extracellular lumen
(Blum et al., 2008). This cellular configuration is more consistent with
a lumen formation process by cord hollowing (Fig. 4D). In this model,
cells in the stalk rearrange to form a continuous apical surface. The
lumen is then formed by a process, in which small pre-luminal spaces
(rather than vacuoles) are formed by exocytosis and/or paracellular
influx of liquids. The stepwise opening of the lumen from the direction
of the aorta would then be consistent with the completion of cell
rearrangements in the stalk. The events described here would be quite
comparable to those described above for the lumen formation in the
dorsal aorta.
The threemechanisms discussed here are not necessarily mutually
exclusive. For example, it is possible that sprouting angiogenesis
contains aspects of both, budding and chord hollowing, depending on
the extent to which apical–basal polarity is maintained in the stalk
cells. Likewise, it is possible that a single blood vessel contains regions
of intracellular as well as regions of extracellular lumen. Taken
together, it is clear that different vessels can form by various morpho-
genetic mechanisms. It remains to be explored what the decisive
factors are that determine which mechanism is used. It is likely that
parameters such as vessel caliber, blood pressure of the parental
vessel as well as cell number within the sprout play important roles.
Guidance cues along the way—endothelial pathfinding
To effectively oxygenate a given organ, blood vessels have to be
evenly distributed within this tissue. This can be achieved in different
ways, for example by controlling the number of angiogenic sprouts
that are generated (e.g. ISV) or by the formation of a plexus (e.g.
retinal vasculature in the mouse), which is then remodeled by a
pruning process. In recent years, a number of ligands (and their
respective receptors) that provide endothelial guidance cues have
been described, including the Semaphorin, Netrin, Ephrin and Slit
systems (reviewed by Larrivée et al., 2009). Interestingly, these
signals were originally described as cues for axonal growth cones
(reviewed by Eichmann et al., 2005). It has become clear since that
many of the signaling pathways that act during axonal pathfinding are
also employed for guidance of angiogenic sprouts.
In the zebrafish, the guidance of angiogenic sprouts is best studied
during SA formation. Segmental arteries sprout from the DA at the
intersomitic boundary; as they grow out, they follow the intersomitic
fissure up to the horizontalmyoseptum, fromwhere they change their
path to growmore or less straight to the dorsal roof of the neural tube.
The exit point of intersegmental sprouts is regulated by molecular
guidance cues. In out of bounds (obd) mutants, angiogenic sprouts
form ectopically along the ventral somite border (Childs et al., 2002).
Furthermore, these sprouts no longer avoid the ventral somite and the
ISVs take on a plexus-like organization. Molecular analyses showed
that obd encodes the receptor PlexinD1 that is expressed in ECs and
interacts with the ligands SEMA3A1/2, which is expressed in ventral
somites. Upon ligand binding, a repulsive signal is activated in the ECs
prohibiting them from moving into the somite region (Torres-
Vazquez, 2004). Recently, it has been shown that the interaction of
different Plexins and Semaphorins is also important for the timing of
SA sprout formation (Lamont et al., 2009).Analyses in mouse have uncovered an additional and quite
different molecular mechanism that limits the number of sprouts.
Bautch and coworkers have shown that a soluble form of FLT-1
(VEGFR-1), sFLT-1, is secreted from ECs adjacent to the forming sprout
(Chappell et al., 2009). This isoform is able to bind VEGF, thereby
removing it from the environment surrounding the sprout. It is
thought that sFLT-1 serves two purposes: it ensures the ordered
formation of sprouts from an activated endothelium and it prevents
the early sprout to connect back to its original vessel.
The sharing of attracting and repulsive signaling pathways by
neurons and ECs appears to be a common theme. In fact, it has been
shown that growing neurons and nascent capillaries can walk the
same tracks (Mukouyama et al., 2002). It will be interesting to see
whether in these instances neurons and ECs simply use the same
cues provided by the stromal cells or whether they also navigate by
direct cell–cell interactions. It is noteworthy that not only the tip cell
but also stalk cells appear to express guidance receptors albeit at
lower levels (Larrivée et al., 2009). In zebrafish, for example, the
guidance receptor PlexinD1 is expressed at comparable levels in the
tip and the stalk of nascent SA (Torres-Vázquez et al., 2004). This
raises the possibility that also stalk cells are involved in angiogenic
pathfinding. Indeed, it appears that the tip cell fate is not fixed and
that cells at the stalk can become tip cells and vice versa. In murine
allantoic explant cultures, migratory ECs are passing each other at
the tip (Perryn et al., 2008). In a similar fashion, ECs are changing
lead during the outgrowth of vascular cords that sprout from
differentiating murine embryonic stem cells (Holger Gerhardt,
personal communication). It has been suggested that these tip cell
turnovers are regulated by oscillations in Notch signaling along the
vascular sprout (Phng and Gerhardt, 2009). It should be noted that
these vascular cords are not perfused during early outgrowth and
are, in that respect, similar to developing SAs rather than vessels in
the postnatal mouse retina.
Cell–cell adhesion during sprouting angiogenesis
The above observations indicate that the angiogenic sprout is
highly plastic with regard to signaling events and cell–cell interac-
tions and that cellular rearrangements play an important role in blood
vessel morphogenesis. It is generally believed that cellular rearrange-
ments involve remodeling of intercellular junctions (Baer et al., 2009).
In Drosophila, adherens junctions play an important role for cellular
rearrangement during various processes, such as border cell migra-
tion or tracheal morphogenesis (Pacquelet and Rørth, 2005; Ribeiro et
al., 2004). In the case of border cell migration very different cell
behaviors, invasive cell migration and cell adhesion require DE-
cadherin. These distinct cellular activities are mediated by homophilic
interactions of DE-cadherin between different cell types: interactions
among border cells maintain cohesion of the migratory cells while
interactions between border cells and nurse cells allow invasive
migration into the substratum (Niewiadomska et al., 1999). The role
of VE-cadherin during vertebrate angiogenesis is less clear. Mice that
are mutant for VE-cadherin die at mid-gestation exhibiting vascular
defects that are consistent with a role for VE-cadherin in maintaining
vascular integrity (Carmeliet et al., 1999; Crosby, 2005). Further in
vitro analyses have also emphasized a role of VE-cadherin in
endothelial cell survival and stabilizing the endothelium, in part by
antagonizing VEGFR-2 signaling (reviewed by Lampugnani and
Dejana, 2007; Vestweber et al., 2009). Recent organotypic cell culture
and knockdown experiments in zebrafish point at a role of VE-
cadherin in angiogenic sprouting (Abraham et al., 2009). In these
studies, quiescent endothelial tubes did not respond to VEGF
stimulation unless VE-cadherin function was reduced. They further
showed that VE-cadherin suppresses sprouting by inhibiting VEGF-
R2/RAC1 signaling. In the zebrafish ISV, knockdown of VE-cadherin
led to the formation of ectopic “branch points” along the proximo-
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behavior of the ECs within the ISV.
While the above results suggest an anti-angiogenic function, other
studies indicate a more pro-angiogenic role for VE-cadherin. As
discussed above, blood vessel formation is a very dynamic process
involving cell rearrangements and cell migration. These dynamics
have been studied using murine allantoic explant cultures, which
allow to measure the migration of individual and groups of ECs in a
process called vasculogenic sprouting, which involves the outgrowth
of multicellular sprouts from a primary plexus (Perryn et al., 2008;
Rupp et al., 2004). ECs actively migrate over the substrate, frequently
passing each other during outgrowth of the vascular rod. These
rearrangements are effectively inhibited by addition of a VE-cadherin
blocking antibody (Perryn et al., 2008), indicating that VE-cadherin is
required for cellular rearrangements as they occur during vasculo-
genic sprouting. In zebrafish, we have observed that VE-cadherin is
also essential for cellular rearrangements during SA formation (H.-G.
Belting and M. Affolter, unpublished observation). Therefore, it
appears that in addition to functions in vascular integrity and cell
survival, VE-cadherin is also involved in sprouting angiogenesis. One
can easily imagine that, analogous to the role of DE-cadherin in border
cell migration, VE-cadherin may fulfill dual functions at the same
time: maintenance of cell–cell contacts and cellular rearrangements.
Conclusions and perspectives
Blood vessel formation includes a spectrum of different morpho-
genetic processes such as budding, cord hollowing, cell hollowing, cell
wrapping and intussusception. The genetic and molecular bases,
which initiate and control these different processes is not known. It is
clear, however, that ECs of different vascular beds are different in their
gene expression profile and that blood vessels are anatomically highly
diverse (Rocha and Adams, 2009). Morphogenesis may also be
influenced by extraneous factors such as diverse extracellular
matrices and signals, shear stress due to blood pressure or differences
in cell number (Aird, 2007; Nguyen et al., 2006; Sottile, 2004).
The morphogenetic events that underlie blood vessel formation
are likely to determine the way a vessel ultimately lumenizes. During
sprouting angiogenesis, larger vessels appear to extend their lumens
in conjunction with the outgrowing sprout, while small capillaries
may form their lumens de novo by cell hollowing or cord hollowing.
The respective contribution to lumen formation in different vessels
remains to be determined.
Elaboration of the vascular tree requires additional processes, such
as vessel fusion and pruning. How these processes occur at the
morphogenetic level has not yet been described in much detail. With
regard to vessel fusion, one can envisage that cellular remodeling
plays a major role. Furthermore, it is likely that the fusion process
occurs differently depending on vessel type. In the zebrafish, the
DLAVs form in a non-perfused state and blood circulation commences
subsequently. Recently, VE-cadherin localization during DLAV forma-
tion revealed that cells from adjacent sprouts undergo extensive
rearrangements (Blum et al., 2008). Initial contacts between neigh-
boring sprouts require VE-cadherin, as knockdown of VE-cadherin
function leads to slowed-down formation of cell–cell contacts
(Montero-Balaguer et al., 2009). It will be interesting to examine
the exact cellular mechanisms that drive vessel fusion during DLAV
formation and compare them with those occurring in perfused
vessels.
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Sprouting angiogenesis expands the embryonic
vasculature enabling survival and homeostasis. Yet
how the angiogenic capacity to form sprouts is
allocated among endothelial cells (ECs) to guarantee
the reproducible anatomy of stereotypical vascular
beds remains unclear. Here we show that Sema-
PlxnD1 signaling, previously implicated in sprout
guidance, represses angiogenic potential to ensure
the proper abundance and stereotypical distribution
of the trunk’s segmental arteries (SeAs). We find
that Sema-PlxnD1 signaling exerts this effect by
antagonizing the proangiogenic activity of vascular
endothelial growth factor (VEGF). Specifically,
Sema-PlxnD1 signaling ensures the proper endothe-
lial abundance of soluble flt1 (sflt1), an alternatively
spliced form of the VEGF receptor Flt1 encoding
a potent secreted decoy. Hence, Sema-PlxnD1
signaling regulates distinct but related aspects of
angiogenesis: the spatial allocation of angiogenic
capacitywithin aprimaryvessel andsproutguidance.
INTRODUCTION
Blood vessels form a pervasive tubular network that distributes
oxygen, nutrients, hormones, and immunity factors. The first
blood vessels assemble de novo via EC coalescence or vasculo-
genesis. Later, they expand via angiogenesis, the growth of new
blood vessels from preexisting ones. In some locales, this
process is stereotypic and vascular sprouts form with evolution-
arily conserved and organ-specific distribution, abundance and
shapes (Carmeliet, 2005; Isogai et al., 2001; Isogai et al., 2003).
For example, zebrafish SeAs sprout bilaterally from the trunk’s
aorta just anterior to each somite boundary (SB) (Figure 1A).
SeA sprouts contain migratory, proliferative and filopodia-rich
arterial angiogenic ECs molecularly distinct from the sedentary
‘‘phalanx’’ ECs remaining in the aorta (De Bock et al., 2009; Siek-Developmann and Lawson, 2007; Torres-Va´zquez et al., 2004). Normally,
only aortic ECs near SBs acquire angiogenic capacity (Ahn et al.,
2000; Childs et al., 2002). It is thought that nonendothelial para-
crine VEGF signals promote angiogenic capacity, while Notch-
mediated lateral inhibition between ECs antagonizes it (Phng
and Gerhardt, 2009; Siekmann et al., 2008). However, the
mRNA expression of vegf-a and Notch pathway genes is incon-
sistent with the distribution of SeA sprouts. vegf-a is not tran-
scribed along SBs, but rather expressed dorsal to the aorta at
both the flanking somites’ centers and the hypochord, a midline
endodermal cell row. Notch pathway genes are expressed con-
tinuously along the aorta or broadly through the body (Hogan
et al., 2009b; Lawson et al., 2002; Leslie et al., 2007; Phng
et al., 2009; Siekmann and Lawson, 2007) (C.M.G., J.B., and
J.T.-V., unpublished data). Hence, other cascades likely modu-
late VEGF and/or Notch signaling at presprouting stages to
enable the stereotypical allocation of angiogenic capacity within
the aorta. Perturbing these unidentified cascades might change
the SeA sprouts’ reproducible number or distribution, the ratio of
aortic ECs that acquire angiogenic capacity, and/or the respon-
siveness of these cells to angiogenic cues.
Besides VEGF and Notch activity, proper SeA development
requires paracrine Sema-Plxn signaling. Type 3 semas (sema3s)
are repulsive guidance cues secreted by somites. Sema3s direct
SeA sprout pathfinding by modulating cytoskeletal dynamics via
the endothelial Sema3-receptor PlxnD1. Hence, sema3 or
plxnD1 inactivation yields similar SeA sprout pathfinding defects
in zebrafish and mice (Gay et al., 2011). Two observations made
in zebrafishmake Sema-PlxnD1 signaling a candidatemodulator
of angiogenic capacity. First, sema3 and plxnD1 expression
begins hours before SeAs sprout from the aorta at 21 hr post-
fertilization (hpf). Second, loss of Sema-PlxnD1 signaling
induces ectopic SeA sprout launching (Childs et al., 2002;
Torres-Va´zquez et al., 2004).
In wild-type (WT) animals SeA sprouts grow dorsally with
a chevron-like shape, bifurcate anteroposteriorly at the neural
tube’s roof level and interconnect with their ipsilateral neighbors
at 32 hpf forming the paired Dorsal Longitudinal Anastomotic
Vessels (DLAVs) (Isogai et al., 2003). In contrast, in plxnD1 (out
of bounds - obd) mutants and plxnD1 morphants, SeA sprouts
are misshaped and interconnect ectopically with their ipsilateralmental Cell 21, 301–314, August 16, 2011 ª2011 Elsevier Inc. 301
Figure 1. Sema-PlxnD1 Signaling Is Cell Autonomously Required within the Endothelium for Proper SeA Sprout Abundance and Distribution
(A and B) 23 hpf vasculatures, green. SBs, red. Horizontal myoseptum (HM), white dotted line. SeA sprouts, numbered. (A) WT. (B) obd.
(C and D) SeA sprout position (C) and abundance (D) in 23 hpf WT and obd. n = 8 WT, 12 obd. Error bars represent SEM. ***p < 0.001.
(E and F) WISH, 28 hpf trunks. Ectopic SeA sprouts, white arrowheads. Riboprobes: flt4 (blue), cdh5 (red). WT (E). obd (F). n = 10/10 WT, 10/10 obd.
(G and H) 32 hpf chimeric vasculatures with ECs of donor (green) and host (red) origin. Examples of ectopic SeA sprouts, white arrowheads.
(A, B, E–H) Anterior, left; dorsal, up. Scale bars represent 30 mm. See Figure S1.
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Sema-PlxnD1 Signaling Limits Angiogenic Potentialneighbors but form properly placed DLAVs (Childs et al., 2002;
Torres-Va´zquez et al., 2004). Thus, we further examined Sema-
PlxnD1’s signaling role during zebrafish SeA development,
finding that it plays a presprouting role as a repressor of the302 Developmental Cell 21, 301–314, August 16, 2011 ª2011 Elsevieaorta’s angiogenic potential—the probability that ECs acquire
angiogenic capacity. This role stems from its ability to promote
sflt1’s endothelial abundance and thus antagonize pro-
angiogenic VEGF activity (Rahimi, 2006). We propose thatr Inc.
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Sema-PlxnD1 Signaling Limits Angiogenic PotentialSema-PlxnD1 signaling allocates angiogenic capacity among
aortic ECs in a reproducible spatial pattern, guaranteeing the
proper abundance and distribution of SeA sprouts.
RESULTS
Lack of Sema-PlxnD1 Signaling Induces Too Many
and Ectopic SeA Sprouts
To investigate if Sema-PlxnD1 signaling modulates angiogenic
capacity we measured SeA sprout abundance and positioning
in WT and obd at 23 hpf, when individual obd SeA sprouts are
readily identifiable as they are yet to interconnect ectopically.
We found obd has almost twice theWT’s number of SeA sprouts,
with most of them launching ectopically (Figures 1A–1D). Hence,
Sema-PlxnD1 signaling limits the abundance and defines the
position of SeA sprouts.
To molecularly verify the angiogenic character of ECs within
obd SeA sprouts, we used whole-mount RNA in situ hybridiza-
tion (WISH) (Moens, 2008) to visualize expression of the pan-
endothelial marker cdh5 (Larson et al., 2004) and flt4/vegfr-3,
which labels arterial angiogenic ECs within SeA sprouts and
the vein (Covassin et al., 2006; Hogan et al., 2009b; Siekmann
and Lawson, 2007). flt4 is expressed in all SeA sprouts and
vein of WT and obd (Figures 1E and 1F), confirming the angio-
genic character of ECs within obd’s SeA sprouts and the lack
of artery/vein differentiation defects in obd (Torres-Va´zquez
et al., 2004).
Loss of Sema-PlxnD1 Signaling Yields More
Angiogenic Cells
To determine if obd’s SeA sprout overabundance is associated
with too many angiogenic ECs we compared the number of EC
nuclei found within developing SeAs and DLAVs of WT and
obd at 21, 23, and 32 hpf. We found that obd’s SeAs/DLAVs
collectively harbor more angiogenic ECs than WT (see Figures
S1A and S1B available online). We next aimed to compare the
WT and obd ratios of angiogenic to phalanx arterial ECs.
However, SeA sprouts arise while the aorta and vein segregate
from each other (Herbert et al., 2009), making the quantification
of early aortic EC abundance unfeasible. We thus instead
counted EC nuclei in the axial vasculature (aorta and vein taken
together) and found that obd shows increased axial vasculature
EC abundance (Figures S1A and S1B). Hence, loss of
Sema-PlxnD1 signaling yields more angiogenic and axial vascu-
lature ECs.
Sema-PlxnD1 Signaling Is Cell-Autonomously Required
within the Endothelium
To ask if Sema-PlxnD1 signaling acts cell autonomously to limit
the number and define the position of SeA sprouts, we per-
formed cell transplants (Carmany-Rampey and Moens, 2006)
to make heterogenotypic WT:obd (WT-to-obd and obd-to-WT)
chimeras. We analyzed these at 32 hpf to determine SeA
sprout abundance and distribution and examine the SeA contri-
bution of ECs from donors and hosts (Figures 1G and 1H). We
found too many SeA sprouts in WT:obd chimeras. As in obd,
some SeA sprouts launched ectopically and others were
positioned correctly. WT ECs were found only within properly
positioned SeA sprouts, while obd ECs contributed toDevelopmisshapen SeAs sprouts at both ectopic and correct positions
(Figures 1G and 1H and Figure S1C). Control homogenotypic
(WT-to-WT and obd-to-obd) chimeras also showed mosaic
SeAs with both host and donor ECs (Figure S1E). Hence, SeAs
are not necessarily of clonal origin, in agreement with results
from prior transplantation and mosaic transgenic labeling exper-
iments (Childs et al., 2002; Siekmann and Lawson, 2007).
obd ECs found within WT hosts contribute to SeAs/DLAVs
much more often than WT ECs contribute to these angiogenic
vessels in obd hosts (Figures S1C, S1D, and S2C). Since obd
ECs show exacerbated angiogenic capacity in a WT environ-
ment this property is not caused by axial vasculature EC
overabundance. Finally, nonendothelial obd cells, like ventral
somitic muscle fibers (Childs et al., 2002), did not influence the
abundance, distribution or anatomical patterning of SeA sprouts
(Figure S1C), consistent with plxnD1’s endothelial-specific
expression (Torres-Va´zquez et al., 2004) and the identical
vascular phenotypes of mice with global or EC-specific plxnD1
inactivation (Gay et al., 2011). Thus, Sema-PlxnD1 signaling
acts cell autonomously within the endothelium to limit angio-
genic potential and ensure the proper abundance and posi-
tioning of SeA sprouts.
Aortic ECs with Less Sema-PlxnD1 Signaling (obd/+)
Become Angiogenic Tip Cells More Often and Are
Enriched in the Aorta’s Dorsal Side
Each SeA sprout has a spearheading tip cell that becomes ‘‘T’’
shaped during DLAV formation and which is trailed by a few stalk
cells (Siekmann and Lawson, 2007). Tip cells embody an
enhanced angiogenic state promoted by increased proangio-
genic signaling and characterized by exacerbated filopodia
dynamics whose acquisition and/or maintenance involves cell
competition (Jakobsson et al., 2010; Leslie et al., 2007; Roca
and Adams, 2007).
Thus, if Sema-PlxnD1 signaling antagonizes angiogenic
potential then ECs with reduced Sema-PlxnD1 signaling levels
should acquire an enhanced angiogenic state more often. To
test this hypothesis, we used cell transplantation experiments
to compare the properties of ECs from WT and obd/+ heterozy-
gotes. These embryos have the same number of ECs within both
the SeAs/DLAVs and the axial vasculature (Figure S2A) and iden-
tical SeA sprout abundance, positioning and patterning
(Figures 2A and 2B). We determined the frequency at which
donor ECs become tip cells in homogenotypic (WT-to-WT and
obd/+-to-obd/+) and heterogenotypic (WT-to-obd/+ and
obd/+-to-WT) chimeras. To ensure competition between donor
and host ECs had occurred, we scored only mosaic SeAs
harboring both donor and host ECs. All chimeras showed
correctly patterned and positioned SeA sprouts (Figures 2C
and 2D and data not shown) and both kinds of homogenotypic
chimeras showed identical donor tip cell percentages (Figure 2E).
In contrast, the donor tip cell percentage was significantly larger
in obd/+-to-WT chimeras and smaller in WT-to-obd/+ chimeras
(Figure 2E).
Hence, the angiogenic capacity and angiogenic positional fate
of aortic ECs is not prespecified but is acquired and/or main-
tained competitively, agreeing with prior related observations
(Jakobsson et al., 2010; Siekmann and Lawson, 2007). Indeed,
within developing SeA sprouts angiogenic cell nuclei swapmental Cell 21, 301–314, August 16, 2011 ª2011 Elsevier Inc. 303
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Figure 2. ECs with Less Sema-PlxnD1 Signaling Tend to Become Tip Cells and Occupy the Aorta’s Dorsal Side
(A and B) 32 hpf vasculatures. EC nuclei (green), membranes (red). SBs, blue. (A) WT. (B) obd/+.
(C and D) 28 hpf vasculatures with ECs of donor (green) and host (red) origin. Asterisks: Tip cells (white), stalk cells (blue).
(E) Percentage of mosaic SeAs with tip cells of donor origin in homogenotypic (gray bars) and heterogenotypic (black bars) chimeras. n = 27 WT to obd/+, n = 18
obd/+ to obd/+, n = 38 obd/+ to WT, n = 34 WT to WT. Error bars represent SEM.
(F) Percentage of ECs of donor origin found within the dorsal side of the host’s arterial tree in homogenotypic (gray bar) and heterogenotypic (black bar) chimeras.
(E and F) *p < 0.05, **p < 0.01, ***p < 0.001. Error bars represent SEM. n = 24 WT to WT, n = 32 obd/+ to WT.
(A–D) Anterior, left; dorsal, up. Scale bars represent 30 mm. See Figure S2 and Movie S1.
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Sema-PlxnD1 Signaling Limits Angiogenic Potentialpositions (Movie S1), suggesting that angiogenic cells within SeA
sprouts can exchange places. Thus, the SeA tip cell population
scored in Figures 2C–2E likely includes both the angiogenic cells
that launched first from the aorta and kept their leading position
and those that trailed the original tip cell but later overtook it.
Prior studies suggest that migration speed is similar between
cells with differential abilities to acquire/maintain a tip cell posi-
tional status (Jakobsson et al., 2010). Of note, both WT and
obd/+ embryos form DLAVs at similar times, suggesting that
their SeA sprouts grow with matching speeds. Thus, indepen-
dently of its roles in guiding SeA sprouts (Gay et al., 2011) and
limiting EC abundance (Figures S1A and S1B), Sema-PlxnD1
signaling antagonizes angiogenic responses.
Both the angiogenic potential of obd ECs and the angiogenic
response of obd/+ ECs within WT hosts is enhanced, suggest-304 Developmental Cell 21, 301–314, August 16, 2011 ª2011 Elsevieing that Sema-PlxnD1 signaling acts prior to SeA sprouting. To
investigate this possibility and determine its potential cellular
basis, we made obd/+-to-WT and WT-to-WT chimeras and
plotted the distribution of donor ECs within the host’s trunk
vasculature shortly after SeA sprouts launch (Figure S2B).
Consistent with Sema-PlxnD1 signaling’s dispensability for
artery-vein differentiation (Torres-Va´zquez et al., 2004), ECs
from both donors contributed to the WT host’s aorta equally.
However, ECs from obd/+ donors were enriched along the
aorta’s dorsal side (Figure 2F) and obd ECs also preferentially
occupy this locale in WT hosts (Figures S1C and S2C). In
contrast, ECs with a cell autonomous impairment in down-
stream VEGF signaling that abrogates SeA angiogenesis
localize to the aorta’s ventral side within WT hosts (Covassin
et al., 2009).r Inc.
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Figure 3. Sema-PlxnD1 Signaling Ensures the Proper Endothelial Abundance of sflt1
(A) Alternative flt1 splicing yields sflt1 and mflt1 isoforms with unique eleventh exons. Exons, colored boxes. Introns, black lines.
(B) sflt1 encodes a soluble 474 aa protein. mflt1 encodes a 1,273 aa transmembrane protein. Protein domains: Immunoglobulin (Ig, red numbered boxes),
transmembrane (TM, gray box), tyrosine kinase (TK, pink box).
(C–H) WISH, embryo trunks (genotypes and ages indicated) hybridized with sflt1 (C and D, F and G) and mflt1 (E and H) riboprobes (blue).
(I) qPCR measurements. Relative mRNA abundance of sflt1, mflt1, and YFP (from Tg(flt1:YFP)hu4624/+) in 28 hpf obd/+ (WT level = 1, dashed line). Error bars
represent coefficient of variance *p < 0.05.
(J) ELISA-based quantification of FLT1 prepared from cell extracts of HUVECs treated with both VEGF and Sema3E and the control or PLXND1-targeting
shRNAs. Error bars represent SEM. ***p < 0.001.
(C–H) n = 10 embryos per riboprobe, stage and genotype. Pictures of representative examples of stainings observed (10/10 embryos in each category). Anterior,
left; dorsal, up. Scale bars represent 50 mm. See Figure S3.
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Sema-PlxnD1 Signaling Limits Angiogenic PotentialThe aorta’s dorsal side lies near the trunk’s paracrine sources
of proangiogenic VEGF (Lawson et al., 2002) and is the aortic
angiogenic region (Ahn et al., 2000; Wilkinson et al., 2009).
Importantly, obd/+ lacks aortic dorsoventral polarization
defects: bothWT and obd display similar expression of the aortic
dorsal side marker tbx20 (data not shown) and make red blood
cells, which derive from the aorta’s ventral side (data not shown)
(Wilkinson et al., 2009).
Hence, Sema-PlxnD1 signaling plays a presprouting role in
SeA angiogenesis and the cellular basis for the enhanced angio-
genic response of obd/+ arterial ECs is, at least, related to their
ability to localize early within theWT host’s aortic roof, a property
likely due to increased VEGF responsiveness. Notably, in
heterogenotypic chimeras plxnD1 genetic dosage affects aortic
cell distribution (Figure 2F) and tip cell positional status (Fig-
ure 2E) similarly but to different extents. Hence, Sema-PlxnD1
signaling likely exerts other pre-and/or postsprouting effects,
like modulating the angiogenic cell’s launching schedule and/
or positional persistence (Childs et al., 2002; Jakobsson et al.,
2010; Kearney et al., 2004).DevelopSema-PlxnD1 Signaling Regulates the Abundance
of the VEGF Antagonist Encoded by soluble flt1 (sflt1)
To determine the molecular mechanism by which Sema-PlxnD1
signaling represses angiogenic potential we usedWISH (Moens,
2008) to visualize the expression of twelve components and
targets of the VEGF and Notch signaling cascades, including
artery-vein differentiation markers (see Supplemental Informa-
tion). Only flt1 (fms-related tyrosine kinase/vegf receptor 1)
(Bussmann et al., 2007; Krueger et al., 2011) expression was
visibly affected in obd. We found that zebrafish flt1 pre-mRNA
is alternatively spliced into transcripts encoding products similar
to the soluble (sFlt1) and membrane (mFlt1) mammalian proteins
that function as high-affinity VEGF decoys or receptor/corecep-
tor tyrosine kinases, respectively (Figures 3A and 3B) (Krueger
et al., 2011; Rahimi, 2006). Using isoform-specific riboprobes
we detected sflt1 and mflt1 transcripts in the WT trunk arterial
tree at 21–28 hpf (Figures 3C–3E) (Krueger et al., 2011). In
contrast, sflt1 was barely detectable in obd despite robust
mflt1 staining (Figures 3F–3H), suggesting that Sema-PlxnD1
signaling modulates the relative abundance of flt1 isoformsmental Cell 21, 301–314, August 16, 2011 ª2011 Elsevier Inc. 305
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Sema-PlxnD1 Signaling Limits Angiogenic Potentialand/or flt1 transcription. We used qPCR to compare the mRNA
levels of WT and obd/+, which have identical EC abundances.
We measured the transcript levels of both flt1 isoforms and,
separately, quantified the YFPmRNA output of the flt1 transcrip-
tional reporter Tg(flt1:YFP)hu4624 (Hogan et al., 2009a). obd/+
shows reduced sflt1 (4-fold) and increased mflt1 (3-fold) levels,
but unaltered flt1 transcriptional levels (Figure 3I), and, confocal
imaging reveals no clear differences in Tg(flt1:YFP)hu4624 expres-
sion between WT and obd (Figure S3C). Finally, ELISA-based
measurements of FLT1 from extracts of HUVECs (human umbil-
ical vein ECs) exposed to both VEGF and the canonical PlxnD1
ligand Sema3E reveal that shRNA-mediated PLXND1 knock-
down reduces FLT1 without decreasing FLT1 transcription (Fig-
ure 3J and Figure S3A; see also Figure S3B).
We conclude that Sema-PlxnD1 signaling acts via a posttran-
scriptional mechanism to ensure sflt1’s proper abundancewithin
the trunk’s arterial tree and propose this model: sflt1 acts as
a PlxnD1 effector that antagonizes proangiogenic VEGF
signaling to limit angiogenic potential.
Partial Reduction of Both plxnD1 and sflt1 Enhances
SeA Angiogenesis
If the proposed model is true, plxnD1 and sflt1 should interact
genetically to limit SeA angiogenesis. We tested this prediction
with a morpholino (MO) (Morcos, 2007) that inhibits the alterna-
tive splicing event that yields sflt1 (Figures S4A and S4B). The
sflt1-splice MO induces aberrantly branched SeA sprouts in
WT and obd-like SeA sprout defects such as ectopic launching
and aberrant branching in obd/+ heterozygotes (Figures 4B
and 4D–4F and Figure S4C). Similarly, a pan-flt1 splice-blocking
MO (Rottbauer et al., 2005) targeting both sflt1 and mflt1 also
induces obd-like SeA sprout defects in obd/+ (Figures S4E and
S4F). Of note, a different pan-flt1 MO also induces SeA
misbranching in WT (Krueger et al., 2011). Both the expressivity
and penetrance of these abnormalities is greater in sflt1-splice
than in pan-flt1 morphants, likely due to differences in knock-
down efficiencies and the combined effects of inactivating flt1
isoforms with opposite roles (Figure 4F and Figure S4F) (Rahimi,
2006). In contrast, WT and obd/+ treated with mismatched
control sflt1 splice-blocking MO or an mflt1-specific splice-
blocking MO (Rottbauer et al., 2005) display normal SeA sprouts
(Figures 4A and 4C; Figures S4D and S4F).
These observations agree with the vascular organization roles
of plxnD1 (Gay et al., 2011) and flt1 (Krueger et al., 2011; Rahimi,
2006), the differential activities of flt1 isoforms (Chappell et al.,
2009; Kappas et al., 2008; Rahimi, 2006) and sflt1’s low level in
obd/+ (Figure 3I). In short, plxnD1 and sflt1 (but notmflt1) interact
genetically to modulate SeA sprout positioning, abundance, and
patterning.
Endothelial Overexpression of sflt1, but notmflt1,
Inhibits SeA Angiogenesis
Based on our model sflt1, like Sema-PlxnD1 signaling, should
inhibit SeA angiogenesis. We tested this idea by overexpressing
sflt1 in an endothelial-specific fashion in bothWT and obd via the
GAL4/UAS system (Figure S4G). We found that sflt1 overexpres-
sion suppresses SeA sprouting inWT and obd (Figures 4G–4H00).
To determine if mflt1 plays similar vascular roles during SeA
angiogenesis, we analyzed the effects of mflt1 overexpression.306 Developmental Cell 21, 301–314, August 16, 2011 ª2011 ElsevieThis treatment does not abrogate SeA sprouting but instead
induces ectopic SeA sprouting at low frequency, consistent
with the weak mflt1 proangiogenic activity reported (Rahimi,
2006) (Figure S4H). Hence, within the trunk vasculature sflt1
and mflt1 play distinct roles, with sflt1 acting as an inhibitor of
SeA angiogenesis.sflt1 Inhibits SeA Angiogenesis Cell Autonomously
Based on the model proposed, sflt1, like plxnD1, should act cell
autonomously within the trunk’s endothelium to suppress SeA
angiogenesis. Given the lack of flt1 mutants, we tested this
prediction by combining sflt1 overexpression with cell transplan-
tation experiments using donors and hosts carrying different
endothelial reporters to distinguish ECs according to their geno-
type. We made chimeras to determine if overexpressed sflt1
inhibits SeA sprouting non-cell-autonomously. We transplanted
obd cells into WT hosts with GAL4/UAS system-dependent
mosaic endothelial coexpression of sflt1 and fluorescent DsRed
protein. We found that WT aortic ECs overexpressing sflt1
(DsRed+) fail to form SeA sprouts. However, neighboring obd
donor and WT host aortic ECs without sflt1 overexpression
(DsRed-) form SeA sprouts (Figures 4I and 4I0). In another exper-
iment, we transplanted cells from obd donors with endothelial
sflt1 overexpression (DsRed+) into WT hosts. While the obd
aortic ECs with sflt1 overexpression (DsRed+) failed to form
SeA sprouts, neighboring WT and donor obd ECs not overex-
pressing sflt1 (DsRed-) formed SeA sprouts (Figure S4I). Thus,
sflt1 acts cell autonomously despite the potential diffusible
nature of its encoded product.The Exacerbated SeA Angiogenesis of obd Requires
VEGF Signaling
sflt1 encodes a VEGF signaling antagonist whose levels are
greatly reduced in obd (Figure 3). To test if VEGF signaling is
required for obd’s SeA angiogenesis, we chemically inhibited
VEGF receptor activation with SU5416 (Herbert et al., 2009).
SU5416, but not its vehicle (DMSO), abrogates SeA sprouting
in WT and obd (Figures 5A, 5B, 5E, and 5F; see also Figure S5B).
Similarly, MO-induced vegfa activity reduction also abrogates
obd’s SeA angiogenesis (Childs et al., 2002). These findings indi-
cate obd’s excessive SeA angiogenesis is VEGF dependent.VEGF Signaling Is Enhanced in obd
The VEGF cascade splits downstream of the VEGF receptors
into PLCG1 (phospholipase C gamma1; plcg1) and PI3Kp110a
(phosphoinositide 3-kinase p110a isoform)-dependent proan-
giogenic branches (Figure 5M) (Covassin et al., 2009; Graupera
et al., 2008). Our model predicts enhanced VEGF signaling in
obd. Hence, angiogenic deficits due to impaired VEGF signaling,
such as those of plcg1mutants, should be ameliorated in an obd
background. plcg1 lacks SeA sprouts (Figure 5C) (Covassin
et al., 2009). However, obd; plcg1 double mutants show too
many and ectopic SeA sprouts (Figure 5D and Figure S5A) that
express flt4 and a trunk arterial tree with reduced sflt1 abun-
dance (data not shown). obd; plcg1’s SeA sprouting recovery
requires VEGF signaling, sinceSU5416 suppresses it (Figure 5H).
These observations support the notion that Sema-PlxnD1
cascade inactivation enhances VEGF signaling, suggestingr Inc.
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Figure 4. plxnD1 and sflt1 Interact Genetically, sflt1 Limits SeA Angiogenesis Cell Autonomously
(A–I) Thirty-two hpf trunk vasculatures, green.
(A–E) SBs, red. White arrowheads, ectopic SeA sprouts. Blue arrowheads, ectopic SeA branching. (A, C, E) Embryos treated with 20 ng of sflt1-ctrl MO: WT (A),
obd/+ (C), obd (E). Embryos treated with 20 ng of sflt1-splice MO: WT (B), obd/+ (D).
(F) 23 hpf SeA sprout abundance in WT (left, gray bar) and obd/+ (right, black bar) sflt1-splice morphants. n = 20WT and n = 19 obd/+. Error bars represent SEM.
***p < 0.001.
(G–I0) SBs, blue. GAL4FF/UAS-mediated endothelial-specific sflt1 overexpression, red. White arrows, missing SeA sprouts.
(G0–H00) Endothelial sflt1 overexpression inhibits SeA sprouting. WT (G–G00). obd (H and H00), note lack of sflt1 overexpression (red) in remaining SeA sprout (white
arrowhead).
(I and I0) Mosaic vasculature with ECs from both obd donor and WT host. Endothelial-specific and mosaic sflt1 and DsRed coexpression restricted to the WT
endothelium (red, I and I0). obd ECs express cytosolically targeted EGFP (gray in I; green in I0). WT ECs express nuclear-targeted EGFP (white in I; green in I0). obd
andWT ECs without sflt1 overexpression (DsRed-) from SeA sprouts even next to sflt1 overexpressing WT ECs (DsRed+). WT ECs overexpressing sflt1 (DsRed+)
fail to form SeA sprouts (white arrows, I and I0).
(G–H00) n = 30 embryos with overexpression per genotype, all showing suppression of SeA sprouting. Anterior, left; dorsal, up. Scale bars represent 30 mm. See
Figure S4.
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Figure 5. Enhanced VEGF Signaling Causes obd’s Exacerbated SeA Angiogenesis
(A–L) Thirty-two hpf trunk vasculatures. WT, obd, plcg1 and obd; plcg1 treated with DMSO, SU5416 (VEGFR inhibitor), or AS605240 (PI3K inhibitor). Genotypes,
top; treatments, left. Endothelium, green. SBs, red.White arrowheads, recovered SeA sprouts in obd; plcg1. Anterior, left; dorsal, up. Scale bars represent 30 mm.
n = 18 embryos per genotype and treatment. Pictures show representative phenotypes (18/18 embryos per category).
(M) Diagram of the VEGF cascade and steps inhibited by sflt1 and drugs used in (E)–(L).
(N) HUVEC proliferation in response to combinations of VEGF, Sema3E, and shRNAs (control, PLXND1 and FLT1). ***p < 0.001. Error bars represent SEM. See
Figure S5.
Developmental Cell
Sema-PlxnD1 Signaling Limits Angiogenic Potentialthat obd; plcg1’s angiogenic recovery is VEGF/PI3Kp110a
dependent.
We tested this possibility via chemical inhibition of PI3Kp110a
activity with AS605240 (Herbert et al., 2009). PLCG1 function
removal has a greater impact on angiogenesis than PI3Kp110a
inactivation (Covassin et al., 2009;Graupera et al., 2008). Accord-
ingly, AS605240 neither abrogates SeA angiogenesis in WT or
obd nor ameliorates plcg1’s angiogenic deficit (Figures 5I–5K).
However, AS605240 blocks SeA sprouting in obd; plcg1 (Fig-
ure 5L), indicating that proangiogenic VEGF/PI3Kp110a activity is
limiting under plcg1-deficient conditions. Hence, compared
with obd (Figure 5B), obd; plcg1 show fewer and stunted SeA
sprouts that fail to form DLAVs (Figures 1D, 5D, and 6L).
We further confirmed the link between Sema-PlxnD1 and
VEGF signaling by observing that hypomorphic mutants of kdrl,
which encodes the duplicate canonical VEGF pathway compo-308 Developmental Cell 21, 301–314, August 16, 2011 ª2011 Elsevienent VEGF receptor 2/VEGFR-2/KDR, show SeA angiogenic
deficits (Covassin et al., 2009; Habeck et al., 2002) that are
ameliorated in an obd background (Figure S5C).
To selectively determine Sema-PlxnD1 signaling’s effect on
VEGF-induced cellular responses, we used a HUVEC prolifera-
tion assay (Figure 5N). We found that VEGF-induced HUVEC
proliferation is reduced by Sema3E exposure and that the latter
effect is abrogated via PLXND1 (Bellon et al., 2010; Fukushima
et al., 2011; Sakurai et al., 2010; Uesugi et al., 2009) or FLT1
knockdown (Figure 5N and Figure S5D). Accordingly, VEGF/
Sema3E-treated HUVECsmake less FLT1 protein upon PLXND1
knockdown (Figure 3J). Of note, PLXND1 knockdown in
HUVECs does not affect FLT1 transcription (Figure S5D), paral-
leling our in vivo data indicating that Sema-PlxnD1 signaling
modulates sflt1 abundance posttranscriptionally (Figures 3C–3I
and Figure S3C).r Inc.
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Figure 6. Notch Signaling Loss Does Not Phenocopy obd
(A and B) Expression of Notch’s activity nuclear reporter Tg(Tp1bglob:hmgb1-mCherry)jh11 (red) in the endothelium (gray) of WT (A) and obd (B).
(C–F) obd; mib. (C) Endothelium, green. SBs, red. (D–F) WISH with sflt1, flt4 and mflt1 riboprobes, as indicated. Double mutant phenotypes classed as obd-like
(C and D) or mib-like (E and F) based on the mutant they resemble most. Note lack of sflt (as in Figure 3G) and ectopic aortic flt4 (yellow arrowhead; as in
Figure S6A) and venous mflt1 stainings (green arrowhead, as in Figure S6B).
(G–I) Angiogenic cell abundance within the trunk’s arterial tree of WT, obd, mib (G) and obd; mib (H) in Tg(fli1:nEGFP)y7 embryos.
(G–H) EC nuclei, green. SBs, red.
(I) Quantification; n = 10 per genotype.
(J–L) SeA sprout abundance in plcg, mib; plcg, obd; plcg (J) and obd; plcg embryos injected with 10 ng of mib MO (mib MO) (K).
(J and K) Endothelium, green. SBs, red.
(L) n = 8, 7, 11 and 9 for plcg, mib; plcg, obd; plcg and obd; plcg (mib MO), respectively.
Scale bars represent 50 mm (A, B, and D–F), 30 mm (C, G, H, J, and K).
(I and L) *p < 0.05, ***p < 0.001. Error bars represent SEM.
(A–F, G, H, J, and K) Anterior, left; dorsal, up. Trunk images and quantifications: 32 hpf (A–C, G–L), 28 hpf (D–F). See Figure S6.
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Sema-PlxnD1 Signaling Limits Angiogenic PotentialWISHs suggest that sflt1’s level in the trunk’s arterial tree is
independent of VEGF signaling: SU5416 treatment does not
reduce sflt1 abundance in WT nor increases it in obd (Fig-
ure S5B). Hence, obd’s decreased sflt1 abundance is not
secondary to enhanced VEGF signaling but rather at least one
of its causes.
Sema-PlxnD1 and Notch Signaling Play Distinct
and Additive Roles in SeA Angiogenesis
Notch signaling also negatively regulates SeA sprouting (Leslie
et al., 2007; Siekmann and Lawson, 2007). We thus compared
the arterial tree phenotypes induced by loss of Sema-PlxnD1
and Notch signaling.We found that unlike obd, SeA sprout abun-
dance and distribution are normal inmind bomb (mib) mutants, in
which a ubiquitin ligase required for Notch signaling is inactive
(Figure S6A) (Itoh et al., 2003; Lawson et al., 2002; Lawson and
Weinstein, 2002). Likewise, Notch pathway inactivation via
mutations in eithermib or delta-like ligand 4 (dll4), which encodes
a Notch ligand expressed in the trunk’s arterial tree (Leslie et al.,
2007), fails to ameliorate the angiogenic deficit of plcg1
(Figure S6C).
Studies in other systems and/or vascular beds suggest Notch
signaling promotes flt1 expression (Bussmann et al., 2011; del
Toro et al., 2010; Funahashi et al., 2010; Harrington et al.,
2008; Jakobsson et al., 2010; Suchting et al., 2007), prompting
us to ask if Notch signaling is reduced in obd or modulates the
trunk’s arterial tree expression of flt1 and its isoforms.
WISH expression analysis of Notch pathway components
(deltac, dll4 notch5, and gridlock) and targets (gridlock, ephrin-
B2a, flt4, and ephB4a) fails to uncover evidence for reduced
Notch signaling in obd (data not shown) and, endothelial
expression of the transgenic Notch signaling reporters
Tg(Tp1bglob:hmgb1-mCherry)jh11 and Tg(Tp1bglob:eGFP)um14
(Nicoli et al., 2010; Parsons et al., 2009) is similar in WT and
obd (Figures 6A and 6B and data not shown), consistent with
the notion that in obd Notch activity is preserved.
Visual comparison of the expression of the flt1 transcriptional
reporter (Hogan et al., 2009a, 2009b) in WT, obd mutants and
mib morphants (Figure S3C) reveals no significant differences.
Tg(flt1:YFP)hu4624 expression is also unaffected in dll4
morphants (Geudens et al., 2010). Moreover, WISH of mib
mutants reveals no visible reduction in sflt1 or mflt1 abundance
but rather a mild enhancement in sflt1 and mflt1 venous
expression (Figure S6B). Consistent with the role of Notch
signaling in artery/vein differentiation and angiogenesis, mib
displays ectopic aortic flt4 expression (Figure S6A) (Lawson
et al., 2001; Siekmann and Lawson, 2007).
To elucidate the relationship between Sema-PlxnD1 and
Notch signaling, we analyzed the anatomical, cellular andmolec-
ular vascular phenotypes of obd; mib and the combined impact
of inactivating both pathways on plcg1’s SeA angiogenesis
deficit. We found that within the arterial tree obd; mib show
obd-like SeA anatomical organization and sflt1 abundance
(Figures 6C and 6D) but mib-like flt4 and mflt1 expression
patterns (Figures 6E and 6F). This mix of obd- and mib-like
phenotypes reveals that Sema-PlxnD1 and Notch signaling
play distinct vascular roles.
Yet we also find additive genetic interactions between both
pathways: obd; mib have greater angiogenic cell abundance310 Developmental Cell 21, 301–314, August 16, 2011 ª2011 Elseviethan obd or mib (Figures 6G–6I) (Leslie et al., 2007; Siekmann
and Lawson, 2007). Likewise, silencing mib (Itoh et al., 2003) in
obd; plcg further increases their SeA sprout abundance (Figures
6J–6L). Hence, in this sensitized background Notch signaling
seems to play a minor role as a negative regulator of SeA sprout
abundance, consistent with the loss of SeA sprouting induced by
overexpression of constitutive-active Notch forms, the complex
interplay between VEGF and Notch signaling and the lateral
inhibition role of the latter (Jakobsson et al., 2010; Roca and
Adams, 2007; Siekmann and Lawson, 2007). While these
additive interactions suggest that Sema-PlxnD1 and Notch
signaling modulate common aspects of angiogenic develop-
ment, these pathways clearly make qualitatively and quantita-
tively different contributions via molecularly distinct mecha-
nisms. For example, while both pathways antagonize VEGF
signaling, they modulate different pathway components, namely
sflt1 and flt4. Together, these observations indicate that Notch
signaling remains active in obd and that Sema-PlxnD1 signaling
functions without Notch activity (Figure 7A), underscoring the
distinct roles of Sema-PlxnD1 and Notch signaling in SeA
angiogenesis.DISCUSSION
Our findings reveal that Sema-PlxnD1 signaling acts as a pre-
sprouting repressor of angiogenic potential in the trunk’s arterial
tree. We posit that Sema-PlxnD1 signaling fulfills this role, at
least in part, bymaintaining sflt1’s proper endothelial abundance
to antagonize proangiogenic VEGF signaling (Figure 7A). We
propose that the somitic sema3a and endothelial plxnD1 expres-
sion preceding SeA sprouting (Torres-Va´zquez et al., 2004)
(Figure 7B) reproducibly yield differences in Sema-PlxnD1
signaling level, and thus in sflt1 abundance, along the aorta (Fig-
ure 7C). Although the proposed variation in WT sflt1 aortic levels
appears beyond the resolution of WISH, we find that ECs from
obd/+ donors (which have less sflt1) are more likely to become
SeA tip cells in WT hosts. Indeed, ECs with the lowest Flt1 abun-
dance make the angiogenic sprouts of WT and Flt1lacZ/+ mouse
retinas and ES cell-derived vessels (Chappell et al., 2009).
Our WISH and qPCR data indicate that loss or reduction of
Sema-PlxnD1 signaling leads to low sflt1 abundance within
both the aorta and SeA sprouts. Accordingly, our cell transplants
show that Sema-PlxnD1 signaling acts cell autonomously to
spatially restrict the aorta’s angiogenic capacity (Figure 7D)
and limit the angiogenic responses of ECs within SeA sprouts
(Figure 7E).
While sFlt1 can act non-cell autonomously (Ambati et al.,
2006); (Chappell et al., 2009; Kearney et al., 2004), its effective
range is context dependent (Goldman et al., 1998; James
et al., 2009; Kendall and Thomas, 1993). In the trunk’s arterial
tree the antiangiogenic effects of endothelial-specific sflt1 over-
expression appear cell autonomous. sFlt1 forms VEGF-bridged
inhibitory complexes with the proangiogenic receptors Flk1/
Kdr (Bussmann et al., 2008; Kendall et al., 1996) and mFlt1
(Kendall and Thomas, 1993) and binds to the endothelial extra-
cellular matrix, which abundantly surrounds the aorta (Jin
et al., 2005; Orecchia et al., 2003). Both observations suggest
how sFlt1’s effective range might be limited within the aorta.r Inc.
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Figure 7. Model for How Sema3-PlxnD1 Signaling Restricts Angiogenic Potential along the Aorta and Limits Angiogenic Responses within
SeA Sprouts
(A) Sema3-PlxnD1 signaling inhibits VEGF’s proangiogenic effects via sFlt1, limiting angiogenic potential. The complex cross-regulation (gray lines) between the
VEGF and Notch cascades implies Sema-PlxnD1 signaling impacts Notch activity indirectly.
(B) Somitic sema3s (dark red) and endothelial plxnD1 (light red) expression precedes SeA sprouting (SB, gray) (Roos et al., 1999; Torres-Va´zquez et al., 2004; Yee
et al., 1999).
(C)WT aortic Sema-PlxnD1 signaling levels (red solid line) are highest in ECs next to the somites and lowest in ECs next to SBs, where angiogenic potential (green
solid line) is highest. obd lacks Sema-PlxnD1 activity and thus sflt1 abundance is greatly reduced (red dotted line), leading to uniformly enhanced angiogenic
potential levels (green dotted line) that yield too many and ectopic SeA sprouts.
(D and E) VEGF signaling and angiogenic responses are cell autonomously enhanced by loss (obd) or decreased (obd/+) endothelial plxnD1 activity, as
exemplified by obd to WT (D) and obd/+ to WT (E) chimeras. VEGF signaling and PlxnD1 activity levels are indicated by font size.
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Sema-PlxnD1 Signaling Limits Angiogenic PotentialAlternatively, sFlt1 might act in an intracrine manner, as
proposed for mFlt1 (Lee et al., 2007b).
Our model implies that PlxnD1 signaling in response to para-
crine Sema3 cues is key for the proper spatial modulation of
angiogenic capacity within the aorta (Gay et al., 2011). Yet our
findings do not rule out the potential involvement of autocrine
Sema3cues inPlxnD1signalingprior toand/orduringSeAsprout-
ing (Banu et al., 2006; Kutschera et al., 2011; Lamont et al., 2009;
Serini et al., 2003; Toyofuku et al., 2007). Similarly, endothelial
Sema-PlxnD1 signaling could impact the proangiogenic activity
of both paracrine and autocrine VEGFs (Childs et al., 2002; Cova-
ssin et al., 2006; da Silva et al., 2010; Hogan et al., 2009b; Lee
et al., 2007a; Siekmann and Lawson, 2007; Tammela et al., 2008).
Our study reveals a key mechanistic link between
Sema-PlxnD1 and VEGF signaling (Bellon et al., 2010; Fukush-
ima et al., 2011; Sakurai et al., 2010; Uesugi et al., 2009). Consis-
tent with defects in exon selection during flt1’s alternative
splicing and/or alterations in the mRNA stability of flt1 isoforms,
impaired Sema-PlxnD1 signaling leads to contrasting posttran-
scriptional changes in sflt1 and mflt1 abundance. Sema-PlxnD1
signaling inactivates Ras-related proteins, antagonizes integrin
and PI3K signaling and modulates cytoskeletal dynamics
(Gay et al., 2011). How these PlxnD1-mediated events are con-
nected to flt1’s posttranscriptional regulation and angiogenesis
will be addressed by future studies.
Here we show that Sema-PlxnD1 and Notch signaling can
function independently of each other and play largely distinct
cellular and molecular roles. However, Sema-PlxnD1 activityDevelopantagonizes VEGF responsiveness and Notch and VEGF
signaling are linked by complex feedback loops (Jakobsson
et al., 2009; Lobov et al., 2007; Williams et al., 2006). Hence,
we anticipate functional interactions between both pathways
via the VEGF cascade. For example, it is likely that the enhanced
VEGF signaling of ECs with less Sema-PlxnD1 activity allows
them to exert a stronger Dll4/Notch-mediated lateral inhibition
upon their neighbors, enabling the former to more often become
angiogenic and/or, acquire and/or keep a tip cell positional
status (Jakobsson et al., 2010; Leslie et al., 2007; Siekmann
and Lawson, 2007). Remarkably, the combined loss of both
Sema-PlxnD1 (plxnD1) and Notch signaling (mib) signaling
does not enable every aortic EC to sprout, suggesting that other
pathways and/ormechanisms limit the trunk’s arterial tree angio-
genic capacity.
Together with prior studies (Gay et al., 2011), our findings
indicate that Sema-PlxnD1 signaling regulates distinct yet inter-
connected aspects of angiogenic development: the spatial
allocation of angiogenic capabilities and the guidance of growing
sprouts. It is likely that these roles, and their bases, are evolution-
arily conserved (see Gay et al., 2011). Changes in sflt1 abun-
dance induce congenital vascular malformations (Acevedo and
Cheresh, 2008), gestational hypertension (Rahimi, 2006) and
are associated with cancer (Aref et al., 2005). Hence, mutations
and polymorphisms that affect Sema-PlxnD1 signaling are likely
modifiers of these diseases. Conversely, alterations in sflt1
abundance and/or activity might impact Sema-PlxnD1 signaling
dependent processes like cardiovascular and nervous systemmental Cell 21, 301–314, August 16, 2011 ª2011 Elsevier Inc. 311
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Sema-PlxnD1 Signaling Limits Angiogenic Potentialdevelopment and both tumor angiogenesis and metastasis (Gay
et al., 2011; Raab and Plate, 2007; Takahashi and Shibuya,
2005). Overall, the regulation of sflt1 abundance via Sema-
PlxnD1 signaling has broad biomedical implications beyond
angiogenesis and provides a new way of understanding how
Sema and VEGF signals might be integrated in many contexts.
EXPERIMENTAL PROCEDURES
Zebrafish
Embryos and adults kept and handled using standard laboratory conditions
under New York University IACUC guidelines. Zebrafish stocks and genotyp-
ing methods/reagents described in the Supplemental Information.
Imaging
Live and fluorescently immunostained embryos imaged via confocal micros-
copy, whole mount RNA in situ hybridized embryos and drug treated animals
imaged via transmitted light microscopy. All embryos mounted sideways.
Details are in the Supplemental Information.
SeA Sprout Abundance and Position Quantification
Quantifications done using confocal images of immunofluorescently stained
23 hpf Tg(fli:EGFP)y1 embryos. SeA sprouts: individual EGFP-positive aortic
dorsal projections that reach or surpass the horizontal myoseptum (HM; see
Figure 1). SeA sprout positions: Correct (SeA base abuts directly the anterior
side of neighboring somite boundary), ectopic (all other base locations). SeA
sprouts were counted in four adjacent anterior trunk segments and averaged
to yield a SeA sprouts/somite boundary ratio. Student’s t test (homocedastic,
two-tail distribution) was used to analyze the differences between the means
of cell number data sets.
Endothelial Cell Abundance Quantification
We used 21, 23, and 32 hpf Tg(fli1:nEGFP)y7; Tg(flk1:ras-mCherry)s896 and
Tg(flk1:EGFP-NLS); Tg(flk1:ras-mCherry)s896 immunofluorescently stained
embryos to visualize EC nuclei and vascular anatomy. Confocal sections
across the width of the anterior trunk were collected and 3D-projected with
Imaris 6.2.1 software (Bitplane AG). EGFP-positive nuclei were marked
(measurement point application) and counted. Since WT SeAs launch next
to somite boundaries (SBs) but obd SeAs arise from these and other sites
we divided the trunk vasculature into segments delimited by the posterior
and anterior halves of consecutive bilateral somite pairs and counted EC nuclei
within each segment. Based on their location, EC nuclei were assigned to the
axial vessels (AxV; aorta and vein), the SeAs and/or DLAVs. AxV (rather than
aortic- and venous-specific) EC abundance was scored since the aorta and
vein are not fully distinct at 21 and 23 hpf (Herbert et al., 2009). We counted
ECs in three consecutive trunk segments (located dorsal to the yolk extension)
and averaged them to obtain ECs/bilateral somite pair ratios for each location.
Student’s t test (homocedastic, two-tail distribution) was used to analyze the
differences between the means of EC number data sets. Note: not every EC
whose nucleus is labeled by Tg(fli1:nEGFP)y7 (green) is marked by
Tg(flk1:ras-mCherry)s896 (red) due to the latter’s expression mosaicism
(Figure S1A).
Cell Transplants
Cell transplants done with 3–4 hpf donor and host blastula-stage embryos as
in (Carmany-Rampey andMoens, 2006). Thirty to 50 cells were aspirated from
the donor’s animal pole and placed into the host’s lateral margin zone. Donors
and hosts carried distinct endothelial-specific reporters to easily identify the
source of ECs within chimeras.
plxnD1’s Cell Autonomy
We used both WT and obd as Tg(fli:EGFP)y1 donors and as Tg(flk1:
ras-mcherry)s896 hosts. 1 nl of a 5% solution of lineage tracer (dextran Alexa
Fluor 647; Invitrogen) was injected into 1-cell-stage donors. Chimeras fixed
at 32 hpf.
Quantification of Mosaic SeA Sprouts with Tip Cells of Donor Origin
We used both WT and obd/+ as Tg(fli:EGFP)y1 donors and as Tg(flk1:
ras-mcherry)s896 hosts. Chimeras fixed at 28 hpf.312 Developmental Cell 21, 301–314, August 16, 2011 ª2011 ElsevieQuantification of the Distribution of ECs of Donor Origin within
the Trunk Vasculature of Chimeras
We used both WT and obd/+ as Tg(flk1:EGFP-NLS) donors. Tg(flk1:
ras-mcherry)s896 used as hosts. Chimeras fixed at 21–23 hpf. Embryos with
ECs of donor origin within the trunk’s vascular tree were selected. Confocal
images of their whole trunk vasculature were taken and analyzed as described
in Figure S2B.
sflt1’s Cell Autonomy
We used Tg(fli:EGFP)y1 donors and Tg(flk1:EGFP-NLS) hosts. Endothelial-
specific, sflt1 mosaic overexpression in donors or hosts done using the
Tg(fliep:gal4ff)ubs4 GAL4 driver line and the bidirectional UAS vector pTol
[DsRed::UAS::sFlt1].
Whole-Mount RNA In Situ Hybridization (WISH)
WISH performed as in (Moens, 2008). The list of analyzed genes and riboprobe
synthesis protocols are in the Supplemental Experimental Procedures.
Morpholino Oligo (MO) Injection
MOs (Gene Tools, LLC) were injected into 1-cell-stage Tg(fli1:EGFP)y1
embryos as in (Morcos, 2007). MO sequences and validation methods are in
the Supplemental Experimental Procedures.
Drug Treatments
Embryos were dechorionated before treatment. Treatments began at 16
(Figures 5A–5L) or 20 hpf (Figure S5B; to prevent the dramatic aortic size
reduction induced by earlier treatments). Control embryos were treated with
0.025% dimethyl sulfoxide (DMSO; Sigma) in water. Inhibitor-treated embryos
were incubated in 0.25 mM AS605240 or 0.5 mM SU5416 (Sigma) aqueous
solutions of 0.025% DMSO.
Quantitative Real-Time Polymerase Chain Reaction (qPCR)
Total mRNA (zebrafish embryos) and RNA (HUVECs) extraction and cDNA
synthesis done as per Supplemental Experimental Procedures. qPCR DNA
products amplified with Power SYBR Green 2X Master Mix (Applied Biosys-
tems) as per manufacturer’s instructions. Whole embryo qPCR products
were quantified with a 7900HT Real-Time PCR System (Applied Biosystems).
Relative sflt1, mflt1, and YFP mRNA levels normalized to bactin2 transcript
abundance. For shRNA control experiments, products were quantified with
a PRISM 7900 (Applied Biosystems). Relative PLXND1 and FLT1 levels
normalized to glyceraldehyde-3-phosphate (GAPDH) abundance. Primer
sequences are in the Supplemental Experimental Procedures.
ACCESSION NUMBERS
The sequence of the sflt1 mRNA can be accessed at GenBank (accession
number: HQ322130, released upon publication).
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, Supplemental Experimental
Procedures, and one movie and can be found with this article online at
doi:10.1016/j.devcel.2011.06.033.
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INTRODUCTION
The embryonic heart tube is initially a two-layered structure: the
outer layer of muscular myocardium contracts to propel circulation
and the inner layer of endothelial endocardium provides continuity
with the rest of the vasculature. Myocardial and endocardial cells
originate in neighboring regions of the lateral mesoderm
(Schoenebeck et al., 2007). During the process of cardiac fusion,
both cell types migrate medially in a synchronized fashion and
merge at the midline to assemble the heart tube (Bussmann et al.,
2007; Holtzman et al., 2007; Moreno-Rodriguez et al., 2006). At
later stages, cardiac maturation involves remodeling of both
juxtaposed layers during valve formation and trabeculation
(Armstrong and Bischoff, 2004; Hinton and Yutzey, 2010; Sedmera
et al., 2000). Despite the continual proximity of the myocardium
and endocardium, little is known about the mechanisms that
coordinate their development.
The coordination of myocardial and endocardial development
has been particularly well established in the context of
atrioventricular canal (AVC) formation. Both the myocardium and
endocardium undergo specialized differentiation in order to create
the characteristic morphology of the AVC and to establish the
endocardial cushions that will remodel into the atrioventricular
valve (Armstrong and Bischoff, 2004; Beis et al., 2005; Chi et al.,
2008; Hinton and Yutzey, 2010). Several studies indicate that
myocardium-endocardium communication regulates these spatially
coincident events (Armstrong and Bischoff, 2004; Hinton and
Yutzey, 2010). For example, chick explant experiments suggest that
signal transduction between atrioventricular myocardium and
atrioventricular endocardium induces endocardial cushion
formation (Mjaatvedt et al., 1987). Although several signaling
pathways have been implicated in promoting endocardial cushion
development (Armstrong and Bischoff, 2004; Beis et al., 2005;
Hinton and Yutzey, 2010), it is less clear which genes are
responsible for attenuating these signals so as to spatially restrict
atrioventricular differentiation.
Myocardium-endocardium coordination is also crucial during
cardiac fusion. The synchronization of myocardial and endocardial
migration suggests that both tissues respond to the same cues in the
extracellular environment. Some cues may emanate from the
endoderm: both myocardial and endocardial fusion are inhibited
when endodermal specification or morphogenesis is disrupted (e.g.
Holtzman et al., 2007; Kikuchi et al., 2001; Kupperman et al.,
2000). Additionally, either diminished or excessive deposition of
extracellular matrix (ECM) can hinder myocardial and endocardial
movement (e.g. Arrington and Yost, 2009; Garavito-Aguilar et al.,
2010; Trinh and Stainier, 2004). Furthermore, the myocardium and
endocardium may impact the behavior of one another.
Cardiomyocytes display aberrant migration patterns in the absence
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SUMMARY
Coordination between adjacent tissues plays a crucial role during the morphogenesis of developing organs. In the embryonic
heart, two tissues – the myocardium and the endocardium – are closely juxtaposed throughout their development. Myocardial
and endocardial cells originate in neighboring regions of the lateral mesoderm, migrate medially in a synchronized fashion,
collaborate to create concentric layers of the heart tube, and communicate during formation of the atrioventricular canal. Here,
we identify a novel transmembrane protein, Tmem2, that has important functions during both myocardial and endocardial
morphogenesis. We find that the zebrafish mutation frozen ventricle (frv) causes ectopic atrioventricular canal characteristics in
the ventricular myocardium and endocardium, indicating a role of frv in the regional restriction of atrioventricular canal
differentiation. Furthermore, in maternal-zygotic frv mutants, both myocardial and endocardial cells fail to move to the midline
normally, indicating that frv facilitates cardiac fusion. Positional cloning reveals that the frv locus encodes Tmem2, a predicted
type II single-pass transmembrane protein. Homologs of Tmem2 are present in all examined vertebrate genomes, but nothing is
known about its molecular or cellular function in any context. By employing transgenes to drive tissue-specific expression of
tmem2, we find that Tmem2 can function in the endocardium to repress atrioventricular differentiation within the ventricle.
Additionally, Tmem2 can function in the myocardium to promote the medial movement of both myocardial and endocardial cells.
Together, our data reveal that Tmem2 is an essential mediator of myocardium-endocardium coordination during cardiac
morphogenesis.
KEY WORDS: Zebrafish, Heart development, Atrioventricular canal, Cardiac fusion
The novel transmembrane protein Tmem2 is essential for
coordination of myocardial and endocardial morphogenesis
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of endocardial cells, implying that myocardium-endocardium
communication influences the direction of cell movement
(Holtzman et al., 2007). However, the molecular basis for
myocardium-endocardium interactions during cardiac fusion is not
yet clear.
To elucidate the molecular mechanisms underlying
myocardium-endocardium communication, we have investigated
the zebrafish mutation frozen ventricle (frv). Zygotic frv mutants
display ectopic AVC characteristics, and maternal-zygotic frv
mutants exhibit defects in cardiac fusion. Positional cloning
indicates that the frv locus encodes Tmem2, a previously
uncharacterized transmembrane protein. Tissue-specific rescue
experiments suggest that Tmem2 acts in the endocardium to
spatially restrict atrioventricular differentiation, whereas during
cardiac fusion Tmem2 acts in the myocardium to promote the
medial movement of both myocardial and endocardial cells.
Together, our studies illuminate crucial roles of a novel
molecule, Tmem2, in regulating the coordination of myocardial
and endocardial morphogenesis.
MATERIALS AND METHODS
Zebrafish
We discovered the recessive lethal mutation frozen ventricle (frvsk38)
through routine intercrosses in the Skirball zebrafish facility. To obtain
maternal-zygotic frv embryos, we generated germline replacement
chimeras through transplantation, as previously described (Ciruna et al.,
2002). Donor embryos were generated by intercrossing frv heterozygotes,
and wild-type host embryos were screened for germ cells derived from
frv–/– donors. We raised 273 chimeric embryos and recovered eight fertile
adult females. These females were bred to male frv heterozygotes to
generate maternal-zygotic frv mutants.
In situ hybridization
We conducted in situ hybridization using previously reported probes for
myl7 (ZDB-GENE-991019-3), notch1b (ZDB-GENE-990415-183), bmp4
(ZDB-GENE-980528-2059), versican (ZDB-GENE-011023-1), tbx2b
(ZDB-GENE-990726-27) and cdh5 (ZDB-GENE-040816-1). Mutant
embryos were identified by PCR genotyping.
Immunofluorescence
We performed MF20/S46 whole-mount immunofluorescence as
previously described (Alexander et al., 1998). To detect Dm-grasp, we
used the monoclonal antibody zn-5 (ZIRC; 1:10), rabbit polyclonal anti-
GFP (Invitrogen; 1:100), goat anti-mouse IgG Alexa 594 (Invitrogen;
1:100) and goat anti-rabbit IgG Alexa 488 (Invitrogen; 1:100). Embryos
were fixed in 4% PFA at 4°C overnight and were cut coronally posterior
to the common cardinal vein to facilitate antibody penetration. Staining
was performed in PBS with 0.5% Triton X-100 and 1% DMSO.
Confocal images were obtained using a Zeiss LSM510 microscope, and
z-stacks were rendered in three dimensions and analyzed with Volocity
software (Perkin Elmer).
Positional cloning of frv
Meiotic mapping demonstrated that the frv mutation is located on
chromosome 5, between SSLP markers z61852 and z22523. Analysis of
SNPs narrowed the interval to a region containing five candidate genes.
Sequencing of the coding region of tmem2 (GenBank HQ997922) revealed
a nonsense mutation in frv.
mRNA and morpholino injection
Embryos were injected at the one-cell stage with 200-500 pg mRNA or 8-
13.5 ng anti-tmem2 morpholino (MO) (5-AGCAGTCCAAGCATACC -
ATTACTCC-3; Gene Tools). Capped mRNA was synthesized from a
pCS2 vector containing the tmem2 or tmem2-gfp coding sequence. The MO
blocks splicing between exon 4 and intron 4-5, which is predicted to result
in a truncated protein that contains the first 404 amino acids of Tmem2 and
44 amino acids encoded by intronic sequence.
Transgenes
We used the Gateway system (Kwan et al., 2007; Villefranc et al., 2007)
to create the transgenes Tg(myl7:tmem2-gfp), Tg(kdrl:gal4vp16) and
Tg(uas:tmem2-gfp). We employed Tol2 transposase-mediated transgenesis
for both transient transgene expression and generation of transgenic
founders (Fisher et al., 2006). Additional transgenic lines used were
Tg(kdrl:GRCFP) (Cross et al., 2003) and Tg(fliep:gal4ff)ubs4, which drives
endothelium-specific expression of the GAL4-VP16 derivative Gal4FF and
is described elsewhere (Zygmunt et al., 2011).
RESULTS AND DISCUSSION
frv restricts atrioventricular differentiation to the
atrioventricular canal
The zebrafish mutation frozen ventricle (frv) has a distinctive impact
on cardiac morphology and function. At 48 hours post-fertilization
(hpf), embryos homozygous for frv exhibited contractility and
dysmorphic cardiac chambers, with poor demarcation of the AVC and
an abnormal separation between the ventricular myocardium and
endocardium (Fig. 1A-H). By 72 hpf, the frv mutant ventricle ceased
to contract, although atrial function seemed unaffected, inspiring the
use of frozen ventricle as the locus name.
Expression patterns of cardiac genes appeared normal during the
initial steps of heart tube assembly in frv mutants (see Fig. S1 in
the supplementary material). By contrast, defects in expression of
the AVC markers notch1b, bmp4, versican, and tbx2b were evident
in frv mutants by 48 hpf. In wild-type embryos, expression of each
of these markers becomes restricted to the AVC (Hurlstone et al.,
2003; Walsh and Stainier, 2001) (Fig. 1I-K, see Fig. S2A in the
supplementary material). In frv mutants, none of these markers
became properly restricted (Fig. 1L-N, see Fig. S2B in the
supplementary material): notch1b expression was evident in the
ventricular endocardium, bmp4 expression was expanded into the
ventricular myocardium, and versican and tbx2b expression
expanded into both the ventricular and atrial myocardium.
Additionally, frv mutants exhibited expanded localization of the
adhesion molecule Dm-grasp. Dm-grasp is normally detectable in
differentiated endocardial cells within the AVC, but not in the
remainder of the endocardium (Beis et al., 2005) (Fig. 1O-Q). In
frv mutants, Dm-grasp was found throughout the entire ventricular
endocardium, as well as in the AVC endocardium (Fig. 1R-T).
Thus, the presence of ectopic atrioventricular characteristics in the
frv mutant ventricle indicates an important role for frv in the
regional restriction of atrioventricular differentiation.
Positional cloning of frv reveals a novel
transmembrane protein
To gain insight into the molecular mechanisms of frv function, we
positionally cloned the gene encoded by the frv locus. Meiotic
mapping of frv identified a 0.28 cM genetic interval, and the
annotated zebrafish genome assembly indicated five candidate
genes in this region (Fig. 2A). Examination of the coding sequence
of one of these genes, transmembrane protein 2 (tmem2), revealed
a nonsense mutation in frv mutant genomic DNA that is predicted
to truncate the Tmem2 protein (Fig. 2B). To test the hypothesis that
loss of tmem2 function is responsible for the frv mutant phenotype,
we injected tmem2 mRNA into frv mutant embryos and found that
this can rescue the frv mutant defects in chamber morphology,
ventricular contractility and Dm-grasp distribution (see Table S1
and Fig. S3G-I in the supplementary material). Injection of tmem2
mRNA did not cause any detectable phenotype in wild-type
embryos. Additionally, we found that injection of anti-tmem2
morpholinos (MOs) into wild-type embryos could cause
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Dm-grasp (see Fig. S3J-L in the supplementary material). Together,
the linkage, nonsense mutation, rescue and MO phenocopy data
indicate that disruption of the tmem2 gene is the cause of the frv
phenotype.
Tmem2 is predicted to be a type II transmembrane protein
with a single transmembrane helix, a short cytoplasmic tail and
a long extracellular portion (Fig. 2B). A BLAST local alignment
search detected two identifiable domains – a G8 domain and a
GG domain – within the extracellular sequence (Fig. 2B),
consistent with previous bioinformatic analysis of the human
TMEM2 homolog (see Fig. S4 in the supplementary material)
(Guo et al., 2006; He et al., 2006). The structure of Tmem2 is
highly conserved: Tmem2 homologs are detectable in a wide
variety of vertebrate genomes, including Homo sapiens, Mus
musculus, Gallus gallus, Xenopus tropicalis and Takifugu
rubripes, all of which share at least 63% amino acid similarity
with zebrafish Tmem2 (see Fig. S4 in the supplementary
material). However, we were unable to identify Tmem2
homologs in Caenorhabditis elegans or Drosophila
melanogaster. Despite its conservation among vertebrates, no
prior studies have investigated Tmem2 function. Thus, our data
provide novel evidence of an essential role for Tmem2.
Endocardial expression of tmem2 represses
inappropriate atrioventricular differentiation
The frv phenotype indicates that Tmem2 prevents atrioventricular
differentiation in the ventricular endocardium, but it is not clear in
which tissue Tmem2 acts to execute this role. Human and mouse
Tmem2 homologs are expressed in a wide array of tissues (Scott et
al., 2000). Consistent with this, we found broad expression of
tmem2 throughout the early zebrafish embryo, and we also detected
a maternal supply of tmem2 (see Fig. S5 in the supplementary
material).
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Fig. 1. The frv mutation disrupts
myocardial and endocardial
morphogenesis. (A,E)Lateral views of wild-
type (wt) and frv mutant zebrafish embryos
at 48 hpf reveal mild pericardial edema in frv
mutants (arrowheads). Other than their
cardiac defects, frv mutants appear
morphologically normal. (B,F)Frontal views
depict myl7 expression in wild type (B) and in
frv mutants (F) at 48 hpf. (C,G)Lateral views
showing endocardial expression of
Tg(kdrl:GRCFP) in wild type (C) and in frv
mutants (G) at 52 hpf. (D,H)Lateral views at
52 hpf depict the close juxtaposition of the
ventricular endocardium (arrowhead) and
myocardium (arrow) in wild type (D) and their
greater separation in frv mutants (H). 
(I-N)Frontal views depict expression of
atrioventricular canal (AVC) markers in wild
type (I-K) and in frv mutants (L-N) at 48 hpf.
Dotted lines outline the chambers flanking
the AVC. (O-T)Three-dimensional projections
of selected confocal sections of wild-type (O-
Q) and frv mutant (R-T) hearts expressing
Tg(kdrl:GRCFP) (green) in the endocardium at
57 hpf. Immunofluorescence reveals Dm-
grasp (red) throughout the myocardium and
in the AVC endocardium (arrowheads). In frv
mutants, Dm-grasp is also seen ectopically in
the ventricular endocardium. Grids are 23m
per segment. A, atrium; V, ventricle. Scale
bars: 50m.
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Since the expression pattern of tmem2 does not clarify its site of
action, we designed tissue-specific transgenes to test whether
expression of tmem2 in the myocardium or endocardium could
rescue the frv mutant phenotype. These transgenes drive expression
of a fusion protein in which the C-terminus of Tmem2 is tagged
with GFP. Tmem2-GFP appears functionally equivalent to Tmem2:
injection of tmem2-gfp mRNA yielded results similar to injection
of tmem2 mRNA (see Table S1 in the supplementary material).
Expression of tmem2 throughout the myocardium, driven by the
stably integrated transgene Tg(myl7:tmem2-gfp) (see Fig. S6A-C
in the supplementary material), was not sufficient to rescue the
ectopic atrioventricular characteristics in frv mutants (see Fig. S7
in the supplementary material). Expression of tmem2 in the
endocardium was more challenging to attain. Since no
endocardium-specific driver is available, we employed endothelial
drivers (Jin et al., 2005; Villefranc et al., 2007). First, we used the
transgenes Tg(kdrl:gal4vp16) and Tg(uas:tmem2-gfp) to generate
transient mosaic expression within the endocardium (Fig. 3A-C).
Expression of tmem2 in atrial endocardium did not alter the frv
mutant phenotype (Fig. 3D-F; n4). By contrast, we observed loss
of ectopic Dm-grasp in ventricular endocardial cells exhibiting
mosaic tmem2 expression (Fig. 3G-I; n5). In an effort to generate
a more thorough rescue of the frv endocardium, we next employed
the stably integrated driver Tg(fliep:gal4ff) (Zygmunt et al., 2011).
Unfortunately, stable integration of both Tg(fliep:gal4ff) and
Tg(uas:tmem2-gfp) did not result in uniform expression of tmem2
throughout the endocardium (Fig. 3J-L, see Fig. S6D in the
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Fig. 2. The frv locus encodes the transmembrane protein Tmem2.
(A)Meiotic and physical maps of the zebrafish genomic region containing
frv. Meiotic mapping revealed a 0.28 cM interval for frv defined by SNPs
on the ends of overlapping contigs (BX323080, BX294191). Fractions
indicate the number of proximal (red) and distal (blue) recombination
events out of 2528 meioses. Five candidate genes are shown as
represented in Ensembl. (B)The predicted structures of Tmem2 protein in
wild-type and frv mutant embryos. Amino acid positions defining the
domains are indicated. Histograms demonstrate that frv mutants contain
a C-to-T transition at position 2623 of the tmem2 coding region. This
mutation changes an Arg codon to a premature stop codon at amino
acid position 875 and is predicted to result in a truncated Tmem2 protein.
Fig. 3. Endocardial expression of tmem2 rescues the frv mutant
endocardium. Three-dimensional projections of selected confocal
sections of wild-type (A-C,J-L) and frv mutant (D-I,M-O) zebrafish hearts
expressing tmem2-gfp (green) in the endocardium at 57 hpf.
Immunofluorescence indicates Dm-grasp localization (red). (A-I)Transient
mosaic expression of tmem2-gfp is driven by injection of the transgenes
Tg(kdrl:gal4vp16) and Tg(uas:tmem2-gfp). (J-O)Mosaic expression of
tmem2-gfp is driven by stably integrated Tg(fliep:gal4ff) and
Tg(uas:tmem2-gfp) transgenes. (A-C,J-L) Expression of tmem2-gfp in
ventricular endocardium (A,J, arrowheads) does not affect wild-type
development. (D-F)Ectopic Dm-grasp remains in the frv mutant ventricle
when tmem2-gfp is expressed only in atrial endocardium (D, arrowhead).
(G-I)Mosaic expression of tmem2-gfp in the ventricular endocardium of
frv mutants suppresses ectopic Dm-grasp localization. Ventricular
endocardium that does not express tmem2-gfp retains ectopic Dm-grasp
(G, arrowheads). (M-O)Broad tmem2-gfp expression in the ventricular
endocardium rescues ectopic Dm-grasp expression in an frv mutant. AVC
endocardium still expresses Dm-grasp as in wild type (compare M,N with
K, arrowheads). Endocardial expression of tmem2-gfp does not improve
ventricular contractility, but does reduce the abnormal gap between the
myocardium and endocardium. Grids are 23m per segment.
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supplementary material), potentially owing to epigenetic silencing
of Tg(uas:tmem2-gfp) (Goll et al., 2009). Accordingly, the effects
of this transgene combination in frv mutants were comparable to
the effects of mosaic expression of Tg(kdrl:gal4vp16) and
Tg(uas:tmem2-gfp) (n3); however, in one frv mutant, broad
expression of tmem2 in the ventricular endocardium eliminated the
ectopic Dm-grasp (Fig. 3M-O). These data indicate that the activity
of Tmem2 in the ventricular endocardium is sufficient to prevent
the ectopic assumption of atrioventricular characteristics.
Moreover, our data imply the existence of repressive mechanisms
that restrain atrioventricular differentiation in the ventricle.
Tmem2 facilitates medial migration of both
myocardium and endocardium
Given the contrast between the broad expression pattern of tmem2
and the specific defects in frv mutants, we suspected that the
maternal supply of tmem2 partially compensates for the loss of
zygotic tmem2 function. To uncover additional roles of tmem2, we
generated maternal-zygotic frv (MZfrv) mutant embryos via germline
replacement (Ciruna et al., 2002). MZfrv mutants underwent
gastrulation normally and began to display morphological defects
during somitogenesis; by contrast, maternal frv (Mfrv) mutants
appeared normal (Fig. 4A,B, see Fig. S8 in the supplementary
material). Cardiac defects emerged in MZfrv mutants at an earlier
stage than in zygotic frv mutants. Whereas cardiac fusion proceeded
normally in Mfrv mutants, the medial migration of MZfrv
cardiomyocytes was significantly hindered (Fig. 4C,D). However,
the bilateral populations of cardiomyocytes were not permanently
separated, and they eventually formed two linked sets of dysmorphic
chambers (see Fig. S9 in the supplementary material). Additionally,
MZfrv mutants displayed abnormal endocardial migration. Instead of
meeting at the midline to form an endocardial tube, MZfrv
endocardial cells were substantially delayed in their medial migration
and remained bilaterally separate (Fig. 4E,F). Therefore, Tmem2 is
crucial for facilitating cell movement during cardiac fusion.
Myocardial expression of tmem2 promotes both
myocardial and endocardial fusion
The failure of both myocardial and endocardial fusion in MZfrv
mutants suggested the possibility that both phenotypes result from a
primary defect in endoderm formation. However, endodermal
specification and morphogenesis appeared normal in MZfrv mutants
(data not shown). We therefore hypothesized that Tmem2 functions
in migrating cardiac cells. Using the stably integrated transgene
Tg(myl7:tmem2-gfp), we found that myocardial expression of tmem2
could rescue myocardial migration in MZfrv mutants; although
morphogenesis was still slightly delayed in rescued embryos, cardiac
fusion was complete and heart tube extension was under way by 26
hpf (Fig. 4G-J, see Fig. S10A-D in the supplementary material;
n15). Remarkably, the positive effects of Tg(myl7:tmem2-gfp)
expression extended to the endocardium. Myocardial expression of
tmem2 rescued endocardial migration in MZfrv mutants, such that
the endocardial cells reached the midline and extended into a tube
(Fig. 4K-N, see Fig. S10E-H in the supplementary material; n12).
These data demonstrate that Tmem2 activity in the myocardium is
sufficient to facilitate both myocardial and endocardial fusion.
Moreover, our data provide the first evidence for a myocardial factor
that influences the migration of endocardial cells.
Tmem2 is essential for the coordination of
myocardial and endocardial morphogenesis
Our studies provide the first demonstration that the previously
unappreciated transmembrane protein Tmem2 has multiple
important functions during development. Notably, Tmem2 is
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Fig. 4. Maternal-zygotic frv mutants
exhibit myocardial and endocardial
fusion defects that are rescued by
myocardial tmem2 expression.
(A,B)Lateral views of zebrafish maternal
(Mfrv) and maternal-zygotic (MZfrv) frv
mutant siblings reveal body length and
yolk extension defects in MZfrv embryos
at 24 hpf. (C,D,G-J) Dorsal views depict
myl7 expression at 20 somites (som) and
26 hpf. (E,F)Dorsal views depict
endocardial expression of Tg(kdrl:GRCFP)
(arrowheads) at 24 hpf. (K-N)Dorsal views
depict endocardial expression of cdh5
(arrows) at 28 hpf In Mfrv embryos,
expression of Tg(myl7:tmem2-gfp) has no
effect on myocardial or endocardial
morphogenesis (G,H,K,L), whereas in
MZfrv embryos expression of
Tg(myl7:tmem2-gfp) rescues both
myocardial and endocardial fusion
(I,J,M,N). Non-transgenic (non-tg) and
transgenic siblings were distinguished by
examination of fluorescence before
fixation. Comparable results were
obtained with two independent
transgenic founders. Scale bars: 50m.
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essential for two crucial aspects of cardiac morphogenesis: the
spatial restriction of atrioventricular differentiation during AVC
formation and the medial migration of cardiac cells during cardiac
fusion. In each context, we have identified one location where
Tmem2 can function – in the endocardium during AVC formation
and in the myocardium during cardiac fusion – although our results
do not rule out additional sites for Tmem2 activity during these
processes. Our data suggest intriguing mechanisms for the
coordination of myocardial and endocardial morphogenesis by
Tmem2, and it is attractive to speculate that Tmem2 might play
similar roles during AVC differentiation and cardiac fusion.
The transmembrane localization of Tmem2 evokes the hypothesis
that it could facilitate myocardium-endocardium signaling. Perhaps
certain signals repress atrioventricular differentiation in the ventricle,
and Tmem2 plays a permissive role in facilitating signal reception
by the endocardium. Similarly, Tmem2 could act to limit the activity
of inductive signals that specify AVC endocardium; for example, the
similarities between frv mutants and apc mutants suggest a possible
role of Tmem2 in restricting Wnt signaling (Hurlstone et al., 2003;
Verhoeven et al., 2011). During cardiac fusion, Tmem2 might
facilitate the transduction of an unknown myocardial-to-endocardial
motility cue; however, this scenario seems unlikely because the
endocardium can move to the midline in hand2 mutants, which
possess very few cardiomyocytes (Garavito-Aguilar et al., 2010).
Alternatively, rather than influencing specific signaling pathways,
Tmem2 might impact myocardial and endocardial morphogenesis by
modulating the extracellular environment. Perhaps Tmem2
influences ECM organization between the endocardium and
myocardium in a manner that normally insulates the ventricular
endocardium from myocardial signals that induce atrioventricular
differentiation. Likewise, since specific parameters of ECM
composition are known to be fundamental for cardiac fusion
(Arrington and Yost, 2009; Garavito-Aguilar et al., 2010; Trinh and
Stainier, 2004), Tmem2 could play a permissive role in ensuring the
appropriate ECM organization to facilitate both myocardial and
endocardial movement. Whatever the molecular role of Tmem2, its
activity, as described here, broadens our comprehension of the
mechanisms that underlie the coordination of myocardial and
endocardial development. Elucidating the biochemical basis for
Tmem2 function will further advance our understanding of the roles
of this novel developmental regulator.
Note added in proof
An accompanying paper (Smith et al., 2011) characterizes the
phenotype caused by zebrafish mutations referred to as wickham
(wkm) and reports that the wkm locus encodes tmem2.
Complementation tests performed by breeding frv heterozygotes to
wkm heterozygotes have demonstrated that the two mutant alleles
fail to complement each other: summarizing the results of five
independent clutches, 27.7% (49/177) of the progeny display a
phenotype indistinguishable from that of zygotic frv mutants. These
data further reinforce the conclusion that the frv and wkm mutations
disrupt the same gene: tmem2.
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The hypothalamo-neurohypophyseal system (HNS)
is the neurovascular structure through which the
hypothalamic neuropeptides oxytocin and arginine-
vasopressin exit the brain into the bloodstream,
where they go on to affect peripheral physiology.
Here, we investigate the molecular cues that regulate
the neurovascular contact between hypothalamic
axons and neurohypophyseal capillaries of the ze-
brafish. We developed a transgenic system in which
both hypothalamic axons and neurohypophyseal
vasculature can be analyzed in vivo. We identified
the cellular organization of the zebrafish HNS as
well as the dynamic processes that contribute to
formation of the HNS neurovascular interface. We
show that formation of this interface is regulated
during development by local release of oxytocin,
which affects endothelial morphogenesis. This cell
communication process is essential for the estab-
lishment of a tight axovasal interface between the
neurons and blood vessels of the HNS. We present
a unique example of axons affecting endothelial
morphogenesis through secretion of a neuropeptide.
INTRODUCTION
The neuroendocrine system is composed of neurosecretory
brain cells that transfer hormones into the bloodstream to influ-
ence the function of target cells throughout the body. The hypo-
thalamo-neurohypophyseal system (HNS) is a major neuroendo-
crine conduit through which the brain controls peripheral
physiology (Burbach et al., 2001). The anatomy and activities
of the HNS are conserved in all vertebrates. Ramon Cajal
was the first to provide a description of the nerve fibers that
connect the hypothalamus with the posterior pituitary (Cajal,
1911). It has since been established that these hypothalamic642 Developmental Cell 21, 642–654, October 18, 2011 ª2011 Elsevneurons themselves secrete neurohormones directly into the
blood circulation, a finding that arose from experiments in both
fish and mammalian models (Bargmann, 1949; Harris, 1948b;
Scharrer, 1928). The hypothalamic neuropeptides arginine-
vasopressin (AVP) and oxytocin (OXT) are synthesized in mas-
sive magnocellular neurons in the hypothalamus, transported
along axons all the way down to the neurohypophysis, where
they are secreted (Brownstein et al., 1980). Within the neurohy-
pophysis, AVP and OXT are released from axons of the supraop-
ticohypophyseal tract into fenestrated capillaries, thus leaving
the brain and entering the general circulation without disrupting
the blood-brain barrier (Burbach et al., 2001).
In the general circulation, secreted AVP regulates water
homeostasis by increasing water permeability of the collecting
duct of the kidney, and oxytocin regulates labor and milk let
down by causing the respective contraction of the smooth
muscle of the uterus and of the myoepithelial cells of breast
ducts (for review, see Burbach et al., 2001; Gimpl and Fahren-
holz, 2001; Verbalis, 2007). These physiological activities are
conserved: in teleost fish, the AVP-like neuropeptide (Avpl)
(a.k.a. arginine-vasotocin) regulates water balance by affecting
filtration in the kidney (Amer and Brown, 1995; Macfarlane and
Maetz, 1974; Peter and Fryer, 1983) and oxytocin-like neuropep-
tide (Oxtl) (a.k.a. isotocin) regulates contraction of smooth
muscles in the ovary and oviduct during parturition or oviposition
of live bearing and egg laying fish (La Pointe, 1977; Peter and
Fryer, 1983). Avpl and Oxtl also regulate blood pressure in the
ventral aorta (Chan, 1977; Kulczykowska, 1998; Le Mevel
et al., 1993; Peter and Fryer, 1983). TheHNS is therefore a central
point of interface between the hormonal, neuronal, and vascular
systems common to all vertebrate species.
The neurohypophysis is an elaborate three-dimensional struc-
ture, which substantially complicates the interpretation of
cellular interactions and dynamics based solely on tissue
sections. Although the anatomical structures of the neurohypo-
physeal axons and blood vessels have been the focus of intense
study for over a century (Bargmann, 1949; Fink and Smith, 1971;
Harris, 1948a; Scharrer, 1928), little progress has been made in
uncovering the molecular and cellular processes that underlie
formation of the interface between hypothalamic axons andier Inc.
Figure 1. Oxytocinergic Reporter Transgene Tags
HN Projections
(A and B) 3D reconstruction of the hypothalamic-neuro-
hypophseal system of an optically sectioned 9-day-old
zebrafish embryo carrying the oxtl:EGFP transgene
(anterior to the left; A, lateral view; B, ventral view). Axonal
projections to the neurohypophysis (NH) are highly visible
in oxtl:EGFP transgenic animals due to extensive arbori-
zation of NH nerve termini.
(C and D) Immunohistochemical analysis of Oxytocin
protein in oxtl:EGFP transgenic zebrafish showing coloc-
alization of EGFP+ and Oxytocin+ nerve termini in the
neurohypophysis of either 6-day-old larva (C, anterior up)
or coronally sectioned adult (D); 14-day-old).
Scale bars, 20 mm. See also Figure S1 and Movie S1.
Developmental Cell
Axovasal Interactions in the Neurohypophysishypophyseal vasculature. Here, we present a unique transgenic
approach in which both zebrafish oxytocinergic axonal termini
and vascular endothelia cells within the neurohypophysis are
labeled. We use this system to analyze the morphogenesis of
the neurohypophyseal axonal trajectories and neuroendocrine
vasculature in live zebrafish embryos and demonstrate that
neurohypophyseal angiogenesis is regulated by the developing
hypothalamo-neurohypophyseal nerve termini. Our results sug-
gest that local secretion of oxytocin into the neurohypophysis
is an intrinsic developmental event essential for the formation
of the hypophyseal neurovascular connection.
RESULTS
Cellular Organization of the Zebrafish HNS
The optically transparent zebrafish embryo offers a unique tool to
study the ontogenesis of the HNS in vivo without the need for
surgical intervention, although the formation and structure of
the zebrafish neurohypophysis is, to date, still poorly character-
ized. We recently identified the genomic regulatory region of the
zebrafish oxtl gene and have generated a transgenic reporter
line, oxtl:EGFP, in which zebrafish oxytocinergic cell bodies in
the hypothalamus are labeled (Blechman et al., 2011). We first
examined whether this line can be used to track axonal projec-
tions from the hypothalamus to the neurohypophysis. Three-
dimensional reconstitution of optically-sectioned 9-day-old
oxtl:EGFP larvae revealed extensive EGFP-positive axonal
trajectories of oxytocinergic neurons throughout the nervous
system (Figures 1A and 1B; see Movie S1 available online). In
particular, we observed a prominent oxtl:EGFP+ tract originating
from the two hemispheres of the neurosecretory preoptic areas
(NPO) converging into the midline and terminating at the ventral
part of the hypothalamus at the presumed location of the pitui-
tary (Figure 1B). Immunostaining of the oxtl:EGFP with an anti-
oxytocin antibody confirmed that these ventral hypothalamicDevelopmental Cell 21, 64axonal termini colocalize with oxytocinergic-
positive vesicles of the presumed neurohypoph-
ysis of embryonic and adult brains (Figures 1C
and 1D and Figure S1). To further validate this
observation we crossed the oxtl:EGFP line with
another transgenic line in which the adenohy-
pophyseal pituitary cell-type, prolactin (Prl)
is labeled (Liu et al., 2003, 2006). Two-colorimaging of this double-transgenic line revealed that the ventral
hypothalamic oxytocinergic trajectories terminate near the Prl-
positive adenohypophyseal cells (Figure 2A). This transgenic
system provided us with a new tool to study the morphogenesis
of the zebrafish preopticohypophyseal axonal tract analogous
to the supraopticohypophyseal tract in mammals.
We next visualized the neurovascular interface within the
neurohypophysis by crossing our HNS specific line with a
vascular endothelial reporter expressing mCherry in vegfr2-
positive cells (Chi et al., 2008; Jin et al., 2005). Previous work,
based on microangiography, has provided an extensive map of
the vascular network in the zebrafish head (Isogai et al., 2001).
Using our axovasal double transgenic line, we were able to iden-
tify GFP+ oxytocinergic projections converging posteriorly and
medially into the neurohypophysis, arborizing extensively and
interfacing with a formation of blood vessels previously anno-
tated as palatocerebral veins (Figures 2B and 2E and Movies
S2 and S3). The hypothalamo-neurohypophyseal (HN) axonal
termini project onto the posterior part of this loop-shaped
vascular structure. To ascertain the position of this structure
in relation to the adenohypophysis, we generated double
transgenic lines with labeled blood vessels (vegfr2:EGFP or
vegfr2:mCherry) and adenohypophyseal cell types (pomc:GFP
or prl:RFP). Three-dimensional image reconstruction of the
ventral diencephalon in these embryos revealed that these blood
vessels engulf part of the pituitary area abutting the adenohy-
pophysis (Figures 2C and 2D and Movie S4). The NH is posi-
tioned in a pocket-like indentation formed by the ventrally
located adenohypophysis (Figures 2B0 and 2D0).
The vessels forming the hypophyseal vascular structure
has been previously annotated as median palatocerebral vein
(MPLV) and palatocerebral vein (PLV) (Isogai et al., 2001). As
we now identify these vessels as the zebrafish hypophyseal
vessels, we set out to reassess their arterial and venous identity.
We performed live imaging of hypophyseal blood flow using2–654, October 18, 2011 ª2011 Elsevier Inc. 643
Figure 2. Axovasal Interactions in the Zebrafish
Pituitary
(A–D) Three-dimensional reconstructionsof thehypophysis
of 9-day-old zebrafish embryos carrying pairs of transgenic
fluorescent markers of different hypophyseal components.
(A) The oxtl:EGFP transgene (green) marks oxytocinergic
axons terminating at the neurohypophysis, just dorsal and
posterior to the adenohypophyseal prolactin-producing
cells marked with prl:RFP (red).
(B) Double transgenic animals expressing oxtl:EGFP
(green) together with the vascular endothelial marker
vegfr2:Cherry (red) reveal a distinct, previously unidentified
structure of the zebrafish hypophyseal vasculature.
(C and D) Hypophyseal vasculature, visualized by either
vegfr2:EGFP or vegfr2:Cherry, together with the adenohy-
pophyseal markers prl:RFP and pomc:EGFP. The ring-like
vascular structure resided dorsal to the adenohypophysis.
(B0) and (D0 ) show optical Z-slices that demonstrate the
positionof theNH inan indentationof theadenohypophysis.
(E) Schematic map of ventral head vasculature of the ze-
brafish larvae, including the location of the hypophyseal
vasculature. The asterisk marks the location of the
neurohypophysis.
AH, adenohypophysis; CrDI, cranial division of the internal
carotid artery; NH, neurohypophysis; OA, optic artery;
PLA, palatocerebral artery; PLV, palatocerebral vein;
pomc, proopiomelanocortin; prl, prolactin; vegfr, vascular
endothelial growth factor receptor. Scale bar, 20 mm. See
also Movies S2–S4.
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Axovasal Interactions in the Neurohypophysistime-lapse microscopy of a triple transgenic line with labeled
erythrocytes (gata1:dsRed), blood vessels (vegfr2:EGFP) and
adenohypophyseal cells for positional reference (prl:RFP). By
following individual dsRed+ erythrocytes, we determined the
direction of blood flow into and out of the hypophysis to the
lateral venous sinuses (Figure 3A and Movie S5). This allowed
us to deduce the identity of the hypophyseal artery and veins
(Figure 3B and Figure S2).
Taken together, our analyses identify the organization of the
zebrafish neurovascular HNS structure in relation to the other
pituitary cell populations (Figure 3C).
Morphogenesis of the Hypothalamo-Neurohypophyseal
System
We set out to delineate the morphogenic events leading to the
formation of axovasal contact between hypothalamic axons
and neurohypophyseal blood capillaries. Although the expres-
sion of oxytocin is apparent from the Prim-15 stage (30–36 hr;
Unger and Glasgow, 2003), we found that our oxtl:EGFP did
not express sufficient levels of the EGFP protein to detect axonal
expression at this embryonic stage (data not shown). To resolve
this, we sought an earlier transgenic reporter that would allow
detection of the initial stages of hypophyseal innervation. We
previously reported that the homeodomain-containing protein
Orthopedia (Otp) is expressed in hypothalamic neuronal progen-
itors, including the magnocellular oxytocinergic neurons of
the NPO area (Blechman et al., 2007; Machluf et al., 2011). More-
over, we recently identified a genomic cis-regulatory region
driving expression of the zebrafish otpb gene in the NPO (Fuji-
moto et al., 2011). We made use of this cis-regulatory element
to generate a transgenic otpb:EGFP-caax line driving expression
of a membrane-tagged EGFP in Otp+ cell bodies and axons,644 Developmental Cell 21, 642–654, October 18, 2011 ª2011 Elsevincluding hypothalamo-neurohypophyseal (HN) projections
(Figures 4A–4C). We analyzed neurovascular formation at 36,
54, and 72 hr using an otpb:caax-EGFP;fli:dsRed double trans-
genic line. This analysis shows that HN axonal projections inner-
vate the neurohypophysis before the vessels are formed and
a tight neurovascular interface is established between 2 and
3 days of development (Figures 4D–4F).
A dynamic analysis of hypophyseal vascularization/angiogen-
esis has never been reported. We used time-lapse microscopy
to track vascular endothelial cells in the ventral diencephalon
of zebrafish embryos carrying the vegfr2:Cherry vascular
reporter transgene in which a membrane-localized monomeric
Cherry is expressed in endothelial precursors and mature
vessels (Chi et al., 2008). The embryos were imaged from
2 days postfertilization (dpf), when the hypophyseal vascular
structure is yet absent, through 3 dpf, at which time the vascular
loop around the neurohypophysis is fully established. Three-
dimensional reconstitution followed by cell tracking of such
time-lapse movies (n = 4) showed that formation of the hypo-
physeal artery begins prior to that of the veins; the artery is initi-
ated at the hypophysis itself and extends anteriorly until it
connects with the palatocerebral arteries at day 2.5 (Figure 4G).
As the primary lateral vein sinuses extend forward through the
diencephalon, they sprout medially and wrap around the poste-
rior edge of the neurohypophysis to form the hypophyseal veins.
These fuse bilaterally with one another and with the hypophy-
seal arteries to form a ring around the neurohypophysis and
connect it to the general circulation at approximately 3 days.
(Figure 4G and Movie S6). High-resolution 3D rendering of an
embryo fixed at this time point clearly shows that the hypophy-
seal veins connect bilaterally to the primary vein sinuses
(Figure S2).ier Inc.
Figure 3. 3D Structure of the Hypophyseal Neurovascular Interface
(A and B) Identification of hypophyseal arteries and veins by real-time analysis of hypophyseal blood flow.
(A) Confocal time-lapsed images (t1–t10) of a single gata1+ blood cell (arrowhead) traveling from the hypophyseal artery into the neurohypophysis and its outflow
through the hypophyseal veins. Superposition of all time points and the direction of blood flow (red arrow) are shown in the right panel. Adjacent Prl-RFP+
adenohypophyseal cells (arrow) served as a positional landmark.
(B) Schematic map of ventral head vasculature of the zebrafish larvae, including the newly annotated hypophyseal artery (red) and veins (blue). AH, adenohy-
pophysis, CrDI, cranial division of the internal carotid artery; HyA, hypophyseal artery; HyV, hypophyseal veins; OA, optic artery; PLA, palatocerebral artery.
(C) Schematic representation of the 3D structure of the zebrafish pituitary depicting the various cellular components of the adeno- and neurohypophysis. A
longitudinal section of this structure is shown on the right.
See also Figure S2 and Movie S5.
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Axovasal Interactions in the NeurohypophysisThe above analyses of neurohypophyseal axons and blood
vessels highlight key cellular events of HNS morphogenesis: (1)
HN axons appears at the site of the prospective neurohypoph-
ysis as early as 24–36 hr after fertilization. (2) Endothelial cells
forming the hypophyseal artery and veins appear at 2 days,
approximately 24 hr after the axons start to innervate the neuro-
hypophysis. (3) It takes another 24 hr for the endothelial cells of
the artery and veins of the hypophysis to sprout and fuse to
form the aforementioned loop-like structure, creating a tight
interface with the neurohypophyseal axons.DevelopmHypothalamic Neurons Are Necessary for Pituitary
Vascular Organization
During its morphogenesis, the neurohypophysis becomes a
point of intersection between axons and vessels. We next exam-
ined the interdependence of blood vessels for axon patterning
in the neurohypophysis. The zebrafish mutant cloche (clo) has
an overall deficiency of endothelial and hematopoietic lineages,
including a complete lack of head vasculature (Stainier et al.,
1995). We examined whether the neurohypophyseal axonal
projections are affected in cloche mutants by comparingental Cell 21, 642–654, October 18, 2011 ª2011 Elsevier Inc. 645
Figure 4. Morphogenesis of the Neurohypophysis
(A–C) Dynamics of hypophyseal innervation. Images of transgenic otpb:caax-EGFP embryos reveal that innervation of the hypophysis by neurons of the
neurosecretory preoptic nucleus (NPO) occurs as early as 36 hr postfertilization and becomes well established by 54 hr. Scale bar, 20 mm.
(D–F) Dynamics of neurovascular interface. Images of double transgenic otpb:caax-EGFP;fli1:dsRed embryos at different developmental stages showing
innervation of the neurohypophysis prior to hypophyseal vessel formation.
(G) Dynamics of hypophyseal vascularization. Time-lapsed (48–72 hr) confocal microscopy was used to track vascular endothelial cells in the ventral dien-
cephalon of vegfr2:Cherry embryos. The upper panels display snapshots of critical stages in the formation of the hypophyseal loop-like structure. A schematic
representation of the corresponding images with arterial (red) and venous (blue) color-coding is shown at the bottom.
CrDI, cranial division of the internal carotid artery; HyA, hypophyseal artery; HyV, hypophyseal veins; OA, optic artery; PHS, primary head sinus; PLA, palato-
cerebral artery. The asterisk (*) demarcates the location of the neurohypophysis. See also Movie S6.
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Axovasal Interactions in the Neurohypophysisoxytocinergic-positive neurohypophyseal axonal termini in mu-
tant and wild-type siblings. This analysis revealed no significant
differences in oxytocinergic immune-reactive projections indi-
cating that the presence of endothelial cells/vessels is not
required for HN innervation (Figures 5A and 5B; n = 13/15).
This result is consistent with the observation that axons begin
to innervate the NH before the blood vessel network is estab-
lished (Figures 4D–4F).
We next examined whether the presence of HN neuronal
tracts is important for morphogenesis of the neuroendocrine
vasculature. We undertook a conditional HN cell ablation
strategy using tissue-specific expression of the nitroreductase
(NTR), an enzyme that converts the prodrug metronidazole into
a cytotoxic agent (Curado et al., 2008; Davison et al., 2007).
We chose to target Otp+ neurons as this cell population includes
all NPO neurons that innervate the neurohypophysis (Figure 4646 Developmental Cell 21, 642–654, October 18, 2011 ª2011 Elsevand Machluf et al., 2011). To this end, we generated a trans-
genic line, otpb:Gal4;UAS:NTR-Cherry, in which the NTR-Cherry
fusion protein is expressed in Otp+ neurons using a tissue-
specific Gal4 transgene to drive an NTR-Cherry that was placed
under multiple Gal4 upstream activation sequences (Davison
et al., 2007). We crossed the otpb:Gal4;UAS:NTR-Cherry fish
with the vascular-specific vegfr2:EGFP line to generate triple
transgenic embryos inwhich vascular development can bemoni-
tored in the presence or absence of Otp+ HN cells. The metroni-
dazole drug was applied to embryos at 24–72 hr, from the stage
at which the first HN neuronal tracts are detected and until the
intact hypophyseal vascular structure is formed and contacts
the axons. The efficiency of HN cell ablation was assessed by
monitoring NTR-Cherry+ (Figures 5D and 5J) and oxtl+ neurons
(FiguresS3AandS3B) in control andmetronidazole-treated triple
transgenic (otpb:Gal4;UAS:NTR-Cherry;vegfr2:EGFP) embryos.ier Inc.
Figure 5. Abnormal Development of Pituitary
Vasculature in the Absence of HN Innervation
(A and B) Immunostaining of oxytocin (Oxtl) in wild-type (A)
and the endothelial-deficient mutant cloche (/) (B)
mutants, which lack all blood vessels.
(C–L) Genetic cell ablation of Otp+ neurons of the
neurosecretory preoptic nucleus (NPO). (C) Quantitative
analysis of the vascular phenotype caused by HN neu-
ronal ablation (see text). Using the Gal4/UAS system
(otpb:Gal4;UAS:NTR-Cherry) to drive expression of a
Nitroreductase-Cherry (NTR-Cherry) fusion protein only in
Otp+ neurons make these cells and their projections
visible (red) and susceptible to the prodrug metronidazole.
This transgenic fish was crossed to the vascular reporter
line, vegfr2:EGFP, to generate a triple transgenic line (D–F
and J–L). Double transgenic line (otpb:Gal4;vegfr2:EGFP,
G–I) expressing vascular EGFP but not the NTR-Cherry
protein served as a control for nonspecific drug toxicity.
The presence of Cherry+ neurons (D, G, J), EGFP+ blood
vessels (E, H, and K) and oxytocin immunoreactivity (F, I,
and L) were monitored in three experimental conditions;
the respective genotypes as well as the application of the
metronidazole killing agent are indicated below. Filled and
empty arrowheads indicate normal and abnormal blood
vessels, respectively.
See also Figure S3.
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Axovasal Interactions in the NeurohypophysisTo verify the deleterious effects of Otp+ cell ablation on HN
neurosecretion, we measured the levels of the Oxytocin protein
in the neurohypophysis by anti-oxytocin immunostaining and
determined that Otp+ cell ablation causes a marked decrease
in neurohypophyseal oxytocin levels (Figures 5F, 5I, and 5L and
Figure S3C).
We then went on to analyze the head vasculature in metro-
nidazole-treated vegfr2:EGFP embryos carrying the otpb:Gal4
and UAS:NTR-Cherry transgenes, as compared to siblings not
carrying them. As expected, application of the metronidazole
prodrug to embryos not carrying theUAS:NTR-Cherry transgene
had no significant effect on hypophyseal or other blood vessels,
indicating that in the absence of NTR-Cherry, metronidazole
treatment is not toxic and does not affect vasculature (Fig-
ures 5G–5I, n = 15/15). In contrast, Otp+ cell ablation in
metronidazole-treated triple transgenic (vegfr2:EGFP;otpb:Gal4;
UAS:NTR-Cherry) embryos was accompanied by a marked
impairment of hypophyseal vasculature, indicating that impaired
HN neurosecretion is associated with hypophyseal vascular
abnormality (Figures 5J–5L, n = 12/15). While the hypophyseal
vasculature of normal embryos tightly surrounds the neurohy-
pophysis forming an elliptical loop (Figures 5E and 5H), ablation
of Otp+ neurons caused abnormalities characterized by: failure
to close the neurohypophyseal vascular loop, incomplete
connection of the hypophyseal artery to the PLA and overallDevelopmental Cell 21, 64thin hypophyseal vascular structures (Figure 5K).
We used two measurable parameters to quan-
tify changes to this morphology (Figure 5C): (1)
‘‘loop roundness index’’– samples with ablated
axons display a more round loop as opposed
to the ellipsoid shaped loop in the control
samples, and (2) ‘‘loop area’’– axonal ablated
embryos exhibit a significant increase in theloop area. In short, ablation of Otp+ neurons led a significantly
rounder loop surrounding a larger area (n = 15, *p < 0.05). In all
cases, all neighboring head vessels remained unaffected.
These results suggest that a tissue interaction between HN
neurons projecting to the neurohypophysis and endothelial cells
contributes to the formation of an intact neurohypophyseal
vascular structure. We hypothesize that HN axons provide
a proangiogenic cue necessary for morphogenesis of the hypo-
physeal vasculature and establishment of a functional neurovas-
cular connection.
Oxytocin and Its Receptor Are Required for Pituitary
Vascular Morphogenesis
We set out to identify a secreted axonal-derived cue that might
be involved in pituitary vascular morphogenesis. Previous
studies have effectively shown that vascular endothelial cells
of many tissues express oxytocin receptor (Jankowski et al.,
2004; Thibonnier et al., 1999; Wakasa et al., 2009). Furthermore,
recent reports have demonstrated that oxytocin stimulates
migration and sprouting of human endothelial cells in vitro (Cas-
soni et al., 2006; Cattaneo et al., 2008). These findings, together
with our finding that the neurohypophysis is innervated before
its vascularization (Figure 3) and the coincidence of vascular
abnormality with HN oxytocin levels (Figure 5), have led us to
hypothesize that hypophyseal secretion of oxytocin acts as2–654, October 18, 2011 ª2011 Elsevier Inc. 647
Figure 6. Oxytocin and Its Receptor Are Necessary for Pituitary Vascularization
(A–D) High-resolution confocal images of the head vasculature of 3-day-old embryos following targeted knockdown of the gene encoding for oxytocin (oxtl-MO)
or oxytocin receptor (oxtlr-MO) using antisense morpholino oligonucliotides, leads to severe impairment of neurohypophyseal vasculature, but does not impede
development of neighboring vessels. A schematic representation of the corresponding phenotype with arterial (red) and venous (blue) color-coding is shown in
(A0)–(C0 ).
(D and E) By crossing nuclear- and membrane-tagged fluorescent vascular reporter lines, we are able to count the number of vascular endothelial cells in each
vessel. A dot-plot histogram showing the x,y positions of EGFP+;Cherry+ endothelial cells nuclei of the hypophyseal vessels aswell as the adjacent internal carotid
arteries (CrDI, between thePICAand thePLA) is shown in (D0 ) and (E0 ). Individual cells belonging to thehypophyseal vessels (red)andCrDI (gray) arecolor coded.The
oxtlr-MO-injected embryos (E) display amarkedly reduced number of endothelial cells in the hypophyseal vessel but no change in the nearby internal carotid artery.
(F) Bar histogram showing EGFP+;Cherry+ cell counts in the internal carotid arteries and hypophyseal vessels in control and following oxtlr knockdown. *p < 0.01,
n = 14.
(G) RT-PCR analysis of vegfr2:Cherry-positive and -negative FACS sorted endothelial cells demonstrating vascular expression of the oxytocin receptor (oxtlr).
CaDI, caudal division of internal carotid; CrDI, cranial division of the internal carotid artery; MO, morpholino antisense oligonucleotide; OA, optic artery; PICA,
primitive internal carotid artery; PLA, palatocerebral artery; PLV, palatocerebral vein. The asterisk (*) demarcates the location of the neurohypophysis. See also
Figure S4.
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Axovasal Interactions in the Neurohypophysisa developmental cue that induces angiogenesis of neurohypo-
physeal vessels during embryonic development.
We went on to test whether specific disruptions of oxytocin
signaling cause a hypophyseal vascular phenotype. We injected
1 cell stage embryos with splice-blocking morpholino oligonu-
cliotides targeted against either the oxytocin-like (oxtl) gene or
its receptor (oxtlr). These genetic perturbations caused aberrant648 Developmental Cell 21, 642–654, October 18, 2011 ª2011 Elsevoxtlr splicing and a dramatic reduction in Oxytocin protein levels
(Figures S4A–S4D). Targeted knockdown of either oxtl or oxtl-
receptor led to malformation of neurohypophyseal vessels
ranging from mild to severe hypoplasia and vessel dysmor-
phism, but, importantly, did not disrupt nearby internal carotid
arteries (Figures 6A–6E). This vascular phenotype appeared to
be mediated by oxytocinergic neurons as knockdown of theier Inc.
Developmental Cell
Axovasal Interactions in the Neurohypophysisgene encoding the other neurohypophyseal hormone, arginine-
vasopressin (avpl), did not result in any visible vascular pheno-
type (data not shown). We went on to quantify this effect using
double-transgenic embryos that express distinct fluorescent
markers in both nuclei and the plasma membranes of vascular
endothelial cells (fli1:nuc-EGFP;vegfr2:ras-mCherry) (Figures
6D and 6E). This allowed us to readily identify and count the indi-
vidual endothelial cells. We found that targeted knockdown of
the oxtl-receptor, which affected the neurohypophyseal vascula-
ture, led to marked reduction in the number of endothelial cells
that make up the hypophyseal vessel but did not affect the
number of cells in the nearby internal carotid arteries (Figure 6F).
Our findings suggest that the neuropeptide oxytocin serves as
a developmental angiogenic cue regulating the morphogenesis
of neurohypophyseal vessels during embryonic development.
Oxytocin signaling may affect vascular endothelial cells di-
rectly or it may do so by regulating a secondary angiogenic
cue that is received by the forming hypophyseal vasculature.
For example, blocking oxytocin signaling may interfere with
autocrine activation of the oxytocin receptor that could in turn
regulate the secretion of a proangiogenic cue, thus affecting
hypophyseal vascular morphogenesis. Alternatively, the oxy-
tocin receptor might be autonomously affecting hypophyseal
vascular morphogenesis as was shown in the case of cultured
human endothelial cells (Cassoni et al., 2006; Cattaneo et al.,
2008, 2009; Thibonnier et al., 1999). In agreement with these
studies, RT-PCR expression analysis of oxtlr mRNA in FACS-
sorted endothelial cells derived from vegfr2:mCherry transgenic
embryos clearly shows that the zebrafish oxytocin receptor is
expressed in vascular endothelia (Figure 6G and Figure S4E).
To directly address whether oxytocin receptor autonomously
affects hypophyseal vascular morphogenesis, we performed
a tissue-specific rescue of oxtlr deficient embryos (Figure 7).
To this end, we knocked down the oxtlr gene in the entire embryo
and simultaneously re-expressed Oxtlr in discrete endothelial
clones.We used a fli1:Gal4;UAS:Kaede transgenic line (Zygmunt
et al., 2011) to drive endothelial-specific expression of oxytocin
receptor. fli:Gal4;UAS:Kaede embryos were microinjected with
a transgenic vector harboring the oxytocin receptor cDNA under
the control of multiple Gal4 upstream activation sequences
(10xUAS), resulting in mosaic vascular clones expressing the
oxytocin receptor. To identify these clones, we made use of
a multicistronic gene expression cassette in which the viral 2A
peptide sequence (Provost et al., 2007) was placed between
the oxytocin receptor and EGFP, causing simultaneous expres-
sion of EGFP+ oxytocin receptor in discrete clones throughout
the Kaede-positive blood vessels (Figures 7A–7C). We analyzed
hypophyseal vasculature by scoring two parameters: (1) integrity
of the hypophyseal vascular structure, and (2) presence of
clones expressing the Oxtlr-2A-EGFP cassette in the hypophy-
seal vessels. We found that the existence of Oxtlr-expressing
clones in the hypophyseal vasculature is significantly associated
with a rescued hypophyseal vascular structure (Figure 7C; n =
20/22, p < 0.0001). These results suggest that oxytocin receptor
mediates a proangiogenic signal by acting autonomously in
vascular endothelial cells.
Taken together, this study demonstrates that the formation of
the neurovascular interface of the neurohypophysis is regulated
during development by the neuropeptide oxytocin and itsDevelopmreceptor. Oxytocin secreted from developing NH nerve termini
signals to nearby endothelial cells at the site of the neurohypo-
physeal primordium. Other vascular endothelial cells may also
express the receptor but the ligand is not available to them.
This axovasal cell communication event is essential for the
establishment of a tight interface between HN neurons and
blood vessels of the HNS (Figure 7D).
DISCUSSION
The HNS is a main conduit by which the brain exerts control over
peripheral organs. The activities of the HNS are conserved in all
vertebrates and itsmain anatomical hallmark is the tight interface
between hypothalamic nerve termini and neurohypophyseal
blood vessels. In the present study, we have characterized the
structure and morphogenesis of the zebrafish HNS and showed
that HN axons secrete a localized proangiogenic cue (oxytocin)
that is received by endothelial cells leading to the formation of
a specialized neurovascular interface.
Morphogenesis of the HN System
The embryonic development of the neurohypophysis has been
previously described in other model organisms and in human
(Eurenius, 1977; Fink and Smith, 1971; Galabov and Schiebler,
1983; Okado and Yokota, 1980). However, the elaborate three-
dimensional structure of the neurohypophysis makes it difficult
to study its developmental dynamics. Moreover, the above
studies were based on electron microscopy and immunohisto-
logical methods, which are useful to study fine structure of the
neurovascular interface, but are limited in their ability to resolve
the spatiotemporal cellular processes that shape the developing
organ. To overcome these limitations, we have utilized a unique
transgenic reporter system, in which zebrafish HN cell bodies
and neurovascular contacts are labeled. Using this vertebrate
model system we were able to monitor the spatiotemporal
morphogenesis of neurohypophyseal axons and blood vessels
in an intact developing brain. Based these results, we can now
conclude that the anatomy of the HNS is largely conserved
between fish and mammals.
We show that the zebrafish neurohypophysis is a discernable
area, which develops within a concave-shaped indentation
formed by the adenohypophysis. The identity of the zebrafish
hypophyseal blood vessels has not been reported before (Isogai
et al., 2001). Our study provides a structural and functional
description of this unique vascular formation. Using real-time
imaging, we showed that the hypophyseal artery develops
before the veins and separately from them. As the vascular
network of the brain is predominantly formed by angiogenesis,
it is likely that the hypophyseal vessels we identified sprout
from existing vascular network of the head. Future identification
of the exact origins of the hypophyseal artery and veins may
contribute to elucidation of the factors regulating these vascular
identities. Interestingly, HN axons begin to innervate the neuro-
hypophysis 24 hr prior to the appearance of endothelial neuro-
hypophyseal precursors and approximately 48 hr before the
establishment of the tight neurovascular contacts between the
axon termini and the hypophyseal blood vessels suggesting
that the final morphogenesis of these axons and vessels is regu-
lated by temporally distinct pathway(s).ental Cell 21, 642–654, October 18, 2011 ª2011 Elsevier Inc. 649
Figure 7. Cell-Autonomous Effect of the Oxytocin Receptor on the Pituitary Vasculature
(A–C) Genetic complementation of oxytocin receptor in the vascular endothelia of oxtlr-deficient embryos. Double transgenic embryos expressing an endothelial
Gal4 driver (fli1:Gal4) and a fluorescent reporter protein (UAS:Kaede; green) were injected with transposon-based transgenic vector containing a multicistronic
gene expression cassette (UAS:oxtlr-2A-EGFP) allowing simultaneous mosaic coexpression of the oxytocin receptor and EGFP in discrete vascular clones (red).
These clones were detected by immunostaining with an anti-EGFP antibody that does not react with the Kaede protein followed by a secondary cy3-conjugated
antibody. The asterisk (*) demarcates the location of the neurohypophysis.
(D) Schematic model describing the hypothalamohypophyseal neurovascular connection by local secretion of oxytocin (see text).
CaDI, caudal division of internal carotid; CrDI, cranial division of the internal carotid artery; OA, optic artery; PHS, primary head sinus; PLA, palatocerebral artery.
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Axovasal Interactions in the NeurohypophysisMechanisms of Neurovascular Connection
The elaborate networks of vertebrate vascular and neuronal
systems display striking anatomic similarities. Nerve fibers and
blood vessels often follow parallel routes in the body. Further-
more, attraction and repulsion of axons and vascular endothelial
cells to/from target tissues were found, in some instances, to be
regulated by common guidance molecules (Adams and Eich-650 Developmental Cell 21, 642–654, October 18, 2011 ª2011 Elsevmann, 2010; Carmeliet and Tessier-Lavigne, 2005). The question
we addressed here is: how do hypothalamic axons contact
neuroendocrine blood capillaries? The formation of this vital neu-
rovascular interface could potentially be regulated in different
ways: neurohypophyseal blood vessels may attract HN neurons
to the site of the neurohypophysis similar to the reported
guidance of a subset of developing sympathetic axons byier Inc.
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Axovasal Interactions in the Neurohypophysisvascular-derived endothelins (Makita et al., 2008). We have ruled
out this possibility in the present case by showing that oxytoci-
nergic axons display normal hypophyseal innervation and axonal
branching in the avascular zebrafish mutant cloche. On the
other hand, tissue-specific genetic ablation of HN neurons and
knockdown of the HN neuropeptide oxytocin specifically
impaired the formation of neurohypophyseal vasculature. These
results indicate that neurohypophyseal morphogenesis is regu-
lated by the local release of the neuropeptide oxytocin from
the developing nerve termini. A similar type of mechanism, in
which axons affect endothelial cells, was shown in the case of
peripheral sensory nerves that regulate the pattern of arterial
branching via local secretion of VEGF-A (Mukouyama et al.,
2002, 2005) and more recently, in the case of motor neurons-
derived Netrin-1a that mediates lymphangiogenesis (Lim et al.,
2011). A third, nonexclusive possibility is that blood vessels
and nerve fibers of the HNS respond to a common attractant
that is expressed in the ventral diencephalic midline.
Notably, our data indicate that blocking oxytocinegic signaling
does not prevent the guidance of blood vessels to the area of the
neurohypophysis. Therefore, it is likely that oxytocin signaling
cooperates with other guidance cues to orchestrate vascular
morphogenesis in the neurohypophysis, leading to the formation
of a tight neurovascular interface.
Role of Oxytocin in Angiogenesis
It has been known for some time that when the HN tract is trans-
ected, many of the axons regenerate and re-establish functional
neurovascular connections with blood capillaries (Harris, 1948b,
1955). Regenerated areas are characterized by a marked in-
crease in angiogenesis, which was found to occur near large
deposits of neurosecretory material derived from the regener-
ated axon fibers (Moll, 1958). A possible interpretation of these
studies is that neurohypophyseal angiogenesis may be regu-
lated by the release of a proangiogenic factor from the devel-
oping nerve termini.
Our present finding that the neuropeptide oxytocin has
a proangiogenic role during the embryonic development of the
HNS receives reinforcement frommany studies. Human vascular
endothelial cells derived from several organs express the
oxytocin but not the arginine-vasopressin receptor (Thibonnier
et al., 1999). Oxytocin induces differentiation of embryonic
stem cells and adult Sca-1-positive cells to cardiomyocytes
(Matsuura et al., 2004; Paquin et al., 2002). Remodeling of
uterine blood during human pregnancy involves increased
oxytocin receptor expression in vessel walls (Wakasa et al.,
2009). Oxytocin and its receptor have been implicated in devel-
opmental formation of the coronary vessels and in angiogenic
remodeling following myocardial infarction (Jankowski et al.,
2004; Kobayashi et al., 2009). Finally, oxytocin stimulates migra-
tion and sprouting of cultured human vascular endothelial cells
and this angiogenic effect is dependent on oxytocin receptor
signaling events (Cassoni et al., 2006; Cattaneo et al., 2008,
2009). Several studies have reported metabolic abnormalities
in mice deficient in either oxytocin or its receptor (Kasahara
et al., 2007; Takayanagi et al., 2008). As none of these studies
have analyzed the integrity of the hypophyseal neurovascular
interface it remains to be determined whether the metabolic
abnormalities observed in these mice are caused by compro-Developmmised neurohypophyseal development. Finally, loss of functional
Otp disrupts the development of oxytocinergic neurons as
well as the neurohypophysis (Acampora et al., 1999; Wang and
Lufkin, 2000).
The question of why hypophyseal vasculature responds to
oxytocin while other vessels do not remains open. The simplest
explanation is that the local secretion of the oxytocin protein by
HN termini is a focal attractant that affects the sproutingmorpho-
genesis of only nearby endothelial cells, as shown in our model
(Figure 7D) Another nonexclusive possibility is that hypophyseal
vascular precursors have a unique molecular composition that
renders them responsive to oxytocin signal.
Mechanism of Action of Oxytocin during
Neurohypophyseal Morphogenesis
Given that the primary function of the HNS is the mass secretion
of oxytocin into the neurovascular interface, we favor the possi-
bility that localized developmental secretion of oxytocin is impor-
tant for the integrity of neurovascular contacts at the site of the
neurohypophysis. We show that endothelial-specific re-expres-
sion of the oxytocin receptor rescues the vascular phenotype of
in oxtlr-deficient embryos suggesting that this receptor mediates
a proangiogenic signal by acting in vascular endothelial cells that
receive oxytocin signal from HN neurons. However, we still
cannot rule out the possibility that, in addition to the oxytocin-
oxytocin receptor-mediated neurovascular signaling event we
found here, autocrine activation of the oxytocin receptor regu-
lates another, yet undiscovered, angiogenic cue released by
HN axons. So far, we have examined the expression of various
isoforms of vegf, semaphorin, and tgfb/Bmp that could conceiv-
ably be involved in HN neurovascular development and found
none of them is expressed in HN neurons (data not shown).
Oxytocin receptor belongs to the rhodopsin-type (class I) G
protein-coupled receptor family and is coupled to phospholi-
pase C through Gaq11 (Gimpl and Fahrenholz, 2001). Recent
reports show that oxytocin stimulates migration and sprouting
of human umbilical vein endothelial cells (HUVEC) through a
3D angiogenesis assay, via Gq coupling of the oxytocin receptor
leading to phospholipase C activation and phosphorylation of
the Pyk2 Src kinase proteins and that knockdown of Pyk2
impaired this effect (Cattaneo et al., 2008, 2009). As these
proteins are known to be involved in Semaphorin and/or VEGF
signaling in the vascular system, the signal transduction cascade
underlying the effect of oxytocin on hypophyseal vascular
morphogenesis may feed into known intracellular pathways
used for branching morphogenesis of endothelial cells (Gelfand
et al., 2009).
Finally, oxytocin-mediated vascular angiogenesis might prove
relevant to adult regenerative processes. The regeneration of
the HNS following hypophysectomy has been extensively
studied in many vertebrate species including fish and humans
(Billenstien and Leveque, 1955; Daniel and Prichard, 1972;
Harris, 1955; Moll, 1957; Sathyanesan and Gorbman, 1965; Stu-
tinsky, 1951). A strong association has been found between
deposition of neurosecretory material and high vascularity in
HNS regeneration models (Moll, 1958). The communication
between the oxytocinergic neurons and the vasculature re-
ported herein may play a role in this well-documented regener-
ation of the HNS following local lesion.ental Cell 21, 642–654, October 18, 2011 ª2011 Elsevier Inc. 651
Developmental Cell
Axovasal Interactions in the NeurohypophysisIn summary, we present a genetic system to study the devel-
opmental assembly of the vertebrate HNS. Using this system, we
have identified key cellular and biochemical processes required
for formation of the neurohypophyseal neurovascular interface,
a vital intersection that allows neuropeptidergic hormones from
the central nervous system to be transferred directly into the
blood and regulate the body’s homeostasis.
EXPERIMENTAL PROCEDURES
Antibodies and Transgenesis Plasmids and Lines
Guinea pig polyclonal antibody directed to the Oxytocin peptide was pur-
chased from Bachem (Bachem California, Torrance, CA, Cat. T-5021.0050).
Antibodies made in rabbit and mouse (Molecular Probes, Eugene, OR) were
used to detect the transgenic EGFP expression. For all plasmid DNA con-
structs we used the Tol2kit transposon-based transgenic vectors system for
site-specific recombination-based cloning (Kwan et al., 2007). cDNA encoding
to the oxtlr (gene locus FJ556870) was cloned downstream of the Gal4 re-
sponsive 10xUAS element and basal promoter. We used a multicistronic
gene expression cassette in which the viral 2A peptide sequence was placed
between the gene of interest and EGFP fluorescent protein, which reports the
expression of the transgene (Provost et al., 2007). Genotypes of transgenic
lines used in this study are as follows: Tg(oxtl:EGFP); Tg(vegfr2:EGFP) [a.k.a.
Tg(kdrl:EGFP)s843]; Tg(vegfr2:mCherry) [a.k.a. Tg(kdrl:HsHRAS-mCherry)
s896]; Tg(prl:RFP); Tg(pomc:EGFP) [a.k.a. Tg(-1.0pomca:GFP)zf44]; Tg(gata1:
dsRed)sd2; Tg(otpb:caax-EGFP) [a.k.a. = Tg(otpb:1EGFP)zc49]; Tg(fli1:
dsRed) [a.k.a. Tg(fli1a.ep:DsRedEx)um13]; Tg(otpb:Gal4) [a.k.a Tg(otpb.A:
Gal4, myl7:EGFP)zc67]; Tg(UAS:NTR-Cherry) [a.k.a. Tg(UAS-E1b:NfsB-
mCherry)c264]; Tg(fli1:nuc-EGFP) [a.k.a. Tg(fli1a:nEGFP)y7]; Tg(fli1:Gal4)
[a.k.a. Tg(fliep:gal4ff)ubs4].
Microinjection of Transgenic DNA and Oligonucleotides
Gene knockdowns were performed using synthetic antisense morpholino
oligonucleotides (MO; Gene Tools, LLC, Corvallis, OR) targeted to an RNA-
splicing sites (Figure S2) of oxtl, (CACTGCAGATGGTAAGGGAAACCTA) and
oxtlr (CATCGCTTTGGAGGAGAAGAAAACA). MOs were microinjected (each
at 1.5 ng per 1.7 nl) into 1 cell stage embryos as we previously described
(Blechman et al., 2007). The oxtlr cDNA sequence (gene locus FJ556870)
used for the rescue experiment lacked the respective MO binding site and
was therefore resistant to its effect.
Tissue Preparation and Immunohistochemistry
Immunofluorescent staining of transgenic embryos was performed as we
previously described (Russek-Blum et al., 2008). The skulls of Juvenile and
adult fish were exposed using sharp forceps and fixed at 4C overnight in
2%–4% paraformaldehyde/0.1 M phosphate buffer (pH 7.5). Samples were
washed twice with phosphate buffer and transferred into 20% sucrose/20%
EDTA in 0.1M PB (pH 7.5) for decalcification and cryoprotection. Brains
were frozen in 7.5% gelatine/20% sucrose and cut at 14 mm. Sections were
stored at 20C. Primary and secondary antibodies were incubated in PBS
with 0.3% Triton X-100 (PBS TX). Primary antibodies were incubated overnight
at 4 C and secondary antibodies for 1 hr at room temperature. The slides
were then washed in PBS TX followed by washes in PBS and mounted in
PBS:Glycerol (1:1).
Tissue-Specific Cell Ablation
For the nitroreductase-mediated tissue-specific cell ablation we used the
analytical-grademetronidazole drug, Vetranal (Sigma-Adridch, Rehovot, Israel
Cat. #46461), whichwas dissolved in E3medium (1.74mMNaCl, 0.21mMKCl,
0.12 mMMgSO4, 0.18 mMCa[NO3], 0.15 mMHEPES [pH 7.4]). Embryos were
manually dechorionated at 22 hpf and treated with 5 mM Vetranal from 24–48
hpf, and then switched into 10 mM Vetranal for additional 30 hr.
FACS and RNA Extraction
Three-day-old vegfr2:mCherry embryos were dissociated by Liberase blend-
zyme 3 (Roche, Basel, Switzerland) in combination with GIBCO-trypsin
(Invitrogen, Carlsbad, CA), each for 15 min at 28C, with occasional pipetting.652 Developmental Cell 21, 642–654, October 18, 2011 ª2011 ElsevReaction was stopped by three washes of 1% bovine serum. Cells were sus-
pended in L15 medium, and filtered by nylon mesh. Fluorescence activated
cell sorting (FACS) was performed using a SORP FACSAriaII cell sorter. RNA
was extracted from approximately 50,000 cells and RT-PCR with specific
primer pairs (see Supplemental Experimental Methods) were performed as
described (Blechman et al., 2007).
Live Imaging and Image Analysis
Embryos growing in E3 solution were embedded in drops of warm 1% Ultra
Pure LMP agarose (Invitrogen, Carlsbad, CA) and imaged on a Zeiss 710
inverted confocal microscope with 488 and 561 nm lasers. Data sets were
analyzed using Imagej and ZEN (Zeiss). 3D reconstructions were generated
and analyzed with Volocity (Improvision, Covington, UK).
Statistical Analyses
Statistical significance between average cell counts was determined using
Student’s t test (two-tailed, a = 0.05) on Excel (Microsoft Corp., Redmond,
WA). All error bars indicate the standard error of the mean. Correlation
between the occurrence of oxtlr-positive clones in ventral head vessels and
phenotypic rescue of hypophyseal vasculature was determined by calculating
the Phi coefficient of association, then performing a chi-square test of associ-
ation (p < 0.0001) using the statistical web tool VassarStats.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and six movies and can be found with this article online at
doi:10.1016/j.devcel.2011.09.004.
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from California public schools over a 9-year pe-
riod, Graves examined the effect of year-round 
school calendars on nationally standardized 
test performance of traditionally disadvantaged 
students. Analysis showed that year-round 
calendars, especially multitrack year-round 
calendars in which the student body is never 
all in attendance at the same time, have a 
larger negative impact on the lower end of the 
distribution of scores, with Hispanics/Latinos 
and low–socioeconomic status students expe-
riencing a larger fall in performance than the 
overall population. African American students 
are more negatively affected than the overall 
student population with respect to reading. 
Policy-makers take note: These results present 
an additional cost of implementing year-round 
calendars. — MM 
Econ. Educ. Rev. 30, 1281 (2011).
G E N E T I C S
Evolution Illuminates Function
Long noncoding RNAs (lncRNAs) are enigmatic 
transcripts of the genome defi ned as noncoding 
RNAs over 200 bp in length. Although function 
has been ascribed to some lncRNAs, most are 
expressed at low levels, and their function, or 
even whether they have a specifi c function, is 
unknown. By examining the transcription of 
mammalian lncRNAs, focusing on comparisons 
between lncRNAs found in mice and humans, 
Managadze et al. set out to determine how 
B I O M E D I C I N E
Young at Heart 
Cell-mediated repair of heart damage is one 
of the most exciting areas of cardiovascular 
research but is also one of the most challenging 
and controversial. One key point of disagree-
ment is which cell type is optimal for such 
therapy. Among the list of candidates being 
actively explored are resident cardiac stem cells, 
embryonic stem cells, induced pluripotent stem 
cells, and bone marrow–derived cells. 
A new candidate cell has emerged from a 
study of peripartum cardiomyopathy, a form of 
heart failure that affects a small percentage of 
pregnant women and is associated with an unusu-
ally high rate of spontaneous recovery. Kara et 
al. speculated that fetal or placental cells might 
contribute to this high recovery rate. Consistent 
with their hypothesis, they found that when the 
heart of a pregnant mouse is subjected to acute 
injury, fetal cells migrate through the blood to 
the injury site in the maternal heart, where they 
differentiate into three distinct cell types required 
for heart repair: endothelial cells, smooth muscle 
cells, and cardiomyocytes. About 40% of these 
fetal cells express a marker gene (Cdx2) associ-
ated with trophoblast stem cells, which form the 
placenta. This raises the intriguing possibility that 
readily accessible cells in the placenta might be 
capable of heart repair. — PAK 
Circ. Res. 10.1161/circresaha.111.249037 (2011).
E D U C A T I O N
Calendar Effects
Does the organization of the school calendar 
affect student learning? Year-round school-
ing, which distributes school days with short, 
frequent breaks, is becoming more popular 
because it is thought to prevent the summer 
learning loss that occurs under a more tradi-
tional school calendar. Using longitudinal data 
A S T R O P H Y S I C S
A Test to See in the Dark
According to current models of structure formation in the universe, 
large galaxies, like our Milky Way, formed from the merging of 
many smaller systems. The models predict that a large number of 
small satellite galaxies should exist in our galaxy’s vicinity, but this 
prediction does not match the observations. However, some of these 
small galaxies may be too diffi cult to detect, because they may be 
dominated by dark matter, a mysterious type of matter that does 
not emit or absorb light but does exert a gravitational pull. The Tid-
al Analysis method, developed to derive the locations and masses 
of satellite galaxies from the gravitational perturbations the satel-
lites induce in the gas disk of the primary galaxy, has the potential 
to reveal satellite galaxies dominated by or composed entirely of 
dark matter. To demonstrate its validity, Chakrabarti et al. applied 
the Tidal Analysis method to two nearby spiral galaxies, M51 and 
NGC 1512, which each interact with a known visible companion. 
The method successfully recovered the masses and locations of the 
smaller companions; their masses ranging from one-third to one-
hundredth of the mass of the primary galaxy. — MJC
Astrophys. J. 743, 35 (2011).
Published by AAAS
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lncRNAs evolve. Calculation of the degree of 
evolution of these lncRNAs and examina-
tion of their relative expression levels 
revealed a negative correlation between 
evolutionary rate and expression 
level. This is similar to what has 
been observed with protein-coding 
genes, and like protein-coding 
genes, nonsynonymous mutations 
were observed in lncRNAs; that is, 
mutations predicted to change the 
amino acid encoded by the codon. 
No signifi cant correlation was 
observed between the evolutionary 
rate of lncRNAs and their predicted 
secondary structure. On the basis of 
these fi ndings, the authors conclude that 
lncRNAs are subject to weak purifying selection 
and thus are probably functional. — LMZ 
Genome Biol. Evol. 10.1093/gbe/evr116 (2011).
C H E M I S T R Y
Colloidal Construction Kit
Total-synthesis approaches have made an art 
form of building complex organic molecules 
from much simpler and smaller pieces, using 
established rules of reactivity to selectively form 
specifi c products at each step. Colloidal par-
ticles are often described as “artifi cial atoms,” 
and hooking them together can produce “ar-
tifi cial molecules” that manifest combinations 
of useful optical, magnetic, catalytic, and elec-
tronic properties. However, synthetic strategies 
at this scale have largely been limited to fusing 
two particles together or growing a second par-
ticle on the surface of an existing one. Buck et 
al. have now developed a rational and stepwise 
approach for constructing hybrid nanoparticle 
oligomers. They started with Fe3O4 grown on Pt 
seed particles. The addition of a gold precursor 
surprisingly yielded Au-Pt-Fe3O4 as the exclusive 
trimetallic product. Using the same reaction 
method, the authors produced trimers in which 
the Au could be replaced by Ag, Ni, or Pd. A 
fourth component (PbS or mixed-valence CuxS) 
could also be added selectively, and the Au-Pt-
Fe3O4 trimers could be fused into superdimers 
or higher-ordered branched nanostructures by 
heating in the presence of a trace quantity of 
sulfur. — MSL
Nat. Chem. 10.1038/NCHEM.1195 (2011).
C H E M I S T R Y
Electrifying Peroxide Synthesis
Traditionally, the purpose of a fuel cell has 
been to channel chemical energy into electrical 
energy, and research has focused on optimizing 
the design to maximize the effi ciency of this 
transformation. In this context, reducing oxygen 
all the way to water, rather than stopping 
halfway at hydrogen peroxide, is a central 
feature. On the other hand, there’s a mar-
ket for hydrogen peroxide, and the cur-
rent production route is frustratingly 
indirect (featuring the intermediacy 
of an organic quinone compound). 
Jirkovsky et al. consider the prospect 
of using polymer electrolyte fuel cells 
to cogenerate electricity and hydro-
gen peroxide. Beginning with the 
knowledge that certain gold surfaces 
manifest relatively high selectivity 
toward the partial reduction reac-
tion, they performed density functional 
theory calculations to guide optimization. 
The calculations suggested that isolated Pd or 
Pt sites on the gold surface should enhance O2 
binding while suppressing scission of the O-O 
bond, but that adjacent centers of the second 
metal would promote further reduction to 
water. These predictions were then borne out 
in rotating ring-disc electrode measurements: 
Peroxide selectivity peaked near 95% at a Pd 
alloying concentration of 8%, but then plum-
meted as the Pd abundance passed 15% (the 
threshold for aggregation). — JSY
J. Am. Chem. Soc. 133, 10.1021/ja206477z (2011).
D E V E L O P M E N T
Network Development
The circulatory system is made up of complex 
vascular networks that originate from the as-
sociation of numerous angiogenic sprouts with 
motile tip cells and trailing stalk cells. Tip cells 
contact each other, fuse, and subsequently 
form an interconnected lumen. Herwig et al. 
now visualize the behavior of single zebrafi sh 
endothelial cells during blood vessel fusion 
(anastomosis) and lumen formation. They used 
transgenic zebrafi sh whose endothelial cell 
junctions of dorsal longitudinal anastomotic 
vessels were fl uorescently labeled to monitor 
cell movements and cell shape. Anastomosis 
is seen to result from different morphogenetic 
mechanisms—one involving cell rearrangement 
for a process of cord hollowing to generate 
a multicellular tube or through cell shape 
changes involving membrane invagination for a 
unicellular tube.  These processes are associated 
with lumen formation at the position of vessel 
fusion. In addition, the luminal membrane 
compartments are polarized apically. With the 
elegant complexity of the vascular network, 
perhaps it is not surprising that multiple 
mechanisms are used to establish blood vessel 
morphology. — BAP 
Curr. Biol. 21, 1942 (2011). 
17050 Montebello Road
Cupertino, California 95014
Email:AAASInfo@betchartexpeditions.com
www.betchartexpeditions.com
For a detailed brochure,
please call (800) 252-4910
All prices are per person twin share + air
DeathValley
March 25–April1, 2012
Explore California’sMojaveDesert.
Relive the days of the 49’er gold
seekers and prospectors at historic
Scotty’s Castle. Enjoy intriguing land­
scapes, geologic heritage, and learn
aboutman’s attempts
to live in this vast
desert paradise.
$2,595 + air to
Las Vegas, Nevada.
Heritageof
SouthernChina
March 28–April 13, 2012
See iconic landscapes with misty
silhouettes. Venture off the beaten
track for a wealth of cultural oppor­
tunities of drum towers, wind­rain
bridges and terraced
rice fields that will
captivate you!
$3,995 + air
BETCHART EXPEDITIONS Inc.
AAAS is here –
preparing minority students
for careers in science.
Part of AAAS’s mission is to diversify and
strengthen the scientific work force. To help
achieve this goal, AAAS partners with NSF
to present the Historically Black Colleges
and Universities Undergraduate Program,
a conference where students from HBCUs
get experience presenting their research,
networking with peers,meeting with
representatives from graduate schools,
and learning about career opportunities.
If you’re not yet a AAASmember, join us.
Together we can make a difference.
To learn more, visit
aaas.org/plusyou/hbcuup
Published by AAAS
 
o
n
 J
an
ua
ry
 2
7,
 2
01
2
w
w
w
.s
ci
en
ce
m
ag
.o
rg
D
ow
nl
oa
de
d 
fro
m
 
Curiculum Vitae - Lebenslauf 
 
 
 
 
 
 
 
Persönliche Daten 
 
Name:   Herwig 
Vorname:   Lukas Walter 
Adresse:   Peter Rot-Strasse 68, 4058 Basel 
Telefon  Mobil:  078 835 90 19 
Geburtsdatum:   03.04.1983 
Geburtsort:    Basel (BS) 
Staatsangehörigkeit: Schweiz 
Bürgerort:   Basel BS 
Familienstand:   ledig 
 
Ausbildung 
 
1999-2002 Gymnasium Münchenstein, Matur, Typus B (Latein) 
2003-2006  Bachelor of Science in Biology (Major in Molecular Biology) an der 
Universität Basel 
2006-2007 Master of Science in Molecular Biology (betreut von Prof. Markus 
Affolter), Titel der Arbeit: “Cellular characterization of the intersegmental vessels 
in the zebrafish embryo by different tools” 
2008-2012 Doktorarbeit Biozentrum Universität Basel (betreut von Prof. Markus 
Affolter), Titel der Arbeit: Morphogenetic mechanisms of blood vessel fusion in 
the zebrafish embryo 
 
Publikationen 
 
Blum, Y., Belting, H.-G., Ellertsdottir, E., Herwig, L., Lüders, F., and Affolter, 
M.. Complex cell rearrangements during intersegmental vessel sprouting and 
vessel fusion in the zebrafish embryo. Developmental biology 316 (2008) 312-22. 
 
 
Elín Ellertsdóttir, Anna Lenard, Yannick Blum, Alice Krudewig, Lukas 
Herwig, Markus  Affolter, Heinz-Georg Belting Vascular morphogenesis in the 
zebrafish embryo Developmental Biology 341 (2010) 56–65 
 
Tomasz Zygmunt, Carl Michael Gay, Jordan Blondelle, Manvendra K. Singh, 
Kathleen McCrone Flaherty, Paula Casey Means, Lukas Herwig, Alice 
Krudewig, Heinz-Georg Belting, Markus Affolter, Jonathan A. Epstein and 
Jesus Torres-Vazquez Semaphorin-PlexinD1 Signaling Limits Angiogenic 
Potential via the VEGF Decoy Receptor sFlt1 Developmental Cell 21 (2011) 1-14 
 
Roland Totong, Thomas Schell, Fabienne Lescroart, Lucile Ryckebüsch, Yi-
Fan Lin, Tomas Zygmunt, Lukas Herwig, Alice Krudewig, Dafna Gershoony, 
Heinz-Georg Belting, Markus Affolter, Jesus Torres-Vazquez and Deborah 
Yelon The novel transmembrane protein Tmem2 is essential for coordination of 
myocardial and endocardial morphogenesis Development 138 (2011) 4199-4205 
 
Gutnick A, Blechman J, Kaslin J, Herwig L, Belting HG, Affolter M, 
Bonkowsky JL, Levkowitz G. The hypothalamic neuropeptide oxytocin is 
required for formation of the neurovascular interface of the pituitary. 
Developmental Cell 21 (2011) 642–654 
 
Lukas Herwig*, Yannick Blum*, Alice Krudewig, Elin Ellertsdóttir, Anna 
Lenard, Heinz-Georg Belting and Markus Affolter *these authors contributed 
equally to this work Distinct Cellular Mechanisms of Blood Vessel Fusion in the 
Zebrafish Embryo Current Biology 21 (2011) 1942–1948 
 
Besondere Weiterbildung, Kenntnisse und Kurse 
 
Meetings: 
First Swiss Zebrafish Meeting in Ovronaz, 2008 
8th International Conference on Zebrafish Development and Genetics, Madison 
(USA), 2008  
9th International Conference on Zebrafish Development and Genetics, Madison 
(USA), 2008  
6th European Zebrafish Genetics and Development Meeting, Rome (Italy) 2009 
USGEB 2011, IMAGING Meeting at University of Zürich 2011 
Gordon Research Conference on Vascular Cell Biology, Ventura (CA, USA), 
2011 
 
Kurse: 
Labortierkunde Kurs Modul 20E, Universität Zürich (Irchel), 2008 
Venture Challenge Kurs Herbstsemester 2011, Kommission für Technologie und 
Innovation KTI (Switzerland) 
 
Hobbies 
 
Musik: Oboe und E-Gitarre 
Sport: MountainBike, Schwimmen, Joggen, Wandern, Outdoor-aktivitäten, 
Reisen 
Literatur: Sachbücher, Romane mit geschichtlichem Hintergrund, Science Fiction 
Kochen 
